<SEC-DOCUMENT>0001628280-25-015761.txt : 20250401
<SEC-HEADER>0001628280-25-015761.hdr.sgml : 20250401
<ACCEPTANCE-DATETIME>20250401085731
ACCESSION NUMBER:		0001628280-25-015761
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		24
CONFORMED PERIOD OF REPORT:	20250515
FILED AS OF DATE:		20250401
DATE AS OF CHANGE:		20250401

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DELCATH SYSTEMS, INC.
		CENTRAL INDEX KEY:			0000872912
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				061245881
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16133
		FILM NUMBER:		25796855

	BUSINESS ADDRESS:	
		STREET 1:		566 QUEENSBURY AVENUE
		CITY:			QUEENSBURY
		STATE:			NY
		ZIP:			12804
		BUSINESS PHONE:		(518) 743-8892

	MAIL ADDRESS:	
		STREET 1:		566 QUEENSBURY AVENUE
		CITY:			QUEENSBURY
		STATE:			NY
		ZIP:			12804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DELCATH SYSTEMS INC
		DATE OF NAME CHANGE:	19990607
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>dcth-20250401.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:8e8767f3-7eb1-4cff-a7d0-834772931a41,g:6cabea0e-947c-485b-aec9-13e4b3de570f,d:161d31b071a7458ab37fccdf98f11dd1-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dcth-20250401</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-2">DEF 14A</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-3">0000872912</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-4">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dcth-20250401.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000872912</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i161d31b071a7458ab37fccdf98f11dd1_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SCHEDULE 14A </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Rule 14a-101)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INFORMATION REQUIRED IN PROXY STATEMENT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SCHEDULE 14A INFORMATION </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section 14(a) of the </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:1.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Proxy Statement </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Material Under &#167; 240.14a-12</span></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">Delcath Systems, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Registrant as Specified In Its Charter) </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Person(s) Filing Proxy Statement, if Other Than The Registrant) </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of Filing Fee (Check the appropriate box): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:1.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required. </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials. </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</span></td></tr></table></div><div style="margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="dcth-20250401_g1.jpg" alt="New_Delcath.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:164px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">566 Queensbury Avenue</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Queensbury, NY 12804</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TO BE HELD ON MAY 15, 2025</span></div><div style="margin-top:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders of Delcath Systems, Inc.: </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice is hereby given that the 2025 Annual Meeting of Stockholders of Delcath Systems, Inc., a Delaware corporation (the &#8220;Company&#8221;), will be held virtually at 10:00 a.m. Eastern Time on May&#160;15, 2025 (the &#8220;Annual Meeting&#8221;). There will not be an option to attend the Annual Meeting at a physical location. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Annual Meeting, the stockholders of the Company will be asked to consider and take action on the following proposals: </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">to elect Gerard Michel and Gilad Aharon as a Class I directors for a term expiring at the 2028 annual meeting of the Company&#8217;s stockholders and until their successors are elected and qualified, or, if sooner, until the director&#8217;s death, resignation, retirement, disqualification or removal; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">to approve an amendment of the Company&#8217;s 2020 Omnibus Equity Incentive Plan to increase by 2,200,000 the number of shares of common stock, $0.01 par value per share (&#8220;Common Stock&#8221;) available thereunder;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">to approve an amendment of the Company&#8217;s 2021 Employee Stock Purchase Plan to increase by 300,000 the number of shares of Common Stock available thereunder;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">to ratify the selection, by the Audit Committee of our Board of Directors, of CBIZ CPAs (&#8220;CBIZ CPAs&#8221;), Inc. as the independent registered public accounting firm of the Company for the fiscal year ending December&#160;31, 2025; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">to approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the accompanying proxy statement (&#8220;Proxy Statement&#8221;); and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">to transact such other business as may properly come before the Annual Meeting or any adjournments thereof. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The matters listed in this Notice are described in detail in the accompanying Proxy Statement. The Board of Directors is not aware of any other business to come before the Annual Meeting. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors fixed the close of business on March&#160;20, 2025 as the record date (the &#8220;Record Date&#8221;) for determining those stockholders who are entitled to notice of and to vote at the Annual Meeting or any adjournment of our Annual Meeting. Stockholders on the Record Date will be able to attend the Annual Meeting virtually and vote your shares during the Annual Meeting by first registering at https://web.viewproxy.com/DCTH/2025 and entering the 11-digit Virtual Control Number on the Notice of Internet Availability of Proxy Materials, on your proxy card or on the instructions that accompanied your proxy materials. A complete list of registered stockholders entitled to vote at the Annual Meeting will be available for ten days prior to the Annual Meeting for any purposes germane to the Annual Meeting between the hours of 9:00 a.m. and 5:00 p.m., at our principal executive offices at 566 Queensbury Avenue, Queensbury, NY 12804, by contacting the Secretary of the Company. </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 15, 2025 at 10:00 a.m. EASTERN TIME</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Notice, the 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proxy Statement and the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024, and any other materials concerning the Annual Meeting, together with any amendments to any of these materials, are available at https://web.viewproxy.com/DCTH/2025. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your vote is important. You will not be able to attend the Annual Meeting in person. Whether or not you plan to attend the Annual Meeting virtually, please vote over the telephone or via the internet as instructed in Notice of Internet Availability of Proxy Materials or by completing, signing and returning the proxy card mailed to you as promptly as possible to ensure your representation at the Annual Meeting. To ensure that your vote will be counted, you must register at https://web.viewproxy.com/DCTH/2025 by 11:59 p.m. Eastern Time on May&#160;12, 2025. Once registered, please cast your </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vote before 11:59 p.m. Eastern Time on May&#160;14, 2025. Even if you have voted by proxy, you may still vote online if you attend the Annual Meeting. Stockholders who attend the Annual Meeting should follow the instructions at www.FCRvote.com/DCTH to vote online at the Annual Meeting. Please note, however, that if your shares are held of record by a bank, broker or other nominee and you wish to vote at the Annual Meeting, you must obtain a proxy issued in your name from that record holder. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors, </span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:32.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.082%"/><td style="width:0.1%"/></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><div><img src="dcth-20250401_g2.jpg" alt="Screenshot 2023-07-13 174516.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:97px"/></div></td><td colspan="3" style="padding:0 1pt"><div><img src="dcth-20250401_g3.jpg" alt="Screenshot 2023-07-13 174634.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:93px"/></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Queensbury, New York</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">John R. Sylvester</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gerard Michel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chair of the Board</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DELCATH SYSTEMS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:94.651%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.149%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_13">INFORMATION ABOUT THE 2025 ANNUAL MEETING AND VOTING</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_13">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_16">PROPOSAL 1: ELECTION OF TWO CLASS I DIRECTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_16">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_19">PROPOSAL 2: APPROVAL OF AN AMENDMENT TO THE DELCATH SYSTEMS, INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span id="i3d9dd854509049f4b6259e420b992cf1_4-1-1-1-51789"></span><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_19">12</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_22">EQUITY COMPENSATION PLAN INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_22">19</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_251">PROPOSAL 3: APPROVAL OF AN AMENDMENT TO THE DELCATH SYSTEMS, INC</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_251"> 2021</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_251"> EMPLOYEE STOCK PURCHASE PLAN </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_251">20</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_25">PROPOSAL 4: RATIFICATION OF THE SELECTION, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF CBIZ CPAs P.C. AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_25">25</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_28">PROPOSAL </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_28">5</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_28">: APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE NAMED EXECUTIVE OFFICER COMPENSATION AS DISCLOSED IN THIS PROXY STATEMENT</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_28">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_31">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_31">27</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_37">CORPORATE GOVERNANCE AND RELATED MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_37">29</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_40">TRANSACTIONS WITH RELATED PERSONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_40">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_43">NON-EMPLOYEE DIRECTOR COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_43">35</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_46">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_46">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_49">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_49">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_52">SUMMARY COMPENSATION TABLE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_52">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_55">OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END  &#8212;2024</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_55">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_58">PAY VERSUS PERFORMANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_58">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_64">AUDIT COMMITTEE REPORT</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_64">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_67">STOCKHOLDER PROPOSALS FOR THE 2026 ANNUAL MEETING</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_67">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_70">HOUSEHOLDING OF PROXY MATERIALS </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_70">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_73">OTHER MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_73">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_76">WHERE YOU CAN FIND MORE INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_76">51</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_79">APPENDIX A: DELCATH SYSTEMS, INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN, AS AMENDED </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_79">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_260">APPEN</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_260">D</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_260">IX B: DELCATH SYSTEMS, INC. 2021 EMPLOYE</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_260">E</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_260"> STOCK PURCHASE PLAN</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_260">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_82">PROXY CARD</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i161d31b071a7458ab37fccdf98f11dd1_82">1</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="dcth-20250401_g1.jpg" alt="New_Delcath.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:164px"/></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">566 Queensbury Avenue,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Queensbury, NY 12804</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION ABOUT THE 2025 ANNUAL MEETING AND VOTING </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The enclosed proxy is solicited by the Board of Directors (the &#8220;Board&#8221;) of Delcath Systems, Inc. (&#8220;Delcath,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or &#8220;the Company&#8221;) to be voted at our 2025 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) to be held at 10:00 a.m. Eastern Time on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;15, 2025 in a virtual meeting format only by registering at https://web.viewproxy.com/DCTH/2025. Registration must be received by 11:59 p.m. Eastern time on May&#160;12, 2025. The Board knows of no matters to come before the Annual Meeting other than those described in this Proxy Statement. If any other matters properly come before the Annual Meeting (or any adjournment thereof), the persons named in the proxy card as proxies will vote on such matters in their discretion in accordance with their best judgement.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:19.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.305%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matters to be Voted on at the Annual Meeting.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Annual Meeting, the stockholders of the Company will be asked to consider and take action on the following proposals:</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8202;to elect Gerard Michel and Gilad Aharon as Class I directors to hold office until the 2028 annual meeting of the Company&#8217;s stockholders and until their successors are elected and qualified (the &#8220;Director Election Proposal&#8221;);</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8202;to approve an amendment to the Company&#8217;s 2020 Omnibus Equity Incentive Plan (the &#8220;2020 Plan&#8221;) to increase by 2,200,000 the number of shares of common stock, $0.01 par value per share (&#8220;Common Stock&#8221;) available thereunder (the &#8220;2020 Plan Amendment Proposal&#8221;);</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">to approve an amendment to the Company&#8217;s 2021 Employee Stock Purchase Plan to increase by 300,000 the number of shares of Common Stock available thereunder (the &#8220;ESPP Plan Proposal&#8221;);</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8202;to ratify the selection, by the Audit Committee of our Board, of CBIZ CPAs as the independent registered public accounting firm of the Company for the fiscal year ending December&#160;31, 2025 (the &#8220;Ratification Proposal&#8221;);</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8202;to approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in this proxy statement (the &#8220;Proxy Statement&#8221; and such proposal, the &#8220;Say-on-Pay Proposal&#8221;); and</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#8202;to transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:19.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.305%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholders entitled to vote.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only stockholders of record of our Common Stock, our Series E Convertible Preferred Stock, $0.01 par value per share (the &#8220;Original Series E Preferred Stock&#8221;), our Series E-1 Convertible Preferred Stock, $0.01 par value per share (the &#8220;Series E-1 Preferred Stock&#8221; and, together with the Original Series E Preferred Stock the &#8220;Series E Preferred Stock&#8221;), our Series F-2 Convertible Preferred Stock, $0.01 par value per share (the &#8220;Series F-2 Preferred Stock&#8221;), and our Series F-4 Convertible Preferred Stock, $0.01 par value per share (the &#8220;Series F-4 Preferred Stock&#8221; and, together with the Series F-2 Preferred Stock the &#8220;Series F Preferred Stock&#8221; and together with the Series E Preferred Stock, the &#8220;Preferred Stock&#8221;) at the close of business on March&#160;20, 2025 (the &#8220;Record Date&#8221;) are entitled to notice of and to vote at the Annual Meeting, but, in the case of the Series E Preferred Stock, subject to the application of the Beneficial Ownership Limitation and, in the case of the Series F Preferred Stock, subject to the Maximum Percentage Limitation. At the close of business on the Record Date, there were 33,432,605 shares of Common Stock outstanding, 9,205 shares of our Series E Preferred Stock outstanding, 1,753 shares of our Series E-1 Preferred Stock outstanding, 1,085 shares of our Series F-2 Preferred Stock outstanding and 2,150 shares of our Series F-4 Preferred Stock outstanding. See &#8220;Number of votes&#8221; below for more information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock: Each share of our Common Stock outstanding as of the Record Date is entitled to one vote per share on all matters properly brought before the Annual Meeting.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series E Preferred Stock: Each share of our Series E Preferred Stock outstanding as of the Record Date has the right to vote on all matters presented to the stockholders for approval, together with the shares of Common Stock and Series F Preferred Stock, voting together as a single class, on an as-converted to Common Stock basis, based on a conversion price of $10.00 per share and stated value of $1,000 per share, subject to the Beneficial Ownership Limitation. The voting of the Series E Preferred Stock is limited by the certificates of designation for such Series E Preferred Stock, which provide that the Company shall not affect any conversion of the Series E Preferred Stock, and a holder of Series E Preferred Stock will not have the right to convert any portion of the Series E Preferred Stock, to the extent that, after giving effect to the conversion, the holder (together with its affiliates and any persons acting as a group together with the holder or any of the holder&#8217;s affiliates) (such persons, &#8220;Attribution Parties&#8221;), would beneficially own in excess of the Beneficial Ownership Limitation. For purposes of determining the Beneficial Ownership Limitation, the number of shares of Common Stock beneficially owned by such holder and its affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon conversion of the Series E Preferred Stock with respect to which such determination is being made, but will exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted portion of Series E Preferred Stock beneficially owned by such holder or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company subject to a limitation on conversion or exercise analogous to the limitation contained in the certificate of designations, beneficially owned by such holder or any of its affiliates or Attribution Parties. To the extent that the Beneficial Ownership Limitation applies, the determination of whether the Series E Preferred Stock is convertible (in relation to other securities owned by such holder together with any affiliates and Attribution Parties) and of how many shares of Series E Preferred Stock are convertible is in the sole discretion of such holder. The &#8220;Beneficial Ownership Limitation&#8221; is 4.99% (or, upon written election by a holder which is delivered to the Company prior to the issuance of any shares of Series E Preferred Stock to such holder, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Series E Preferred Stock held by the applicable holder. Additional Information regarding the Beneficial Ownership Limitation can be found in the Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock and Certificate of Designation of Preferences, Rights and Limitations of Series E-1 Convertible Preferred Stock, incorporated by reference as Exhibits 4.1 and 4.2 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024.</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:19.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.305%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Series F Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Each share of our Series F Preferred Stock outstanding as of the Record Date has the right to vote on all matters presented to the stockholders for approval, together with the shares of Common Stock and Series E Preferred Stock (subject to the Beneficial Ownership Limitation), voting together as a single class, on an as-converted to Common Stock basis, as determined by dividing the Liquidation Preference (as defined in the Series F Certificate of Designation, and which is three times the original per share price of $1,000 per share, together with any dividends declared but unpaid thereon) by the voting conversion price, which is the lower of (i) the Nasdaq Official Closing Price of the Common Stock immediately preceding March 27, 2023 (or $4.84) and (iii) the average Nasdaq Official Closing Price of the Common Stock for the five trading days immediately preceding March 27, 2023 (or $4.58) (such conversion mechanism, the &#8220;Voting Conversion Mechanism&#8221;), subject to the Maximum Percentage Limitation. The voting of the Series F Preferred Stock is limited by the Series F Certificate of Designation (as defined below), which provides that the Company shall not affect any conversion of the Series F Preferred Stock, and the portion of the Series F Preferred Stock shall not automatically convert, to the extent that, after giving effect to the conversion, the holder and its affiliates and Attribution Parties would beneficially own in excess of the Maximum Ownership Limitation. For purposes of determining the Maximum Ownership Limitation, the number of shares of Common Stock beneficially owned by such holder and its affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon conversion of the Series F Preferred Stock with respect to which such determination is being made, but will exclude the number of shares of Common Stock which are issuable upon (i) exercise of the remaining unconverted portion of the Series F Preferred Stock beneficially owned by such holder or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company subject to a limitation on conversion or exercise analogous to the limitation contained in the Series F Certificate of Designation, beneficially owned by such holder or any of its affiliates or Attribution Parties. To the extent that the Maximum Ownership Limitation applies, the determination of whether the Series F Preferred Stock is convertible (in relation to other securities owned by such holder together with any affiliates and Attribution Parties) and of how many shares of Series F Preferred Stock are convertible is in the sole discretion of such holder. The &#8220;Maximum Ownership Limitation&#8221; is 9.99% (or, upon written election by a holder which is delivered to the Company prior to the issuance of any shares of Series F Preferred Stock to such holder, any other percentage not in excess of 19.99% of the issued and outstanding Common Stock immediately after giving effect to the issuance of Common Stock issuable upon conversion of the Series F Preferred Stock if exceeding that limit would result in a change of control under Nasdaq Listing Rule 5635(b)) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Series F Preferred Stock held by the applicable holder. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional Information regarding the Series F Preferred Stock and the terms thereof can be found in the Certificate of Designation of Preferences, Rights and Limitations of Series F Convertible Voting Preferred Stock (the &#8220;Series F Certificate of Designation&#8221;), incorporated by reference as Exhibit 3.7 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A complete list of registered stockholders entitled to vote at the Annual Meeting will be available for ten days prior to the Annual Meeting for any purposes germane to the Annual Meeting between the hours of 9:00 a.m. and 5:00 p.m., at our principal executive offices at 566 Queensbury Avenue, Queensbury, NY 12804, by contacting the Secretary of the Company.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:19.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.305%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of votes.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Common Stock have one vote for each share of Common Stock held and holders of Preferred Stock are entitled to vote with the holders of shares of Common Stock, and not as a separate class, on an as-converted to Common Stock basis, subject to, with respect to the Series E Preferred Stock, the Beneficial Ownership Limitation and, with respect to the Series F Preferred Stock, the Maximum Ownership Limitation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the Record Date, 33,432,605 shares of Common Stock are issued and outstanding. In addition, the following shares of Preferred Stock are issued and outstanding:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">9,205 shares of Original Series E Preferred Stock where 494,600 shares are entitled to vote after taking into account the Beneficial Ownership Limitation;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1,753 shares of Series E-1 Preferred Stock where no shares are entitled to vote after taking into account the Beneficial Ownership Limitation;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1,085 shares of Series F-2 Preferred Stock where no shares are entitled to vote, as calculated in accordance with Voting Conversion Mechanism, after taking into account the Maximum Ownership Limitation; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">2,150 shares of Series F-4 Preferred Stock where no shares are entitled to vote, as calculated in accordance with Voting Conversion Mechanism, after taking into account the Maximum Ownership Limitation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Therefore, there are 33,927,205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares of Common Stock, including Preferred Stock on an as-converted basis, subject to the Beneficial Ownership Limitation with respect to the Series E Preferred Stock and the Maximum Ownership Limitation with respect to Series F Preferred Stock, entitled to vote as of the Record Date.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Attending the virtual meeting.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders as of the Record Date will be able to participate in the Annual Meeting by visiting our 2025 Annual Meeting website at https://web.viewproxy.com/DCTH/2025. To participate in the Annual Meeting, you will need the 11-digit control number included on your proxy card or on the instructions that accompanied your proxy materials. You must register by 11:59 p.m. Eastern Time on May&#160;12, 2025. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Annual Meeting will begin promptly at 10:00 a.m. Eastern Time on May&#160;15, 2025.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Online check-in will begin at 9:45 a.m. Eastern Time on May&#160;15, 2025, and you should allow approximately 15 minutes for the online check-in procedures.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:19.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.305%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.002%"/><td style="width:0.1%"/></tr><tr style="height:164pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">How to vote.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whether or not you plan to virtually attend the Annual Meeting and regardless of the number of shares of the Company&#8217;s Common Stock and/or Preferred Stock that you own, please vote as soon as possible.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder of Record: Shares Registered in Your Name</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, on the Record Date, your shares were registered directly in your name with our transfer agent, Equiniti Trust Company, LLC, you are a stockholder of record. As a stockholder of record, you may vote online during the Annual Meeting, vote by proxy through the internet or telephone or vote by proxy using a proxy card that you may request or that was delivered to you. Whether or not you intend to attend the Annual Meeting, we urge you to vote by proxy through the internet or telephone as instructed below, or by completing a proxy card as soon as possible.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may vote using the following methods:</span></div></td></tr><tr style="height:63pt"><td colspan="3" style="padding:0 1pt"><div><img src="dcth-20250401_g4.jpg" alt="1 Hi.jpg" style="height:31px;margin-bottom:5pt;vertical-align:text-bottom;width:32px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Go to www.FCRvote.com/DCTH to complete an electronic proxy card. You will be asked to provide the 11-digit control number included on your Notice, your proxy card (that you may request or that was delivered to you) or the instructions that accompanied your proxy materials. Your vote must be received by 11:59 p.m. (Eastern Time) on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> May&#160;14, 2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be counted.</span></div></td></tr><tr style="height:75pt"><td colspan="3" style="padding:0 1pt"><div><img src="dcth-20250401_g5.jpg" alt="1 History.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:32px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dial 1-866-402-3905 using a touch-tone phone and following the recorded instructions. You will be asked to provide the 11-digit control number included on your Notice, your proxy card (that you may request or that was delivered to you) or the instructions that accompanied your proxy materials. Your vote must be received by 11:59 p.m. (Eastern Time) on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">May&#160;14, 2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to be counted.</span></div></td></tr><tr style="height:54pt"><td colspan="3" style="padding:0 1pt"><div><img src="dcth-20250401_g6.jpg" alt="3.jpg" style="height:27px;margin-bottom:5pt;vertical-align:text-bottom;width:34px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Complete, sign, date and return the proxy card that you may request or that was delivered to you and return it promptly in the envelope provided. If you return your signed proxy card to use before the Annual Meeting, your shares will be voted as you direct.</span></td></tr><tr style="height:344pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, you may vote online during the Annual Meeting. To do so, during the Annual Meeting, visit our Annual Meeting website at https://web.viewproxy.com/DCTH/2025. You will be asked to provide the 11-digit control number included on your Notice, your proxy card that you request or that was delivered to you or the instructions that accompanied your proxy materials. Once you have logged onto the Annual Meeting, please follow the instructions to vote your shares. If you do not have your 11-digit control number, you will be able to access and listen to the Annual Meeting, but you will not be able to vote your shares or submit questions. You must register by 11:59 p.m. Eastern Time on May&#160;12, 2025 to vote your shares at the Annual Meeting.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beneficial Ownership: Shares Registered in the Name of Bank, broker or other nominee</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, on the Record Date, your shares were held not in your name, but rather in an account at a bank, broker or other nominee, then you are the beneficial owner of shares held in &#8220;street name.&#8221; Your bank, broker or other nominee is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you should have received a notice containing voting instructions from your bank, broker or other nominee rather than from us. Simply follow the instructions in the notice to ensure that your vote is counted. Please also note that since you are not the stockholder of record, you may only vote your shares during the Annual Meeting if you request and obtain a valid 11-digit control number from your bank, broker or other nominee. Beneficial owners who attend the Annual Meeting should follow the instructions at https://web.viewproxy.com/DCTH/2025 to vote during the Annual Meeting.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If your shares are registered directly in your name with our transfer agent, Equiniti Trust Company, LLC, you are a stockholder of record. As a stockholder of record, you may vote online during the Annual Meeting, vote by proxy through the internet or telephone or vote by proxy using a proxy card that you may request or that was delivered to you. Whether or not you intend to attend the Annual Meeting, we urge you to vote by proxy through the internet or telephone as instructed below, or by completing a proxy card as soon as possible.</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:19.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.305%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:65.002%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quorum.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presence at the Annual Meeting, in person virtually or represented by proxy, of the holders of a majority of the shares of the Company&#8217;s Common Stock and Preferred Stock (on an as-converted to Common Stock basis, subject to the Beneficial Ownership Limitation with respect to the Series E Preferred Stock and the Maximum Ownership Limitation with respect to the Series F Preferred Stock) issued and outstanding and entitled to vote at the Annual Meeting will constitute a quorum for purposes of voting at the Annual Meeting. Attendance at the Annual Meeting, albeit virtual, constitutes presence in person for purposes of a quorum. Abstentions and broker non-votes are counted as present and entitled to vote for purposes of determining the existence of a quorum.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Broker non-votes.</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A broker &#8220;non-vote&#8221; occurs when a nominee, such as a bank or broker, holding shares in &#8220;street name&#8221; for a beneficial owner, returns the proxy but abstains from voting on a particular proposal because, under most circumstances, such nominee does not have discretionary authority to vote on proposals unless it has received instructions from the beneficial owner of the securities on how to vote those securities. Under applicable rules, such nominees do not have discretionary authority to cast votes on non-routine matters without instructions from the beneficial owner of the securities. If you do not provide your bank, broker or other nominee with instructions on how to vote your shares held in &#8220;street name,&#8221; your bank, broker or other nominee will have discretionary authority to vote your shares with respect to &#8220;routine&#8221; proposals, but not with respect to &#8220;non-routine&#8221; proposals.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Routine proposal. We have been advised by the New York Stock Exchange (&#8220;NYSE&#8221;) that the Ratification Proposal is a routine proposal and may be voted upon by your bank, broker or other nominee if you do not submit voting instructions to your bank, broker or other nominee.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-routine proposals. We have been advised by the NYSE that the Director Election Proposal, the 2020 Plan Amendment Proposal, the ESPP Plan Proposal, and the Say-on-Pay Proposal are non-routine proposals and may not be voted upon by your bank, broker or other nominee in the absence of specific instructions from you as to how you would like your shares to be voted. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If you hold your shares in &#8220;street name,&#8221; we strongly encourage you to provide instructions regarding the voting of your shares because your bank, broker or other nominee cannot vote your shares with respect to these proposals without voting instructions from you. </span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.787%"><tr><td style="width:1.0%"/><td style="width:13.010%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.182%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote required; <br/>treatment of <br/>abstentions and <br/>broker non-votes.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Proposal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Vote Required to Adopt the Proposal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Effect of <br/>Abstentions /<br/>Withheld Votes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Effect of &#8220;Broker</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-Votes&#8221;</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposal 1 &#8211; Director Election Proposal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nominees receiving the most &#8220;FOR&#8221; votes from the holders of shares present by remote communication or represented by proxy and entitled to vote on the election of directors will be elected. Only votes &#8220;FOR&#8221; will affect the outcome. </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">No effect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:114%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposal 2 &#8211; 2020 Plan Amendment Proposal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Plan Amendment Proposal must receive &#8220;FOR&#8221; votes from the majority of shares entitled to vote and represented at the meeting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An abstention will have the same effect as a vote &#8220;AGAINST&#8221;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">No effect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:114%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposal 3 &#8211; ESPP Plan Proposal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP Plan Proposal must receive &#8220;FOR&#8221; votes from the majority of shares entitled to vote and represented at the meeting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An abstention will have the same effect as a vote &#8220;AGAINST&#8221;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">No effect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:114%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposal 4 -Ratification Proposal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ratification Proposal must receive &#8220;FOR&#8221; votes from the holders of a majority of shares entitled to vote and represented at the meeting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An abstention will have the same effect as a vote &#8220;AGAINST&#8221; </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposal 5 - Say-on-Pay Proposal</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Say-on-Pay Proposal must receive &#8220;FOR&#8221; votes from the holders of a majority of shares entitled to vote and represented at the meeting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An abstention will have the same effect as a vote &#8220;AGAINST&#8221;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">No effect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:114%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This proposal is considered to be a &#8220;non-routine&#8221; matter. Accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank or other agent that holds your shares, your broker, bank or other nominee does not have discretionary authority to vote your shares on this proposal.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This proposal is considered to be a &#8220;routine&#8221; matter. Accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank or other agent that holds your shares, your broker, bank or other nominee has discretionary authority to vote your shares on this proposal.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The resolution that is the subject of this proposal is advisory in nature and, therefore, is not binding on Delcath, the Compensation and Stock Option Committee (the &#8220;Compensation Committee&#8221;), or our Board. However, the views expressed by our stockholders, whether through this vote or otherwise, are important to us and our Board and the Compensation Committee intends to take the results of the vote on this proposal into account when considering future decisions regarding the compensation of our named executive officers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"/><td style="width:14.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting recommendation of the Board; voting of proxies.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board recommends a vote &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; each of the proposals. Your shares will be voted in accordance with the instructions contained in your signed proxy card. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If you return a signed proxy card without giving specific voting instructions with respect to each proposal, proxies will be voted in favor of the Board&#8217;s recommendations with respect to the proposals as set forth in this Proxy Statement. </span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">How to revoke your proxy.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your proxy is revocable. The procedure you must follow to revoke your proxy depends on how you hold your shares.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are a registered holder of our Common Stock or Preferred Stock, you may revoke a previously submitted proxy by submitting another valid proxy (whether by telephone, the Internet or mail) or by providing a signed letter of revocation to the Corporate Secretary of the Company before the closing of the polls at the virtual annual meeting on May&#160;15, 2025. Only the latest-dated validly executed proxy will count. You also may revoke any previously submitted proxy and vote your shares online during the virtual annual meeting; however, simply attending the Annual Meeting in virtual format without taking one of the above actions will not revoke your proxy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you hold shares in &#8220;street name,&#8221; in general, you may revoke a previously submitted voting instruction by submitting to your bank, broker or other nominee another valid voting instruction (whether by telephone, the Internet or mail) or a signed letter of revocation. Please contact your bank, broker or other nominee for detailed instructions on how to revoke your voting instruction and the applicable deadlines. Please note that your attendance at the virtual annual meeting in and of itself will not be sufficient to revoke your proxy.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expenses and solicitation.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will bear the cost for the solicitation of proxies, including printing and mailing costs. In addition to the solicitation of proxies by mail, proxies may also be solicited personally by directors, officers and employees of Delcath, without additional compensation to these individuals. We will request that banks, brokers and other firms holding shares in their names that are beneficially owned by others forward proxy materials to and obtain proxies from such beneficial owners, and will, upon request, reimburse such banks, brokers and other firms for their reasonable out-of-pocket costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have engaged Alliance Advisors, LLC (&#8220;Alliance&#8221;) as the proxy solicitor for the Annual Meeting for a base fee of $36,500, plus fees for additional services. We have agreed to reimburse Alliance for its reasonable out-of-pocket expenses. If you have questions about the proposals or if you need copies of this Proxy Statement or a proxy card, you should contact:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alliance Advisors, LLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150 Clove Rd Suite 400</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Little Falls, NJ 07424</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1-833-215-7515</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">DCTH@allianceadvisors.com</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other matters.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not aware of any matters to be presented at the Annual Meeting other than those described in this Proxy Statement. If any matters not described in this Proxy Statement are properly presented at the Annual Meeting, the proxy holders will use their own judgment to determine how to vote your shares. If the Annual Meeting is adjourned or postponed, the proxy holders can vote your shares at the new meeting as well unless you have subsequently revoked your proxy.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote results.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary results of the voting on the proposals will be reported at the Annual Meeting. The final certified results of the voting will be reported in a Current Report on Form 8-K within four business days after the Annual Meeting.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Who should I call if I have additional questions?</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you need assistance with voting or have questions regarding the Annual Meeting, please contact:</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alliance Advisors, LLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150 Clove Rd Suite 400</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Little Falls, NJ 07424</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1-833-215-7515</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">DCTH@allianceadvisors.com</span></div></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL 1: ELECTION OF TWO CLASS I DIRECTORS </span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation and bylaws, each as currently amended and in effect, state that our Board will consist of a number of directors that will be fixed exclusively by the Board from time to time in accordance with the bylaws of the Company. Our Board has fixed the number of directors comprising the Board at six members. Each director holds office until his or her successor is duly elected and qualified or, if sooner, until the director&#8217;s death, resignation, retirement, disqualification or removal. Any vacancy in the Board, including a vacancy that results from an increase in the number of directors, may be filled only by the vote of a majority of the remaining directors then in office. Our certificate of incorporation also provides that our Board is divided into three classes of directors, with the classes as nearly equal in number as possible. Subject to any earlier resignation or removal in accordance with the terms of our certificate of incorporation and bylaws, our current Class I directors, if elected, will serve until the Company&#8217;s 2028 annual meeting of stockholders; our current Class II directors will serve until the 2026 annual meeting of stockholders; and our current Class III directors will serve until the 2027 annual meeting of stockholders. Any additional directorships resulting from an increase in the number of directors will be apportioned by our Board among the three classes as equally as possible. </span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board has nominated Gerard Michel and Gilad Aharon for election as Class I directors at the Annual Meeting, to serve until the Company&#8217;s 2028 annual meeting of stockholders. The nominees are presently directors, and have indicated a willingness to continue to serve as director, if elected. If a nominee becomes unable or unwilling to serve, proxies may be voted for substitute nominees selected by our Board. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominee for Election as Class I Director </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position with Delcath</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Director Since</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer (CEO) and Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gilad Aharon, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr></table></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biographical information, including principal occupation and business experience during the last five years, for our director nominee is set forth below. </span></div><div style="margin-top:6pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gerard Michel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was appointed as a director of the Company and its CEO in October 2020. Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries across multiple functional areas. Prior to joining the Company as its CEO on October 1, 2020, he was Chief Financial Officer of Vericel Corporation, a biopharmaceutical company, since June 2014 where he was a key member of the management team that integrated a transformative acquisition and revised the company&#8217;s business model from a research focused company to a fully integrated, profitable commercial business. Mr. Michel also served as Chief Financial Officer and Vice President, Corporate Development of Biodel, Inc. from November 2007 to May 2014, and Chief Financial Officer and Vice President of Corporate Development of NPS Pharmaceuticals Inc. from August 2002 to November 2007. Prior to that, Mr. Michel was a Principal at Booz Allen and held a variety of commercial roles at both Lederle Labs and Wyeth Labs. Mr. Michel holds an M.S. in Microbiology from the University of Rochester School of Medicine, an M.B.A. from the Simon School of Business, and a B.S. in both Biology and Geology from the University of Rochester. </span></div><div style="margin-top:12pt;text-indent:55.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the Board is greatly enhanced by Mr. Michel&#8217;s decades of experience in the pharmaceutical and medical technology industries, his strong leadership skills and his in-depth understanding of the Company and its goals from his experience as our CEO. </span></div><div style="margin-top:12pt;text-indent:55.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gilad Aharon, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was appointed as a director of the Company in May 2020. Dr. Aharon is a co-founder of and has served as a Portfolio Manager at Rosalind Advisors, Inc., since 2006. Dr. Aharon holds a Ph.D. in Biophysics and Molecular Biology from the University of Toronto. Prior to co-founding Rosalind Advisors, Dr. Aharon worked as an equity analyst at Infinium Securities Inc. </span></div><div style="margin-top:12pt;text-indent:55.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Aharon&#8217;s financial and investment industry experience, his understanding of our business and our industry and his educational background make him extremely valuable to our Board. Dr. Aharon also provides a valuable stockholder perspective to the Board. Dr. Aharon was elected to our Board pursuant to a Board Appointment Agreement entered into with certain of our stockholders, Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center;text-indent:55.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#8220;FOR&#8221; THE ELECTION OF THE TWO CLASS I DIRECTOR NOMINEES.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors Continuing in Office Until the 2026 (Class II) and 2027 (Class III) Annual Meetings</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning our continuing directors:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position with Delcath</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Director Since</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elizabeth Czerepak</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John R. Sylvester</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Executive Chairman</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven Salamon</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridget Martell, M.A. M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biographical information, including principal occupation and business experience during the last five years, for our directors whose terms continue is set forth below. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class II Directors (Term Expires at 2026 Annual Meeting)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Elizabeth Czerepak </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was appointed as a director of the Company in February 2020. Ms. Czerepak has more than thirty-five years of financial leadership and strategy development experience across the pharmaceutical and biotechnology fields. Ms. Czerepak has served as the Acting Chief Executive Officer and Chief Financial Officer at Mirror Biologics, Inc., a private, clinical-stage company focused on cell-based oncology therapies, since July 2024. She has served as Chief Financial Officer since April 2024. Before joining Mirror Biologics, Inc., she served as the Chief Financial Officer at Sorrento Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing oncology, non-opioid pain, and Covid therapies, from May 2022 to November 2023. Ms. Czerepak also served as Chief Financial Officer at Scilex Holdings Company, a commercial pharmaceutical company focused on developing and commercializing non-opioid pain therapies, from May 2022 to September 2023. She continued to serve as consultant to Scilex until September 2024. Prior to that, from September 2020 to May 2022, she served as Chief Financial Officer at BeyondSpring Inc. (NASDAQ:BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies, and from May 2018 to January 2020, she served as Chief Financial Officer and Chief Business Officer of Genevant Sciences, Inc., a technology focused nucleic acid delivery company. Her pharma executive level experience includes M&amp;A, licensing, business development and finance. Ms. Czerepak served as a member of the board of directors of Sorrento Therapeutics, Inc. from October 2021 to May 2022. In February of 2023, Sorrento announced it commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code and in November 2023 entered into a court-approved asset sale. Ms. Czerepak also served as a director of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) from June 2019 to December 2020, and as a director of Scilex Pharmaceuticals, Inc., a private company, from 2019 to 2020. She received a B.A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">magna cum laude </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Spanish and Mathematics Education from Marshall University and an MBA from Rutgers University. In 2020, Elizabeth earned a Corporate Director Certificate from Harvard Business School. </span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Czerepak brings to our Board extensive experience in the pharmaceutical and biotech industries, including as a senior finance executive of publicly traded biopharmaceutical companies. </span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">John R. Sylvester</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was appointed as a director of the Company in July 2019. He has served as the Non-Executive Chairman of the Board since February 2023. Mr. Sylvester most recently served as CEO of Curium Pharma&#8217;s SPECT and International businesses. Prior to that he served as Chief Commercial Officer of BTG plc, which he joined in 2011 and had roles leading both their Interventional Oncology and Interventional Vascular businesses as well as a period as Chief Development Officer accountable for Strategy, M&amp;A and Market Access. This culminated in an exit to Boston Scientific for $4.2 billion. Prior to BTG, Mr. Sylvester was Managing Director of Biocompatibles plc, building their Interventional Oncology business which led to a successful exit to BTG for &#163;166.0 million. Mr. Sylvester joined Biocompatibles following a period as the Vice President of Marketing for Baxter Healthcare&#8217;s $750.0 million European Medication Delivery business based in Brussels then Zurich accountable for six strategic business units incorporating drugs, devices and drug device combinations. Before this, Mr. Sylvester held a number of senior commercial roles in the industrial sector. Immediately prior to Baxter Healthcare, Mr. Sylvester was the General Manager of a Minerals company with $4.0 billion of assets on three continents, $500.0 million of sales and 1,500 employees. Mr. Sylvester graduated with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">joint honors in Biochemistry and Applied Molecular Biology from the University of Manchester Institute of Science and Technology (U.M.I.S.T.). </span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Sylvester&#8217;s extensive international experience with business strategy and commercialization in the healthcare space as well as his educational background enhances our Board.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class III Directors (Term Expires at 2027 Annual Meeting)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Steven Salamon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was appointed as a director of the Company in May 2020. Mr. Salamon is a co-founder of, and has served as Portfolio Manager at, Rosalind Advisors, Inc., a life sciences-focused investment manager (&#8220;Rosalind Advisors&#8221;), since 2006. Mr. Salamon holds an MBA from the Ivey Business School and a Bachelors of Applied Science degree in Engineering Physics from the University of Toronto. Prior to co-founding Rosalind Advisors, Mr. Salamon worked as an equity analyst at HSBC Securities and RBC Capital Markets (formerly RBC Dominion Securities). Prior to completing his MBA, Mr. Salamon worked as a product engineer for Chrysler Corporation. </span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Salamon brings to our Board his manufacturing, financial and investment industry experience, his understanding of our business and our industry and his strategic insight. In addition, Mr. Salamon provides a valuable stockholder perspective to the Board. Mr. Salamon was elected to our Board pursuant to a Board Appointment Agreement entered into with certain of our stockholders, Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P.</span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bridget Martell, M.A. M.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was appointed to Delcath Systems&#8217; Board of Directors in May 2024. She brings a wealth of experience from her roles in senior management and as a director at multiple biotechnology companies. Currently, she serves as an independent director at Aligos Therapeutics and Achieve Life Sciences. Dr. Martell previously held director roles at POINT Biopharma Global and Ayala Pharmaceuticals. Dr. Martell is also a Biotechnology Operating Partner at Two Bear Capital and founded BAM Consultants. Her past executive roles include President and CEO of Artizan Biosciences and Chief Medical Officer for various biotech companies.</span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Martell holds a B.S. in Microbiology from Cornell University, an M.A. in Molecular Immunology from Boston University, and an M.D. from Chicago Medical School. She completed her internal medicine residency and served as Chief Resident at Yale University, where she continues to engage as an Entrepreneur In Residence at Yale Ventures.</span></div><div style="margin-top:12pt;text-indent:54pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL 2: APPROVAL OF AN AMENDMENT TO THE DELCATH SYSTEMS, INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Overview</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are asking our stockholders to approve an amendment to the Company&#8217;s 2020 Omnibus Equity Incentive Plan, as amended (the &#8220;2020 Plan&#8221; and, as proposed to be approved by the stockholders, the &#8220;2020 Plan Amendment&#8221;), to increase the number of shares of our Common Stock available for issuance under the 2020 Plan by 2,200,000. We are proposing the increase in the number of shares available under the 2020 Plan to enable us to continue offering effective equity compensation to our employees, non-employee directors and consultants and to take advantage of the significant motivation and retention benefits provided by equity compensation. Our Board determined on February 6, 2025, that it is in the best interests of us and our stockholders to seek stockholder approval of the 2020 Plan Amendment as described in this proposal. The following is a summary of the key changes to the 2020 Plan Amendment, as proposed to be amended and restated hereby. This summary, however, does not purport to be a complete description of all of the provisions of the 2020 Plan Amendment and is qualified in its entirety by reference to the full text of the 2020 Plan Amendment, which is attached as Appendix A to this proxy statement. If approved by the stockholders, the 2020 Plan Amendment will become effective as of the date of the Annual Meeting. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board recommends that the stockholders approve the 2020 Plan Amendment. If the requisite stockholder approval of the 2020 Plan Amendment is not obtained, the 2020 Plan Amendment will not take effect. On March&#160;20, 2025, the closing price of a share of Common Stock on Nasdaq was $14.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Reasons for the 2020 Plan Amendment</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2024, the Company commercially launched the HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) for the treatment of patients with unresectable hepatic-dominant metastatic uveal melanoma, or mUM. We are asking our stockholders to approve the 2020 Plan Amendment because, among other things, we believe that the 2020 Plan Amendment is in the best interests of us and our stockholders because of the continuing need to grant equity awards to attract and retain qualified personnel and to respond to relevant market changes in equity compensation practices. We do not view the 285,036 shares currently available for grant under the 2020 Plan as sufficient to allow us to execute on our near-term plans, and the proposed increase in the share reserve under the 2020 Plan is expected to provide sufficient shares available for approximately the next year as we scale the business. If our stockholders do not approve the 2020 Plan Amendment, we will be limited in our ability to continue to issue awards under the 2020 Plan in numbers sufficient to attract and motivate the highly skilled employees we need to recruit and retain. We are not able to provide a public forecast as to the level of total shares outstanding and utilization of equity awards as a result of the unpredictability of the underlying assumptions and estimates. In particular, our actual usage of stock plan shares for employee awards under the 2020 Plan (and the 2020 Plan Amendment) will be impacted by changes in the number and level of our employees, the type of equity awards we grant, our potential growth and activities, the financial impact of grants and financing activities, as well as other factors, such as industry performance and general business, economic, regulatory, market and financial conditions. These general factors and ones specific to our business are difficult to predict, many are beyond our control and some or all could combine to change the expected life of the stock plan request. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If approved by our stockholders, the 2020 Plan Amendment will increase by 2,200,000 shares of Common Stock the current authorization of 7,125,000 shares of Common Stock for equity compensation awards, for a total share reserve under the 2020 Plan, as proposed to be amended, of 9,325,000 shares of Common Stock. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the amount of the increase contemplated by the 2020 Plan Amendment, the Board has taken into consideration the analysis conducted by our compensation consultant Frederick W. Cook &amp; Co., Inc. (&#8220;FW Cook&#8221;), which looked to manage annual share spend, total overhang levels and competitive market grant practices in an appropriate manner. The analysis considered that we have a large number of outstanding in-the-money warrants and convertible preferred shares, which results in a capital structure that has approximately 38,173,223 shares of Common Stock and Common Stock equivalents outstanding. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed reservation of an additional 2,200,000 shares under the 2020 Plan Amendment is most appropriately considered as less than six percent (6.0%) of the totality of common share equivalents with the in-the-money warrants and convertible preferred shares included. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another factor considered is our anticipated &#8220;burn rate&#8221; for issuances of new awards under the 2020 Plan Amendment over the next year, which is defined generally as (a) shares subject to options and other awards granted in the year, divided by (b) weighted-average common shares and common share equivalents outstanding for the applicable year (common share equivalents include in-the-money warrants and convertible preferred shares). Taking into account our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hiring plans over that period, we believe that our burn rate will be approximately six percent (6.0%) if awards are granted as stock options; the Board believes that a burn rate of approximately six percent (6.0%) is a reasonable burn rate. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;20, 2025, only 285,036 shares of Common Stock remained available for grant of future equity awards under the 2020 Plan. We believe that the additional 2,200,000 reserved shares will be sufficient to provide an adequate number of awards to provide additional incentive awards to the Company&#8217;s current employees, consistent with the market for their services. This increase will improve the Company&#8217;s ability to grant equity awards that are competitive with the levels of equity compensation provided by the companies with which it competes to attract and retain talented executives and other key employees. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity compensation is a critical element of our compensation program. Offering a broad-based equity compensation program is vital to attracting and retaining highly skilled people in the highly competitive life sciences industry. We use equity awards to provide increased incentives to the eligible employees, non-employee directors and consultants who provide significant services to us and our affiliates. We believe that providing an equity stake in the future success of our business encourages our employees to be highly motivated to achieve our long-term business goals and to increase stockholder value. Their innovation and productivity are critical to our success. Accordingly, approving the 2020 Plan Amendment is in the best interest of our stockholders because equity awards help us to:</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#183;     attract, motivate and retain talented employees, directors and consultants;</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#183;     align the interests of employees, non-employee directors and consultants with stockholder interests; and</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#183;     link employee compensation to Company performance.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strongly believe that approval by stockholders of the 2020 Plan Amendment will enable us to achieve our goals in attracting and retaining our most valuable asset: our employees.</span></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of the 2020 Plan Amendment</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the material terms of the 2020 Plan, as proposed to be amended pursuant to the 2020 Plan Amendment. This summary is qualified in its entirety by reference to the full text of the 2020 Plan (as amended if this Proposal 2 is approved), marked to show the changes implemented by the 2020 Plan Amendment, attached as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Appendix A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to this Proxy Statement. The 2020 Plan Amendment (and 2020 Plan) is not a tax-qualified deferred compensation plan under Section 401(a) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and is not intended to be an employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974. </span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Board has the authority to interpret the terms and conditions of the 2020 Plan, to determine eligibility for and terms of awards for participants and to make all other determinations necessary or advisable for the administration of the 2020 Plan. The Board may delegate its authority to any committee of the Board (the Board or such committee is referred to below as the &#8220;Administrator&#8221;). To the extent consistent with applicable law, the Administrator may further delegate the ability to grant awards to our CEO or other of our officers. In addition, subcommittees may be established to the extent necessary to comply with Rule 16b-3 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). </span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eligible Award Recipients.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our non-employee directors, employees and consultants, and any individual to whom we or our Affiliates have extended a formal offer of employment (provided that no grants to such individuals can become effective until they actually commence employment), are eligible to receive awards under the 2020 Plan. As of March&#160;20, 2025, approximately 105 employees and 5 directors were eligible to receive future grants from the 2020 Plan. </span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Awards under the 2020 Plan may be made in the form of incentive stock options, non-qualified options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards, other stock-based awards or cash awards. </span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares Subject to the 2020 Plan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Subject to adjustment as set forth below, the total number of shares of Common Stock reserved and available for grant and issuance pursuant to awards under the 2020 Plan is equal to 9,325,000 (reflecting all prior increases to the share reserve under the 2020 Plan and assuming that the stockholders approve the 2020 Plan Amendment), the full amount of which may be issued pursuant to incentive stock options. For purposes of counting shares against the share reserve, awards denominated in shares of Common Stock and other awards that may be exercised for, settled in or convertible into shares of Common Stock will be counted against the 2020 Plan reserve on the date of grant of the award based on the maximum number of shares that may be issued pursuant to the award, as determined by the Administrator. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Award Limits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to any one participant (other than a non-employee director), during any calendar year, (i) the maximum number of shares of Common Stock underlying options and stock appreciation rights that may be granted under the 2020 Plan is 500,000 shares; (B) the maximum number of shares of Common Stock subject to restricted stock awards, awards of restricted stock units and other stock-based awards that may be granted under the 2020 Plan is 500,000 shares; and (C) the maximum amount of a cash award that may be paid is $3,000,000. No director, in any approximate 12-month period beginning on the date of a regular annual meeting and ending on the date of the next regular annual meeting may be granted awards, that, together with any cash fees received from the Company during such period, exceed an aggregate value of $750,000 (with value of each equity award based on its grant date fair value). </span></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions of Awards </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Options and Stock Appreciation Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An &#8220;incentive stock option&#8221; is an option that meets the requirements of Section 422 of the Code, and a &#8220;non-qualified stock option&#8221; is an option that does not meet those requirements. A &#8220;stock appreciation right&#8221; (or SAR) is the right of a participant to a payment, in cash, shares of Common Stock, or a combination of cash and shares equal to the amount by which the market value of a share of Common Stock exceeds the base price of the stock appreciation right. An option or SAR granted under the 2020 Plan will be exercisable only to the extent that it is vested on the date of exercise. No option or SAR may be exercisable more than ten years from the grant date. The Administrator may include in the option agreement the period during which an option may be exercised following termination of employment or service. SARs may be granted to participants in tandem with options or separately. Tandem SARs will generally have substantially similar terms and conditions as the options with which they are granted. The exercise price or base price per share under each option or SAR granted under the 2020 Plan may not be less than 100% of the fair market value of the Company&#8217;s Common Stock on the grant date of such award. For this purpose, and for so long as the Company&#8217;s Common Stock is listed on the Nasdaq Stock Market, fair market value of the Common Stock will be the closing price of the Company&#8217;s Common Stock on the grant date. The 2020 Plan prohibits repricing of options and SARs without stockholder approval. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Restricted Stock and Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Restricted stock is an award of Common Stock on which certain restrictions are imposed over specified periods that subject the shares to a substantial risk of forfeiture. A restricted stock unit is a unit, equivalent in value to a share of Common Stock, credited by means of a bookkeeping entry in our books to a participant&#8217;s account, which is settled in stock or cash upon or after vesting. Subject to the provisions of the 2020 Plan, the Administrator will determine the terms and conditions of each award of restricted stock or restricted stock units, including the restricted/vesting period for all or a portion of the award, and the restrictions applicable to the award. Restricted stock and restricted stock units granted under the 2020 Plan will vest based on a period of service specified by our Administrator or the occurrence of events specified by our Administrator. Unless otherwise provided in an award agreement, dividends declared with respect restricted stock will be held back and paid only to the extent the related restricted stock vests. Further, dividend equivalent rights may be granted with respect to restricted stock units, entitling the participant to receive, subject to the vesting conditions applicable the restricted stock unit, an amount equal to cash or stock dividends or other distributions paid by the Company in respect of one share of Common Stock. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Performance Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Performance awards may be granted as an option, stock appreciation right, restricted stock award, restricted stock unit award, other stock-based award or cash award. Performance awards will be based on the attainment of performance goals that are established by the Administrator for the relevant performance period prior to the grant of the award. The Administrator will determine and set forth in the award agreement such terms as (i) the nature, length and starting date of any performance period; (ii) the applicable performance goals that shall be used to determine the time and extent to which the award has been earned; and (iii) the effect of a termination of participant&#8217;s service on a performance award. At the end of the applicable performance period, the Administrator will determine the extent to which a performance award has been earned, including the extent to which performance goals have been attained and the degree of achievement between minimum and maximum levels. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Other Stock-Based Awards and Cash Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrator may grant other stock-based awards or cash awards not otherwise described by the terms of the 2020 Plan. Other stock-based awards are payable in, valued in whole or in part by reference to, or otherwise based on or related to shares of the Company&#8217;s Common Stock, including, but not limited to, shares of Common Stock awarded as a bonus or other compensation which are issued without restrictions on transfer and free from forfeiture conditions. A cash </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">award is an award denominated in cash that is subject to such performance goals and service requirements as specified by the Administrator in the applicable award agreement. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Termination of Employment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise determined by the Administrator, in the event a participant&#8217;s employment terminates for any reason other than &#8220;cause&#8221; (as defined in the 2020 Plan), all of such participant&#8217;s unvested options and SARs will be forfeited and all vested options and SARs will remain exercisable until the 90th day following the date of termination (or the expiration of the award&#8217;s maximum term, whichever is earlier); however, in the event of termination by reason of death or &#8220;disability&#8221; (as defined in the 2020 Plan), vested options and SARs will remain exercisable for 12 months (or the expiration of the award&#8217;s maximum term, whichever is earlier). Except as otherwise determined by the Administrator, in the event of a participant&#8217;s termination for cause, all unvested and vested options then outstanding will immediately be forfeited and canceled. Further, for all other types of awards under the 2020 Plan, the Administrator may specify in any award agreement that a participant&#8217;s award will be forfeited upon termination for cause. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Other Forfeiture Provisions; Clawback</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All awards granted under the 2020 Plan will be subject to recoupment in accordance with the Company&#8217;s clawback policy or applicable law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an award agreement or compensation clawback policy as the Board determines necessary or appropriate, including a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event constituting cause. Further, unless otherwise provided in an award agreement, if at any time within 1 year after an award is exercised, vests, becomes payable, either (i) the participant is terminated for cause, or (ii) the Administrator determines that while in service the participant had engaged in an act which would have warranted termination for cause, or following termination of service the participant violated continuing obligation or duty to the Company, the Administrator may require the participant to pay back to the Company any gain realized by the participant. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Change in Capitalization or Other Corporate Event</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The number or amount of shares of stock, other property or cash covered by outstanding awards, the number and type of shares of stock that have been authorized for issuance under the 2020 Plan, the exercise or base price (as applicable) of each outstanding award, and the other terms and conditions of outstanding awards, will be subject to adjustment by the Administrator in the event of any stock dividend, extraordinary dividend, stock split or share combination or any recapitalization, merger, consolidation, exchange of shares, spin-off, liquidation or dissolution of the Company or other similar transaction affecting the</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s Common Stock. Any such adjustment would not be considered repricing for purposes of the prohibition on repricing described above.  </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Effect of a Change in Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Administrator has the ability to prescribe the effect of a future change in control in the award agreement or otherwise, including, for example, settlement of awards based on the consideration provided for in the agreement pursuant to which the change in control awards. Unless otherwise determined by the Administrator, no accelerated vesting of awards will occur if awards are assumed and/or replaced in the change in control with substitute awards unless the participant&#8217;s employment is involuntarily terminated without &#8220;cause&#8221; within 12 months following the date of the change in control. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Deferrals of Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under the 2020 Plan, the Administrator may determine that payment pursuant to an award shall be deferred and may establish programs and procedures for deferral elections to be made by participants, provided that such deferrals will be made in accordance with Section 409A of the Code. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Non-Transferability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The 2020 Plan restricts the ability of an award holder from transferring awards granted under the 2020 Plan other than by will, the laws of descent and distribution or, with the prior approval of the Administrator. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Amendment and Termination</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board may, in its discretion, amend or terminate the 2020 Plan at any time; provided that the Board may not take any action that materially impairs the rights of any participant with respect to an outstanding award without the consent of the participant. Stockholder approval is required (i) to materially increase the number of shares subject to the 2020 Plan (other than pursuant to an equitable adjustment in connection with changes relating to the Company&#8217;s Common Stock as permitted under the 2020 Plan); (ii) to materially expand the class of individuals eligible to receive awards under the 2020 Plan; (iii) materially reduce the price at which Common Stock may be issued or purchased under the 2020 Plan; (iv) </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materially extend the term of the 2020 Plan; (v) materially expand the types of awards available for issuance under the 2020 Plan, or (vii) as otherwise required by applicable law. </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:19pt">Term of the 2020 Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The term of the 2020 Plan extends for a period of ten years from September 30, 2020 and, accordingly, will remain in effect unless sooner terminated through September 30, 2030. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Income Tax Consequences </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a brief summary of the intended United States federal income tax consequences applicable to awards granted under the 2020 Plan. The discussion below is based upon United States federal income tax laws in effect as of the date of this Proxy Statement. This summary is not intended to be exhaustive and does not address all matters that may be relevant to a particular participant based on his or her specific circumstances, or the tax consequences of any awards granted to participants who reside outside of the United States. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonqualified Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nonqualified stock options will not be taxable to a participant at grant but generally will result in taxation at exercise, at which time the participant will recognize ordinary income in an amount equal to the difference between the option&#8217;s exercise price and the fair market value of a share of our Common Stock on the exercise date. The Company will be entitled to deduct a corresponding amount as a business expense in the year the participant recognizes this income, subject to Section 162(m) of the Code. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incentive Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A participant will generally not recognize ordinary income on receipt or exercise of an incentive stock option (an &#8220;ISO&#8221;) so long as he or she has been an employee of the Company or its subsidiaries from the date the ISO was granted until three months before the date of exercise; however, the amount by which the fair market value of the shares of our Common Stock on the exercise date exceeds the exercise price is an adjustment in computing the participant&#8217;s alternative minimum tax in the year of exercise. If the participant holds the shares of our Common Stock received on exercise of the ISO until at least one year after the date of exercise (and for at least two years from the date of grant of the ISO), any difference between the amount realized upon the disposition of the shares and the amount paid for the shares will be treated as long-term capital gain (or loss, if applicable) to the participant. If the participant exercises an ISO and satisfies these holding period requirements, the Company may not deduct any amount in connection with the ISO. If the participant exercises an ISO but engages in a &#8220;disqualifying disposition&#8221; by selling the shares acquired on exercise before the expiration of the one and two-year holding periods described above, the participant generally will recognize ordinary income (for regular income tax purposes only) in the year of the disqualifying disposition equal to the excess, if any, of the fair market value of the shares on the date of exercise over the exercise price; and any excess of the amount realized on the disposition over the fair market value on the date of exercise will be taxed as long- or short-term capital gain (as applicable). If, however, the fair market value of the shares on the date of the disqualifying disposition is less than on the date of exercise, the participant will recognize ordinary income equal only to the difference between the amount realized on the disqualifying disposition and the exercise price. In either event of a disqualifying disposition, the Company will generally be entitled to deduct an amount equal to the amount constituting ordinary income to the participant in the year of the disqualifying disposition, subject to Section 162(m) of the Code. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There are no immediate tax consequences to a participant when a stock appreciation right is granted. When a participant exercises a stock appreciation right, the participant will recognize ordinary income equal to the amount of cash and the fair market value of any shares received. The Company will generally be entitled to deduct the same amount as a business expense in the same year, subject to Section 162(m) of the Code. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The recognition of income from an award of restricted stock for federal income tax purposes depends on the restrictions imposed on the shares. Generally, taxation will be deferred until the first taxable year the shares are no longer subject to substantial risk of forfeiture. At the time the restrictions lapse, the participant will recognize ordinary income equal to the then fair market value of the stock. The participant may, however, make an election, within 30 days following the date the shares are issued, to include the value of the shares in gross income in the year of the award despite such restrictions; in such case, any subsequent appreciation of the shares will be treated as a capital gain. Generally, the Company will be entitled to deduct the fair market value of the shares transferred to the participant as a business expense in the year, and in the same amount, that the participant includes the compensation in income, subject to Section 162(m) of the Code. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Generally, a participant will not recognize ordinary income until Common Stock, cash, or other property becomes payable under a restricted stock unit, even if the award vests in an earlier year. The Company will generally be entitled to deduct the amount the participant includes in income as a business expense in the year of payment, subject to Section 162(m) of the Code. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Generally, a participant will not incur any income tax liability upon the initial grant of performance awards. At the end of the performance or measurement period, however, the participant will generally realize </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ordinary income on any amounts received in cash or shares of our Common Stock, and any subsequent appreciation in shares will be treated as a capital gain (unless the award is in the form of an option or stock appreciation right in which case the tax consequences described above for such awards will generally apply). The Company will generally be entitled to deduct the amount the participant includes in income as a business expense in the year of payment, subject to Section 162(m) of the Code. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Stock-Based Awards and Cash Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any cash payments or the fair market value of any shares of our Common Stock or other property a participant receives in connection with other stock-based awards or cash awards are includable in income in the year received or made available to the participant without substantial limitations or restrictions. The Company will generally be entitled to deduct the amount the participant includes in income as a business expense in the year of payment, subject to Section 162(m) of the Code. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Section 409A of the Code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain types of awards under the 2020 Plan, such as restricted stock units (and any related dividend equivalent rights), may constitute, or provide for, a deferral of compensation under Section 409A of the Code. Unless certain requirements set forth in Section 409A of the Code are complied with, holders of such awards may be taxed earlier than would otherwise be the case (e.g., at the time of vesting instead of the time of payment) and may be subject to an additional 20% penalty tax (and, potentially, certain interest penalties). To the extent applicable, the 2020 Plan has been, and we intend that awards under the 2020 Plan will be, structured and interpreted in a manner intended to either comply with or be exempt from Section 409A of the Code and the Department of Treasury regulations and other interpretive guidance that may be issued under Section 409A of the Code. To the extent determined necessary or appropriate by the Administrator, the 2020 Plan and applicable award agreements may be amended to further comply with Section 409A of the Code or to exempt the applicable awards from Section 409A of the Code. However, the 2020 Plan does not provide for an indemnity by the Company of any participant for any taxes incurred by reason of Section 409A of the Code. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Section 162(m) of the Code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Section 162(m) of the Code generally disallows public companies a tax deduction for federal income tax purposes of remuneration in excess of $1 million paid to certain executive officers in one year. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Plan Benefits </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All future awards granted under the 2020 Plan will be made at the discretion of the Compensation Committee and, accordingly, are not yet determinable. In addition, benefits under the 2020 Plan will depend on a number of factors, including the fair market value of our shares on future dates and the exercise decisions made by the participants. Consequently, it is not possible to determine the benefits that might be received by participants under the 2020 Plan. The table below shows the number of options granted under the 2020 Plan in 2024, our last completed fiscal year, to the persons and groups of persons identified in the table. The table does not include any information on future awards under the 2020 Plan. </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and Position</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options<br/>(#)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel, Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,500</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vojislav Vukovic, Chief Medical Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,500</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martha Rook, Chief Operating Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Executive Director Group</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,500</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Executive Officer Employee Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323,000</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">In 2024, Dr. Rook received an option to purchase 125,000 shares of Common Stock under our 2023 Inducement Plan.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The executive group is comprised of Gerard Michel, Vojislav Vukovic and Martha Rook. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The non-executive officer employee group includes all employees, including all current officers who are not executive officers, as a group.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Benefits </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for each of the individuals and various groups indicated, certain information regarding awards that have been granted under the 2020 Plan since its inception through March&#160;20, 2025. A total of 349,995 shares of Common Stock have been issued under the 2020 Plan as of March&#160;20, 2025.</span></div><div style="margin-top:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"/><td style="width:84.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and Position</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options<br/>(#)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel, Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241,924</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vojislav Vukovic, Chief Medical Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,500</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martha Rook, Chief Operating Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All current executive officers as a group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,568,424</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All current directors who are not executive officers as a group</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,228</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each nominee for election as a director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Gerard Michel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241,924</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Gilad Aharon, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,182</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each associate of any executive officers, current directors, or director nominees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each other person who received or is to receive 5% of shares under the 2020 Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All employees, including current officers who are not executive officers, as a group </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,716,515</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This amount represents employee grants from the 2020 Plan except for grants issued to those specified in this table. The amount shown does not include historical forfeitures and does not represent current options outstanding or issuable upon exercise for this group. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to &#8220;Equity Compensation Plan Information&#8221; below for further information about shares that may be issued under all of our equity compensation plans as of December 31, 2024, including the 2020 Plan.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registration with the Commission</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (the &#8220;Commission&#8221;) for the purpose of registering shares of Common Stock under the 2020 Plan pursuant to the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and intend to file a Registration Statement on Form S-8 with the Commission as soon as practicable to register additional shares of Common Stock under the 2020 Plan, subject to the approval of the 2020 Plan Amendment by our stockholders at the Annual Meeting. </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF PROPOSAL 2. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EQUITY COMPENSATION PLAN INFORMATION </span></div><div style="margin-top:12pt;text-indent:24.48pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information as of December&#160;31, 2024 with respect to compensation plans (including individual compensation arrangements) under which shares of Common Stock are authorized for issuance. </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Plan category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">securities to be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">issued upon</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">exercise of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">outstanding options,</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">warrants and rights</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted-average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">exercise price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">outstanding</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">options, warrants</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">and rights</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">remaining available for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">future issuance under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">equity compensation plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(excluding securities</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">reflected in column (a))</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(c)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Equity compensation plans approved by security holders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11pt;text-indent:-10pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,510,302</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,343,767</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equity compensation plans not approved by security holders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,256,625</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">255,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 28.37pt;text-indent:-10pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,766,927</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,598,767</span></td></tr></table></div><div style="margin-top:7pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Includes (a) stock options for an aggregate of 499 shares of Common Stock issued under the Company&#8217;s 2019 Equity Incentive Plan, which allows for grants in the form of incentive stock options, non-qualified stock options, stock units, stock awards, stock appreciation rights, and other stock-based awards to the Company&#8217;s officers, directors, employees, consultants, and advisors, including options to purchase shares of Common Stock at exercise prices not less than 100% of fair value on the dates of grant. As of November 2, 2020, no additional grants may be made under this plan, which has been superseded by the 2020 Plan; however, outstanding awards granted under this plan will remain outstanding and continue to be administered in accordance with the terms of this plan and the applicable award agreements; (b) pursuant to an employment agreement dated as of August 31, 2020 between the Company and Mr. Michel on October 1, 2020, a non-qualified and non-plan stock option &#8220;inducement award&#8221; to purchase 498,000 shares of our Common Stock in reliance on Nasdaq Rule 5635(c)(4) pursuant to the terms of a stock option award agreement between the Company and Mr. Michel (additional information about this stock option award can be found elsewhere in this Proxy Statement under the heading &#8220;Agreements with our Named Executive Officers&#8221;); and (c) new hire inducement awards to purchase 758,126 shares of our Common Stock in reliance on Nasdaq Rule 5635(c)(4) pursuant to the terms of a stock option award agreement between the Company and each of 27 certain employees hired between 2022 and 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_251"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL 3: APPROVAL OF AN AMENDMENT TO THE DELCATH SYSTEMS, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN </span></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Overview</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Board, with shareholder approval in May 2022, adopted the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP provides for a maximum of 260,295 shares of Common Stock to be purchased by participating employees of which 148,506 have been issued as of March&#160;20, 2025. Employees who elect to participate in the ESPP will be able to purchase Common Stock at the lower of 85% of the fair market value of Common Stock on the first or last day of the applicable six-month offering period. We are asking our stockholders to approve an amendment to the ESPP, to increase the number of shares of Common Stock available for issuance under the ESPP by 300,000. The ESPP encourages stock ownership by all eligible employees of the Company and designated subsidiaries so that they may share in our growth by acquiring or increasing their proprietary interest in Delcath. Our Board unanimously approved the proposed amendment of the ESPP on February 6, 2025, subject to stockholder approval at the Annual Meeting (the &#8220;ESPP Amendment&#8221;). If approved by the stockholders, the ESPP Amendment will become effective as of the date of the Annual Meeting.</span></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of the ESPP</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the material terms of the ESPP. These sections are qualified in their entirety by reference to the full text of the ESPP, which is included as Appendix B to this Proxy Statement. </span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purpose.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The ESPP is intended to encourage stock ownership by all eligible employees of Delcath and designated subsidiaries so that they may share in our growth by acquiring or increasing their proprietary interest in Delcath. The ESPP is designed to encourage eligible employees to remain in the employ of Delcath and its designated subsidiaries. The ESPP is intended to constitute an &#8220;employee stock purchase plan&#8221; within the meaning of Code Section 423(b).</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As further described below, the ESPP permits eligible employees to use payroll deductions to purchase shares of the Common Stock at a discount. The payroll deductions accumulate over &#8220;purchase periods.&#8221; On the first day of each purchase period, each participant in the ESPP is automatically granted an option to purchase as many whole shares of the Common Stock as the participant will be able to purchase with the payroll deductions credited to his or her account during the purchase period, subject to various limits described below. At the end of the purchase period, the total payroll deductions of all participants are used to purchase Common Stock directly from Delcath at the discount.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Subject to the ESPP.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The stock subject to options under the ESPP are shares of our authorized but unissued Common Stock, or shares of Common Stock we reacquire, including shares purchased in the open market. If approved by our stockholders, the ESPP Amendment will increase by 300,000 shares of Common Stock the current authorization of 260,295 shares of Common Stock, for a total share reserve under the ESPP as proposed to be amended of 560,295 shares of Common Stock. If any option granted under the ESPP expires or terminates for any reason without having been exercised in full or ceases for any reason to be exercisable in whole or in part, the unpurchased shares subject thereto will again be available under the ESPP. The ESPP is not a tax-qualified deferred compensation plan under Section 401(a) of the Code and is not intended to be an employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Administration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The ESPP is administered by the person or persons appointed by the Board. The Board has appointed the Compensation Committee as the administrator of the ESPP (the Board or such committee is referred to below as the &#8220;Administrator&#8221;). The interpretation and construction by the Administrator of any provisions of the ESPP or of any option granted under it will be final, unless otherwise determined by the Board. The Administrator may from time to time adopt such rules and procedures for carrying out the ESPP as it may deem best, provided that any such rules and regulations will be applied on a uniform basis to all employees under the ESPP. The Administrator may adopt such rules, procedures and sub-plans relating to the operation and administration of the Plan as are necessary or appropriate under applicable local laws, regulations and procedures to permit or facilitate participation in the ESPP by employees of the Company or any designated subsidiary who are foreign nationals or employed or located outside the United States. No member of the Board or the Administrator will be liable for any action or determination made in good faith with respect to the ESPP or any option granted under it.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eligibility.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except as otherwise determined by the Administrator with respect to a purchase period prior to the start date thereof, all employees of Delcath or any of the designated subsidiaries who are (a) so employed on the start date of any purchase period, (b) have continuously been employed with Delcath or the designated subsidiary for at least 30 days prior to such start date and (c) unless otherwise specified in an offering, customarily work greater than 20 hours per week will be eligible to participate and receive an option with respect to such purchase period. All eligible </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees will have the same rights and privileges under the ESPP with respect to such purchase period. In no event, however, may an employee be granted an option if such employee, immediately after the option is granted, would be treated as owning stock possessing five percent or more of the total combined voting power or value of all classes of stock of Delcath or of any parent corporation or subsidiary corporation, as the terms &#8220;parent corporation&#8221; and &#8220;subsidiary corporation&#8221; are defined in Code Sections 424(e) and (f). For purposes of determining stock ownership under this paragraph, the rules of Code Section 424(d) will apply, and stock that the employee may purchase under outstanding options (including options not granted under the ESPP) will be treated as stock owned by the employee. We had approximately 92 employees who were eligible to participate in the current ESPP Offering Period. </span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offerings; Purchase Periods; Exercise Dates; Certain Limits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company will make one or more offerings to eligible employees to purchase Common Stock under the ESPP. The Administrator will designate the duration, frequency and start and end dates of each offering under the ESPP and the number and duration of purchase periods within an offering, provided that no offering shall exceed 27 months.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The end date within each purchase period will be the day on which shares of the Common Stock are purchased by participants in a purchase period, which date we refer to as exercise date. On the start date of each purchase period, we will grant to each eligible employee who has then elected to be a participant in the ESPP an option to purchase on the relevant exercise date, at the option price hereinafter provided for, the lowest of (a) a number of shares of Common Stock determined by dividing such participant&#8217;s accumulated payroll deductions on such exercise date by the lower of (i) 85% of the fair market value of the Common Stock on the first date of the offering or (ii) 85% of the fair market value of the Common Stock on the exercise date, or (b) the maximum number of shares as shall be established by the Administrator in advance of and set forth in the offering. A participant will be entitled to exercise the option so granted only to the extent of the participant&#8217;s accumulated payroll deductions on the exercise date.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option Price.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The purchase price for each share of Common Stock purchased under each option, or the option price, will not be lower than the lesser of 85% of the fair market value of the Common Stock on the start date of each offering or the exercise date. For purposes of the ESPP, the term &#8220;fair market value&#8221; on any date means the value of the Common Stock as determined below. If the Common Stock is listed on any established stock exchange or a national market system, including The New York Stock Exchange or The Nasdaq Stock Market, the fair market value will be the closing price of a share of Common Stock (or if no sales were reported on such date, the closing price on the last trading date) as quoted on such exchange or system. In the absence of an established market for the Common Stock, the fair market value will be determined in good faith by the Administrator and such determination will be conclusive and binding on all persons. As of March&#160;20, 2025, the closing price of a share of Common Stock on Nasdaq was $14.00</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">$25,000 Limitation.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No employee will be granted an option that permits the employee&#8217;s right to purchase stock under the ESPP, and under all other Code Section 423(b) employee stock purchase plans of the Company and any parent corporations or subsidiary corporations, as &#8220;parent corporation&#8221; and &#8220;subsidiary corporation&#8221; are defined in Code Section 424(e) and (f), to accrue at a rate that exceeds $25,000 of fair market value of such stock (determined on the date or dates that options on such stock were granted) for each calendar year in which such option is outstanding at any time. The purpose of the limitation in the preceding sentence is to comply, and such limitation will be administered in accordance, with Code Section 423(b)(8).</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payroll Deductions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> An eligible employee may enroll in the ESPP by submitting an enrollment form to his or her appropriate payroll location at least 15 business days before the first day of the purchase period in which he or she wishes to participate. An employee may authorize payroll deductions in either a dollar amount or as a percentage of the employee&#8217;s Compensation, subject to such minimums and maximums determined by the Administrator and set forth in the offering or enrollment form applicable to such offering. For this purpose, &#8220;Compensation&#8221; means an employee&#8217;s base pay or salary from the Company or designated subsidiary, including such amounts of base pay or salary as are deferred by the employee (a) under a qualified cash or deferred arrangement described in Code Section 401(k) or (b) to a plan qualified under Code Section 125. A participant in the ESPP may not increase or decrease his or her payroll deduction during the purchase period of an offering but may increase or decrease his or her payroll deduction with respect to the next offering.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan Withdrawal.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A participant may withdraw from the ESPP (in whole but not in part) by giving written notice of withdrawal to his or her appropriate payroll location. Such withdrawal will be effective as of the next business day. Following a participant&#8217;s withdrawal, the entire balance of his or her unused payroll deduction account under the ESPP will be promptly refunded, without interest. An employee who has withdrawn from the ESPP may not begin participation again during the remainder of the offering, but may enroll in a subsequent offering by submitting an enrollment form to his or her appropriate payroll location at least 15 business days before the first day of the next purchase period in which he or she wishes to participate.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjustments; Change in Control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board, in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the ESPP, will, in such manner as it may deem equitable, adjust the number of shares of Common Stock available for issuance under the ESPP, the option price, the maximum number of shares that may be purchased during a purchase period, as well as any other terms that the Board determines require adjustment, for: (a) any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock; or (b) any other increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration by the Company.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a Change in Control, each outstanding option may (if approved by the Board) be assumed or an equivalent option substituted by the surviving corporation or the acquiring corporation (or the parent or subsidiary of such surviving or acquiring corporation). If such surviving or successor corporation does not (or will not) assume or substitute the option, the offering with respect to which the option relates will be shortened by setting a new exercise date on which the offering will end. The new exercise date will occur before the date of such Change in Control and all outstanding options under the ESPP will automatically be exercised immediately on such new exercise date. For purposes of the ESPP, &#8220;Change in Control&#8221; means the closing of any one or more of the following events: (a) a corporate merger or consolidation of the Company with any other entity other than a transaction which would result in the voting power of the securities of the Company outstanding immediately prior thereto continuing to represent at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation; (b) any person or group of persons acquires ownership of the stock of the Company such that all the stock held by such person or group constitutes more than 50% of the total voting power of the stock of the Company; (c) a majority of the Company&#8217;s directors is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the Company&#8217;s directors prior to the date of the appointment or election; or (d) any one person or group of persons acquires assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An option granted under the ESPP may not be transferred or assigned, except by will or the laws of descent and distribution, and will be exercised, during a participant&#8217;s lifetime, only by the participant.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Terminations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Whenever a participant ceases to be an eligible employee because of retirement, voluntary or involuntary termination, resignation, layoff, discharge, death, or for any other reason, his or her rights under the ESPP will immediately terminate, and the entire balance of his or her payroll deduction account under the ESPP will be promptly refunded, without interest. Notwithstanding the foregoing, eligible employment will be treated as continuing intact while the participant is on military leave, sick leave, or other bona fide leave of absence (such as temporary employment by the government) if the period of such leave does not exceed three months, or if longer, so long as the participant&#8217;s right to reemployment with the Company or designated subsidiary is provided either by statute or by contract. If the period of leave exceeds three months and the participant&#8217;s right to reemployment with the Company or designated subsidiary is not provided either by statute or by contract, the employment relationship will be deemed to terminate on the first day immediately following such three-month period.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Termination of Plan; Amendment of Plan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The ESPP may be terminated at any time by the Board, at which time all amounts in the accounts of participants shall be promptly refunded. If the ESPP is terminated, the Administrator may elect to terminate all outstanding offerings either immediately or once shares of Common Stock have been purchased on the next exercise date (which may, in the Administrator&#8217;s discretion, be accelerated) or permit offerings to expire in accordance with their terms. If an offering is terminated before its scheduled expiration, all payroll deductions accumulated on behalf of participants under the ESPP that have not been used to purchase shares of Common Stock will be returned to each participant (without interest, except as otherwise required by law) as soon as administratively practicable.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may amend the ESPP in any respect, except that, without the approval within 12 months of such Board action by the stockholders, no amendment shall be made increasing the number of shares approved for issuance under the ESPP or making any other change that would require stockholder approval in order for the ESPP, as amended, to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423(b) of the Code. If the terms of the ESPP are amended in a manner that would require stockholder approval under the requirements of The Nasdaq Stock Market or under Code Section 423, stockholders will be asked to approve such amendment. </span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Designated subsidiaries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The term &#8220;designated subsidiary&#8221; means any of the Company&#8217;s present or future subsidiaries, as that term is defined in Code Section 424(f), that is designated from time to time by the Board to participate in the ESPP. The Board may so designate any subsidiary, or revoke any such designation, at any time and from time to time, either before or after the ESPP is approved by the stockholders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optionees Not Stockholders.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Neither the granting of an option to an employee nor the deductions from his or her pay will constitute such employee a stockholder of the shares covered by an option until such shares have been actually purchased by the employee. A participant will have no interest or voting right in shares covered by the participant&#8217;s option until such shares are actually purchased on the participant&#8217;s behalf in accordance with the applicable provisions of the ESPP.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Application of Funds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company will accumulate and hold for each participant&#8217;s account the amounts deducted from the participant&#8217;s pay. No interest will be paid on these amounts. We may use payroll deductions that we receive or hold under the ESPP for any corporate purpose, and we will not be obligated to segregate such payroll deductions or hold them exclusively for the benefit of participants.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governing Law. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The validity and construction of the ESPP is governed by the laws of Delaware, without giving effect to the principles of conflicts of law thereof.</span></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain U.S. Federal Income Tax Consequences.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following brief summary of the effect of U.S. federal income taxation upon a participant and the Company with respect to shares of Common Stock purchased under the ESPP does not purport to be complete and does not discuss the tax consequences of a participant&#8217;s death or the income tax laws of any state or non-U.S. jurisdiction in which the participant may reside. The ESPP, and the right of U.S. participants to make purchases thereunder, is intended to qualify under the provisions of Code Sections 421 and 423. Under these provisions, no income will be taxable to a participant until shares purchased under the ESPP are sold or otherwise disposed of. Upon sale or other disposition of shares, the participant generally will be subject to tax in an amount that depends upon whether the sale occurs before or after expiration of the holding periods described in the following sentence. If the shares are sold or otherwise disposed of more than two years from the first day of the applicable purchase period and one year from the applicable exercise date, the participant will recognize ordinary income measured as the lesser of (a) the excess of the fair market value of the shares at the time of such sale or disposition over the option price and (b) the excess of the fair market value of a share on the first day of the applicable purchase period over the option price. Any additional gain will be treated as long term capital gain. If the shares are sold or otherwise disposed of before the expiration of either of these holding periods, the participant will recognize ordinary income generally measured as the excess of the fair market value of the shares on the date the shares are purchased over the option price. Any additional gain or loss on such sale or disposition will be long- or short-term capital gain or loss, depending on how long the shares were held from the date of purchase. We generally are not entitled to a deduction for amounts taxed as ordinary income or capital gain to a participant, except to the extent of ordinary income recognized by participants upon a sale or disposition of shares prior to the expiration of the holding periods described above.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Plan Benefits. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits under the ESPP will depend on participants&#8217; elections to participate and the fair market value of Common Stock at various future dates. As a result, it is not possible as of the date of this Proxy Statement to determine future benefits that will be received by executive officers and other employees of Delcath and designated subsidiaries. Each participant is limited to the $25,000 annual purchase restriction described above.</span></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for each of the individuals and various groups indicated, certain information regarding estimated purchase rights that have been granted (even if not currently outstanding) under the ESPP since its inception through March&#160;20, 2025. A total of 148,506 shares of Common Stock have been issued under the ESPP as of March&#160;20, 2025.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"/><td style="width:84.985%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and Position</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Purchase Rights<br/>(#)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel, Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vojislav Vukovic, Chief Medical Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martha Rook, Chief Operating Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All current executive officers as a group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All current directors who are not executive officers as a group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each nominee for election as a director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gilad Aharon, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each associate of any executive officers, current directors, or director nominee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each other person who received or is to receive 5% of purchase rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All employees, including current officers who are not executive officers, as a group </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,766</span></td></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Our non-employee directors are not eligible to participate in the ESPP.</span></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration with the Commission. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate filing a registration statement on Form S-8 with the SEC Commission to register the shares of Common Stock being added to the ESPP under the ESPP Amendment as soon as practicable, subject to and effective upon stockholder approval of the ESPP Amendment.</span></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS VOTE &#8220;FOR&#8221; THE APPROVAL OF PROPOSAL 3. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL 4: RATIFICATION OF THE SELECTION, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF CBIZ CPAs P.C. AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee has appointed CBIZ CPAs P.C.. (&#8220;CBIZ CPAs&#8221;) as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025. On March 18, 2025, Delcath Systems, Inc. (the &#8220;Company&#8221;) was notified by Marcum LLP (&#8220;Marcum&#8221;) that Marcum resigned as the Company&#8217;s independent registered accounting firm. On November 1, 2024, CBIZ CPAs acquired the attest business of Marcum. Marcum served as our independent registered public accounting firm for the fiscal year ended December&#160;31, 2024. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although ratification by our stockholders is not required by law or by our bylaws, the Audit Committee believes that submission of its selection to our stockholders is a matter of good corporate governance. Even if the appointment is ratified, the Audit Committee, in its discretion, may select a different independent registered public accounting firm at any time if the Audit Committee believes that such a change would be in the Company&#8217;s best interests and in the best interests of our stockholders. If our stockholders do not ratify the selection of CBIZ CPAs, the Audit Committee will take that fact into consideration, together with such other factors as it deems relevant, in determining its next selection of an independent registered public accounting firm. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fees Paid to Independent Registered Public Accounting Firms. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fees billed to the Company by Marcum for professional services rendered as our independent registered public accounting firm during the fiscal years ended December&#160;31, 2023 and 2024, respectively, were: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Fees</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$278,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$425,390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit-Related Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$337,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$425,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These are fees for services rendered in connection with the audit of the annual financial statements included in our Annual Reports on Form 10-K; the review of the financial statements included in our Quarterly Reports on Form 10-Q; and for services that are normally provided by an independent auditor in connection with statutory and regulatory filings or engagements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit-Related Fees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Marcum performed assurance and related services that were reasonably related to the performance of the audit or review of our financial statements for the year ended December&#160;31, 2023. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Fees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Marcum did not perform any tax compliance services for us during the years ended December&#160;31, 2023 and 2024. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">All Other Fees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Marcum did not receive any other fees from us for the years ended December&#160;31, 2023 and 2024. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-Approval Policies: Audit and Non-Audit Services. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee pre-approves all audit services and the terms of such services and permissible non-audit services provided by our independent registered public accounting firm, prior to its engagement for the provision of such services. The Chair of the Audit Committee has been delegated the authority by the committee to pre-approve interim services by our independent registered public accounting firm; provided that the Chair reports all such pre-approvals to the entire Audit Committee at the next Audit Committee meeting. There were no non-audit services provided to us by our independent registered public accounting firm for 2023 or 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that required review by the Audit Committee. </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#8220;FOR&#8221; THE RATIFICATION OF THE SELECTION, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF CBIZ CPAs P.C. AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL 5: APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE NAMED EXECUTIVE OFFICER COMPENSATION AS DISCLOSED IN THIS PROXY STATEMENT </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Section 14A of the Exchange Act (which was added by the Dodd-Frank Wall Street Reform and Consumer Protection Act and the related rules of the Commission or the Dodd-Frank Act), we are providing our stockholders with the opportunity to vote on a non-binding, advisory resolution to approve the compensation of our named executive officers, as disclosed in this Proxy Statement pursuant to Item 402 of Regulation S-K, including the compensation tables and narrative discussion. This proposal, commonly known as a &#8220;say-on-pay&#8221; proposal, gives our stockholders the opportunity to express their views on our named executive officers&#8217; compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and our compensation philosophy, policies and practices described in this Proxy Statement. Accordingly, we ask our stockholders to vote &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; the following resolution at the meeting: </span></div><div style="margin-top:12pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;RESOLVED, that the compensation of Delcath&#8217;s named executive officers, as disclosed in this Proxy Statement pursuant to Item 402 of Regulation S-K, including the compensation tables and narrative discussion, is hereby APPROVED.&#8221; </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total compensation of our named executive officers consists primarily of base salary, annual incentive cash bonuses and long-term equity incentive awards in the form of stock options and restricted stock awards, as well as other benefits that are available to all Delcath employees. Base salary and annual incentive cash bonuses are viewed as short-term compensation to reward our named executive officers for meeting individual and company performance objectives, while stock options and restricted stock awards are viewed as rewards for improving corporate performance over the long term and increasing stockholder value. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation philosophy and programs for our named executive officers are described in detail under the heading &#8220;Executive Compensation.&#8221; </span></div><div style="margin-top:12pt;text-align:center;text-indent:24.48pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE &#8220;FOR&#8221; THE APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE NAMED EXECUTIVE OFFICER COMPENSATION AS DISCLOSED IN THIS PROXY STATEMENT. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding the beneficial ownership of our Common Stock, Series E Convertible Preferred Stock, Series E-1 Convertible Preferred Stock, Series F-2 Preferred Stock and Series F-4 Preferred Stock as of March&#160;20, 2025, held by: (i) each director and director nominee; (ii) each of the named executive officers; (iii) all of our directors and executive officers as a group; and (iv) each additional person or group who is known by us to own beneficially more than 5% of the outstanding shares of each class of our voting securities. </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficial ownership is determined in accordance with the rules of the Commission and includes any shares over which a person exercises sole or shared voting or investment power. Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown beneficially owned by them, subject to applicable community property laws. Shares of Common Stock issuable upon vesting, exercise or conversion of outstanding equity awards or preferred stock that are exercisable, subject to vesting or convertible within 60 days after March&#160;20, 2025 are deemed beneficially owned and such shares are used in computing the percentage ownership of the person holding the awards, but are not deemed outstanding for the purpose of computing the percentage ownership of any other person. The information contained in the following table is not necessarily indicative of beneficial ownership for any other purpose, and the inclusion of any shares in the table does not constitute an admission of beneficial ownership of those shares.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as indicated in the footnotes below, the address of the persons or groups named below is c/o Delcath Systems, Inc., 566 Queensbury Avenue, Queensbury, NY 12804. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Beneficially Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Beneficial Owner:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series E<br/>Preferred<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Class</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series<br/>E-1<br/>Preferred<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Class</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series<br/>F-2<br/>Preferred<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Class</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series<br/>F-4<br/>Preferred<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of Class</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Named Executive Officers and Directors:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gerard Michel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,457,615</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Martha Rook</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,391</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kevin Muir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263,626</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sandra Pennell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191,243</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vojislav Vukovic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,490</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">David Hoffman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">267,103</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilad Aharon, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(12)(18)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,385,153</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,149</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,753</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,085</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,150</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Elizabeth Czerepak</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,182</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Steven Salamon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(14)(18)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,379,668</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,149</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,753</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,085</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,150</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">John R. Sylvester</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(15)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bridget Martell, M.A. M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(16)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,500</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All directors and executive officers as a group (11 persons)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,275,414</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,149</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,753</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,085</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,150</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">5% Stockholders:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Rosalind Master Fund L.P.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(18) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Rosalind Opportunities Fund I L.P.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,388,589</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,149</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,753</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,085</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,150</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Vivo Opportunity Fund Holding, LP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(19)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,708,579</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.5pt">Less than 1% </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Except as indicated in these footnotes the number of shares of Common Stock beneficially owned by each person includes any restricted shares of Common Stock, shares of Common Stock that may be acquired through the exercise of options and warrants that such person has the right to acquire as of, or within 60 days of March&#160;20, 2025, excluding any conversion of Preferred Stock.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on 9,205 shares of Series E Preferred Stock issued and outstanding as of March&#160;20, 2025.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on 1,753 shares of Series E-1 Preferred Stock issued and outstanding as of March&#160;20, 2025.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on 1,085 shares of Series F-2 Preferred Stock issued and outstanding as of March&#160;20, 2025.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on 2,150 shares of Series F-4 Preferred Stock issued and outstanding as of March&#160;20, 2025.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 319,334 shares of Common Stock held by Mr. Michel and 1,138,281 shares of Common Stock that may be acquired through the exercise of options that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 4,740 shares of Common Stock held by Dr. Rook and 64,651 shares of Common Stock that may be acquired through the exercise of options that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 21,611 shares of Common Stock held by Mr. Muir and 242,015 shares of Common Stock that may be acquired through the exercise of options that are exercisable as of, or will become exercisable within 60 days of, the March&#160;20, 2025. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 70,303 shares of Common Stock held by Ms. Pennell and 120,940 shares of Common Stock that may be acquired through the exercise of options that are exercisable as of, or will become exercisable within 60 days of, the March&#160;20, 2025. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 126,882 shares of Common Stock held by Dr. Vukovic and 148,608 shares of Common Stock that may be acquired through the exercise of options that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 83,587 shares of Common Stock held by Mr. Hoffman and 183,516 shares of Common Stock that may be acquired through the exercise of options that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 30,882 shares of Common Stock held by Dr. Aharon and 80,182 shares of Common Stock that may be acquired through the exercise of options that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. Also includes shares eligible to vote owned by Rosalind (defined below), which are described in footnote 18. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of 80,182 shares of Common Stock that may be acquired through the exercise of options held by Ms. Czerepak that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 82,197 shares of Common Stock held by Mr. Salamon and 80,182 shares of Common Stock that may be acquired through the exercise of options that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. Also includes shares eligible to vote owned by Rosalind (defined below), which are described in footnote 18. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of 10,550 shares of Common Stock held by Mr. Sylvester and 90,182 shares of Common Stock that may be acquired through the exercise of options that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Consists of 22,500 shares of Common Stock that may be acquired through the exercise of options held by Dr. Martell that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes shares of Common Stock held directly and shares of Common Stock issuable upon the exercise of warrants and options that are exercisable as of, or will become exercisable within 60 days of, March&#160;20, 2025. This number includes shares eligible to vote owned by Rosalind (defined below), which are described in footnote 18. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Based partially on the Company&#8217;s records and in part on information provided on a Statement on Schedule 13D/A filed with the Commission on November 14, 2024 by and on behalf of Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon and Dr. Gilad Aharon (collectively, &#8220;Rosalind&#8221;), Rosalind beneficially own an aggregate of 2,900,389 shares of Common Stock and 1,723,919 shares of Common Stock issuable upon the exercise of warrants. Rosalind&#8217;s shares of Preferred Stock are subject to a 9.99% blocker and Rosalind&#8217;s warrants to purchase shares of Common Stock are subject to a 4.99% blocker. The address for Rosalind Advisors, Inc. is 15 Wellesley Street West, Suite 326 Toronto, Ontario M4Y 0GY Canada. </span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Based partially on the Company&#8217;s records and in part on information provided on the Statement on Schedule 13G/A filed with the Commission on November 14, 2024 by and on behalf of Vivo Opportunity Fund Holdings, L.P. and Vivo Opportunity, LLC (&#8220;Vivo&#8221;). Vivo beneficially owns an aggregate of 1,708,579 shares of Common Stock. The address for Vivo is 192 Lytton Avenue, Palo Alto, CA 94301.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE GOVERNANCE AND RELATED MATTERS </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have six directors serving on the Board. The Board oversees the business affairs of the Company and monitors the performance of management. In accordance with our corporate governance principles, our Board does not involve itself in the day-to-day operations of the Company. The directors keep themselves informed through discussions with the Chairman of the Board, Mr. Sylvester, Mr. Michel, in his capacity as Director and CEO, and other key executives, and by reading the reports and other materials that management sends them and by participating in Board and committee meetings. Our directors hold office until their successors are elected and qualified, or, if sooner, until the director&#8217;s death, resignation, retirement, disqualification or removal.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Independence </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board determined each of its non-employee directors that served as a director during the 2024 fiscal year satisfied the criteria for independence in compliance with Nasdaq listing rules. Five of our six directors are &#8220;independent&#8221; directors within the meaning of the Nasdaq listing rules (Dr. Aharon, Ms. Czerepak, Mr. Salamon, Dr. Martell and Mr. Sylvester). In making such determination, the Board considered the relationships that each such non-employee director has with the Company and all other facts and circumstances that the Board deemed relevant in determining their independence.  </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Meeting and Stockholder Meeting Attendance </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board met eight times in 2024 (including regularly scheduled and special meetings). During 2024, each director attended at least 75% of the aggregate of: (i) the total number of meetings of the Board (held during the period for which he or she served as a director) and (ii) the total number of meetings held by all committees of the Board on which he or she served (held during the period for which he or she served on such committees). </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no specific policy regarding director attendance at its annual meetings of stockholders. Each of our directors attended the Company&#8217;s 2024 annual meeting of stockholders. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership Structure </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John R. Sylvester has served as Non-Executive Chairman of the Board since February 2023 and has been a member of the Board since 2019. It is our policy to separate the Chairman and CEO roles. We believe this structure is appropriate for the Company because it allows our CEO to concentrate on our day-to-day operations, while providing for effective oversight by the Chairman, who is involved in strategic and key matters, such as business strategy, major transactions and the broader business of the Company. For a company like ours that is focused on the commercialization of a specialized product in an extremely technical, highly regulated and intensely competitive industry, we believe our CEO is in the best position to lead our management team and to respond to the current pressures and needs of a company in the stage of growth and development of Delcath, with assistance from our Chairman, who also focuses the Board&#8217;s attention on the broader issues of business strategy and corporate governance. We believe that having the roles of Chairman and CEO held by different individuals minimizes any potential conflicts that may result from combining the roles of CEO and Chairman, and maximizes the effectiveness of our management and governance processes to the benefit of our stockholders. Our CEO and Chairman regularly consult with each other as part of this structure. The Board believes that no single, one-size-fits-all board leadership model is universally or permanently appropriate and, therefore, regularly evaluates whether the interests of the Company and its stockholders would be best served at any particular time by having one individual hold both roles. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Skill Set</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee, in accordance with its charter and the Board&#8217;s governance principles, seeks to create a Board that, as a whole, is strong in its collective knowledge and wisdom with a view to achieving, over time, an appropriate balance of directors with diversified skill sets, backgrounds, experience and viewpoints so that the Board can address the widest possible spectrum of challenges as to vision and strategy, management and leadership, business operations, business judgment, crisis management, risk assessment, industry knowledge, accounting and finance, corporate governance and markets in general for a board of its size. Pursuant to the Nominating and Corporate Governance Committee charter, the Committee is charged with reviewing with the Board, on an annual basis, the current composition of the Board in light of the attributes of independence, skills, background, experience and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">viewpoints. In considering candidates for the Board, the Nominating and Corporate Governance Committee considers the entirety of each candidate&#8217;s credentials in the context of these standards.  </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board&#8217;s Role in Risk Oversight </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board as a whole is responsible for risk oversight, with reviews in certain areas being conducted by the relevant Board committees. Each of the Board&#8217;s committees oversees the management of risks associated with their respective areas of responsibility. In performing this oversight function, the committees are assisted by management which provides visibility about the identification, assessment and monitoring of potential risks and management&#8217;s strategy to mitigate such risks. Key members of management responsible for a particular area report directly to the Board committee charged with oversight of the associated function and, if the circumstances require, the whole Board. The Board committees review various risk exposures with the full Board and otherwise keep the full Board abreast of the committees&#8217; risk oversight activities throughout the year, as necessary or appropriate. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Assessment of Compensation Programs </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee annually evaluates whether our compensation programs encourage excessive risk-taking by employees at the expense of long-term value of the Company. Based upon its assessment, including a review of the overall annual award limitations and individual annual limitations in our stock incentive plans and the Compensation Committee&#8217;s role in the consideration and approval of certain awards, the Compensation Committee does not believe that our compensation programs encourage excessive or inappropriate risk-taking, motivate imprudent risk-taking or create risks that are reasonably likely to have a material adverse effect on the Company. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Committees </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board has three standing committees: an Audit Committee, a Compensation and Stock Option Committee and a Nominating and Corporate Governance Committee. No individual director is the chair of more than one committee. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee provides assistance to the Board in fulfilling its oversight responsibilities with respect to our financial statements, our system of internal accounting and financial controls and the independent audit of our financial statements. Functions of the Audit Committee include: </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the selection, evaluation and, where appropriate, replacement of our outside auditors; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">an annual review and evaluation of the qualifications, performance and independence of our outside auditors; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the approval of all auditing services and permitted non-audit services provided by our outside auditors; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the review of the adequacy and effectiveness of our accounting and internal controls over financial reporting; and </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the review and discussion with management and with our outside auditors of the Company&#8217;s financial statements to be filed with the Commission. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Audit Committee are Ms. Czerepak (Chair), Mr. Salamon and Dr. Martell. The Board has determined that each of Ms. Czerepak, Mr. Salamon and Dr. Martell qualifies as an &#8220;audit committee financial expert&#8221; as defined by SEC rules. During 2024, the Audit Committee met five times. Each member of the Audit Committee is &#8220;independent&#8221; within the meaning of the Nasdaq listing rules and otherwise meets the financial statement proficiency requirements of the Nasdaq listing rules. The Audit Committee has a written charter, that satisfies the applicable listing standards of Nasdaq and can be accessed on our website; go to www.delcath.com, click on &#8220;Investors,&#8221; then &#8220;Governance.&#8221; </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation and Stock Option Committee </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Stock Option Committee, or the Compensation Committee, assists the Board in the discharge of the Board&#8217;s responsibilities with respect to the compensation of our directors, executive officers, and other key employees and consultants. The Compensation Committee establishes our overall compensation philosophy and is authorized to approve the compensation payable to our executive officers, including our named executive officers, and other key employees, including all perquisites, equity incentive awards, cash bonuses, and severance packages. The Compensation Committee also administers certain of the Company&#8217;s employee benefit plans, including its equity incentive </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plans, and is responsible for assessing the independence of compensation consultants and legal advisors. The Compensation Committee exercises sole power to retain compensation consultants and advisors and to determine the scope of the associated engagements. During the fiscal year 2024, our Compensation Committee engaged FW Cook in an effort to better align our compensation program with best practices. The current members of the Compensation Committee are Mr. Sylvester (Chair) and Dr. Aharon, each of whom is &#8220;independent&#8221; within the meaning of the Nasdaq listing rules. During 2024, the Compensation Committee met five times. The Compensation Committee has a written charter, that satisfies the applicable listing standards of Nasdaq and can be accessed on our website; go to www.delcath.com, click on &#8220;Investors,&#8221; then &#8220;Governance.&#8221; </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee, or the Nominating Committee, is responsible for identifying individuals qualified to become Board members, and recommends to the Board the director nominees to be proposed by the Board for election by the stockholders (as well as any director nominees to be appointed by the Board to fill interim vacancies). The Nominating Committee also recommends the directors to be selected for membership on each Board committee. The Nominating Committee is also responsible for developing and recommending to the Board appropriate corporate governance guidelines and policies, and for leading the Board in its annual review of the Board&#8217;s performance. The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Martell and Mr. Sylvester, each of whom is &#8220;independent,&#8221; within the meaning of the Nasdaq listing rules. During 2024, the Nominating Committee met four times. The Nominating Committee has a written charter, that satisfies the applicable listing standards of Nasdaq and can be accessed on our website; go to www.delcath.com, click on &#8220;Investors,&#8221; then &#8220;Governance.&#8221; </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating Committee with, when it deems it necessary, the assistance of a third-party search firm, identifies candidates for director nominees. In considering candidates for the Board, the Nominating Committee considers each candidate&#8217;s credentials as a whole, including, but not necessarily limited to, outstanding achievement in a candidate&#8217;s personal career, broad and relevant experience, integrity, sound and independent judgment, experience and knowledge of the business environment and markets in which we operate, business acumen, and willingness and ability to devote adequate time to Board duties. The Nominating Committee considers the competencies required of its members in the context of the Board as a whole, including the personal characteristics, experience and background of directors and nominees to facilitate Board deliberations that reflect a broad range of perspectives. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 8, 2020, the Company entered into a Board Appointment Agreement with its stockholders, Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P., pursuant to which Mr. Salamon and Dr. Aharon were appointed directors of the Company. On March 28, 2023, the Company, as part of the March 2023 Private Investment in Public Equity agreement with investors, agreed that, upon FDA approval of Delcath&#8217;s product candidate, the purchasers of a majority of shares gained the right to designate a director for the Company to appoint to the Board. As of the date of this Proxy Statement, the purchasers have not requested the Company to appoint a new director to the Board. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendations by Stockholders of Director Nominees </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating Committee will consider any recommendation by a stockholder of a candidate for nomination as a director. If a stockholder wants to recommend a director candidate for consideration by the Nominating Committee, the stockholder should submit the name of the proposed nominee, together with the reasons why the stockholder believes the election of the candidate would be beneficial to the Company and our stockholders and the information about the nominee that would be required in a proxy statement requesting proxies to vote in favor of the candidate. The stockholder&#8217;s submission must be accompanied by the written consent of the proposed nominee to being nominated by the Board and the candidate&#8217;s agreement to serve if nominated and elected. Any such submission should be directed to the Nominating Committee at our principal office, 566 Queensbury Avenue, Queensbury, NY 12804. If a stockholder intends to nominate a person for election to the Board at an annual meeting, the stockholder must provide us with written notice of his or her intention no later than the deadline for receiving a stockholder proposal for inclusion in our Proxy Statement for such meeting and must otherwise comply with our amended and restated certificate of incorporation. Copies of any recommendation received in accordance with these procedures will be distributed to each member of the Nominating Committee. One or more members of the Nominating Committee may contact the proposed candidate to request additional information. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholder Communications with the Board of Directors </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any stockholder wishing to communicate with the Board or with any specified director should address his or her communication to the Board or to the particular director(s) in care of the Corporate Secretary, Delcath Systems, Inc., 566 Queensbury Avenue, Queensbury, NY 12804. All such written communication, other than items determined by our legal counsel to be inappropriate for submission to the intended recipient(s), will be submitted to the Board or to the particular director(s). Any stockholder communication not so delivered, will be made available upon request to any director. Examples of stockholder communications that would be considered inappropriate for submission include, without limitation, customer complaints, business solicitations, product promotions, job inquiries, junk mail and mass mailings, as well as material that is unduly hostile, threatening, illegal or similarly unsuitable. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Conduct </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a Code of Business Conduct and Ethics (the &#8220;Code of Conduct&#8221;) that applies to all employees, including our principal executive officer, principal financial officer, principal accounting officer, controller and persons performing similar functions, and including our independent directors, who are not our employees, with regard to their company-related activities. The Code of Conduct incorporates guidelines designed to deter wrongdoing and to promote honest and ethical conduct and compliance with applicable laws, rules and regulations. The Code of Conduct also incorporates our expectations of our employees that enable us to provide accurate and timely disclosure in our filings with the Commission and other public communications. In addition, the Code of Conduct incorporates guidelines pertaining to topics such as complying with applicable laws, rules, and regulations; insider trading; reporting Code of Conduct violations; and maintaining accountability for adherence to the Code of Conduct. The full text of our Code of Conduct is published on our website. Please go to www.delcath.com, click on &#8220;Investors,&#8221; then &#8220;Governance.&#8221; </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Interlocks and Insider Participation </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the members of our Compensation Committee has ever been an executive officer or employee of the Company. None of our executive officers currently serve, or served during the last completed fiscal year, on the compensation committee or board of directors of any other entity that has one or more executive officers that serve as a member of the Board or Compensation Committee. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Hedging and Pledging Policy</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our <ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-5">Insider Trading Policy</ix:nonNumeric>, we prohibit our employees, our executive officers, members of the Board, and certain consultants and contractors from engaging in any hedging or monetization transactions relating to our securities, including through the use of financial instruments such as prepaid variable forwards contracts, equity swaps, collars and exchange funds. We also prohibit our employees, our executive officers, members of the Board, and certain consultants and contractors from holding our securities in a margin account or otherwise pledging our securities as collateral for a loan. </span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clawback Policy</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Commission adopted final rules implementing the incentive-based compensation recovery provisions of the Dodd-Frank Act, and Nasdaq has adopted listing standards consistent with the Commission rules. In compliance with those standards, we have adopted an incentive compensation recoupment policy, or &#8220;clawback&#8221; policy, which applies to our executive officers, within the meaning of Section 10D of the Exchange Act and Rule 10D-1 promulgated thereunder, who were employed by the Company or a subsidiary of the Company during the applicable recovery period. Under the policy, in the event that the financial results upon which a cash or equity-based incentive award was predicated become the subject of a financial restatement that is required because of material non-compliance with financial reporting requirements, the Compensation Committee will conduct a review of awards covered by the policy and recoup any erroneously awarded incentive-based compensation to ensure that the ultimate payout gives retroactive effect to the financial results as restated. The policy covers any cash or equity-based incentive compensation award that was paid, earned or granted to a covered officer during the last completed three fiscal years immediately preceding the date on which the Company is required to prepare the accounting restatement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSACTIONS WITH RELATED PERSONS </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than compensation arrangements for our directors and executive officers, which are described elsewhere in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below is a description of transactions since January 1, 2023 to which we were a party or will be a party, in which: </span></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the amounts involved exceeded or will exceed the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed fiscal years; and </span></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family of, or person sharing the household with, the foregoing persons, had or will have a direct or indirect material interest. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Private Placements </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2023, the Company closed a private placement for the issuance and sale of 24,900 shares of Series F-1 Preferred Stock, warrants to purchase 34,860 shares of Series F-3 Preferred Stock and warrants to purchase 24,900 shares of Series F-4 Preferred Stock. Each share of Series F-1 Preferred Stock was sold at a price per share of $1,000. Each warrant to purchase Series F-3 Preferred Stock has a conversion price of $4.50 per share of Common Stock, subject to the terms and limitations contained in the Series F Certificate of Designation and each warrant to purchase Series F-4 Preferred Stock has a conversion price of $6.00 per share of Common Stock, subject to the terms and limitations contained in the Certificate of Designations governing the Series F Preferred Stock. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rosalind Master Fund L.P., an entity controlled by Rosalind Advisors, which Steven Salamon and Gil Aharon, both Directors of the Company, are co-founders and portfolio managers of, and Investor Company ITF Rosalind Master Fund LP, an entity controlled by Rosalind Advisors, which Steven Salamon and Gil Aharon, both Directors of the Company, are co-founders and portfolio managers of also participated in the offering purchasing an aggregate of 2,150 shares of Series F-1 Preferred Stock, warrants to purchase an aggregate of 3,010 shares of Series F-3 Preferred Stock and warrants to purchase an aggregate of 2,150 shares of Series F-4 Preferred Stock for an aggregated purchase price of $2,150,000. In June 2023, upon shareholder approval, the Series F-1 Preferred Stock were converted to Series F-2 Preferred Stock.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2023, the Company closed an additional private placement for the issuance and sale of 19,646 shares of Common Stock and warrants to purchase 47,776 shares of Common Stock to Gerard Michel, our CEO and Director, for a purchase price of approximately $100,000. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 19, 2024, the Company closed a private placement for the issuance and sale of 876,627 shares of Common Stock and 1,008,102 pre-funded warrants to purchase Common Stock to certain investors. Each share of Common Stock was sold at a price per share of $3.72 and the pre-funded warrants were sold at a price of $3.71 per warrant. The following table summarizes the amount and type of security purchased by each Related Person during this private placement:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.515%"><tr><td style="width:1.0%"/><td style="width:30.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.456%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.469%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-funded Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gerard Michel</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CEO and Director</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$150,001.56</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Steven Salamon</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$100,001.04</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilad Aharon</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Director</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$100,001.04</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investor Company ITF Rosalind Master Fund LP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5% Shareholder</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">619,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,299,999.66</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AIGH Investment Partners, LP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5% Shareholder</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">377,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">388,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2,846,107.16</span></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification Agreements </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an indemnification agreements with the CEO and directors which requires us to indemnify our CEO and directors to the fullest extent permitted by Delaware law. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Related Person Transaction Policy </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Audit Committee Charter, the Company has procedures regarding the review and approval or ratification of transactions between the Company and Related Parties (as defined below). Our Audit Committee will review the material facts of proposed transactions involving Delcath in which a Related Party will have a direct or indirect material interest. The Audit Committee will either approve or disapprove our entry into the transaction or, if advance approval is not feasible, will consider whether to ratify the transaction. The Audit Committee may establish guidelines for ongoing transactions with a Related Party, and will review such transactions at least annually.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A &#8220;Related Party&#8221; is generally anyone who since the beginning of the last full fiscal year is or was an executive officer, director or director nominee, owner of more than 5% of our Common Stock, or immediate family member of any of such persons. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NON-EMPLOYEE DIRECTOR COMPENSATION </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee reviews and recommends to the Board appropriate non-employee director compensation programs for service as directors, committee chairs, and committee members. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In lieu of per-meeting fees, non-employee directors of the Company are paid an annual retainer of $50,000 and certain additional annual retainers for chairing or serving as a member of the committees of the Board as follows: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Annual Retainer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of Audit Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member of Audit Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of Compensation Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member of Compensation Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,500</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of Nominating and Corporate Governance Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Member of Nominating and Corporate Governance Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Following our Compensation Committee and Board&#8217;s review of our non-employee director compensation program in 2024 the following changes were made to our annual retainers, effective May 23, 2024: (i) the Board service retainer was increased from $43,000 to $50,000, (ii) the committee member retainers were increased from $8,000 to $10,000 (Audit Committee), $5,000 to $7,500 (Compensation Committee), and $4,000 to $5,000 (Nominating and Corporate Governance Committee), and (iii) the committee chair retainers for our Compensation and Nominating and Corporate Governance Committees were increased from $12,000 to $15,000 and $8,000 to $10,000, respectively.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each non-employee director who is in service on the date of each annual meeting of stockholders is also entitled to receive an annual grant of options to purchase shares of Common Stock under our 2020 Plan, which vests in 12 equal monthly installments, subject to the director&#8217;s continued service to the Company through each applicable vesting date. The number of options granted each year are approved by the Board based on the recommendation by our independent compensation consultant, FW Cook. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we reimburse all non-employee directors for their reasonable out-of-pocket travel expenses incurred in attending meetings of our Board or any committees of the Board. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the compensation awarded to, earned by or paid to each non-employee director who served on our Board in 2024.</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:57.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.107%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fees Earned<br/>or Paid in<br/>Cash ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Awards</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gil Aharon, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elizabeth Czerepak</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridget Martell, M.A., M.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven Salamon</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roger G. Stoll, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Sylvester</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Amounts shown in this column do not reflect dollar amounts actually received by non-employee directors. Instead, these amounts reflect the aggregate grant date fair value of each stock option granted computed in accordance with the provisions of FASB ASC Topic 718. Assumptions used in the calculation of these amounts are included in Note 13 to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024 filed with the Commission on March 6, 2025. The Black-Scholes assumptions used were an expected term of 5.2 years, expected volatility 101.82%, and a risk-free interest rate of 4.47%. Our non-employee directors will only realize compensation to the extent the trading price of our Common Stock is greater than the exercise price of such stock options. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">As of December&#160;31, 2024, the following non-employee directors held options to purchase the following number of shares of our Common Stock: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.939%"><tr><td style="width:1.0%"/><td style="width:56.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.935%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Options Outstanding </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gil Aharon, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elizabeth Czerepak</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridget Martell, M.A., M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven Salamon</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roger G. Stoll, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Sylvester</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Dr. Martell began serving on the Board effective as of the date of our 2024 annual meeting of stockholders.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Dr. Stoll retired from the Board effective as of the date of our 2024 annual meeting of stockholders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">36</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION ABOUT OUR EXECUTIVE OFFICERS </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a list of the names, ages, positions, and a brief account of the business experience of the individuals who currently serve as our executive officers. </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:72.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Hoffman</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Counsel, Chief Compliance Officer, and Corporate Secretary</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin Muir</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Manager, Interventional Oncology</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martha Rook</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandra Pennell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vojislav Vukovic</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Medical Officer</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning Gerard Michel, one of our Directors and our CEO, is provided under &#8220;Nominee for Election as Class I Director &#8221; and elsewhere in this Proxy Statement. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">David Hoffman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our General Counsel, Chief Compliance Officer, and Corporate Secretary, joined the Company in January 2022 and has more than twenty years of experience advising biotechnology companies with a focus on the commercialization of therapies. Most recently, he served as Associate General Counsel and Chief Compliance Officer at Vericel Corporation, where he was responsible for legal and compliance matters and supported the launch and growth of products in the advanced cell therapy and biologics space. David earned a B.S. in Civil Engineering and a M.S. in Environmental Engineering from Clemson University and his J.D. from Georgia State University. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kevin Muir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our General Manager, Interventional Oncology, joined the Company in December 2020 with 20 years of sales and marketing experience in the biotherapeutics and medical technology industries. Before joining Delcath, Mr. Muir was Director of U.S. Sales for the Interventional Oncology business unit at BTG, where he played a key role in the success of TheraSphere</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(custom ordered micro-embolic 90Y radiation radio isotope-therapy). Prior to that he was Director of Sales at ClearFlow Inc. and Aragon Surgical. Mr. Muir also held leadership sales roles at Kensey Nash Corporation, Kyphon, and Genzyme Biosurgery. Prior to his career in industry, Mr. Muir served as a Field Artillery officer in the United States Army. He completed his BS in Management Systems Engineering at the United States Military Academy at West Point where he was a member of the West Point Cadets Football Team. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Martha S. Rook, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our Chief Operating Officer, is an experienced industry leader who brings more than 25 years of academic and industry experience in molecular biology, diagnostics development, biologics process development and biologics manufacturing. She joined the Company in March of 2024 from insitro where she served as a Chief Technical Operations Officer and was responsible for core research services, facilities and laboratory operations, quality and project and portfolio management. Prior to insitro, she was with Sigilon Therapeutics, where she served as Chief Technical Operations Officer and was responsible for the analytics, manufacturing, supply chain and quality organizations producing a biologic-device combination product. Martha&#8217;s experience also includes 13 years at MilliporeSigma, where she held a variety of roles, ultimately serving as vice president and head of the Gene Editing &amp; Novel Modalities Business and led a team developing and providing tools and services for cell and gene therapies from discovery to manufacturing. Martha received her Ph.D. in biochemistry from MIT and holds a B.S. in chemistry from Texas A&amp;M University. She pursued postdoctoral studies in neuroscience as a Lefler Fellow at Harvard Medical School&#8217;s Center for Neurologic Diseases.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sandra Pennell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our Chief Financial Officer, joined the Company in May 2023 and has over twenty plus years of experience in a variety of financial areas including complete oversight of the Finance and Accounting function specializing in SEC reporting, equity raises, FP&amp;A, all accounting functions in addition to treasury experience related to debt financings and internal investment decisions. She previously held the position of VP, Finance at Invivyd, Inc. and prior to that she was the VP &amp; Corporate Controller, Principal Accounting Officer at Vericel Corporation. Sandra earned a Bachelor and Master of Science in Accountancy from University of Illinois at Urbana-Champaign &#8211; College of Business.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vojislav Vukovic, M.D., M.Sc., Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our Chief Medical Officer, joined the Company is June 2023 and is an experienced drug development executive with a distinguished career in cancer research and global clinical development. His experience spans early- to late-stage clinical development projects across multiple anticancer modalities and tumor types and global medical affairs programs supporting several commercial oncology drugs. He has held the position of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President and Chief Medical Officer at Aileron Therapeutics, Taiho Oncology Inc, and Synta Pharmaceuticals Inc, overseeing various facets of clinical development, medical affairs, and corporate strategy. Dr. Vukovic earned his M.D. from the University of Sarajevo in Bosnia and Herzegovina and an MSc in radiation biology and a Ph.D. in tumor biology from the University of Toronto in Canada. His work has been published in several high-impact scientific journals, and he is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, the American Society of Hematology, and the European Society for Medical Oncology.</span></div><div id="i161d31b071a7458ab37fccdf98f11dd1_49"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section provides an overview of the material components of our executive compensation program for our CEO and each of our two other most highly compensated executive officers (our &#8220;named executive officers&#8221;) during fiscal year 2024. The compensation provided to our named executive officers for fiscal year 2024 is set forth in detail in the tables and accompanying footnotes and narratives that follow in this section. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our named executive officers for fiscal year 2024 were: </span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gerard Michel, our Chief Executive Officer; </span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vojislav Vukovic, our Chief Medical Officer; and </span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Martha Rook, our Chief Operating Officer.</span></div><div id="i161d31b071a7458ab37fccdf98f11dd1_52"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY COMPENSATION TABLE </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total compensation awarded to, earned by or paid to our named executive officers during the fiscal years ending December&#160;31, 2024 and December&#160;31, 2023. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:36.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.489%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.489%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.489%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.489%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.495%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and Position</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Salary<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-Equity Incentive Plan Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Awards</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other<br/>Compensation<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gerard Michel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,622</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,756</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,078</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,888</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,520,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vojislav Vukovic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Medical Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Martha Rook</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,458</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Amounts reported in this column represent annual cash incentive bonuses, which were awarded based on achievement of corporate performance goals for the year indicated. The 2024 cash incentive bonus determinations are described in more detail above under the heading &#8220;Annual Incentive Plan&#8221;.</span></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Amounts shown in this column do not reflect dollar amounts actually received by our named executive officers. Instead, these amounts reflect the aggregate grant date fair value of each stock option granted computed in accordance with the provisions of Financial Accounting Standards Board Accounting Standards Codification Topic 718. Assumptions used in the calculation of these amounts are included in Note 13 to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024 filed with the Commission on March&#160;6, 2025. Our named executive officers will only realize compensation to the extent the trading price of our Common Stock is greater than the exercise price of such stock options. </span></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Dr. Vukovic joined Delcath on June 19, 2023 but was not a named executive officer in 2023 and thus, only 2024 compensation is shown for him in this table. </span></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Dr. Rook joined Delcath on March 18, 2024 and thus, only 2024 compensation information is shown for her in this table. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Narrative to Summary Compensation Table </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee is responsible for formulating and establishing our overall compensation philosophy with respect to our executive officers. The Company believes that a strong executive management team comprised of talented individuals in key positions is critical to the development and growth of our business and to increasing stockholder value. Accordingly, a key objective of our executive compensation program is to attract and retain talented and experienced individuals, while motivating them to perform and make decisions consistent with the Company&#8217;s business objectives, goals and culture. We emphasize pay-for-performance by linking executive compensation to Company performance. For each executive, the amount of pay that is actually realized is primarily driven by the Company&#8217;s performance and each executive&#8217;s contribution to that performance. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee considers the input it receives from our stockholders when designing and evaluating our executive compensation practices.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Components</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The three primary components of our executive compensation are base salary, annual incentive cash awards and long-term equity incentive awards: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.5pt">Base Salary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We pay our executive officers a base salary, which our Compensation Committee reviews and determines annually. Base salaries are used to compensate our executive officers for performing the core responsibilities of their positions and to provide them with a level of security with respect to a portion of their total compensation. Base salaries are set in part based on the executive&#8217;s unique skills, experience and expected contribution to the Company, as well as individual performance, including the impact of such performance on our business results, and the period of the executive&#8217;s performance. Decisions regarding base salary increases take into account the executive&#8217;s current base salary, third- party benchmark and survey data, and the salary compensation paid to executive officers within and outside the Company, as well as the Company&#8217;s overall performance, its ability to afford such increases, its success in achieving its operational and strategic goals and objectives, and the executive officer&#8217;s contribution to Company performance. </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.5pt">Annual Incentive Cash Awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual incentive compensation is intended to establish a direct correlation between annual cash awards and the performance of the Company. The Company&#8217;s Annual Incentive Plan, or AIP, is an annual incentive cash bonus plan designed to align the interests of participants with the interests of the Company and its stockholders. The AIP is designed to strengthen the link between a participant&#8217;s pay and his or her overall performance and the Company&#8217;s performance, focus participants on critical individual and corporate objectives, offer a competitive cash incentive, and encourage and reward performance and competencies critical to the Company&#8217;s success. </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.5pt">Long-Term Incentive Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition to using base salaries and annual incentive cash bonuses, which our Compensation Committee views as short-term compensation, a portion of our executive compensation is in the form of long-term equity compensation. The Compensation Committee continually evaluates the use of equity-based awards and intends to continue to use such awards in the future as part of the Company&#8217;s compensation program. Historically, we have used an annual equity-based incentive plan to align participants&#8217; interests with those of the Company and its stockholders by rewarding participants for their contributions to the long-term success of the Company. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Salary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following table summarizes the amount of base salary and year-over-year increase for each of our named executive officers from 2023 to 2024.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.121%"><tr><td style="width:1.0%"/><td style="width:32.314%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.119%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.119%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023<br/>Base<br/>Salary<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percent<br/>Increase<br/>from 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024<br/>Base<br/>Salary<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vojislav Vukovic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martha Rook</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual Incentive Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under the AIP, annual incentive target award opportunities are expressed as a percentage of a participant&#8217;s base salary for the performance year, beginning January 1. The following table sets forth, for each named </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">executive officer, the applicable target bonus percentage of base salary to which each named executive officer was entitled during 2024 and the amount actually paid to the named executive officer.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.030%"><tr><td style="width:1.0%"/><td style="width:30.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.837%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.837%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.837%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.837%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Target<br/>Bonus<br/>Expressed<br/>as % of<br/>Base<br/>Salary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollars<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Payout</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">as %</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Base</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Salary</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollars<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vojislav Vukovic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martha Rook</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2024, AIP goals were based entirely on Company performance to focus all the executives on the same critical challenges facing the Company. Company performance in 2024 was measured based upon achievement of objectives in the following areas: Clinical Trials, Regulatory, Commercial, Manufacturing and Finance. The Compensation Committee determined an overall achievement against the performance objectives of 100% for 2024. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long Term Incentive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Grants have historically been comprised of stock option awards granted each year with the number of shares subject to the awards designed to deliver a competitive value targeted at the mid-market of the executive compensation comparison group. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee periodically provides long-term equity incentive awards for our named executive officers based upon a holistic assessment of Company and individual performance for the prior year and its view of the appropriate incentives to best help achieve the Company&#8217;s business objectives. In 2024, the Compensation Committee approved the following stock option awards to our named executive officers, which vest in equal monthly installments over a three-year period with the first vesting being the grant date, subject to the executive&#8217;s continued service:</span></div><div style="margin-top:12pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.333%"><tr><td style="width:1.0%"/><td style="width:24.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.565%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares Subject to Option<br/>(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.78</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vojislav Vukovic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.78</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martha Rook</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/18/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.18</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The grant date for Dr. Rook&#8217;s option award was her employment start date with the Company. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Welfare and Health Benefits </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our named executive officers are eligible to participate in all of our benefit plans, such as the 401(k) plan (see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retirement Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below), medical, dental, vision, short-term disability, long-term disability and group life insurance, in each case generally on the same basis as other employees. We do not currently have qualified or nonqualified defined benefit plans or nonqualified deferred compensation plans, nor do we offer pension or other retirement benefits other than our 401(k) plan. Our Board may elect to adopt such plans in the future if it determines that doing so is in our best interest. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retirement Benefits </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a tax-qualified retirement plan that provides eligible U.S. employees, including our named executive officers, with an opportunity to save for retirement on a tax-advantaged basis. Eligible employees may make voluntary contributions from their eligible pay, up to certain applicable annual limits set by the Code. The 401(k) plan is intended to be qualified under Section 401(a) of the Code with the 401(k) plan&#8217;s related trust intended to be tax exempt under Section 501(a) of the Code. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreements with our Named Executive Officers</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mr. Michel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Pursuant to an employment agreement dated as of August 31, 2020 between the Company and Mr. Michel (the &#8220;Michel Employment Agreement&#8221;), the term of Mr. Michel&#8217;s employment began on October 1, 2020. Under </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Michel Employment Agreement, Mr. Michel&#8217;s annualized base salary was originally set at $450,000 for 2020. Pursuant to the Michel Employment Agreement, Mr. Michel was eligible to participate in the Company&#8217;s AIP with a target annual cash bonus equal to 50% of his then-current base salary and in our 2020 Plan or any successor plan, subject to the terms, conditions and vesting provisions of the 2020 Plan and any applicable award agreement to the extent determined by the Compensation Committee or the Board in its sole discretion. In addition, pursuant to the Michel Employment Agreement, the Company agreed to reimburse Mr. Michel up to $6,500 per month to cover his temporary expenses incurred in connection with traveling to and living in the New York City tri-state area to work onsite at the Company&#8217;s principal corporate office for the initial eighteen (18) months of his employment. The Michel Employment Agreement also provided for severance benefits in connection with certain specified terminations of Mr. Michel&#8217;s employment, as detailed below under &#8220;Potential Payments upon Termination or Change of Control.&#8221; </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the commencement of his employment with the Company, Mr. Michel received a nonqualified and non-plan stock option &#8220;inducement award&#8221; to purchase 498,000 shares of our Common Stock in reliance on Nasdaq Listing Rule 5635(c)(4) pursuant to the terms of a stock option award agreement, which had vested in full as of October 1, 2023.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 16, 2024, the Company entered into a new employment agreement with Mr. Michel (the &#8220;New Michel Employment Agreement&#8221;), which supersedes and replaces the Michel Employment Agreement, and pursuant to which Mr. Michel continues to serve as the Company&#8217;s Chief Executive Officer. Under the New Michel Employment Agreement,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Michel&#8217;s annualized base salary is equal to his current base salary ($564,240 for 2024), subject to annual review by the Compensation Committee. Under the terms of the New Michel Employment Agreement, Mr. Michel remains eligible to participate in the Company&#8217;s AIP with an annual target bonus opportunity equal to the current percentage of Mr. Michel&#8217;s then current base salary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Michel also continues to be eligible to participate in our 2020 Plan or any successor plan, subject to the terms, conditions and vesting provisions of the 2020 Plan and any applicable award agreement to the extent determined by the Compensation Committee or the Board in its sole discretion. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New Michel Employment Agreement also provides for severance benefits in connection with certain specified terminations of Mr. Michel&#8217;s employment, as detailed below under &#8220;Potential Payments upon Termination or Change of Control.&#8221;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Vukovic.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pursuant to the offer letter agreement dated as of June 6, 2023, between the Company and Dr. Vukovic (the &#8220;Vukovic Offer Letter&#8221;), Dr. Vukovic&#8217;s annualized base salary was originally set at $450,000 for 2023, subject to annual review by the Compensation Committee. Pursuant to the Vukovic Offer Letter, Dr. Vukovic was eligible to participate in the Company&#8217;s AIP with a target annual cash bonus equal to 40% of his then-current base salary. The Vukovic Offer Letter also provided for severance benefits in connection with certain specified terminations of Dr. Vukovic&#8217;s employment, as detailed below under &#8220;Potential Payments upon Termination or Change of Control.&#8221;</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the commencement of his employment with the Company, on June 20, 2023, the Company granted to Dr. Vukovic a non-qualified and non-plan stock option &#8220;inducement award&#8221; to purchase 150,000 shares of our Common Stock in reliance on Nasdaq Rule 5635(c)(4) pursuant to the terms of a stock option award agreement. The stock option vests ratably over three years, with 33% vesting on the first anniversary of the grant date and the remaining 66% vesting in equal monthly installments over the next two years, subject to Dr. Vukovic&#8217;s continued service with the Company on each respective vesting date. The exercise price of the stock option is equal to $5.93, the closing trading price per share of our Common Stock on the grant date.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 25, 2024, the Company entered into an employment agreement with Dr. Vukovic (the &#8220;Vukovic Employment Agreement&#8221;), pursuant to which Dr. Vukovic continues to serve as the Company&#8217;s Chief Medical Officer. Under the Vukovic Employment Agreement,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Vukovic&#8217;s annualized base salary is equal to his current base salary ($468,000 for 2024), subject to annual review by the Compensation Committee. Under the terms of the Vukovic Employment Agreement, Dr. Vukovic remains eligible to participate in the Company&#8217;s AIP with an annual target bonus opportunity equal to the current percentage of Dr. Vukovic&#8217;s then current base salary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Vukovic is also eligible to participate in our 2020 Plan or any successor plan, subject to the terms, conditions and vesting provisions of the 2020 Plan and any applicable award agreement to the extent determined by the Compensation Committee or the Board in its sole discretion. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Vukovic Employment Agreement also provides for severance benefits in connection with certain specified terminations of Dr. Vukovic&#8217;s employment, as detailed below under &#8220;Potential Payments upon Termination or Change of Control.&#8221; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Rook</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Pursuant to an employment agreement dated as of February 1, 2024, between the Company and Dr. Rook (the &#8220;Rook Employment Agreement&#8221;), the term of Dr. Rook&#8217;s employment began on March 18, 2024. Under the Rook Employment Agreement, Dr. Rook&#8217;s annualized base salary was set at $425,000 for 2024, subject to annual review by the Compensation Committee. Pursuant to the Rook Employment Agreement, Dr. Rook is eligible to participate in the Company&#8217;s AIP with a target annual cash bonus equal to 40% of her then-current base salary and in our 2020 Plan or any successor plan, subject to the terms, conditions and vesting provisions of the 2020 Plan and any applicable award agreement to the extent determined by the Compensation Committee or the Board in its sole discretion. The Rook Employment Agreement also provided for severance benefits in connection with certain specified terminations of Dr. Rook&#8217;s employment, as detailed below under &#8220;Potential Payments upon Termination or Change of Control.&#8221;</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the commencement of her employment with the Company, on March 18, 2024, Dr. Rook was granted a non-qualified stock option as an &#8220;inducement award&#8221; under our 2023 Inducement Plan to purchase 125,000 shares of our Common Stock in reliance on Nasdaq Rule 5635(c)(4), pursuant to the terms of a stock option award agreement. The stock option vests in equal monthly installments over three years from the grant date, subject to Dr. Rook&#8217;s continued service with the Company on each respective vesting date. The exercise price of the stock option is equal to $4.18, the closing trading price per share of our Common Stock on the grant date. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 16, 2024, the Company entered into a new employment agreement with Dr. Rook (the &#8220;New Rook Employment Agreement&#8221;), which supersedes and replaces the Rook Employment Agreement, and pursuant to which Dr. Rook continues to serve as the Company&#8217;s Chief Operating Officer. Under the New Rook Employment Agreement,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Rook&#8217;s annualized base salary is equal to her current base salary ($425,000 in 2024), subject to annual review by the Compensation Committee. Under the terms of the New Rook Employment Agreement, Dr. Rook remains eligible to participate in the Company&#8217;s AIP with an annual target bonus opportunity equal to the current percentage of Dr. Rook&#8217;s then current base salary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Rook also continues to be eligible to participate in our 2020 Plan or any successor plan, subject to the terms, conditions and vesting provisions of the 2020 Plan and any applicable award agreement to the extent determined by the Compensation Committee or the Board in its sole discretion. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New Rook Employment Agreement also provides for severance benefits in connection with certain specified terminations of Dr. Rook&#8217;s employment, as detailed below under &#8220;Potential Payments upon Termination or Change of Control.&#8221;</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Payments upon Termination or Change of Control </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mr. Michel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Under the Michel Employment Agreement, Mr. Michel could resign his at-will employment with the Company for &#8220;Good Reason&#8221; and the Company could terminate Mr. Michel&#8217;s at-will employment other than for &#8220;Cause&#8221;. If Mr. Michel resigned his at-will employment for Good Reason or the Company terminated Mr. Michel&#8217;s employment other than for Cause, then Mr. Michel would have been entitled to his accrued and unpaid compensation and, subject to him entering into and not revoking a general release of claims in favor of the Company and fully complying with the terms of a separation agreement, Mr. Michel would also have been entitled to: </span></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">A severance payment equal in the aggregate to twelve (12) months of his annual base salary at the time of termination, payable in twelve (12) equal monthly installments (and subject to applicable withholdings and deductions) beginning on the last Company payroll date of the first full month following termination of employment; and </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">If Mr. Michel timely and properly elected health plan (medical, dental and/or vision) continuation coverage under COBRA, the Company would have reimbursed Mr. Michel in an amount equal to the difference between the monthly COBRA premium paid by Mr. Michel for him and his dependents and the monthly premium amount paid by similarly situated active executives under the Company&#8217;s group health plans (&#8220;COBRA Benefits&#8221;). Such reimbursement would have been paid to Mr. Michel on or by the last day of the month immediately following the month in which Mr. Michel timely remitted the COBRA premium payment. Mr. Michel will be eligible to receive COBRA premium reimbursement until the earliest of: (x) the twelve-month anniversary of the date his employment with the Company terminated; (y) the date Mr. Michel was no longer eligible to receive COBRA continuation coverage; and (z) the date on which Mr. Michel became eligible to receive substantially similar coverage from another employer. </span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">In addition, the Michel Employment Agreement provided that if Mr. Michel&#8217;s at-will employment was terminated by Mr. Michel for Good Reason or by the Company without Cause, in each case within three (3) months before or twelve (12) months following a change in control of the Company (the &#8220;CIC Period&#8221;), </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="padding-left:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Michel would have been entitled to receive his accrued and unpaid compensation and, subject to Mr. Michel entering into and not revoking a general release of claims in favor of the Company and fully complying with the Restrictive Covenants Agreement the payments and benefits described in the preceding two bullets as well as (i) immediate acceleration of any unvested portion of any other outstanding stock options granted to him that were outstanding at the time of such termination and (ii) a pro-rated annual cash incentive bonus for the fiscal year in which Mr. Michel&#8217;s employment terminated, as determined by the Board or the Compensation Committee based on its assessment of the actual performance of the Company and Mr. Michel following the completion of the fiscal year in which the termination of employment occurred; such pro-rated cash incentive bonus to be paid to Mr. Michel in a lump sum no later than 60 days after the filing of the Company&#8217;s Annual Report on Form 10-K for the fiscal year in which the termination of employment occurred. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New Michel Employment Agreement applies to any termination of Mr. Michel&#8217;s employment occurring on and after July 16, 2024. Under the New Michel Employment Agreement, if Mr. Michel is involuntarily terminated by the Company without &#8220;Cause&#8221; or Mr. Michel resigns with Good Reason (each as defined in the New Michel Employment Agreement), and Mr. Michel executes a separation agreement in a form supplied by the Company, then (i) the Company will pay Mr. Michel an amount equal to fifteen (15) months of Mr. Michel&#8217;s then-current base salary and a pro-rated portion of any earned annual bonus, as determined by the Company at its discretion, subject to required and authorized deductions and withholdings and (ii) if Mr. Michel timely and properly elects health plan continuation coverage under COBRA, the Company will provide COBRA Benefits for a period of fifteen (15) months or until Mr. Michel becomes eligible to receive substantially similar coverage from another employer. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event Mr. Michel is terminated without Cause or resigns with Good Reason within the CIC Period, (i) the Company will pay Mr. Michel eighteen (18) months of Mr. Michel&#8217;s then-current base salary and a pro-rated portion of any earned annual bonus, to be determined at the Company&#8217;s discretion and (ii) the Company will provide COBRA Benefits for a period of eighteen (18) months or until Mr. Michel becomes eligible to receive substantially similar coverage from another employer. Additionally, all then-outstanding unvested stock options granted to Mr. Michel during his employment will become fully vested and exercisable upon such termination.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Vukovic.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under the Vukovic Offer Letter, on and after August 9, 2023, if Dr. Vukovic&#8217;s employment terminated for any reason other than by the Company for cause or his voluntary departure, Dr. Vukovic would have been entitled to three (3) months of severance at his then applicable compensation, which would have included benefits. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Vukovic Employment Agreement applies to any termination of Dr. Vukovic&#8217;s employment occurring on and after July 25, 2024. Under the Vukovic Employment Agreement, if Dr. Vukovic is involuntarily terminated by the Company without &#8220;Cause&#8221; or Dr. Vukovic resigns with Good Reason (each as defined in the Vukovic Employment Agreement), and Dr. Vukovic executes a separation agreement in a form supplied by the Company, then (i) the Company will pay Dr. Vukovic an amount equal to twelve (12) months of Dr. Vukovic&#8217;s then-current base salary and a pro-rated portion of any earned annual bonus, as determined by the Company at its discretion, subject to required and authorized deductions and withholdings and (ii) if Dr. Vukovic timely and properly elects health plan continuation coverage under COBRA, the Company will provide COBRA Benefits for a period of twelve (12) months or until Dr. Vukovic becomes eligible to receive substantially similar coverage from another employer. In the event Dr. Vukovic is terminated without Cause or resigns with Good Reason within the CIC Period, Dr. Vukovic will be entitled to the payments and benefits described in the immediately preceding sentence and all of the then-outstanding unvested stock options granted to Dr. Vukovic during his employment will become fully vested and exercisable upon such termination.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dr. Rook.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under the Rook Employment Agreement, Dr. Rook could resign her at-will employment with the Company for &#8220;Good Reason&#8221; (as defined within the Rook Employment Agreement) and the Company could terminate Dr. Rook&#8217;s at-will employment other than for &#8220;Cause&#8221; (as defined within the Rook Employment Agreement). If Dr. Rook resigned her at-will employment for Good Reason or the Company terminated Dr. Rook&#8217;s employment other than for Cause, then Dr. Rook would have been entitled to her accrued and unpaid compensation and, subject to her entering into and not revoking a general release of claims in favor of the Company and fully complying with the terms of the Restrictive Covenants Agreement, Dr. Rook would also have been entitled to: </span></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A severance payment equal in the aggregate to nine (9) months of her annual base salary at the time of termination, payable in twelve (12) equal monthly installments (and subject to applicable withholdings and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deductions) beginning on the last Company payroll date of the first full month following termination of employment; and </span></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Dr. Rook timely and properly elected health plan (medical, dental and/or vision) continuation coverage under COBRA, the COBRA Benefits. Such reimbursement would have been paid to Dr. Rook on or by the last day of the month immediately following the month in which Dr. Rook timely remitted the COBRA premium payment. Dr. Rook would have been eligible to receive COBRA premium reimbursement until the earliest of: (x) the twelve-month anniversary of the date her employment with the Company terminated; (y) the date Dr. Rook was no longer eligible to receive COBRA continuation coverage; and (z) the date on which Dr. Rook became eligible to receive substantially similar coverage from another employer. </span></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">        </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Rook Employment Agreement provided that if Dr. Rook&#8217;s at-will employment was terminated by Dr. Rook for Good Reason or by the Company without Cause, in each case during the CIC Period, Dr. Rook would have been entitled to receive her accrued and unpaid compensation and, subject to Dr. Rook entering into and not revoking a general release of claims in favor of the Company and fully complying with the Restrictive Covenants Agreement, the payments and benefits described in the preceding two bullets as well as (i) immediate acceleration of any unvested portion of any other outstanding stock options granted to her that were outstanding at the time of such termination and (ii) a pro-rated annual cash incentive bonus for the fiscal year in which Dr. Rook&#8217;s employment terminated, as determined by the Board or the Compensation Committee based on its assessment of the actual performance of the Company and Dr. Rook following the completion of the fiscal year in which the termination of employment occurred, with such pro-rated cash incentive bonus to be paid to Dr. Rook in a lump sum. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New Rook Employment Agreement applies to any termination of Dr. Rook&#8217;s employment occurring on and after July 16, 2024. Under the New Rook Employment Agreement, if Dr. Rook is involuntarily terminated by the Company without &#8220;Cause&#8221; or Dr. Rook resigns with Good Reason (each as defined in the New Rook Employment Agreement), and Dr. Rook executes a separation agreement in a form supplied by the Company, then (i) the Company will pay Dr. Rook an amount equal to twelve (12) months of Dr. Rook&#8217;s then-current base salary and a pro-rated portion of any earned annual bonus, as determined by the Company at its discretion, subject to required and authorized deductions and withholdings and (ii) if Dr. Rook timely and properly elects health plan continuation coverage under COBRA, the Company will provide COBRA Benefits for a period of twelve (12) months or until Dr. Rook becomes eligible to receive substantially similar coverage from another employer. In the event Dr. Rook is terminated without Cause or resigns with Good Reason within the CIC Period, Dr. Rook will be entitled to the payments and benefits described in the immediately preceding sentence and all of the then-outstanding unvested stock options granted to Dr. Rook during her employment will become fully vested and exercisable upon such termination.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">44</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END &#8212;2024 </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning unexercised stock options for each named executive officer as of December&#160;31, 2024 that had been granted under the 2020 Plan, unless otherwise noted in the footnotes to this table. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.030%"><tr><td style="width:1.0%"/><td style="width:27.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Underlying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercised</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options (#)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercisable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Underlying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercised</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options (#)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercisable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Exercise<br/>Price Per Share<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option<br/>Expiration<br/>Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gerard Michel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.67</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/30</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/30</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.34</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/30</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/5/2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/5/31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/8/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,910</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,227</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/8/32</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/8/2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,700</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,700</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.67</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/8/33</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/12/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,148</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,739</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/12/33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,125</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,375</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/34</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vojislav Vukovic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/20/2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,628</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,372</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/20/33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,712</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,788</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/34</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martha Rook</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/18/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,730</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,270</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/18/34</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Unless otherwise noted, option shares vest over three years in equal monthly installments with the first vesting occurring on the grant date.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">On October 1, 2020, Mr. Michel was granted a nonqualified and non-plan stock option &#8220;inducement award&#8221; to purchase 498,000 shares of our Common Stock in reliance on Nasdaq Rule 5635(c)(4) pursuant to the terms of a stock option award agreement. The stock option vests ratably over a 36-month period beginning on October 31, 2020 (i.e., 1/36th will vest at the end of each month during said 36-month period), subject to Mr. Michel&#8217;s continued service with the Company on each respective vesting date. The exercise price of the stock option is equal to (i) $11.67, the closing trading price per share of our Common Stock on October 1, 2020 as to the first 396,000 option shares to vest, (ii) 1.5 times the closing trading price per share of our Common Stock on October 1, 2020 as to the next 51,000 option shares to vest and (iii) 2.0 times the closing trading price per share of the Company&#8217;s Common Stock on October 1, 2020 as to the remaining 51,000 option shares to vest.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Four-thirty-sixths (4/36th) of the option shares immediately vested on the grant date and the remaining option shares vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month for the next thirty-two months.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">On June 20, 2023, Dr. Vukovic was granted a nonqualified and non-plan stock option &#8220;inducement award&#8221; to purchase 150,000 shares of our Common Stock in reliance on Nasdaq Rule 5635(c)(4) pursuant to the terms of a stock option award agreement. The stock option vests ratably over three years, with 33% vesting on the first anniversary of the grant date and the remaining 66% vesting in equal monthly installments over the next two years, subject to Dr. Vukovic&#8217;s continued service with the Company on each respective vesting date. </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">On March 18, 2024, Dr. Rook was granted a nonqualified stock option as an &#8220;inducement award&#8221; under our 2023 Inducement Plan to purchase 125,000 shares of our Common Stock in reliance on Nasdaq Rule 5635(c)(4) pursuant to the terms of a stock option award agreement. The stock option vests in equal monthly installments over three years, subject to Dr. Rook&#8217;s continued service with the Company on each respective vesting date.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">45</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PAY VERSUS PERFORMANCE</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance Table </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Section 953(a) of The Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid, as defined below, and certain financial performance of the Company. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-6" escape="true"><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pay Versus Performance</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for PEO </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually Paid</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">to PEO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) (5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for Non-PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NEOs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) (2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually Paid to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-PEO NEOs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) (2) (6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of Initial Fixed</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$100</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Investment Based On</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shareholder Return </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Income (Loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(8)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(h)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-7">2,157,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-8">4,876,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-9">1,009,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-10">2,000,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-11">152.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-12">26,386,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-13">2,520,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">2,154,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">1,109,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">952,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-17">52.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-18">47,678,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-19">1,472,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-20">188,099</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-21">770,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">266,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-23">45.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-24">36,508,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:Additional402vDisclosureTextBlock" id="f-25" continuedAt="f-25-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">We are a smaller reporting company pursuant to Rule 405 of the Securities Act and as such, we are only required to include information for the past three fiscal years in the table. </span></ix:nonNumeric></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-26" escape="true">For each of the three years presented in the above table, <ix:nonNumeric contextRef="c-1" name="ecd:PeoName" id="f-27"><ix:nonNumeric contextRef="c-3" name="ecd:PeoName" id="f-28"><ix:nonNumeric contextRef="c-2" name="ecd:PeoName" id="f-29">Gerard Michel</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> was our Principal Executive Officer (&#8220;PEO&#8221;). Our Non-PEO Named Executive Officers (&#8220;Non-PEO NEOs&#8221;) were (i) Vojislav Vukovic and Martha Rook in 2024, (ii) John Purpura, M.S. and Kevin Muir in 2023, and (iii) John Purpura, M.S. and Johnny John in 2022.</ix:nonNumeric> </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><ix:continuation id="f-25-1" continuedAt="f-25-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The dollar amounts reported in column (b) are the amounts of total compensation reported for our PEO for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table above and in the Summary Compensation Table as disclosed in the proxy statements for the applicable years.</span></ix:continuation></div><ix:continuation id="f-25-2" continuedAt="f-25-3"><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The dollar amounts reported in column (d) represent the average of the amounts reported for the Non-PEO NEOs as a group for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table above and in the Summary Compensation Table as disclosed in the proxy statements for the applicable years.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-30" continuedAt="f-30-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;) to our PEO has been computed in accordance with Item 402(v) of Regulation S-K under the Exchange Act and does not reflect the actual amount of compensation earned by or paid to our PEO during 2024. The dollar amounts reported in column (c) for 2024 represent total compensation as reflected in the above Summary Compensation Table for 2024, adjusted as follows: </span></ix:nonNumeric></div><div style="margin-top:6pt;padding-right:-4.5pt;text-align:center;text-indent:-9pt"><ix:continuation id="f-30-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.696%"><tr><td style="width:1.0%"/><td style="width:79.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.637%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PEO</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary Compensation Table Totals for PEO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-31">2,157,414</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Additions (Subtractions) for Equity Awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock and Option Award Values Reported in the Summary Compensation Table for the Covered Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">1,230,036</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fair Value at Year-End of Outstanding and Unvested Equity Awards Granted in the Covered Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-33">2,155,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-34">886,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Covered Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-35">570,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Covered Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-36">336,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid to PEO</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-39">4,876,184</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-40" continuedAt="f-40-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The following adjustments were made to average total compensation for the Non-PEO NEOs as a group for 2024 to determine the Compensation Actually Paid, using the same methodology described above in Note 5: </span></ix:nonNumeric></div><ix:continuation id="f-40-1"><div style="margin-top:6pt;padding-right:-4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.696%"><tr><td style="width:1.0%"/><td style="width:79.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.637%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-PEO NEOs<br/>(Average)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary Compensation Table Totals for Non-PEO NEOs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-41">1,009,355</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Additions (Subtractions) for Equity Awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock and Option Award Values Reported in the Summary Compensation Table for the Covered Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-42">427,819</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Fair Value at Year-End of Outstanding and Unvested Equity Awards Granted in the Covered Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-43">829,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-44">243,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Covered Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-45">216,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Covered Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-46">128,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid to Non-PEO NEOs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-49">2,000,353</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:4pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"><ix:continuation id="f-25-3" continuedAt="f-25-4">Cumulative Total Shareholder Return (&#8220;TSR&#8221;) represents the return on a fixed investment of $100 in our Common Stock for the period beginning on the last trading day of 2021 through the last trading day of the applicable fiscal year.</ix:continuation> </span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"><ix:continuation id="f-25-4">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the year ended December&#160;31, 2024.</ix:continuation> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Analysis of the Information Presented in the Pay Versus Performance Table </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Item 402(v) of Regulation S-K, we are providing the following descriptions of the relationships between information presented in the Pay Versus Performance table above. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Actually Paid and Cumulative TSR </span></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-50" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company&#8217;s cumulative TSR over the three most recently completed fiscal years. </span></div><div style="margin-top:12pt;text-align:center"><img src="dcth-20250401_g7.jpg" alt="3050" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">l</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-51" continuedAt="f-51-1" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Actually Paid and Net Income (Loss) </span></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-51-1">We commercially launched the HEPZATO KIT in January 2024 and prior to that we incurred expenses related to completing the FOCUS clinical trial and preparing for commercialization of the HEPZATO KIT. We have incurred net losses during the periods presented. Consequently, we have not looked to our net loss as a performance measure for our executive compensation program. Moreover, we do not believe there is any meaningful relationship between our net loss and Compensation Actually Paid to our named executive officers during the periods presented.</ix:continuation> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All information provided above under the &#8220;Pay Versus Performance&#8221; heading will not be deemed to be incorporated by reference into any filing of the Company under the Securities Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information by reference. </span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POLICIES AND PRACTICES RELATED TO THE GRANT OF CERTAIN EQUITY AWARDS CLOSE IN TIME TO THE RELEASE OF MATERIAL NONPUBLIC INFORMATION</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMethodTextBlock" id="f-54" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMnpiDiscTextBlock" id="f-53" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" id="f-52" escape="true">From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has granted new-hire option awards on or soon after certain new hire&#8217;s employment start date and annual employee option grants in the first quarter of each fiscal year. <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgPredtrmndFlag" format="ixt:fixed-true" id="f-55">Annual grants are typically approved at the regularly scheduled meeting of the Compensation Committee occurring in such quarter. The Company&#8217;s typical practice is to grant annual employee stock options shortly after the date in which the options are approved.</ix:nonNumeric> Also, non-employee directors receive grants of annual stock option awards at the time of each annual meeting of the Company&#8217;s stockholders pursuant to our non-employee director compensation program, as further described under the heading, &#8220;Non-Employee Director Compensation&#8221; above. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The Board and the Compensation Committee <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMnpiCnsdrdFlag" format="ixt:fixed-false" id="f-56">generally do not take material nonpublic information (&#8220;MNPI&#8221;) into account</ix:nonNumeric> when determining the timing of awards and do <ix:nonNumeric contextRef="c-1" name="ecd:MnpiDiscTimedForCompValFlag" format="ixt:fixed-false" id="f-57">not seek to time the award of stock options in relation to the Company&#8217;s public disclosure of MNPI</ix:nonNumeric>. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">48</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_64"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AUDIT COMMITTEE REPORT </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee reviewed and discussed the Company&#8217;s audited financial statements for the fiscal year ended December&#160;31, 2024, with management and Marcum LLP, the Company&#8217;s independent registered public accounting firm for the fiscal year ended December&#160;31, 2024. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee also discussed with Marcum LLP the matters required to be discussed by Auditing Standard 1301 (Communications with Audit Committees), as adopted by the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee has received and reviewed the written disclosures and the letter from Marcum LLP required by applicable requirements of the PCAOB regarding Marcum LLP&#8217;s communications with the Audit Committee concerning independence and has discussed with Marcum LLP its independence from the Company. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the review and discussions referred to above, the Audit Committee recommended to the Board that the Company&#8217;s audited financial statements be included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024, for filing with the Commission. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Submitted by the Audit Committee of the Board, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elizabeth Czerepak (Chair) </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven Salamon </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bridget Martell M.A., M.D.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDER PROPOSALS FOR THE 2026 ANNUAL MEETING </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders of the Company may submit proposals that they believe should be voted upon at the Company&#8217;s annual meeting of Stockholders or nominate persons for election to the Board. The submission of a stockholder proposal does not guarantee that it will be included in the Company&#8217;s proxy statement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order for a stockholder proposal to be eligible for inclusion in our proxy statement for the 2026 annual meeting of stockholders, the proposal must be received by the Corporate Secretary not later than 120 days before the anniversary of the date this Proxy Statement for the Annual Meeting was first released to our stockholders and must otherwise comply with the requirements of Rule 14a-8(e) of the Exchange Act of 1934. In addition, in order for a stockholder to present a proposal or other matter or to nominate a person for election as a director at the 2026 annual meeting of stockholders, the stockholder must give Delcath written notice of the proposal or other matter to be presented at the meeting no later than 120 days before the anniversary of the date this Proxy Statement for the Annual Meeting was first released to our stockholders and must otherwise comply with our amended and restated certificate of incorporation. If the date set for the 2026 annual meeting is more than 30 calendar days before or after May 15, 2026, such notice must instead be received no later than 60 calendar days before the date set for such meeting. In addition to satisfying the deadlines described above, a stockholder who intends to solicit proxies in support of nominees submitted under advance notice provisions, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our nominees must include in their notice the information required by Rule 14a-19 under the Exchange Act.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Proposals or notices of intent to present a proposal should be addressed to the Corporate Secretary, Delcath Systems, Inc., 566 Queensbury Avenue, Queensbury, NY 12804, and should be sent by overnight delivery or certified mail, return receipt requested. If a stockholder fails to provide timely notice of a proposal to be presented at the 2026 annual meeting, the proxies designated by the Board will have discretionary authority to vote on the proposals. </span></div><div id="i161d31b071a7458ab37fccdf98f11dd1_70"></div><div style="margin-top:24pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOUSEHOLDING OF PROXY MATERIALS </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Commission has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices of Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other Annual Meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This year, a number of brokers with account holders who are our stockholders will be &#8220;householding&#8221; our proxy materials. A single Notice of Internet Availability of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials, please notify your broker or notify us by sending a written request to: the Corporate Secretary, Delcath Systems, Inc., 566 Queensbury Avenue, Queensbury, NY 12804 or by calling (518) 743-8892. You will be removed from the householding program, after which you will receive an individual copy of the proxy materials promptly. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders who currently receive multiple copies of the Notices of Internet Availability of Proxy Materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers. </span></div><div id="i161d31b071a7458ab37fccdf98f11dd1_73"></div><div style="margin-top:24pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We know of no other matters to be brought before the Annual Meeting. However, if any other matters do properly come before the Annual Meeting, it is intended that the proxy holders will vote the shares represented by the proxies in the accompanying form as recommended by the Board or, if no recommendation is given, in accordance with the best judgment of the person voting the proxies. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">50</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file annual and quarterly reports and other reports and information with the Commission. We distribute to our stockholders annual reports containing financial statements audited by our independent registered public accounting firm. In addition, the reports and other information are filed through Electronic Data Gathering, Analysis and Retrieval (known as &#8220;EDGAR&#8221;) system and are publicly available on the Commission&#8217;s site on the Internet, located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will provide, without charge, to each person to whom this Proxy Statement is delivered, upon written or oral request of such person and by first class mail or other equally prompt means within one business day of receipt of such request, a copy of any and all of the information that has been incorporated by reference in the Proxy Statement (not including exhibits to the information that is incorporated by reference unless such exhibits are specifically incorporated by reference into the information that the Proxy Statement incorporates). Please direct such request in writing or by telephone at the following address: </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delcath Systems, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">566 Queensbury Avenue</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Queensbury, NY 12804 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attn: Corporate Secretary </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Telephone: (518) 743-8892</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may also access such documents free of charge at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https://www.delcath.com/investors/sec-filings/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as soon as reasonably practicable after such material is electronically filed with, or furnished to, the Commission. Our website and the information contained on that site, or connected to that site, are not incorporated into and are not a part of this Proxy Statement. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your cooperation in giving these matters your immediate attention and in returning your proxy promptly will be appreciated. </span></div><div style="margin-top:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.424%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">BY ORDER OF THE BOARD OF DIRECTORS</span></div><div><img src="dcth-20250401_g8.jpg" alt="Screenshot 2023-07-15 101609.jpg" style="height:25px;margin-bottom:5pt;vertical-align:text-bottom;width:90px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gerard Michel</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">51</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Appendix A </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DELCATH SYSTEMS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020 OMNIBUS EQUITY INCENTIVE PLAN </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(As adopted by Board of Directors on September 30, 2020 and approved by stockholders on November 23, 2020) </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(As amended by the Board of Directors on March 30, 2021 and approved by stockholders on May 6, 2021) </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(As subsequently amended by the Board of Directors on April 17, 2023 and approved by stockholders on June 12, 2023)</span><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(As subsequently amended by the Board of Directors on March 27, 2024, and approved by stockholders on May 23, 2024)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(As subsequently amended by the Board of Directors on February 7, 2025, subject to stockholder approval)</span></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:1.5pt;text-decoration:underline">Purpose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is to align the interests of selected Employees, Non-Employee Directors and Consultants with those of Delcath Systems, Inc.&#8217;s (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) stockholders by providing such individuals with long-term incentive compensation opportunities tied to the performance of the Company&#8217;s Common Stock. The Plan is intended to advance the interests of the Company and its stockholders by attracting, retaining and motivating key personnel upon whose judgment, initiative and effort the successful conduct of the Company&#8217;s business is largely dependent. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Plan was originally adopted by the Board of Directors on September 30, 2020 and approved by the stockholders of the Company on November 23, 2020. The Plan was subsequently amended by the Board of Directors on March 30, 2021 and approved by stockholders of the Company on May 6, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"> subsequently amended by the Board of Directors on April 17, 2023 and approved by stockholders of the Company on June 12, 2023, </span><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">and subsequently amended by the Board of Directors on March 27, 2024 and approved by stockholders of the Company on May 23, 2024</span><span style="color:#80c9ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"> On </span><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">February 7, 2025 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Board approved an amendment of the Plan in the form set forth herein (the &#8220;Amended Plan&#8221;), subject to, and to be effective upon, the approval of the stockholders of the Company in accordance with the requirements of the laws of the State of Delaware at the Company&#8217;s </span><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> annual stockholders&#8217; meeting held on </span><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">May 15, 2025. If the Amended Plan is not so approved by the stockholders, all provisions of the Plan shall remain effective.</span></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:1.5pt;text-decoration:underline">Definitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Certain terms used in the Plan have the meanings set forth below (capitalized terms used in the Plan that are not defined below have the meanings set forth elsewhere in the Plan): </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Subsidiary and any other corporation or other entity (including, but not limited to, partnerships and joint ventures) controlling, controlled by, or under common control with, the Company. For this purpose, &#8220;control&#8221; (including, with correlative meaning, the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;), as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting or other securities, by contract or otherwise. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Law</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any applicable securities, federal, state, foreign, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any governmental or regulatory body or self-regulatory organization (including the Nasdaq Stock Market, the New York Stock Exchange and the Financial Industry Regulatory Authority). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an award under the Plan, including any Incentive Stock Option, a Non-Qualified Option, Stock Appreciation Right, a Restricted Stock Award, a Restricted Stock Unit Award, a Performance Award, an Other Stock-Based Award or a Cash Award. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the written agreement entered into between the Participant and the Company setting forth the terms and conditions applicable to an Award, as provided under Section 5(c). An Award Agreement may, in the discretion of the Committee, be transmitted electronically to any Participant. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Base Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the price per share of Common Stock subject to a Stock Appreciation Right at which the Stock Appreciation Right may be exercised or settled.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s Board of Directors, as constituted from time to time. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an award denominated in cash that is granted pursuant to Section 11. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, with respect to any Employee or Consultant, unless the applicable Award Agreement provides otherwise, shall have the meaning given to such term in any employment or other written agreement between such Participant and the Company or Affiliate, as applicable, or, in the event that such term is not defined in such agreement or in the absence of any such agreement, shall mean the occurrence of any of the following: </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.07pt">The Participant&#8217;s willful failure to perform his or her duties and responsibilities to the Company or an Affiliate, or refusal to perform any lawful and reasonable directive of the Company or an Affiliate; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt">The Participant&#8217;s gross negligence or willful misconduct in the performance of his or her duties for the Company or an Affiliate; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.53pt">The Participant&#8217;s commission of any act of fraud, embezzlement, dishonesty, moral turpitude, misappropriation of funds, breach of fiduciary duty, duty of loyalty and fidelity or other willful misconduct with respect to the Company or an Affiliate, or any act, whether or not related to the performance of the Participant&#8217;s Service, that affects the Company&#8217;s or any Affiliate&#8217;s reputation in a manner that may reasonably be expected to have a material adverse effect on the business, prospects, assets (including intangible assets), liabilities, financial condition, property or results of operation of the Company or any Affiliate; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.07pt">The Participant&#8217;s unauthorized use or disclosure of any proprietary information or trade secrets of the Company or any Affiliate or any other party to whom the Participant owes an obligation of nondisclosure as a result of the Participant&#8217;s relationship with the Company or any Affiliate; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The Participant&#8217;s breach of any of his or her obligations under any written agreement or covenant with, or any material policy of, the Company or any Affiliate; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.07pt">The Participant&#8217;s indictment or conviction of or plea of nolo contendere to a felony or crime of moral turpitude; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.3pt">The Participant&#8217;s debarment, exclusion or disqualification by any government regulator or government agency from participating in the business of the Company or any Affiliate; or </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.53pt">The Participant&#8217;s exhibition of a standard of behavior within the scope of or related to the Participant&#8217;s employment, or is a violation of the Company&#8217;s code of conduct, that is disruptive to the orderly conduct of the Company&#8217;s or its Affiliates&#8217; business operations (including, without limitation, substance abuse, sexual harassment or sexual misconduct, or other unlawful harassment or retaliation). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, with respect to any Non-Employee Director, unless the applicable Award Agreement provides otherwise, means a determination by a majority of the disinterested Directors that the Non-Employee Director has engaged in any of the following: (i) malfeasance while in office; (ii) gross negligence, willful misconduct or neglect with respect to the Company or any Affiliate; (iii) false or fraudulent misrepresentation in connection with the Non-Employee Director&#8217;s appointment; or (iv) conversion of corporate funds. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the avoidance of doubt, references to the Company and Affiliate in the foregoing definitions of &#8220;Cause&#8221; shall include the successor to either as may be appropriate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date of the occurrence of any of the following events, provided that the event constitutes a &#8220;change in control event&#8221; within the meaning of Section 409A of the Code: </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.07pt">The consummation of any consolidation or merger of the Company with any other entity, other than a transaction which would result in the voting power of the securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such consolidation or merger; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt">Any one Person, or more than one Person acting as a group, acquires ownership of the stock of the Company that, together with the stock held by such Person or group, constitutes more than 50% of the total voting power of the stock of the Company; provided, however, that for purposes of this subsection, (A) the acquisition of additional stock by </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any one Person or group, who is considered to own more than 50% of the total voting power of the stock of the Company will not be considered a Change in Control, and (B) if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company&#8217;s voting stock immediately prior to the change in ownership, the direct or indirect beneficial ownership of 50% or more of the total voting power of the stock of the Company or of the ultimate parent entity of the Company, such event will not be considered a Change in Control under this subsection (ii). For this purpose, indirect beneficial ownership will include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.53pt">A majority of the Directors is replaced during any 12-month period by Directors whose appointment or election is not endorsed by a majority of the Directors prior to the date of the appointment or election; or </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.07pt">Any one Person, or more than one Person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iv), the following will not constitute a change in the ownership of a substantial portion of the Company&#8217;s assets: (A) a transfer to an entity that is controlled by the Company&#8217;s stockholders immediately after the transfer, or (B) a transfer of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company&#8217;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3) a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding stock of the Company, or (4) an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a Person described in subsection (3) above. For purposes of this subsection (iv), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this definition, Persons will be considered to be acting as a group if they are owners of an entity that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, as the same may be amended from time to time and any successor statute. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the committee of the Board appointed by the Board to administer the Plan, pursuant to Section 3, which, unless otherwise determined by the Board, shall be the Compensation and Stock Option Committee. In the absence of any such Committee, any action permitted or required to be taken hereunder by the Committee shall be deemed to refer to the Board. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s common stock, par value $0.01 per share, or such other securities of the Company as may be designated by the Committee in substitution thereof. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consultant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Person who provides consulting or other services to the Company or any Affiliate and who is (i) neither an Employee nor a Non-Employee Director and (ii) may be offered securities registrable pursuant to a registration statement on Form S-8 under the Securities Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Director</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Board. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (a) in the case of Incentive Stock Options, total and permanent disability as defined in Section 22(e)(3) of the Code, and (b) in the case of other Awards, unless the applicable Award Agreement provides otherwise, that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment (and considered &#8220;disabled&#8221; within the meaning of Section 409A of the Code). The determination of whether an individual has a Disability shall be determined under procedures established by the Committee, which shall be final, conclusive and binding. Except in situations where the Committee is determining Disability for purposes of the term of an Incentive Stock Option, the Committee may rely on any determination that a Participant is disabled for purposes of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">benefits under any long-term disability plan maintained by the Company or any Affiliate in which a Participant participates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend Equivalent Right</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the right of a Participant, granted pursuant to Section 9 in connection with the Restricted Stock Unit Award, to receive a credit for the account of such Participant in an amount equal to cash or stock dividends or other distributions paid by the Company in respect of one share of Common Stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the original date of adoption of the Plan by the Board. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Person</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the following: (i) any Employee, Consultant, or Non-Employee Director or (ii) any individual to whom the Company or any Affiliate has extended a formal offer of employment, so long as the grant of any Award shall not become effective until such individual commences such employment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual, including, without limitation, any Officer and Director, who is a common law employee of the Company or an Affiliate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the price at which a share of Common Stock subject to an Option may be purchased upon the exercise of the Option. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as of any date, the value of the Common Stock determined as follows: </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.07pt">If the Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or such other source as the Committee deems reliable (subject to compliance with Applicable Law, including Section 409A of the Code); </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt">If the Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or such other source as the Committee deems reliable; or </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.53pt">If none of the foregoing is applicable, by the Board or the Committee in good faith (and in accordance with Section 409A of the Code, as applicable), which such decision shall be final, conclusive and binding. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Grant Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date on which the Committee adopts a resolution, or takes other appropriate action, expressly granting an Award to a Participant that specifies the key terms and conditions of the Award or, if a later date is set forth in such resolution or action, then such date as set forth in such resolution or action. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Stock Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Option that is intended to meet the requirements of Section 422 of the Code and is designated as an Incentive Stock Option. To the extent that any Option is not designated as an Incentive Stock Option, or even if so designated does not qualify as an Incentive Stock Option at or subsequent to its Grant Date, it shall constitute a Non-Qualified Option. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Employee Director</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Director who is not an Employee, and who satisfies the requirements of a &#8220;non-employee director&#8221; within the meaning of Section 16 of the Exchange Act. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Qualified Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Option that is not an Incentive Stock Option. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the right to purchase, at the price and for the term fixed by the Committee in accordance with Section 6, and subject to such other limitations and restrictions in the Plan and the applicable Award Agreement, a number of shares of Common Stock determined by the Committee. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Stock-Based Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award that is not an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award or Cash Award, and that is granted under Section 11 and is payable by delivery of Common Stock and/or which is measured by reference to the value of Common Stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Eligible Person to whom the Committee has granted an Award under the Plan (or, if applicable, such other Person who holds an outstanding Award). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an award that may vest or may become eligible to vest contingent upon the attainment during a Performance Period of certain Performance Goals and which is granted pursuant to the terms of Section 10. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Goal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means one or more goals as may be established by the Committee that must be met by the end of a given Performance Period as a contingency for a given Award to vest and/or become exercisable, settled or payable, or to otherwise determine the numbers of shares of Common Stock or stock-denominated units that are earned under an Award. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means one or more periods of time, as the Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to vesting, exercisability, settlement or payment of an Award. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Person</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual, a partnership, a corporation, a limited liability company, an association, a joint share company, a trust, a joint venture, an unincorporated organization or a governmental entity or any department, agency or political subdivision thereof. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a grant of shares of Common Stock under Section 8 that are issued subject to vesting and transfer restrictions and such other conditions as are set forth in the Plan and the applicable Award Agreement. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Unit Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award of Restricted Stock Units under Section 9. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rule 16b-3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Act of 1933, as amended from time to time or any successor statute. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Service</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as applicable, a Participant&#8217;s service with the Company or an Affiliate, as an Employee, Non-Employee Director or Consultant. For purposes of the Plan, a Participant&#8217;s Service shall not be deemed to have been terminated merely because of a change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant or Non-Employee Director or merely because of a transfer of the Participant&#8217;s Service between the Company and/or Affiliates (except as may be required for compliance with Section 409A of the Code). The Committee, in its sole discretion, may determine whether a Company transaction, such as a sale or spin-off of a division or subsidiary that employs a Participant, shall be deemed to result in a termination of Service for purposes of affected Awards, and such decision shall be final, conclusive and binding. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Appreciation Right</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a contractual right granted under Section 7 entitling the holder of such right to receive, subject to limitation and restrictions in the Plan and applicable Award Agreement, the appreciation in value of Common Stock. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any entity in which the Company owns at least 50% of the combined voting power of all classes of equity entitled to vote or at least 50% of the combined value of all classes of equity. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ten Percent Stockholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Employee who, at the time an Option is granted, owns either directly or indirectly (taking into account the attribution rules contained in Section 424(d) of the Code), stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15pt"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Administration of the Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan shall be administered by the Committee (or the Board if no Committee has been appointed). The Committee shall have the power and authority to (i) prescribe, amend and rescind rules and procedures governing the administration of the Plan; (ii) determine and designate from time to time each Eligible Person to whom an Award will be granted and the type of Award to be granted; (iii) determine the number of shares of Common Stock subject to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each Award and the Grant Date of each Award; (iv) prescribe the terms of each Award, including, without limitation, the time or times when, and the manner and conditions upon which, each Award shall vest, become exercisable, be settled and/or expire, the Exercise Price or Base Price of each Award (as may be applicable), and the form of payment made in settlement of each Award; (v) specify the terms of the Award Agreement relating to each Award; (vi) determine or impose other conditions to the receipt of shares of Common Stock subject to an Award, as it may deem appropriate, including but not limited to, cash payments; (vii) interpret the terms of the Plan and each Award Agreement and the rules of procedures established by the Committee under the Plan; (viii) determine the rights of all Persons under the Plan; (ix) correct any defect or omission or reconcile any inconsistency in the Plan or in any Award Agreement; (x) make all determinations relating to the Service of a Participant; (xi) grant waivers of any conditions of the Plan or any Award Agreement, subject to Applicable Law; and (xii) make all other determinations and take all other actions necessary or advisable for the implementation and administration of the Plan. In the case of any fractional share or unit resulting from the grant, vesting, payment or crediting of dividends under an Award, the Committee shall have the discretionary authority to round such fractional share or unit to the nearest higher whole share or unit, or convert such fractional share or unit into a right to receive a cash payment (unless determined otherwise by the Committee, such fractional share or unit shall be rounded to the nearest higher whole share or unit). All actions, decisions and interpretations of the Committee, the Board and any delegate of the Committee or Board under the Plan or any Award Agreement shall be final, binding, conclusive and non-appealable on all Persons, and shall be given the maximum deference permitted by law. The Committee&#8217;s and the Board&#8217;s determinations under the Plan (including, without limitation, determinations of the persons to receive Awards, the form, amount and timing of such Awards, the terms and provisions of such Awards and the Award Agreements evidencing such Awards) need not be uniform and may be made by the Committee or the Board selectively among Persons who receive, or are eligible to receive, Awards under the Plan, whether or not such Persons are similarly situated. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Composition of the Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise determined by the Board, the Committee shall consist of two or more Directors appointed to such committee from time to time by the Board. To the extent deemed necessary or appropriate by the Board, the Committee shall consist solely of at least two Directors who are Non-Employee Directors and are &#8220;independent directors&#8221; under any applicable exchange requirements. The Board shall have discretion to determine whether or not it intends to comply with the exemption requirements of Rule 16b-3; however, if the Board intends to satisfy such exemption requirements, with respect to any insider subject to Section 16 of the Exchange Act, the Committee shall be a compensation committee of the Board that at all times consists solely of two or more Non-Employee Directors. Nothing herein shall create an inference that an Award is not validly granted under the Plan in the event Awards are granted under the Plan by a committee of the Board that does not at all times consist solely of two or more Non-Employee Directors. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Delegation of Authority</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board or the Committee may delegate to a committee of one or more Directors and/or Officers who are not Non-Employee Directors the authority to grant Awards to Eligible Persons who are not then subject to Section 16 of the Exchange Act. In the event of such delegation of authority, all provisions of the Plan relating to the Committee shall be interpreted in a manner consistent with such delegation by treating any reference to the Committee as a reference to the committee or Officers to whom such delegation has been made. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Limited Liability; Indemnification</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition to such other rights of indemnification as they may have as Directors or members of the Committee, and to the maximum extent allowed by the Company&#8217;s charter, by-laws and Applicable Laws, the Committee shall be indemnified by the Company against the reasonable expenses, including attorney&#8217;s fees, actually incurred in connection with any action, suit or proceeding or in connection with any appeal therein, to which the Committee may be party by reason of any action taken or failure to act under or in connection with the Plan or any Award granted under the Plan, and against all amounts paid by the Committee in settlement thereof (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided, however</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the settlement has been approved by the Company, which approval shall not be unreasonably withheld) or paid by the Committee in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such Committee did not act in good faith and in a manner which such person reasonably believed to be in the best interests of the Company, or in the case of a criminal proceeding, had no reason to believe that the conduct complained of was unlawful; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided, however</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that within 60 days after the institution of any such action, suit or proceeding, such Committee shall, in writing, offer the Company the opportunity at its own expense to handle and defend such action, suit or proceeding. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Shares Subject to the Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Aggregate Limit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to adjustment as set forth in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the total number of shares of Common Stock reserved and available for grant and issuance pursuant to Awards under the Plan is equal to </span><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">9,325,000</span><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share Reserve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the full amount of which may be issued under the Plan through the exercise of Incentive Stock Options. For purposes of counting shares against the Share Reserve, Awards denominated in shares of Common Stock and other Awards that may be exercised for, settled in or convertible into shares of Common Stock will be counted against the Plan reserve on the date of grant of the Award based on the maximum number of shares that may be issued pursuant to the Award, as determined by the Committee. Shares of Common Stock delivered under the Plan shall consist of authorized and unissued shares, treasury shares, forfeited shares and/or shares reacquired by the Company in any manner. As of the Effective Date, no further awards shall be made under the Company&#8217;s 2019 Equity Incentive Plan or any other prior equity incentive plans of the Company (but such plans shall remain in effect as to awards made thereunder that are still outstanding as of the Effective Date). </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Individual Limits.</span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.07pt;text-decoration:underline">Participants other than Non-Employee Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to adjustment under Section 4(d), (A) the maximum number of shares of Common Stock underlying Options and Stock Appreciation Rights that may be granted under the Plan during any calendar year to any one Participant (other than a Non-Employee Director) shall be 500,000 shares; (B) the maximum number of shares of Common Stock subject to Restricted Stock Awards, awards of Restricted Stock Units and Other Stock Based Awards that may be granted under the Plan during any calendar year to any one Participant (other than a Non-Employee Director) shall be 500,000 (where the number of shares earned is dependent on the level of attainment of Performance Goals under a Performance Award, the number of shares counted shall be the number that may be earned at maximum performance); (C) the maximum amount of a Cash Award that may be paid pursuant to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in any calendar year to any Participant (other than a Non-Employee Director) shall be $3,000,000. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt">Non-Employee Directors. In any director year (as described below), no Non-Employee Director may receive Awards under the Plan that, when combined with cash compensation received for his or her service as a Non-Employee Director during such director year, exceed an aggregate value of $750,000 (with value of each equity award based on its grant date fair value, determined in accordance with U.S. generally accepted accounting principles). Any cash compensation paid or Awards granted to an individual for his or her service as an Employee, or for his or her services as a Consultant (other than a Non-Employee Director), will not count for purposes of the limitation under this Section. For purposes of the foregoing, a &#8220;director year&#8221; shall mean the approximate one-year period beginning on the date of a regular annual meeting of the Company&#8217;s stockholders and ending on the date of the next regular annual meeting of the Company&#8217;s stockholders. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Returned Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any shares of Common Stock subject to an outstanding Award or any portion thereof granted under the Plan will be returned to the Share Reserve and will be available for issuance in connection with subsequent Awards under the Plan to the extent such shares (or the Awards covering such shares) (i) are cancelled, forfeited or settled in cash; (ii) expire by their terms at any time; or (iii) are reacquired by the Company pursuant to a forfeiture provision. Notwithstanding the foregoing, shares subject to an Award shall not again be made available for issuance under the Plan if such shares are surrendered or tendered to pay the Exercise Price or Base Price of such Award or any tax withholding obligation arising in connection with vesting, exercise or settlement of such Award. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Adjustments for Changes in Common Stock, Etc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of any change with respect to the outstanding shares of Common Stock by reason of any recapitalization, reclassification, stock dividend, extraordinary dividend, stock split, reverse stock split or other distribution with respect to the shares of Common Stock, or any merger, reorganization, consolidation, combination, spin-off, or other similar corporate change, or any other any relevant change affecting the capitalization of the Company, the Committee shall, in the manner that it, in its sole discretion, determines is appropriate, cause an equitable adjustment or substitution to be made to (i) the maximum number of shares (or other securities or rights) reserved for issuance and future grant from the Share Reserve, (ii) the individual award limits set forth in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (iii) the number and kind of shares (or other securities or rights) subject to then outstanding Awards, (iv) the Exercise Price or Base Price with respect to any Option or Stock Appreciation Right, (v) the Performance Goals applicable to any Award and (vi) any other terms of an Award that are affected by the event. Any such actions shall be taken by the Company in good faith so as to substantially preserve the value, rights and benefits of any affected Awards. In the case of adjustments made pursuant to this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, unless the Committee specifically determines that such adjustment is in the best interests of the Company or Affiliates, the Committee shall, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the case of Incentive Stock Options, ensure that any adjustments under this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> will not constitute a modification, extension or renewal of the Incentive Stock Options within the meaning of Section 424(h)(3) of the Code, and in the case of Non-Qualified Options and Stock Appreciation Rights, ensure that any adjustments under this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> will not constitute a modification of such Non-Qualified Options within the meaning of Section 409A of the Code. Any adjustments made under this Section 4(d) shall be made in a manner which does not adversely affect the exemption provided pursuant to Rule 16b-3 under the Exchange Act. The Company shall give each Participant notice of an adjustment hereunder and, upon notice, such adjustment shall be conclusive and binding for all purposes. In addition, in connection with any of the events described above, the Committee, in its sole discretion, and subject to compliance with Section 409A of the Code may provide that each Award then-outstanding shall terminate in exchange for an equitable payment as determined by the Committee in good faith, which, in the case of Options and Stock Appreciation Rights, may include a cash payment to the extent of the excess, if any, of the then-Fair Market Value of a share of Common Stock subject to the Award, over the Exercise Price or Base Price per share of Common Stock subject to the Award, and in the event that there is no such excess, a payment of zero. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Substitute Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding awards previously granted by an entity acquired by the Company or an Affiliate or with which the Company or Affiliate combines after the Effective Date (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Substitute Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). To the extent permitted by Applicable Law, shares of Common Stock subject to Substitute Awards shall not be counted against the Share Reserve; provided, that, Substitute Awards issued in connection with the assumption of, or in substitution for, outstanding options intended to qualify as &#8220;incentive stock options&#8221; within the meaning of Section 422 of the Code shall be counted against the share limit applicable to Incentive Stock Options. Notwithstanding any other provision of the Plan, the terms of Substitute Awards may vary from the terms set forth in the Plan to the extent the Committee deems appropriate to conform, in whole or in part, to the provisions of the awards in substitution for which they are granted. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Eligibility and Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Designation of Participants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any Eligible Person may be selected by the Committee to receive an Award and become a Participant under the Plan in accordance with the Committee&#8217;s authority under Section 3. In selecting Eligible Persons to be Participants, and in determining the type and amount of Awards to be granted under the Plan, the Committee shall consider any and all factors that it deems relevant or appropriate. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Determination of Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall determine the terms and conditions of all Awards granted to Participants in accordance with its authority under Section 3 and other terms of the Plan. An Award may consist of one type of right or benefit hereunder or of two or more such rights or benefits granted in tandem. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Award Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Award under the Plan shall be evidenced by an Award Agreement in a written or electronic form approved by the Committee setting forth (as applicable) the number of shares of Common Stock, units or other rights subject to the Award, the Exercise Price, Base Price, or purchase price of the Award, the time or times at which an Award will become vested, exercisable, settled or payable, the term of the Award and any Performance Goals applicable to the Award. The Award Agreement may also set forth the effect on an Award of a Change in Control or a termination of Service under certain circumstances. The Award Agreement shall be subject to and incorporate, by reference or otherwise, all of the applicable terms and conditions of the Plan, and may also set forth other terms and conditions applicable to the Award as determined by the Committee consistent with the limitations of the Plan. The grant of an Award under the Plan shall not confer any rights upon the Participant holding such Award other than such terms, and subject to such conditions, as are specified in the Plan as being applicable to such type of Award (or to all Awards) or as are expressly set forth in the Award Agreement. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Option Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Grant of Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Award of an Option may be granted to any Eligible Person selected by the Committee and shall be evidenced by an Award Agreement setting forth the Exercise Price, the term of the Option, the number of shares of Common Stock to which the Option relates, any conditions to the exercise or vesting of all or a portion of the Option and such other terms and conditions as the Committee, in its sole discretion, shall determine. The Award Agreement pertaining to an Option shall designate such Option as an Incentive Stock Option or a Non-Qualified Option. In no event shall an Incentive Stock Option be granted to an individual who is not an employee of the Company or of a &#8220;subsidiary corporation&#8221; or a &#8220;parent corporation,&#8221; whether now or hereafter existing, as such terms are defined in Section 424(f) of the Code. To the extent the aggregate Fair Market Value (determined as of the time the Option is </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">granted) of the shares of Common Stock with respect to which an Incentive Stock Option may first become exercisable by a Participant in any one calendar year under the Plan exceeds $100,000, the Option or portions thereof which exceed such limit (according to the order in which they were granted) shall be treated as Non-Qualified Options. The Company shall have no liability to any Participant, or to any other Person, if an Option (or any portion thereof) that is intended to be an Incentive Stock Option fails to qualify as an Incentive Stock Option at any time or if an Option (or any portion thereof) is determined to constitute &#8220;nonqualified deferred compensation&#8221; under Section 409A of the Code and the terms of such Option do not satisfy the requirements of Section 409A of the Code. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Exercise Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Exercise Price with respect to shares of Common Stock subject to an Option shall be determined by the Committee in its sole discretion, provided, however, that the Exercise Price per share shall not be less than 100% (or 110% in the case of an Incentive Stock Option granted to a Ten Percent Stockholder) of the Fair Market Value of a share of Common Stock on the Grant Date of such Option. Notwithstanding the foregoing, an Incentive Stock Option may be granted with an Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 424(a) of the Code, and a Non-Qualified Option may be granted with an Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 409A of the Code. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Term of Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall determine and set forth in an Award Agreement the term during which an Option may be exercised, provided that in no event shall any Option have a maximum term greater than ten years from the Grant Date (except that the maximum term of an Incentive Stock Option granted to a Ten Percent Stockholder shall be no more than five years from the Grant Date), or such shorter period as set forth in the Award Agreement. Each Option shall terminate, cease to be exercisable and be forfeited not later than the end of the maximum term specified in the Award Agreement pertaining to the Option. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Vesting and Exercisability of Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall, in its sole discretion, provide in an Award Agreement the time or times at which, or the conditions upon which, an Option or portion thereof shall become vested and/or exercisable. The Committee may condition the vesting and/or exercisability upon the passage of time (e.g., subject to the Participant&#8217;s continued Service for specified period) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in its sole discretion, provide, in an Award Agreement or other agreement between a Participant and the Company, for the acceleration of vesting and/or exercisability of any Option upon a Participant&#8217;s termination of Service under specified circumstances or upon the occurrence of other specified events or conditions. To the extent the vesting requirements of an Option are not satisfied, the Option shall be forfeited. In no event may any Option be exercised for a fraction of a share of Common Stock. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Termination of Service.</span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.07pt;text-decoration:underline">General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided in the applicable Award Agreement or other individual written agreement between the Participant and the Company, if a Participant&#8217;s Service terminates (other than for Cause and other than upon the Participant&#8217;s death or Disability), the Participant may exercise his or her Option (to the extent that the Option was vested and the Participant was entitled to exercise such Option as of the date of the termination of Service) within the period of time ending on the earlier of (A) 90 days following the termination of the Participant&#8217;s Service, and (B) the expiration of the term of the Option as set forth in the Plan or Award Agreement. If, after termination of Service, the Participant does not exercise his or her Option within the applicable time frame, the Option will terminate. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt;text-decoration:underline">Disability of Participant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided in the applicable Award Agreement or other individual written agreement between the Participant and the Company, if a Participant&#8217;s Service terminates as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option (to the extent that the Option was vested and the Participant was entitled to exercise such Option as of the date of termination of Service), but only within such period of time ending on the earlier of (A) the date 12 months following such termination of Service, and (B) the expiration of the term of the Option as set forth in the Award Agreement. If, after termination of Service, the Participant does not exercise his or her Option within the applicable time frame, the Option will terminate. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.53pt;text-decoration:underline">Death of Participant.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except as otherwise provided in the applicable Award Agreement or other individual written agreement between the Participant and the Company, if (A) a Participant&#8217;s Service terminates as a result of the Participant&#8217;s death, or (B) the Participant dies within the period (if any) specified in the Award Agreement for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercisability after the termination of the Participant&#8217;s Service for a reason other than death, then the Option may be exercised (to the extent the Option was vested and the Participant was entitled to exercise such Option as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise the Option upon the Participant&#8217;s death, but only within the period ending on the earlier of (A) the date 12 months following the date of death, and (B) the expiration of the term of such Option as set forth in the Award Agreement. If, after the Participant&#8217;s death, the Option is not exercised within the applicable time frame, the Option will terminate. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.07pt;text-decoration:underline">Termination for Cause</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as provided otherwise in a Participant&#8217;s Award Agreement or other individual written agreement between the Company and a Participant, if a Participant&#8217;s Service is terminated by the Company or any Affiliate for Cause, each Option, whether vested or unvested, that is held by such Participant shall terminate, cease to be exercisable/payable and be forfeited as of the date of such termination of Service. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.67pt;text-decoration:underline">Exercise of Options; Payment.</span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.07pt;text-decoration:underline">Notice of Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to vesting, exercisability and other restrictions provided for hereunder or otherwise imposed in accordance herewith, an Option may be exercised, in whole or in part, by a Participant only by delivery of written notice (in the form prescribed by the Committee) to the Company specifying the number of shares of Common Stock to be purchased. An Option may not be exercised after it is forfeited or otherwise terminated. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt;text-decoration:underline">Payment of Exercise Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The aggregate Exercise Price shall be paid in full upon the exercise of the Option. Payment must be made by one of the following methods: (A) cash or a certified or bank cashier&#8217;s check; (B) if and upon the terms approved by the Committee in its sole discretion, by delivery to the Company of previously owned and vested shares of Common Stock, duly endorsed for transfer to the Company, having an aggregate Fair Market Value on the date of exercise equal to the aggregate Exercise Price due for the number of shares being acquired pursuant to such exercise, (C) if and upon the terms approved by the Committee in its sole discretion, through the withholding by the Company of shares of Common Stock otherwise to be received, with such withheld shares of Common Stock having an aggregate Fair Market Value on the date of exercise equal to the aggregate Exercise Price due for the number of shares being acquired; (D) a &#8220;cashless&#8221; exercise program established with a broker; (E) by any combination of such methods of payment, or (F) any other method approved by the Committee in its sole discretion. Unless otherwise specifically provided in the Option, the Exercise Price that is paid by delivery to the Company of other Common Stock acquired, directly or indirectly from the Company, shall be paid only by shares of the Common Stock that have been held for more than six months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes). Notwithstanding the foregoing, during any period the Common Stock is publicly traded, an exercise by a Director or Officer that involves or may involve a direct or indirect extension of credit or arrangement of an extension of credit by the Company, directly or indirectly, in violation of Section 402(a) of the Sarbanes-Oxley Act of 2002 shall be prohibited. The Committee may impose limitations and prohibitions on the exercise of Options as it deems appropriate, including, without limitation, any limitation or prohibition designed to avoid accounting consequences which may result from the use of shares of Common Stock as payment of the aggregate Exercise Price. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Disqualifying Disposition with respect to Incentive Stock Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If shares of Common Stock acquired upon the exercise of an Incentive Stock Option are disposed of by a Participant prior to the expiration of (i) two years from the Grant Date of such Option, or (ii) one year from the date of the transfer of shares to the Participant pursuant to the exercise of such Option, or in any other &#8220;disqualifying disposition&#8221; within the meaning of Section 422 of the Code, such Participant shall notify the Company in writing as soon as practicable thereafter of the date and terms of such disposition and, if the Company (or any Affiliate) thereupon has a tax withholding obligation, shall pay to the Company (or such Affiliate) an amount equal to any withholding tax the Company (or such Affiliate) is required to pay as a result of the disqualifying disposition. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Stock Appreciation Rights</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Grant of Stock Appreciation Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Award of a Stock Appreciation Right may be granted to any Eligible Person selected by the Committee and shall be evidenced by an Award Agreement setting forth the Base Price, the term of the Stock Appreciation Right, the number of shares of Common Stock to which the Stock Appreciation Right relates, any conditions to the exercise of all or a portion of the Stock Appreciation Right and such other terms and conditions as the Committee, in its sole discretion, shall determine. A Stock Appreciation Right may, in the sole discretion of the Committee, be granted in tandem with an Option, and in such event, shall (i) have a Base Price per share equal to the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per share Exercise Price of the Option, (ii) be vested and exercisable at the same time or times that a related Option is vested and exercisable, and (iii) expire no later than the time at which the related Option expires. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Benefits Upon Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to such terms and conditions as specified in an Award Agreement, a Stock Appreciation Right shall entitle the Participant to receive a payment, upon exercise or other settlement of the Stock Appreciation Right, of an amount determined by multiplying (i) the excess of the Fair Market Value of each share of Common Stock covered by the Stock Appreciation Right on the date of exercise or settlement of the Stock Appreciation Right over the Base Price per share of Common Stock covered by the Stock Appreciation Right, by (ii) the number of shares of Common Stock as to which such Stock Appreciation Right is exercised or settled. Such payment may be in cash, in shares of Common Stock (with or without restriction as to substantial risk of forfeiture and transferability, as determined by the Company in its sole discretion) valued at their Fair Market Value on the date of exercise or other settlement, or in any combination, as the Committee shall determine in the Award Agreement. Upon exercise of a tandem Stock Appreciation Right, the number of shares of Common Stock for which any related Option shall be exercisable shall be reduced by the number of shares for which the Stock Appreciation Right has been exercised. The number of shares of Common Stock for which a tandem Stock Appreciation Right shall be exercisable shall be reduced upon any exercise of any related Option by the number of Shares of Common Stock for which such Option has been exercised. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Base Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Base Price per share of Common Stock subject to a Stock Appreciation Right shall be determined by the Committee in its sole discretion, provided, however, that the Base Price per share shall not be less than 100% of the Fair Market Value of a share of Common Stock on the Grant Date of such Stock Appreciation Right. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Term of Stock Appreciation Right</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall determine and set forth in an Award Agreement the term during which a vested Stock Appreciation Right may be exercised or settled, provided that in no event shall any Stock Appreciation Right have a maximum term greater than 10 years from the Grant Date, or such shorter period as set forth in the Award Agreement. Each Stock Appreciation Right shall terminate, cease to be exercisable/payable and be forfeited, not later than the end of the maximum term specified in the Agreement pertaining to the Stock Appreciation Right. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Vesting and Exercisability of Stock Appreciation Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall, in its sole discretion, provide in an Award Agreement the time or times at which, or the conditions upon which, a Stock Appreciation Right or portion thereof shall become vested, exercisable and/or settled. The Committee may condition the vesting and/or exercisability upon the passage of time (e.g., subject to the Participant&#8217;s continued Service for a specified period) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in its sole discretion, provide, in an Award Agreement or other written agreement between a Participant and the Company, for the acceleration of vesting and/or exercisability of any Stock Appreciation Right upon a Participant&#8217;s termination of Service under specified circumstances or upon the occurrence of other specified events or conditions. To the extent the vesting requirements of a Stock Appreciation Right are not satisfied, the Stock Appreciation Right shall be forfeited. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.67pt;text-decoration:underline">Notice of Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to vesting, exercisability and other restrictions provided for hereunder or otherwise imposed in accordance herewith, a Stock Appreciation Right may be exercised, in whole or in part, by a Participant only by delivery of written notice (in the form prescribed by the Committee) to the Company specifying the number of shares of Common Stock with respect to which the exercise applies. A Stock Appreciation Right may not be exercised after it is forfeited or otherwise terminated. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Termination of Service</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The same rules of Section 6(e) that apply to Options regarding termination of Service shall also apply to Stock Appreciation Rights. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Restricted Stock Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Grant of Restricted Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Restricted Stock Award may be granted to any Eligible Person selected by the Committee and shall be evidenced by an Award Agreement setting forth the number of shares of Common Stock subject to the Restricted Stock Award, the payment (if any) required for such shares, the vesting restrictions applicable to such shares and such other terms and conditions as the Committee, in its sole discretion, shall determine. The Committee may require that certificates representing the shares of Common Stock issued pursuant to a Restricted Stock Award bear a legend making appropriate reference to the restrictions imposed, and that certificates representing such shares will remain in the physical custody of the Company or an escrow holder until all restrictions are removed </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or have expired. The Committee may also require the Participant to execute and deliver to the Company (i) an escrow agreement satisfactory to the Committee, if applicable, and (ii) the appropriate blank stock power with respect to the shares of Common Stock covered by such agreement. If a Participant fails to execute an agreement evidencing a Restricted Stock Award and, if applicable, an escrow agreement and stock power, the Award shall be null and void. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Vesting of Restricted Stock Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall, in its sole discretion, provide in an Award Agreement the time or times at which, or the conditions upon which, a Restricted Stock Award shall vest. The restrictions imposed on shares of Common Stock granted under a Restricted Stock Award shall lapse in accordance with the vesting requirements specified by the Committee in the Award Agreement. The Committee may condition the vesting upon the passage of time (e.g., subject to the Participant&#8217;s continued Service for a specified period) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in its sole discretion, provide, in an Award Agreement or other agreement between a Participant and the Company, for the acceleration of vesting of a Restricted Stock Award upon a Participant&#8217;s termination of Service under specified circumstances or upon the occurrence of other specified events or conditions. If the vesting requirements applicable to a Restricted Stock Award are not satisfied, the shares subject to the Award shall automatically be forfeited, the Participant shall assign, transfer, and deliver any certificates evidencing ownership of such shares to the Company, and the Participant shall cease for all purposes to be a stockholder with respect to such shares. If the Participant paid for such forfeited shares in cash or other tangible consideration, then, unless otherwise provided by the Committee in an Award Agreement, the Company will refund to the Participant the lesser of (i) the amount originally paid by the Participant for such shares and (ii) the Fair Market Value of such shares on the date of forfeiture. Without limiting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, by acceptance of a Restricted Stock Award, the Participant shall be deemed to appoint, and does so appoint by execution of the Award Agreement, the Company and each of its authorized representatives as the Participant&#8217;s attorneys-in-fact to effect the transfer of forfeited shares subject to the Restricted Stock Award. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Nontransferability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Shares granted under any Restricted Stock Award may not be transferred, assigned or subject to any encumbrance, pledge, or charge unless and until (i) the vesting conditions applicable to the Award have been achieved, and (ii) the other restrictions on transferability applicable to Common Stock set forth in the Plan, the Award Agreement or otherwise have been satisfied. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Rights as a Stockholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the foregoing provisions of this Section 8 and, unless otherwise stated in the applicable Award Agreement, a Participant generally shall have the rights and privileges of a stockholder with respect to shares of Common Stock granted to the Participant under a Restricted Stock Award, including the right to vote such shares and the right to receive dividends and distributions with respect such shares. However, unless provided otherwise in an Award Agreement, all cash and stock dividends and distributions shall be held back by</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company for the Participant&#8217;s account until such time as the related portion of the Restricted Stock Award vests (at which time such dividends or distributions, as applicable, shall be released and paid) and if such related portion of the Restricted Stock Award is forfeited, such dividends or distributions, as applicable, will be forfeited. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Section 83(b) Election</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If a Participant makes an election pursuant to Section 83(b) of the Code with respect to a Restricted Stock Award, the Participant shall file, within 30 days following the date of grant of the Award, a copy of such election with the Company and with the Internal Revenue Service, in accordance with the regulations under Section 83 of the Code. The Committee may provide in an Award Agreement that the Restricted Stock Award is conditioned upon the Participant&#8217;s making or refraining from making an election with respect to the Award under Section 83(b) of the Code. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Restricted Stock Unit Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Grant of Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Award of hypothetical Common Stock units (&#8220;Restricted Stock Units&#8221;) having a value equal to the Fair Market Value of an identical number of shares of Common Stock may be granted to any Eligible Person selected by the Committee and shall be evidenced by an Award Agreement setting forth the number of shares of Restricted Stock Units subject to the Award, the vesting and/or earnings conditions applicable to the Restricted Stock Units, the timing for settlement of the Restricted Stock Units and such other terms and conditions as the Committee, in its sole discretion, shall determine. No shares of Common Stock shall be issued at the time a Restricted Stock Unit is granted, and the Company will not be required to set aside funds for the payment of any such Award. A Participant shall have no voting rights with respect to any Restricted Stock Units granted hereunder. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Vesting of Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall, in its sole discretion, provide in an Award Agreement the time or times at which, or the conditions upon which, Restricted Stock Units shall vest and/or be settled. The Committee may condition the vesting upon the passage of time (e.g., subject to the Participant&#8217;s continued Service as of a specified date) and/or the occurrence of any other event or condition that is established by the Committee and set forth in the Award Agreement. The Committee may, in its sole discretion, provide, in an Award Agreement or other agreement between a Participant and the Company, for the acceleration of vesting of any Restricted Stock Units upon a Participant&#8217;s termination of Service under specified circumstances or upon the occurrence of other specified events or conditions. If the vesting requirements applicable to Restricted Stock Units are not satisfied, such units shall automatically be forfeited. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Dividend Equivalent Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may permit Participants holding Restricted Stock Units to receive Dividend Equivalent Rights on outstanding Restricted Stock Units if dividends are paid to stockholders on shares of Common Stock. If so permitted by the Committee, such Dividend Equivalent Rights may be paid in cash or shares of Common Stock (in the sole discretion of the Committee), and will be payable to the Participant upon settlement of the Restricted Stock Units to which the Dividend Equivalent Rights relate and, to the extent such Restricted Stock Units are forfeited, the Participant shall have no right to payment in respect of the Dividend Equivalent Rights. If the Committee permits Dividend Equivalent Rights to be made on Restricted Stock Units, the terms and conditions for such Dividend Equivalent Rights will be set forth in the applicable Award Agreement. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the time of settlement of a vested Restricted Stock Unit (which may be upon or following vesting of the Award, as set forth in the Award Agreement), the Company shall deliver to the Participant, or his or her beneficiary, without charge, one share of Common Stock for each such outstanding vested Restricted Stock Unit and cash equal to any Dividend Equivalents credited with respect to each such vested Restricted Stock Unit and any interest thereon (or, at the discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to such Dividend Equivalents and the interest thereon, if any); </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided, however</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, if explicitly provided in the applicable Award Agreement, the Committee may, in its sole discretion, elect to pay cash or part cash and part Common Stock in lieu of delivering only shares of Common Stock for vested Restricted Stock Units. If a cash payment is made in lieu of delivering shares of Common Stock, the amount of such payment shall be equal to the Fair Market Value of the Common Stock as of the date on which the Restricted Stock Unit vested (or specified deferred settlement date, if later). </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt;text-decoration:underline">Performance Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Types of Performance Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the discretion of the Committee, a Performance Award may be granted to any Eligible Person as an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award, Other Stock-Based Award or Cash Award. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Terms of Performance Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Performance Awards will be based on the attainment of Performance Goals that are established by the Committee for the relevant Performance Period. Prior to the grant of any Performance Award, the Committee will determine and each Award Agreement shall set forth the terms of each Performance Award, including, without limitation: (i) the nature, length and starting date of any Performance Period; (ii) the Performance Goals that shall be used to determine the time and extent to which a Performance Award has been earned; (iii) amount of any cash bonus, or the number of shares of Common Stock deemed subject to a Performance Award, and (iv) the effect of a termination of Participant&#8217;s Service on a Performance Award. Participants may participate simultaneously with respect to Performance Awards that are subject to different Performance Periods and Performance Goals. A Performance Award may but need not require the Participant&#8217;s completion of a specified period of Service. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Determination of Achievement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall determine the extent to which a Performance Award has been earned in its sole discretion, including the extent to which Performance Goals have been attained, and the degree of achievement between minimum and maximum levels. The Committee may reduce or waive any criteria with respect to a Performance Goal, or adjust a Performance Goal (or method of calculating the attainment of a Performance Goal) to take into account unanticipated events, including changes in law and accounting or tax rules, as the Committee deems necessary or appropriate, or to reflect the impact of extraordinary or unusual items, events or circumstances to avoid windfalls or hardships. The Committee may also adjust or eliminate the compensation or economic benefit due upon attainment of Performance Goals in its sole discretion, subject to any limitations contained in the Award Agreement and compliance with Applicable Law. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt;text-decoration:underline">Other Stock-Based Awards and Cash Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Other Stock-Based Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may grant, either alone or in tandem with other Awards, to any Eligible Person an Other Stock-Based Award that is payable in, valued in whole or in part by reference to, or otherwise based or related to shares of Common Stock, including, but not limited to, shares of Common Stock awarded as a bonus or other compensation which are issued without restrictions on transfer and other incidents of ownership and free from forfeiture conditions (other than those that generally apply to shares of Common Stock under the Plan). An Other Stock-Based Award shall be evidenced by an Award Agreement setting forth the number of shares of Common Stock subject to the Award, any payment required for such Award, any vesting conditions applicable to the Award and such other terms and conditions as the Committee, in its sole discretion, shall determine. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Cash Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may grant, to any Eligible Person, a Cash Award that is payable contingent upon the attainment during a Performance Period of certain Performance Goals and/or such other terms as the Committee may determine (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). A Cash Award may also require the completion of a specified period of Service. The degree to which Performance Goals applicable to a Cash Award have been attained will be conclusively determined by the Committee, in its sole discretion. The Committee may specify the form of payment of Cash Awards, which may be cash or other property, or may provide for a Participant to have the option for his or her Cash Award, or such portion thereof as the Committee may specify, to be paid in whole or in part in cash or other property. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt;text-decoration:underline">Forfeiture Events</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may specify in an Award Agreement that the Participant&#8217;s rights, payments and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events. Such events may include, without limitation, a termination of Service for Cause and/or breach of noncompetition, confidentiality or other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is materially detrimental to the business or reputation of the Company. The Committee shall have the power to determine whether the Participant has been terminated for Cause and the date upon which such termination for Cause occurs. Any such determination shall be final, conclusive and binding upon the Participant. In addition, if the Company shall reasonably determine that a Participant has committed or may have committed any act which could constitute the basis for a termination of such Participant&#8217;s Service for Cause, the Committee may, subject to compliance with Applicable Law, suspend the Participant&#8217;s rights to exercise any Option or Stock Appreciation Right, receive any payment or vest in any right with respect to any Award pending a determination by the Company of whether an act has been committed which could constitute the basis for a termination for Cause. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Right of Recapture</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise provided in an Award Agreement, if at any time within 1 year after the date on which a Participant exercises an Option or Stock Appreciation Right or on which an another Award vests or becomes payable, or on which income otherwise is realized by a Participant in connection with an Award, </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.07pt">a Participant&#8217;s Service is terminated for Cause, or </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt">the Committee determines in its sole discretion either that, (A) while in Service, the Participant had engaged in an act which would have warranted termination for Cause, or (B) after termination of Service for any reason, the Participant has engaged in conduct that violates any continuing obligation or duty of the Participant in respect of the Company, or any Affiliate, then any gain realized by the Participant from the exercise, vesting, payment or other realization of income by the Participant in connection with an Award, shall be paid by the Participant to the Company upon notice from the Committee. Such gain shall be determined as of the date on which the gain is realized by the Participant, without regard to any subsequent change in the Fair Market Value of a share of Common Stock. The Company shall have the right to offset such gain against any amounts otherwise owed to the Participant by the Company (whether as wages, vacation pay or pursuant to any benefit plan or other compensatory arrangement), subject to compliance with Section 409A of the Code and other Applicable Law. The foregoing shall apply in addition to any other relief available to the Company or any of its Affiliates at law or otherwise and without limiting the ability of the Company or any of its Affiliates to pursue the same. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Clawback/Recovery</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement or compensation clawback policy as the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a right to voluntarily terminate employment upon a &#8220;resignation for good reason,&#8221; or for a &#8220;constructive termination&#8221; or any similar term under any plan of or agreement with the Company or any Affiliate. Without limiting the generality of the foregoing, any such clawback policy of the Company, whether required by applicable listing standards or law, or otherwise adopted by the Board in its discretion, may provide that if a Participant, regardless of his or her position with the Company, receives compensation pursuant to an Award under the Plan based on financial statements that are subsequently required to be restated in a way that would decrease the value of such compensation, the Participant will forfeit and repay to the Company the difference between what the Participant received and what the Participant should have received based on the accounting restatement. By accepting an Award hereunder, the Participant acknowledges and agrees that any such policy shall apply to such Award, and all compensation payable pursuant to such Award shall be subject to forfeiture and repayment pursuant to the terms of such policy. Although not required to give effect to the provisions of this Section 12(c), the Committee may, as it deems appropriate, amend the Plan to reflect the terms of any such policy. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt;text-decoration:underline">Change in Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision of the Plan to the contrary, in the event of a Change in Control, outstanding Awards under the Plan shall be subject to the agreement pursuant to which the Change in Control takes place (or to such treatment as the Committee otherwise determines), which need not treat all outstanding Awards or Participants in an identical manner. Such agreement (or other treatment), without the Participant&#8217;s consent, may provide for one or more of the following with respect to Awards outstanding as of or immediately prior to the effective date of the Change in Control: </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">The continuation of any outstanding Awards by the Company (if the Company is the surviving entity); </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The assumption of any outstanding Awards by the acquirer or surviving entity or its parent or subsidiary in a manner that complies with Sections 424(a) and 409A of the Code (as applicable), or the substitution by the successor or acquiring entity or its parent or subsidiary of equivalent awards with substantially the same terms for such outstanding Award in a manner that complies with Sections 424(a) and 409A of the Code (as applicable); </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Full or partial acceleration of vesting and/or, if applicable, exercisability, of any Awards, and, in the case of Options or Stock Appreciation Rights, followed by the cancellation of such Options or Stock Appreciation Rights, if not exercised within a time period prior to the Change in Control, as specified by the Committee. The full or partial exercisability of such Awards and full or partial vesting of any Awards may be contingent on the closing of such Change in Control. Any exercise of Options or Stock Appreciation Rights during such period may be contingent on the closing of such Change in Control; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">With respect to Performance Awards, the cessation, upon the date of the Change in Control, of any incomplete Performance Periods applicable to such Awards, with the Committee determining the extent to which the Performance Goals applicable to such Awards have been attained as of the date of the Change in Control based on such audited or unaudited financial information then available as the Committee deems appropriate, and partial or full payment to the Participant in respect of such Awards based on such determination by the Committee, or, if not determinable, with the assumption that the applicable &#8220;target&#8221; level of performance has been attained, or on such other basis determined by the Committee; </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">The settlement of Awards (whether or not then vested or exercisable) in cash, cash equivalents, or securities of the successor entity (or its parent, if any) with a fair market value (as determined by the Committee) equal to the required amount provided in the agreement pursuant to which the Change in Control occurs, followed by the cancellation of such Awards; provided however, that such Award may be cancelled without consideration if such Award has no value, as determined by the Committee in its sole discretion. Subject to compliance with Section 409A of the Code, such payment may be made in installments and may be deferred until the date or dates the Award would have become exercisable or vested. Such payment may be subject to vesting based on the Participant&#8217;s continuous Service, provided that the vesting schedule shall not be less favorable to the Participant than the schedule under which the Award would have become vested or exercisable. For purposes of this paragraph, the Fair Market Value of any security shall be determined without regard to any vesting conditions that may apply to such security. Further, subject to compliance with Section 409A of the Code, the Participant may be required to bear his or her pro rata share of any post-closing indemnity obligations with respect to the Award and settlement of the Award may be subject to the same post-closing purchase price adjustments, escrow terms, offset rights, holdback terms, and similar conditions as the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">holders of Common Stock. Without limitation of the foregoing, in the case of Options and/or Stock Appreciation Rights, such settlement may, at the discretion of the Committee, include payment to one or more Participants holding such Options or Stock Appreciation Rights equal to the excess, if any, of (i) the Fair Market Value of the shares subject to each such Option or Stock Appreciation Right (whether or not such Option or Stock Appreciation Right is then vested or exercisable) as of the closing date of such Change in Control over (ii) aggregate Exercise Price or Base Price of such Option or Stock Appreciation Right. With respect to any or every Option or Stock Appreciation Right that has a per share Exercise Price or Base Price that equals or exceeds the Fair Market Value per share of Common Stock as of the closing of the Change in Control, the Committee, in its discretion, may provide for the cancellation of such Option or Stock Appreciation Right without any payment to the Participant therefor; and/or </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.67pt">The cancellation of unvested Awards (or portion thereof) in exchange for no consideration. Unless otherwise determined by the Committee and evidenced in an Award Agreement (or as otherwise determined by the Committee), in the event of a Change in Control and either (i) an outstanding Award is not assumed or substituted in connection with the Change in Control, or (ii) an outstanding Award is assumed or substituted in connection therewith but the Participant&#8217;s Service is terminated by the Company (or its successor or affiliate) without Cause within twelve (12) months after the Change in Control, then: (A) any unvested or unexercisable portion of any Award carrying a right to exercise shall become fully vested and exercisable, and (B) the restrictions (including exercise restrictions), deferral limitations, payment conditions and forfeiture conditions applicable to an Award granted will lapse and such Award will be deemed fully vested, and any performance conditions on the Award will be deemed achieved based on actual performance levels as determined by the Committee. For purposes of the preceding sentence, an Award shall be considered to be assumed or substituted for if, following the Change in Control, the Award remains subject to the same terms and conditions that were applicable to the Award immediately prior to the Change in Control except that, if the Award related to shares of Common Stock, the award instead confers the right to receive, or otherwise relates to, common stock of the acquiring or surviving entity (with adjustment to such number of shares subject to the Award as determined by the Committee). For the avoidance of doubt, the Committee may accelerate the vesting of or waive restrictions on awards in whole or in part at any time, for any reason (subject to compliance with Section 409A of the Code, to the extent applicable to the Award). </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt;text-decoration:underline">General Provisions</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Additional Documentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company may, at any time, require a Participant to execute any additional documents or instruments necessary or desirable, as determined by the Committee, to carry out the purposes or intent of any Award and/or to facilitate compliance with securities, tax and/or other regulatory requirements. Any such additional documents or instructions may, but need not be, appended to an Award Agreement. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Restrictions on Transfer of Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as expressly provided in the Plan or an applicable Award Agreement, or otherwise determined by the Committee, no Participant may sell, transfer, assign, pledge, donate or otherwise dispose of (including any transfer by operation of law or involuntary transfer) Awards or any interest therein for any reason during the Participant&#8217;s lifetime, and any attempt to do so shall be void and shall result in the relevant Award being forfeited. The Committee may grant Awards (except Incentive Stock Options) that are transferable by the Participant during his or her lifetime, but such Awards shall be transferable only to the extent specifically provided in such Participant&#8217;s Award Agreement. In the event of the death of a Participant, an Award may be transferred by will or the laws of descent or distribution. The transferee of the Participant shall, in all cases, be subject to the provisions of the Award Agreement and the terms and conditions of this Plan. Unless otherwise determined by the Committee, an Option or Stock Appreciation Right may be exercised during the lifetime of the Participant, only by the Participant or, during the period the Participant is under a legal disability, by the Participant&#8217;s guardian or legal representative. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Rights as a Stockholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant shall have no rights as a holder of shares of Common Stock with respect to any unissued securities covered by an Award until the date the Participant becomes the holder of record of such securities (except for any Dividend Equivalent Rights permitted by an applicable Award Agreement). Except as otherwise provided for in the Plan or an Award Agreement, after shares of Common Stock are issued to the Participant, the Participant will be a stockholder and have all the rights of a stockholder with respect to such shares, including the right to vote and receive dividends or other distributions. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Prohibition Against Exchange and Buyout of Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision of the Plan to the contrary, except in connection with a corporate transaction involving the Company (including, without limitation, a Change in Control or any transaction or event described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the Committee shall not, without the approval of the Company&#8217;s stockholders, (i) reduce the Exercise Price of an Option or reduce the Base Price of a Stock Appreciation </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right after it is granted, (ii) cancel any outstanding Option or Stock Appreciation Right in exchange for another Award, or Option or Stock Appreciation Right with an Exercise Price or Base Price, as applicable, that is less than the Exercise Price or Base Price of the original Option or Stock Appreciation Right, (iii) cancel an outstanding Option or Stock Appreciation Right when the Exercise Price or Base Price, as applicable, exceeds the Fair Market Value of a share of the Common Stock in exchange for cash or other securities, or (iv) take any other action with respect to an Option or Stock Appreciation Right that would be treated as a repricing under the rules and regulations of the principal securities market on which the Common Stock is traded. Any amendment or repeal of this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 14(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall require the approval of the stockholders of the Company. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Deferrals of Payment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent permitted by Applicable Law, the Committee, in its sole discretion, may determine that the delivery of shares of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award shall or may be deferred and may establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants (or deferred settlement or payment required by the Committee) will be made in accordance with Section 409A of the Code, if applicable, and any other Applicable Law. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.67pt;text-decoration:underline">Acceleration of Exercisability and Vesting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall have the power and authority to accelerate the time at which an Award or any part thereof may be exercised or the time at which an Award or any part thereof will vest, notwithstanding the provisions in the Award stating the time at which an award may be exercised or the time at which it will vest. Any such acceleration shall be subject to compliance with Section 409A of the Code, to the extent applicable to the Award. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Corporate Action Constituting Grant of Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., Exercise Price, Base Price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Securities Law Compliance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.07pt;text-decoration:underline">General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No shares of Common Stock shall be purchased, sold or otherwise issued pursuant to any Award unless and until (A) any then applicable requirements of state or federal laws and regulatory agencies have been fully complied with to the satisfaction of the Committee and its counsel and (B) if required to do so by the Committee, the Participant has executed and delivered to the Company a letter of investment intent in such form and containing such provisions as the Committee may require in its sole discretion. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.3pt;text-decoration:underline">Section 16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. It is the intent of the Company that the Plan satisfy, and be interpreted in a manner that satisfies, the applicable requirements of Rule 16b-3 as promulgated under Section 16 of the Exchange Act so that Participants will be entitled to the benefit of Rule 16b-3, or any other rule promulgated under Section 16 of the Exchange Act, and will not be subject to short-swing liability under Section 16 of the Exchange Act. Accordingly, if the operation of any provision of the Plan would conflict with the intent expressed in this subsection, such provision to the extent possible shall be interpreted and/or deemed amended so as to avoid such conflict. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.23pt;text-decoration:underline">Tax Withholding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All Awards (including the issuance or vesting of shares or payment of cash pursuant to an Award) shall be subject to all applicable tax withholding. Prior to the delivery of any shares of Common Stock or cash pursuant to an Award (or exercise thereof) or such earlier time as any tax withholdings are due, the Company will have the power and right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy U.S. federal, state, or local taxes, non-U.S. taxes, or other taxes (including the Participant&#8217;s FICA obligation) required to be withheld with respect to such Award. The Committee, or its delegate(s), as permitted by Applicable Law, in its sole discretion and pursuant to such procedures as it may specify from time to time and subject to limitations of Applicable Law, may require or permit a Participant to satisfy any applicable tax withholding obligations, in whole or in part by (without limitation) (A) requiring the Participant to make a cash payment, (B) withholding from the Participant&#8217;s wages or other cash compensation paid to the Participant by the Company or any Affiliate; (C) withholding from the shares of Common Stock otherwise issuable pursuant to an Award; (D) permitting </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Participant to deliver to the Company already-owned shares of Common Stock, (E) withholding from the proceeds of the sale of otherwise deliverable shares of Common Stock acquired pursuant to an Award either through a voluntary sale or through a mandatory sale arranged by the Company or (F) such other means as the Committee shall deem appropriate. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.23pt;text-decoration:underline">Section 409A Compliance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. It is intended that this Plan and any Awards will comply with, or avoid application of, the provisions of Section 409A of the Code, and they shall be interpreted and construed on a basis consistent with that intent. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;nonqualified deferred compensation&#8221; under Section 409A of the Code is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code, no distribution or payment of any amount that is due because of a &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that is six months following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lump sum (without interest) on the day after such six month period elapses, with the balance paid thereafter on the original schedule. Notwithstanding the foregoing, the Company and its Affiliates and their respective employees, officers and directors shall have no liability whatsoever to a Participant nor any other Person (i) if an Award that is intended to be exempt from, or compliant with, Section 409A of the Code is not so exempt or compliant, or (ii) in respect of any decision to take action to attempt to comply with Section 409A of the Code, any omission to take such action or for the failure of any action taken by the Company to so comply. Notwithstanding the foregoing, in the sole discretion of the Committee, the Company may, but is under no obligation to, agree to pay all or a portion of the individual tax liability of one or more Participants whose awards do not satisfy the conditions for exemption under Section 409A of the Code. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">No Obligation to Notify or Minimize Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company shall have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising an Award. Furthermore, the Company shall have no duty or obligation to warn or otherwise advise any Participant of a pending termination or expiration of any Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of any Award. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.23pt;text-decoration:underline">Unfunded Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The adoption of the Plan and any reservation of shares of Common Stock or cash amounts by the Company to discharge its obligations hereunder shall not be deemed to create a trust or other funded arrangement. Except upon the issuance of Common Stock pursuant to an Award, any rights of a Participant under the Plan shall be those of a general unsecured creditor of the Company, and neither a Participant nor the Participant&#8217;s permitted transferees or estate shall have any other interest in any assets of the Company by virtue of the Plan. The Plan is not intended to be a plan that is subject to the Employee Retirement Income Security Act of 1974, as amended, and shall be interpreted accordingly. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.23pt;text-decoration:underline">Stop Transfer Orders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All certificates for shares of Common Stock delivered under the Plan pursuant to any Award shall be subject to such stop-transfer orders and other restrictions as the Committee may deem advisable under Applicable Law, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Other Compensation and Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The adoption of the Plan shall not affect any other share incentive or other compensation plans in effect for the Company or any of its Affiliates, nor shall the Plan preclude the Company from establishing any other forms of share incentive or other compensation or benefit program for employees of the Company or any of its Affiliates. The amount of any compensation deemed to be received by a Participant pursuant to an Award shall not constitute includable compensation for purposes of determining the amount of benefits to which a Participant is entitled under any other compensation or benefit plan or program of the Company or an Affiliate, including, without limitation, under any pension or severance benefits plan, except to the extent specifically provided by the terms of any such plan. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Plan Binding on Transferees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan shall be binding upon the Company, its successors, transferees and assigns, and the Participant, the Participant&#8217;s executor, administrator and permitted transferees and beneficiaries. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Severability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Whenever possible, each provision of this Plan will be interpreted in such manner as to be effective and valid under Applicable Law, but if any provision of this Plan is held to be invalid, illegal or unenforceable in any respect under any Applicable Law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affect any other provision or the enforceability of this Plan in any other jurisdiction, but this Plan will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">q.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Foreign Award Recipients</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws and practices in other countries in which the Company and its Affiliates operate or have Employees or other Eligible Persons, the Committee, in its sole discretion, will have the power and authority to: (i) determine which Affiliates will be covered by the Plan; (ii) determine which individuals outside the United States are eligible to participate in the Plan; (iii) modify the terms and conditions of any Award granted to individuals outside the United States or foreign nationals to comply with applicable foreign laws, policies, customs and practices; (iv) establish subplans and modify exercise procedures and other terms and procedures, to the extent the Committee determines such actions to be necessary or advisable (and such subplans and/or modifications will be attached to this Plan as appendices); provided, however, that no such subplans and/or modifications will increase the share limitations contained in Section 4(a); and (v) take any action, before or after an Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals. Notwithstanding the foregoing, the Committee may not take any actions under the Plan, and no Awards will be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code, or any other applicable United States governing statute or law. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.67pt;text-decoration:underline">No Continued Service Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither the Plan nor any Award granted hereunder shall confer on any Participant any right to continuation of the Participant&#8217;s employment or other service relationship with the Company or its Affiliates, nor shall it interfere in any way with such Participant&#8217;s right or the right of the Company or its Affiliates to terminate such relationship, with or without Cause. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.11pt;text-decoration:underline">Governing Law</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All issues concerning this Plan will be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the State of Delaware. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.23pt;text-decoration:underline">Captions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The captions in the Plan are for convenience of reference only, and are not intended to narrow, limit or affect the substance or interpretation of the provisions contained herein. </span></div><div style="margin-top:18pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10pt;text-decoration:underline">Amendment and Termination</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">Amendment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board at any time, and from time to time, may amend the Plan in any respect that it deems necessary or advisable, subject to the limitations of Applicable Law and this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If required by Applicable Law, the Company will seek stockholder approval of any amendment of the Plan that (i) materially increases the number of shares of Common Stock available for issuance under the Plan (except as provided in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to adjustments upon changes in Common Stock), (ii) materially expands the class of individuals eligible to receive Awards under the Plan, (iii) materially increases the benefits accruing to Participants under the Plan, (iv) materially reduces the price at which Common Stock may be issued or purchased under the Plan, (v) materially extends the term of the Plan, (vi) materially expands the types of Awards available for issuance under the Plan, or (vii) as otherwise required by Applicable Law. The Committee at any time, and from time to time, may amend the terms of any one or more Awards, subject to the limitations of this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Termination</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan shall terminate automatically on the 10th anniversary of the Effective Date. The Board at any earlier time may suspend or terminate the Plan. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated, but Awards previously granted may extend beyond suspension or termination of the Plan. Termination of the Plan shall not affect the Board&#8217;s or the Committee&#8217;s ability to exercise the powers granted to it under the Plan with respect to Awards granted or awarded under the Plan prior to the date of such termination. </span></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt;text-decoration:underline">No Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No amendment, suspension or termination of the Plan or any Award pursuant to this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> may materially impair a Participant&#8217;s rights under any outstanding Award, except with the written consent of the affected Participant or as may otherwise be expressly permitted in the Plan. Notwithstanding the foregoing, subject to the limitations of Applicable Law, if any, the Committee may amend the terms of any one or more Awards without the affected Participant&#8217;s consent (i) to maintain the qualified status of the Award as an Incentive Stock Option under </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 422 of the Code; (ii) to clarify the manner of exemption from, or to bring the Award into compliance with, Section 409A of the Code; or (iii) to facilitate compliance with other Applicable Laws. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A-20</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_260"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Appendix B</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DELCATH SYSTEMS, INC. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 EMPLOYEE STOCK PURCHASE PLAN</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Delcath Systems, Inc. 2021 Employee Stock Purchase Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is to provide eligible employees of Delcath Systems, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and each Designated Subsidiary (as defined in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) with opportunities to purchase shares of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Plan is intended to constitute an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and shall be interpreted in accordance with that intent. Subject to adjustment pursuant to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 17(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the shares of Common Stock that may be sold pursuant to the Plan shall not exceed in the aggregate </span><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">560,295</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Common Stock.</span></div><div style="margin-top:6pt;text-align:center;text-indent:36pt"><span style="color:#2d7fff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(As subsequently amended by the Board of Directors on February 7, 2025, subject to stockholder approval)</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Administration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Plan is administered by the person or persons appointed by the Company&#8217;s Board of Directors (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for such purpose or, in the event of no such appointment, the Compensation and Stock Option Committee of the Board (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Administrator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Administrator has authority at any time to: (a) adopt, alter and repeal such rules, guidelines and practices for the administration of the Plan and for its own acts and proceedings as it shall deem advisable; (b) interpret the terms and provisions of the Plan; (c) make all determinations it deems advisable for the administration of the Plan; (d) decide all disputes arising in connection with the Plan; (e) generally, to exercise such powers and to perform such acts as set forth in the Plan and to exercise such other powers and to perform such other acts as it deems necessary or expedient to promote the best interests of the Company and its affiliates and to carry out the intent that the Plan be treated as an &#8220;employee stock purchase plan&#8221; under Section 423(b) of the Code; and (f) to adopt such rules, procedures and sub-plans relating to the operation and administration of the Plan as are necessary or appropriate under applicable local laws, regulations and procedures to permit or facilitate participation in the Plan by employees of the Company or any Designated Subsidiary who are foreign nationals or employed or located outside the United States. All interpretations and decisions of the Administrator shall be final, binding and conclusive on all persons, including the Company and the Participants. No member of the Board or the Administrator or any other individual exercising administrative authority with respect to the Plan shall be liable for any action or determination made in good faith with respect to the Plan or any option granted hereunder.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Offerings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company will make one or more offerings to eligible employees to purchase Common Stock under the Plan (each, an &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Offering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Any Offering may, as determined by the Administrator, consist of one or more periods of time specified in the Offering beginning on the first day of the Offering or on the next day following an Exercise Date (as defined in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) within an Offering and ending on the next-following Exercise Date (each, a &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Purchase Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Administrator shall designate the duration, frequency, and start and end dates of each Offering (which may overlap with another Offering) and the number and duration of Purchase Periods within an Offering, provided that no Offering shall exceed twenty-seven (27) months. The Administrator shall have the authority to set such other terms of each Offering, consistent with the Plan, and subject to compliance with the requirement of Section 423(b)(5) of the Code that all employees granted the right to purchase shares of Common Stock pursuant to the any Offering shall have the same rights and privileges. The provisions of separate Offerings need not be identical. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrator may, in its sole discretion, structure an Offering so that if the Fair Market Value of the Common Stock on the first day of a new Purchase Period within the period of such Offering is less than or equal to the Fair Market Value of the Common Stock on the Offering Date, then (i) that Offering will terminate immediately (after giving effect to the exercise and purchase of shares of Common Stock for the Purchase Period within such Offering that just ended), and (ii) the Participants in such terminated Offering will be automatically enrolled in a new Offering beginning on the first day of the new Purchase Period.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Eligibility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All individuals classified as employees on the payroll records of the Company and each Designated Subsidiary are eligible to participate in any one or more of the Offerings under the Plan, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of the first day of the applicable Offering (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Offering Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) they have completed at least 30 days of employment, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, unless otherwise specified in an Offering, employees whose customary employment is 20 hours or less per week shall not be eligible.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provision herein, individuals who are not contemporaneously (with the first day of the applicable Offering) classified as employees of the Company or a Designated Subsidiary for purposes of the Company&#8217;s or applicable Designated Subsidiary&#8217;s payroll system are not considered to be eligible employees of the Company or any Designated Subsidiary and shall not be eligible to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">B-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">participate in the Plan. In the event any such individuals are reclassified as employees of the Company or a Designated Subsidiary for any purpose, including, without limitation, common law or statutory employees, by any action of any third party, including, without limitation, any government agency, or as a result of any private lawsuit, action or administrative proceeding, such individuals shall, notwithstanding such reclassification, remain ineligible for participation. The exclusive means for individuals who are not contemporaneously classified as employees of the Company or a Designated Subsidiary on the Company&#8217;s or Designated Subsidiary&#8217;s payroll system to become eligible to participate in the Plan is through an amendment to this Plan, duly executed by the Company, which specifically renders such individuals eligible to participate herein.  </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Participation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.91pt">Enrollment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An eligible employee who is not a Participant on any Offering Date may participate in such Offering by submitting an enrollment form (which may be in written or electronic form) to his or her appropriate payroll location at least 15 business days before the Offering Date (or by such means, at such place or by such other deadline as shall be established by the Administrator for the Offering). The enrollment form will (a) state a whole percentage or the amount to be deducted from an eligible employee&#8217;s Compensation (as defined in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) per pay period, (b) authorize the purchase of Common Stock in each Offering in accordance with the terms of the Plan and (c) specify the exact name or names in which shares of Common Stock purchased for such individual are to be issued pursuant to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An employee who does not enroll in accordance with these procedures will be deemed to have waived the right to participate. Unless a Participant files a new enrollment form or withdraws from the Plan, such Participant&#8217;s deductions and purchases will continue at the same percentage or amount of Compensation for future Offerings, provided he or she remains an eligible employee.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Notwithstanding the foregoing, participation in the Plan will neither be permitted nor be denied contrary to the requirements of the Code.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Employee Contributions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each eligible employee may authorize payroll deductions in either a dollar amount or as a percentage of Compensation, and subject to such minimums and maximums, as determined by the Administrator and set forth in the Offering or enrollment form applicable to such Offering. The Company will maintain book accounts showing the amount of payroll deductions made by each Participant for each Offering. No interest will accrue or be paid on payroll deductions. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Deduction Changes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as provided in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a Participant may not increase or decrease his or her payroll deduction during any Offering, but may increase or decrease his or her payroll deduction with respect to the next Offering (subject to the limitations of Section 5) by filing a new enrollment form at least 15 business days before the next Offering Date (or by such other deadline as shall be established by the Administrator for the Offering).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Withdrawal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  A Participant may withdraw from participation in the Plan by delivering a written notice of withdrawal to his or her appropriate payroll location. The Participant&#8217;s withdrawal will be effective as of the next business day. Following a Participant&#8217;s withdrawal, the Company will promptly refund all payroll deductions accumulated on behalf of such Participant under the Plan that have not been used to purchase shares of Common Stock (without interest) as soon as administratively practicable. Partial withdrawals are not permitted. Such an employee may not begin participation again during the remainder of the Offering, but may enroll in a subsequent Offering in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Grant of Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  On each Offering Date, the Company will grant to each eligible employee who is then a Participant in the Plan an option (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to purchase on the last day of such Offering (or, where there are multiple Purchase Periods within the period of an Offering, the last day of a Purchase Period) (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), at the Option Price hereinafter provided for, the lowest of (a) a number of shares of Common Stock determined by dividing such Participant&#8217;s accumulated payroll deductions on such Exercise Date by the lower of (i) 85 percent of the Fair Market Value of the Common Stock on the Offering Date, or (ii) 85 percent of the Fair Market Value of the Common Stock on the Exercise Date, or (b) the maximum number of shares as shall be established by the Administrator in advance of and set forth in the Offering; provided, however, that such Option shall be subject to the limitations set forth below. Each Participant&#8217;s Option shall be exercisable only to the extent of such Participant&#8217;s accumulated payroll deductions on the Exercise Date. The purchase price for each share purchased under each Option (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Price</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) will not be lower than the lesser of 85 percent of the Fair Market Value of the Common Stock on the Offering Date or the Exercise Date. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">B-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, no Participant may be granted an Option hereunder if such Participant, immediately after the option was granted, would be treated as owning stock possessing 5 percent or more of the total combined voting power or value of all classes of stock of the Company or any Parent or Subsidiary (as defined in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). For purposes of the preceding sentence, the attribution rules of Section 424(d) of the Code shall apply in determining the stock ownership of a Participant, and all stock which the Participant has a contractual right to purchase shall be treated as stock owned by the Participant. In addition, no Participant may be granted an Option which permits his or her rights to purchase stock under the Plan, and any other &#8220;employee stock purchase plan&#8221; (under Section 423(b) of the Code) of the Company and its Parents and Subsidiaries (which, for the avoidance of doubt, does not include the Company&#8217;s 2020 Omnibus Equity Incentive Plan), to accrue at a rate which exceeds $25,000 of the fair market value of such stock (determined on the option grant date or dates) for each calendar year in which the Option is outstanding at any time. The purpose of the limitation in the preceding sentence is to comply with Section 423(b)(8) of the Code and shall be applied taking Options into account in the order in which they were granted.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Exercise of Option and Purchase of Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Option of each employee who continues to be a Participant in the Plan on the Exercise Date shall be automatically exercised on such date and he or she shall acquire from the Company such number of whole shares of Common Stock reserved for the purpose of the Plan as his or her accumulated payroll deductions on such date will purchase at the Option Price, subject to any other limitations contained in the Plan. Any amount remaining in a Participant&#8217;s account at the end of an Offering solely by reason of the inability to purchase a fractional share will be carried forward to the next Offering; if the amount remaining in the Participant&#8217;s account after the purchase of shares of Common Stock is at least equal to the amount required to purchase one (1) whole share of Common Stock on the Exercise Date of the Offering, then such remaining amount shall be distributed in full to such Participant at the end of the Offering without interest. If any Option granted under the Plan shall for any reason terminate without having been exercised, the shares of Common Stock not purchased under such Option shall again become available for issuance under the Plan.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Issuance of Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Shares of Common Stock purchased under the Plan may be issued only in the name of the employee, in the name of the employee and another person of legal age as joint tenants with rights of survivorship, or in the name of a broker authorized by the employee to be his, her or their, nominee for such purpose.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Certain Definitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the amount of base pay, prior to salary reduction pursuant to Sections 125, 132(f) or 401(k) of the Code, but excluding overtime, incentive or bonus awards, imputed income, allowances and reimbursements for expenses such as relocation allowances or travel expenses, income or gains on the exercise of Company stock options, and similar items.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Designated Subsidiary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any present or future Subsidiary (as defined below) that has been designated by the Board to participate in the Plan. The Board may so designate any Subsidiary, or revoke any such designation, at any time and from time to time, either before or after the Plan is approved by the stockholders. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value of the Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; on any given date means the fair market value of the Common Stock determined in good faith by the Administrator; provided, however, that if the Common Stock is admitted to quotation on the Nasdaq Stock Market or another national securities exchange, the determination shall be made by reference to the closing price on such date. If there is no closing price for such date, the determination shall be made by reference to the last date preceding such date for which there is a closing price.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a &#8220;parent corporation&#8221; with respect to the Company, as defined in Section 424(e) of the Code.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual who is eligible as determined in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and who has complied with the provisions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a &#8220;subsidiary corporation&#8221; with respect to the Company, as defined in Section 424(f) of the Code.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Rights on Termination of Employment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If a Participant&#8217;s employment terminates for any reason before the Exercise Date for any Offering (or any Purchase Period within the period of an Offering), no payroll deduction </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">B-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will be taken from any pay due and owing to the Participant and the balance in the Participant&#8217;s account will be paid (without interest) to such Participant or, in the case of such Participant&#8217;s death, to his or her designated beneficiary as if such Participant had withdrawn from the Plan under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing, an Offering may provide that if a Participant&#8217;s employment terminates under specified circumstances other than by the Company for cause (as determined in the sole discretion of the Company), then the Participant will continue to participate in the Offering (or any Purchase Period within the Offering) that ends (and the Exercise Date of which occurs) within three months following the Participant&#8217;s termination of employment. An employee will be deemed to have terminated employment, for purposes of this section, if the corporation that employs him or her, having been a Designated Subsidiary, ceases to be a Subsidiary, or if the employee is transferred to any corporation other than the Company or a Designated Subsidiary. An employee will not be deemed to have terminated employment for this purpose if the employee is on an approved leave of absence for military service or sickness or for any other purpose approved by the Company, if the employee&#8217;s right to reemployment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise provides in writing.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Special Rules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding anything herein to the contrary, the Administrator may adopt special rules applicable to the employees of a particular Designated Subsidiary whenever the Administrator determines that such rules are necessary or appropriate for the implementation of the Plan in a jurisdiction where such Designated Subsidiary has employees; provided that such rules are consistent with the requirements of Section 423(b) of the Code. Any special rules established pursuant to this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall, to the extent possible, result in the employees subject to such rules having substantially the same rights as other Participants in the Plan.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Optionees Not Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the granting of an Option to a Participant nor the deductions from his or her pay shall constitute such Participant a holder of the shares of Common Stock covered by an Option under the Plan until such shares have been purchased by and issued to him or her upon an Exercise Date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Rights Not Transferable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Rights under the Plan are not transferable by a Participant other than by will or the laws of descent and distribution and are exercisable during the Participant&#8217;s lifetime only by the Participant. Any attempt at transferring rights under the Plan in violation of the foregoing shall be null and void without effect.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Application of Funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All funds received or held by the Company under the Plan may be combined with other corporate funds and may be used for any corporate purpose</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company shall not be required to segregate any payroll deductions made under the Plan.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Adjustment in Case of Changes Affecting Common Stock; Dissolution or Liquidation; Change in Control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Adjustments. In the event that any dividend or other distribution (whether in the form of cash, Common Stock, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Common Stock or other securities of the Company, or other change in the Company&#8217;s structure affecting the Common Stock occurs without the receipt of consideration by the Company, then the Board shall, in such manner as it deems equitable, adjust the number of shares and class of Common Stock that may be delivered under the Plan, the Exercise Price per share and the number of shares of Common Stock covered by each outstanding Option under the Plan, and the numerical limits of the preamble hereof and/or in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Dissolution or Liquidation. Unless otherwise determined by the Administrator, in the event of a proposed dissolution or liquidation of the Company, any Offering then in progress will be shortened by setting a new Exercise Date and the Offering will end immediately prior to the proposed dissolution or liquidation. The new Exercise Date will be before the date of the Company&#8217;s proposed dissolution or liquidation. Before the new Exercise Date, the Administrator will provide each Participant with written notice, which may be in electronic form, of the new Exercise Date and that the Participant&#8217;s Option will be exercised automatically on such date, unless before such time, the Participant has withdrawn from the Offering in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Change in Control. In the event of a Change in Control, each outstanding Option may (if approved by the Board) be assumed or an equivalent option substituted by the surviving corporation or the acquiring corporation (or the Parent or Subsidiary of such surviving or acquiring corporation). If such surviving or successor corporation does not (or will not) assume or substitute the Option, the Offering with respect to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">B-4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which the Option relates will be shortened by setting a new Exercise Date on which the Offering will end. The new Exercise Date will occur before the date of such Change in Control and prior to the new Exercise Date, the Administrator will provide each Participant with written notice, which may be in electronic form, of the new Exercise Date and that the Participant&#8217;s Option will be exercised automatically on such date, unless before such time, the Participant has withdrawn from the Offering in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes hereof, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">The consummation of any consolidation or merger of the Company with any other entity, other than a transaction which would result in the voting power of the securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such consolidation or merger; </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">Any one Person, or more than one Person acting as a group, acquires ownership of the stock of the Company that, together with the stock held by such Person or group, constitutes more than 50% of the total voting power of the stock of the Company; provided, however, that for purposes of this subsection, (A) the acquisition of additional stock by any one Person or group, who is considered to own more than 50% of the total voting power of the stock of the Company will not be considered a Change in Control, and (B) if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company&#8217;s voting stock immediately prior to the change in ownership, the direct or indirect beneficial ownership of 50% or more of the total voting power of the stock of the Company or of the ultimate parent entity of the Company, such event will not be considered a Change in Control under this subsection (ii). For this purpose, indirect beneficial ownership will include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities; </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">A majority of the Company directors is replaced during any 12-month period by Company directors whose appointment or election is not endorsed by a majority of the Company directors prior to the date of the appointment or election; or</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">Any one Person, or more than one Person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iv), the following will not constitute a change in the ownership of a substantial portion of the Company&#8217;s assets: (A) a transfer to an entity that is controlled by the Company&#8217;s stockholders immediately after the transfer, or (B) a transfer of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company&#8217;s stock, (2) an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3) a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding stock of the Company, or (4) an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a Person described in subsection (3) above. For purposes of this subsection (iv), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. </span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">For purposes of this definition, (i) &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Person</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an individual, a partnership, a corporation, a limited liability company, an association, a joint share company, a trust, a joint venture, an unincorporated organization or a governmental entity or any department, agency or political subdivision thereof, and (ii) Persons will be considered to be acting as a group if they are owners of an entity that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Designation of Beneficiary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">A Participant may file a written designation of a beneficiary who is to receive any shares of Common Stock and/or cash, if any, from the Participant&#8217;s account under the Plan in the event of such Participant&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">B-5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">death subsequent to the end of an Offering but prior to delivery to the Participant of such shares of Common Stock or cash. In addition, a Participant may file a written designation of a beneficiary who is to receive any cash from the Participant&#8217;s account under the Plan in the event of such Participant&#8217;s death during an Offering. Any such designation shall be on a form provided by the Administrator, which may be electronic.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Participant may change such designation of beneficiary at any time by written notice to the Company, on a form provided by the Administrator, which may be electronic. In the event of the death of a Participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such Participant&#8217;s death, the Company shall deliver such shares of Common Stock and/or cash to the executor or administrator of the estate of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may deliver such shares of Common Stock and/or cash to the spouse or to any one or more dependents or relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:3.57pt">No Continued Service Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Neither the Plan nor any right granted under the Plan shall confer on any Participant any right to continuation of the Participant&#8217;s employment with the Company or any Designated Subsidiary, nor shall it interfere in any way with the right of the Company or Designated Subsidiary to terminate such employment relationship, with or without cause.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:0.8pt">Amendment of the Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Board may at any time and from time to time amend the Plan in any respect, except that, without the approval within 12 months of such Board action by the stockholders, no amendment shall be made increasing the number of shares approved for the Plan or making any other change that would require stockholder approval in order for the Plan, as amended, to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423(b) of the Code.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:34.03pt">Insufficient Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If the total number of shares of Common Stock that would otherwise be purchased on any Exercise Date plus the number of shares purchased under previous Offerings (or previous Purchase Periods within the current Offering) under the Plan exceeds the maximum number of shares issuable under the Plan, the shares then available shall be apportioned among Participants in proportion to the amount of payroll deductions accumulated on behalf of each Participant that would otherwise be used to purchase Common Stock on such Exercise Date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:3.57pt">Termination of the Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Plan may be terminated at any time by the Board. Upon termination of the Plan, all amounts in the accounts of Participants shall be promptly refunded. If the Plan is terminated, the Administrator may elect to terminate all outstanding Offerings either immediately or once shares of Common Stock have been purchased on the next Exercise Date (which may, in the discretion of the Administrator, be accelerated) or permit Offerings to expire in accordance with their terms. If any Offering is terminated before its scheduled expiration, all payroll deductions accumulated on behalf of each Participant under the Plan that have not been used to purchase shares of Common Stock will be returned to each Participant (without interest, except as otherwise required by law) as soon as administratively practicable. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Governmental Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company&#8217;s obligation to sell and deliver Common Stock under the Plan is subject to obtaining all governmental approvals required in connection with the authorization, issuance, or sale of such stock. No Option may be exercised to any extent unless the shares of Common Stock to be issued upon such exercise under the Plan are covered by an effective registration statement pursuant to the Securities Act of 1933, as amended, and the Plan is in material compliance with all applicable federal, state, and foreign laws, and any other securities laws and other laws applicable to the Plan, and the requirements of any stock exchange upon which the shares of Common Stock may then be listed. If on an Exercise Date the shares of Common Stock are not so registered or the Plan is not in such compliance, no Option shall be exercised on such Exercise Date, and the Exercise Date shall be delayed until the shares of Common Stock are subject to such an effective registration statement and the Plan is in such compliance, except that the Exercise Date shall not be delayed more than twelve (12) months and the Exercise Date shall in no event be more than twenty-seven (27) months from the Offering Date. If, on the Exercise Date under any Offering hereunder, as delayed to the maximum extent permissible, the shares of Common Stock are not registered and the Plan is not in such compliance, no Options shall be exercised and all payroll amounts accumulated during the Offering (reduced to the extent, if any, such contributions have </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">B-6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">been used to acquire shares of Common Stock) shall be distributed to the Participants without interest (unless required by applicable law).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:3.57pt">Governing Law</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All issues concerning this Plan will be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the law of any jurisdiction other than the State of Delaware.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:0.8pt">Issuance of Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Shares may be issued upon exercise of an Option from authorized but unissued Common Stock, from shares held in the treasury of the Company, or from any other proper source.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:34.03pt">Tax Withholding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participation in the Plan is subject to any minimum required tax withholding on income of the Participant in connection with the Plan. Each Participant agrees, by entering the Plan, that the Company and its Subsidiaries shall have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant, including shares issuable under the Plan.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xiv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:34.57pt">Certain Tax Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Code Section 409A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Rights granted under the Plan are intended to be exempt from the application of Section 409A of the Code under U.S. Treasury Regulation Section 1.409A-1(b)(5)(ii).  </span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">No Guarantee of Tax Treatment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Although the Company may endeavor to qualify a right granted under the Plan for special tax treatment under the laws of the United States or jurisdictions outside the United States or avoid adverse tax treatment (e.g., under Section 409A of the Code), the Company makes no representation to that effect and expressly disavows any covenant to maintain special or to avoid unfavorable tax treatment, notwithstanding anything to the contrary in the Plan. Neither the Company, any Designated Subsidiary, any other affiliate of the Company, nor any of their respective employees, officers or directors, shall have any liability whatsoever to any Participant or beneficiary thereof in the event rights granted under the Plan do not qualify for special tax treatment under the law of the United States or any other jurisdiction or in the event any adverse tax treatment applies with respect to participation in the Plan. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:1.34pt">Notification Upon Sale of Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Participant agrees, by entering the Plan, to give the Company prompt notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the Offering Date of the Option pursuant to which such shares were purchased or within one year after the Exercise Date of such Option.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xvi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:34.57pt">Successors and Assigns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan shall be binding on the Company and its successors and assigns.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xvii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:31.8pt">Captions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The captions in the Plan are for convenience of reference only, and are not intended to narrow, limit or affect the substance or interpretation of the provisions contained herein.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xviii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:29.03pt">Effective Date and Approval of Shareholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Plan shall take effect on the date it is adopted by the Board (and an Offering may commence at any time on or after such date) but no Option shall be exercised unless and until the Plan has been approved by the stockholders of the Company in accordance with Section 423(b) of the Code within twelve (12) months after the date the Plan is adopted by the Board. If the Plan is not so approved by the stockholders of the Company, all payroll deductions accumulated on behalf of each Participant under the Plan will be returned to each Participant (without interest, except as otherwise required by law) as soon as administratively practicable.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">B-7</span></div></div></div><div id="i161d31b071a7458ab37fccdf98f11dd1_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div><img src="dcth-20250401_g9.gif" alt="Proxy 1.gif" style="height:648px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline" href="#i161d31b071a7458ab37fccdf98f11dd1_10">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><img src="dcth-20250401_g10.gif" alt="Proxy 2.gif" style="height:415px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div style="margin-top:12pt;text-align:center"><img src="dcth-20250401_g11.gif" alt="Proxy 3.gif" style="height:426px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>dcth-20250401.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:8e8767f3-7eb1-4cff-a7d0-834772931a41,g:6cabea0e-947c-485b-aec9-13e4b3de570f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dcth="http://www.delcath.com/20250401" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.delcath.com/20250401">
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo/>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>dcth-20250401_g1.jpg
<TEXT>
begin 644 dcth-20250401_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_[0$H4&AO=&]S:&]P(#,N,  X0DE-! 0
M     0P< 5H  QLE1QP">  51&5L8V%T:"!3>7-T96US+"!);F,N' ):  A.
M15<@64]22QP"=  ! !P"90 ! !P"4  (2&%N9"UO=70< E\  DY9' (9  $
M' )I  M.97<@1&5L8V%T:!P"!0 +3F5W($1E;&-A=&@< C< "C(P,C,Z,#,Z
M,C<< G, %41E;&-A=&@@4WES=&5M<RP@26YC+AP";@ 51&5L8V%T:"!3>7-T
M96US+"!);F,N' )G  $ ' )Z  )#3AP"*  ,4V5E(%)E;&5A<V4@' (4 "I7
M96)S:71E1&ES=')I8G5T:6]N?$5N=&5R;65D:6%$:7-T<FEB=71I;VX< @\
M 0  _^("'$E#0U]04D]&24Q%  $!   "#&QC;7,"$   ;6YT<E)'0B!865H@
M!]P  0 9  , *0 Y86-S<$%04$P
M /;6  $     TRUL8VUS
M                       *9&5S8P   /P   !>8W!R=    5P    +=W1P
M=    6@    48FMP=    7P    4<EA96@   9     49UA96@   :0    4
M8EA96@   ;@    4<E120P   <P   ! 9U120P   <P   ! 8E120P   <P
M  ! 9&5S8P         #8S(
M
M            =&5X=     !&0@  6%E:(        /;6  $     TRU865H@
M         Q8   ,S   "I%A96B        !OH@  ./4   .06%E:(
M &*9  "WA0  &-I865H@        )*    ^$  "VSV-U<G8         &@
M ,L!R0-C!9((:POV$#\541LT(?$ID#(8.Y)&!5%W7>UK<'H%B;&:?*QIOWW3
MP^DP____VP!#  0" P,# @0# P,$! 0$!0D&!04%!0L(" 8)#0L-#0T+# P.
M$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_VP!# 00$! 4%!0H&!@H6
M#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A;_P  1" "  E@# 1$  A$! Q$!_\0 '0   @(" P$
M      @'"04& 0,$ O_$ %@0  $# P(# P,*$@<%" ,   $" P0 !08'$0@2
M(3%!40D3810B,CA"<76!D;,5&",S-C=28G)S=H*2E:&QLK074U5TP='2%C17
MDZ(D0U9C@Y2C\$149?_$ !L! 0 " P$!               %!@,$!P$"_\0
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MVX(!!%:U[;4KBA*$UGH>6]/(%I]<W 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
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M)T_U9)"O<D^Q%.Q/ Y6Z=6AIAM6U>J[?$#*U! * * * * * * * * * * *
M* * * B3CG]JGFO]Q1\^W4G@WXA2X^3!6]5_!ZL>^R6S_"L3Y]%?$\_9RX/D
M"W*N8 * * * * * * * * * * * * * * * * * * * * * * * * CKB9U2
MBZ2:72<J=@*N,I3[<2!##GFP^^YORA2MCRH "E$@$[).W6MS#K)WEPJ6>2UM
M]@%)=XT-8%NJ6BW8HTE78V(3R@CT;EW<U:8]';)+2Y>*] 2YPA\3]XU(S_\
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MU7\'JQ[[)K1\*Q/GT5\U/<EP?(%N5<O 4 4 4 4 4 4 4 4 4 4 4 4 4 4
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M/.-*;!!5TZ<V_6M2_M7=6TJ*>6>6G@P,Q]/7CW_#:_?^^C_YU7?\:J?[5X,
MCCJQSG 7IQ?PG?UQ$V.2![W,*/HS4_VKP8&$T8U%QK5#!V<JQ9]U<1QQ;+K4
MAOS;T9Y&W,VXGKLH;@]"00002"#4!=6E6TJNE5U\UO!MU8054ZW?;IS3\HY_
MSZZZ39?"T_VKD#6:V06*>3]]JMC7X4O^:=JA8Y\?/NY($N7.?!MEN>N-RF,0
MXL9!<?D2'0VVTD=JE*5L !XFHF,92:C%9L"S:O\ &GBEI>>M^G-F<R:0@E/T
M1D+,: #XH.Q<=';U"0D]RC5BL^CE6:ZUQ+JK=K?H@03E/%5KC>W7"UDL.S,K
M.Z6;7;FT\@\.=WG4?EJ:I8'8TU[F?%^F0-<&N^M87SC4^_[[]ZF=OD\WM6S]
M5V'^I?/U!LN+<5FN-E>;+V1P;RR@[J9N=M;/./#G:Y%"M:I@5C/5%K@_7,$^
MZ'\9&(Y'-8L^H%N&*3WE!")P>\[;G%GN4X0%,[G;V8Y?OJ@[SH]6I)SH/KK=
MM_GN\ ,PTM+C86VH*2H I4D[@CQ%0 .R@(PXA-0;WC*K'B&#P8\_-,OD+C6A
MJ43ZGAMH3S/3'P.OFFDD'8=5$I%;UA:0J]:K6>5.&E[WN2[6?+9"=_DZ96Z_
MW:V:BZHZOWZ_V)T,WF[VT7"- @.E <)0B&GS+* E0(!YMAVDU,4XW4H1E0I4
MXQEJ3ZK;_P#K2P;SA6:9!IYE&-1+MF*\ZTWSAU$;'LHDE"IENE+!4TQ)=0 E
MYMW8A#A 4%>M5W&M&K;T[FG-QAU*L-,H[&MK2V9;5N&8@SGU]S\8K]YJ]+4?
M1Q0%D_!)[5?!O@E/\2JY]B_Q]7B"5:C@% % % % % % *5Y4C#FWL?QO4".V
M [;Y1M<Q8[5,O;J;^1Q)'_J&K+T:N,ISH/;I7%:_ER G%6T&:TRR%S$]2,<R
MEH[&T7:/(5UVW;YPEP'T%"EBL-Q2]M0G3>U->GS!:^VI*DA2"%)4-P0>A%<S
M!]T!UN+0TA2UJ"4I&ZE*.P \2: 27BRXJ[C?)<K#M*KBY!M32E,S<@85L]-(
MW"D15>X;_P#-'KE>YV'KC;<*P*--*K<K.6R.Q<>WL\0*^VA*-^4>R45*).Y4
MH]I)/4D]Y/4U90#BDMH*UJ2E*1N5*.P% 9/'<<R6_IYK!C5[NJ.Y<*V//(/O
M*2DI_;6.I6I4_?DEQ:!WWW#\SLD?U1>\.R*WL][LFT/H0/?44[#XZ\A<4:CR
MA-/O0,(RXVZV%M+2M![%).X/QUE>@'+C:'6BVXA*TJ[0H;@T3:U :?@GXE)U
MMND'3G4BYKE6^4M,>S7J4YNY%</1$>0L]5(4=@AP]4G9*B0016<8P:,HNXMU
MDUK2V]J\UX =>JF H")..?VJ>:_W%'S[=2>#?B%+CY,%;U7^(/5COV36<?\
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MSRU/L8-#XW];KKI/B]MMV,16%WW(%.ICR9*.=J"TV$\[I1[M>ZTA*3TWW)W
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M 4 4!4([]=<_&*_>:ZEL!Q0%D_!)[5?!O@E/\2JY]B_Q]7B"5:C@% % % %
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MSO>LOS)/OU/D!@*A@*EY53[!<.^&W?Y9=67HU][4X+F!,*MN8)>X"/;68O\
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MMUBV-;'J?.. J_Z$KJ5P&E[2^@_TYOP_D%>-7T'5+0X[%6RUN77AYML>*E=
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MV3+:'3D-[D[?QUB^CT$\_9Q\%Z PCX\_(]4R5KD/_P!<^LN.?I*)-9EH62U
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MGY1S_GUUTJS?_BTOVKD#6:V-@+%/)^^U6QK\*7_-.U0L<^/GW<D":*B@% %
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M/3MG2[22UX8B8)K\0+=F2DHY ^^XLK<4$[G9.ZM@/ "J=?WCN[B5;++/4NQ
)WRM8!0!0'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>dcth-20250401_g10.gif
<TEXT>
begin 644 dcth-20250401_g10.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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MLL(>YW)>&J0LG.)'VU* ?<!CP8" M% AP31R_F(TCB=Z/>4NU*8Y20-1Z9>
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M_P45CVES^P=&\F STU1E7 -!NH)\(R8YY_&I=?B A.4=T@28+4N)'R< ".>
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MA2NPM[."7L;SK88'I[/(J!E\<T'U>?]!<@M<O 91F[HC?CLR66/T4K^UP+7
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M=XT)%""T2H-Y8*$,JIS4VH4UV@@A#Y3M=^(W(=V=4+N O7F'17Y$W@HA#RQ
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M954T68.HLLN&=8P*__A*W<NQ*AXU:8!G9@T1&*,<\TO$;LTLE)!5+YPGIP"
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MG$H@9_I!P);5+)TN[< !*((6#)03 (AEP3)YD0!?1"8'@,% V!*B/K(+  ?
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M9\3@STN9X)]I\+-,NPV.OTQ$<E^/KV<7L80X6EH9@CFP'6*IH0L[!*2Z9$A
MURLZKH- R.,ZL$N[H5NZJ",\#&0["ZPZRF- NBLZ9: \90 %$72ZK_L\OALZ
MKX.Z3XBZ%62\%W2Z"U1 %J3 L'O KDL[NYM !P3!KF.\I;/ (*R["#3"'1R\
M_[A30=_SO<]KP >$/&7X.K.3P26\0"JD.Q@,0='C.QO\/!@$P[@;PC',0JC+
M0"[\O"G$0!%DPS9TPS>$PSB4PSFDPSJTPSO$PSP4P9];#'8YJ@DJ"^"PG8:[
M"_T8C@$L&''9$\8@*X3Q+8:3I1\Z'8I["DC;IX7X)V/J'MCZHW^JQ'"*F2KB
M1 8QJ@ 4(?%+Q'I1LJ/3AWW@DGV !HBH!U>," 6SD0FJ19L8BUB$B(?HGHBH
MAU9LQ8=0AI$8B6"$$8J(Q6'4A[&815]L15=L1A@9BV4P1EZ$18G 1EKLQ6C$
M16G$Q;$0QUP<$YM01KSHQ8C81F.D19^81FK4Q62DQ?]6U 1J]$9O-,97I AH
M[,:)\,5T[$=P3$:1B<6"#,9ET >$1,AZ@ :&=,B$A,B%;,B)/$A]J+MHH(=]
M*,:-W =ZP,B/S$B.+$:/)$F,U,B3'$F0-$F1[$B5#$F4;,F2?$F.E,F5A,F:
M]$BC^SGI29O(N9>#&+$' (7]>!E(4P2Q@)N***=]B(TCT(_(T(4&^!AHP#*W
M$H"7V23^>Q90JXG-BK**")+"<!"(,B^=L .IZ+#Z&I(R <KQRKC'L)@S,,NZ
M&"\7RQ@.P)BYS(MFL;(ATTL[ R7Y8A:Q@! ZLXAX6(NDG+4'&)FBX9.9P99R
MVA%):8P+J(ANT2E=2$ORNI3_+*,(6I-+*\L2H4@2S3P/$$D6E:@>3] "^,-,
M@$$(!^@E!D&P9/ #_%*RHK/&@]R'>H@&WVQ%DNQ(F)Q%CBS.X2S&A4S(WH3(
M8'3.WYQ(5_3-C)3%?;!&Z/3-Z33)6=Q-Y,S&C)S.WFS)611.?<C.\8Q)YE3.
MA3Q)\-Q.\11.FFQ/F%3(Y:S/W:3(WS3/ANQ-E0S/E]3.XRS&X[3&C+3&83A)
M[C3/^2S0_L3)X6Q0:Y3/C*30[>3/YW1.BKQ0\7R(621'B1"9$(6(J -($-W'
M$_5'%#71%&71%771#X71$I6(HN-#EIB$S/ >8(*THZJ:T]J-!T"& 7H;#<FS
M_'";_ZJ(&K<YC#M 3"9=@>D(J*H1"ZL*DF(:")^R*>U31)-@C 0ZC&+2A;FX
MCA$A!(C+T6E"B*U",[BPF%C:B+> (]C*!S^0I#*-!I[\4O?BB5O9B*/*4HL
MAN*14R%1G8O )Q]]B#IA"]NPDXB0+I&PE6OC$SOP@R@R0,JA+8UJC03XT[=I
ML("Z4S7MC.JH%(4@HN?Z)8?P4VURTWNC*K-2(V_;NGT0A@HKKP (!7T@ANO+
M@66(AGE(EII(!CF#@UK8B44HE(Z,E+H)BDPC%#@0L?,BAF,DQFPTSV@TQE;T
M35A$QH;TB5D$SE[TR&2T1NE\16L<QO[D5EI\Q@5]"(2$"/^$G*!R]=!9;$9[
M_4US+->3E,5T%<][A8B&C$9['<X.#5A[W=99C$7J7,Z1B 9B\ G^=$7J-$GH
M%,_JE$YIW-8%E46JA!6,E 3YTX0)$IL 4 .#/<F%;<GFW,^'K$CE=$B!/4BC
MNU:'',F8-,F9;*U-B+^_F@<J^(%%$ "YA)5A4 $@,,_6TH2=U0=E((0$:$AA
M8# U:,B=G<AV:)8RZ=5K70;AG,GAK,EZR+OJTP>D$0#-XA7G2=3W\0ISDLIP
M X95\3&*:Q?0H@XB[9P^PM'/& RQ[)&DQ"SM(I1'X9P;,1P/B41( 4"\4:"^
M@8SVL+?JP5'1>(JN?$0W 0\KJ1S_2Q69]E,=*4&([@!+.3L(4F%**P@%"(F<
MB%@3[\$QS>"#\UO*T5 )"&D?V](-D2$>[M(2/^JCJ,F4T_C=-:&9OSVM !R0
MMI&5;FNIMONC9*E'8<#5I3C9?8@$!%@&8 6 OV('A8D$ 5 &*-L(28':1?@1
M81#2_4@9V?%5X*G.ZPQ0BZ7.\PS."3))]CQ)=%7.\6Q%B1Q.X S&^YW88[1.
M;>W8E,U.@,U/>X77BM1/ADS09LS(W[18^$5@:AW."WW7CIU%!.7/YAQ@_?S7
M^C1)F<5@CJ157-V;!RC&85A?\[V=WHA.</U'#CU/=>U.Z\S89]Q6$O7%>MU@
M\;1@]>V-_T5PENQ-F:>R1F#]J_W0#FLDGE"07LO="/2M1WH  QV(&0$ !0^=
MAY09"?.UQGW587HUUWIM11*M/A@)ADR<"GZ+CS=@+*D( "KJ/L#E(<JRVV1C
M-"$+"GW@!:0Q"F&0EA>J&STZ78)R7%IUF<*!I*79OH.PF4;$"_EPN"0!EU*J
ME%49Y$:>BWD S&<X9%=MC:S Y,5A7HEX#O%YB<W($,H0$B!!%%Z9C VA5,[M
MK<5]#:'9%U=E#:IYMU%=M,Z0!]OX R:H&S&R")3AF:H()&^SNFB07C&H@#P#
M!;K5!WK0 B/XXA@ #5YH@!58VJW*IS"( ]E1!D70@9%82.*9U_^$9(< Z%48
M^=G'*<;@)&!D5-=B7,8QQMB*75!W[<6$C44/+5=<Y.%HO%8=1NAWOMCA[%\"
M!IYYE47[%4^);5<T-D9DS$A>5-AMG6#FG"!DY.=>G-8 SN@19>=LW%>#3L=B
M',Z(*,:G&LIB;!&QK 6N*-/>'%8C\-"5!=N/7.CHS,AFA,@,YM;Z3;N:+4B(
MEE=\7LZEV [M"HKJB0:M$@JLU:QAT)Z.Y 5<?:I0H =H* 2=9A<18P%0^.J:
M:,@OOI(IKM^B9F<)OD8(ML:Q];E\F].#* MP4HP5L(.N+I6'>K$FP=O&Y-VH
MZ:(%^5U&DQ3Q.!Q".JKK\8TZ4:G'4(=B!#"B1SJG66(0LX"0+^ZV%5&']_(9
M:UED0T0-1ZJD8*@")A"-=6.B*K("2NJ^APL+2AFMDE#MU64;W@X*WVJ_,>EK
MVP4IWXA21HN;^K W'.L?69N+QEX*.XCMHT#>V,Z2LDG_Y94BT;>" T,(!>+1
MA*,L:'TPWR^6A+1>!$E(F>^%AN]-AAQ0AD6 VF6# &BH53,)BDDC,5! 2.U!
MQNS<8/N%X/E5UZ*&8)CF3?F%: CNSZ-VSZ.64'.%4+K6X?R4SHB>81B!8' M
MZ(EM:(BDX'&UX XG8)-<3AZNZ& DAEC,5_.LUG_]UY@]R9I5:>S$-GR!@]WU
M2!'C8G6.1;?&V7C-V(O-814'8O%T:8T<!NZL3A47XHR=H*/\8C2H C@P7ZH<
M@&+LZ27.6D()[U4IG&1PH:A.&>+IC5E,$3A8XI11<0JN5R+7Z+7CPRIXG#:V
MTNGP+!XUK7$R+0PY;,D*F()X_Z%/@1 !&A$4"I$=40VWLJ%/O$3+@KC'').\
M02W5V@MYR1P]=RQ=<E6V.=(+60RD/4JRBBBBVF;4,AQ.Y ])!U1!31?7 LL.
MXH]*7"M;]Y/-Y:/<^B?GT1J%""I!$@@HC:1P^J;+ @L_2I*"&!%%@)DC>12J
MB8<GM1V3(A)-MXA=P#B-6HIPHZ6\XZ, L -V  *:/LJ I8<R_>(WV (T8 $R
MAX.GBH9%@)I%  664(9"*!EZX 68D8AZ2 8CU@EQA&"H9D\83]G_#6(&CHCY
MW6 %/VH/+<;WY%?RQ&#P'&".K=F',/ "IF"1ILY[-FB [=<#+FIXE5< SEBZ
M)FI71/]0DG9?C\_.6&QI;7U7DJ=8CPSKB)!W\7PJLM;O>G1&"'_G$D9@"7;H
MDKYGA$PZ7(Q.@15JCAYI0'8 24  9=""(E"$OZ+W4Z@')H8(K88(FN[WKF0)
M,J_'CD3[*<[&=@!C?7![&0[@HA9J>.7G;8V&KJL^>;B^^A,P'G.6FL@(G3#*
M*2WL/1H3*!O:9R\=+ ,8"5HD0.,^^L*X/4NJC+MIMAH17&,!78-DI82K:L,(
M2_9WU@@S<:*SO-0I5%<S3_RU'V.5C,N+"F@M4%K2BR _L#JE8P.4 ],)0!E-
MK2 VV/_]_3B/_OM,&[+=W4FUC#O5/[J0^!M:9>:<+:D*\^#_S'NI +"YB'R(
M! 2+!NCQ-AJ-YW-FA#/@8F& 6GNE B!PZUV(@0> =YH.ZWG  3"H;Q;FURB&
MR1$%B$4!X.Q3MH_>OGW+"NZ+5B^APH8(]SVL%TU?-(3Z&$)["(UAQHOU-B8T
M&"TAO8L+*>[[V+%DRX@9$ZK<:+'ES87Z%H;<:7,C0H<X&];[:/"ASV48+>I[
M&%%B0J0/9WYDZO3F/DTI(^XD:O/C3YP?=2JEB'&K08K" FSJ.F]%J)3Z(B6
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M4<A*4<>2$3*M$/\*H>S&IFS'JJP.%5#"2E',PBP"69(_79')?E'$YBS-XJS
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M6S_>'\K8>WD?)E/P)N^44]8-5*8-\W(J?Y9S.)/J7W$=J-&' Z[ 9:76FU4
M4K6SA1TP^[P8#+@C537D8='7"@!6.5)6D0670N(F)8IV2F:J9:?=.Z]/,!@
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MH9=[EF?2*-B+25,7/\3I/OW7O_W?/_ZOSXM5RXNC"D#D(_3@U#Z#^X2! 2"
MR4&'#PT" S"1H@6(%S%FU+B18T>/'SOJL@CR8CY ?3P&4R'_ *5#DWWR_6E"
M<I\^850 !# 2C6;/B_H4C=PX3V& 'SQOYC12<]?$!Z&83D1P!Z--G$9YDHS9
M9-V @C[!AA4[EFQ9LV?1IE6[EFU;MV_A GW D]V*I7 / DV0=5\^+1"BK1-
M]:-(O(<1.S0L%I\5PAOUT1+JTG',.#1U3>U+:'+B=9U_!NVKQ0)0#OO8L;@#
M+,&IR'/EJ=:G:RY$?;L<V*FIJ+5/>5X3!Q<^G'AQX\>1)U>.46#M?%1**SH
M9O"^8#@?@-JW#H #A19X6@60O:8NIP7%#V[.U^&Z )<+GS8H_NE/E0OM '6
M$[R\*F&4ZNL/&P#@8!Y%%H+#M(@@_]B'*/PP0D:+G( (3  S(+1M%Q4@U,6!
M"2V0AXH CJ@I*8+T0Y"@W;H#PX)\JKA!A0":,*\W?2"A,!K_*!@1B&?\6.@K
MA^@#Q;SQV,LG2 'L\(."&2ND;TB'8FL)M2A/#&6V#P$(<<02UT% (<WR07 \
MUQ1Q0,53%H/QCEJ: $K'C72!H#&H8GIL'WD$."68VGZ;TJ#8'@/JQ3\:F/$.
M&]%4\\RMXA' $RTT$ZR@>+R29T(FE^O4TT]!#57443W5BZ?G*MA'%YT&72%.
M75KC#C:[]G1UMEC54^2!OJSH0RYH!A)T-U8+$RJV5Q$05C!?=?&*EJD$>I$*
MV&3SPR*_*O^,QU5Y]M*'D".B#4PUB&!<:IT5[@B&5=;8,VC9V;P"ID]Y5)@K
MF&3EL94V:&A1CS-588-.(,"X.\+06T/QZPA\IMT1W7P<NXC0UTX1#:+&3EDO
MWSORC9.6VAY:9R^()H;5SWGKC>9>/UFE+1I: /.KM'[OB!;B@M:I39^<HW%3
MH\@XX!,EH.YR=R^7]\$8(I'94P>"9PAI,!@ # XJ,G\/C2/?I6@[1>2"?C.%
M$'-[(]7LL]%.6^VU/_6VMF!LI;FFCWG*]XAX6'4[&EWK7N$(B1"  ZKY>$%0
M %-X:U<?E5;T:#:AVJQBIHR"20#QD?Y$IHH238NI1';ZW.W%*CC_9N&4V-!3
MI,2,8&Q"'>"Z$M:ARMF\5B;4!HBF3I[FL8(/T1[WO#P.]/EC*=!=$\G;U7-.
M9O.^2)>G5]M$X@F?*NRP^*%Y6$CX^:W( 2SIB!\"1GPBJT^:].JWV@=3"PMJ
MK%#)#"UOYJH[.$A>.-J]*/:NPJ.Z@[3N-B/IG9X,\B?V_$D?5/A<GQY7/U65
MAG28*HB; +B= 4!#5W!@VP=!&$(1CI"$/S-33OBGJM#)I6Y4X,"Y.,<;#HY,
M1,1KRD0L(J('?$(1 Q ;R Y2CIP@D".[&(D$+7,1860"09:3C$$PY3S"B,1G
ML3.(86AAA&#DD$,5N<@\)A&)&7$E=(%2_R(3 9 [P^B#='OJTY$F$H [/'$?
M1O19'4='%0OB42 42:,SVNBY.]G&8L5C AT?TAB8_($J;H+C$"$2*4$A\0]'
M6.,?+A,HV@DH3I+ !(@D:)C/Y"DO]ZD/1J1'%4+MYBY$NV)M%+DT(.[#?,]@
MI/N 8\10'JH)[' .(U>&RU/,(T<!J% )D9E,92Z3F7A9#_J \YJ^W:U ->&,
M-&NUNGE\LD_!& Q0#C<0]L1C1JO[R&SD,\%6$?%>;]B$R$Q!Q\P]+S(=:)\D
MYV818"! "Z>QE$;\4P0U7"]=(WL?1-JYB949YIYJG$S]T*D//W".BK?[330B
M^+R#^&<F>>J=E?\4,Q+_W$%[#CE@^[:RF(P<<*.J6<P\L,?0-@)0':&#J1T^
M-HEXSDP^NC@-Q"XQLNV5-"_"8(%NQH<2X<U#"\?<COB01S)TY65L[;MH1&EQ
MFMMP($\'A2G'8%<VZTBNF64UZUG1FM;Y).XAN@A=-F]U"G:D3%M+L=NMHB$O
ME.QB+NZY \-\R)LA^858>U)!.C6BTKN:#"(NRP=U]H:UYQ#D7#7#I#4K)(RI
MTJLZWJJ0PDCVS5K0R(I\$I9C!6M$ 5W&@K%I2&HN9Q!=\O5TT"E>)D.WQ=F@
MJ$XPNDSQ%M9&DK' "+=Q(FC4=X?;KK9CVS$=]1R@2M+ U61;Y*0;O1;_ .)]
MS);'4T%T1K+&76C7(7S%J"(0.Q]O%HH0%4I-;8NV)]G4"2.X\:!>7%,%W!9$
M>1937B7SU0%IYBL_/0261;ZJ5@4OF,$-#I7>B"38@YP(9^/1@C&S$HP)K>@V
M'*J/G!X B7 "D3L4(1&]S)E8H2S.PX-[B%\ @(!+'#5-/HK&]6RPDD8*5U/X
M":!0'U18(M$B)T70@A:3A3MAP1@!D3BJ3Z%'%79X13S1!9K]6.0=KLXT=X\K
M#PY/1U8W >4]MC&EEM ;F@#8(9"DJS(1Y[.A -7DS%XFI04%HY 5W:<"D)B+
M?T<B&#V5:2+G<PE.*-)7#K'JA MAUD184I6D'6!%0%3)8'_#F\=(?9+#3;E0
M:^11E/@ZF-2E-O6I_Y.#MU&7\,H'@>GD4$WJ36)FEK&V]:UQG6M=@X0[^5NF
M! U"T%TK^)\@>8X#7#QL92^;V<UV]K.A'>UD>LO$M7Z+M\0ZP(9Q1$Y^))%8
MH"Q*'6N$9S%9=5B\S!&36#;%-!&>1WS9LTK21$3()5<E/4=*B C#3*<L2[YO
M"66R1 9)97EDXWR2[I\1V=K2=OC#(;Z69\(P,<]$7Y>,?;NQ ,6<P*9<S(1K
M%I4"]+ECN6-'%-@^D@3#  U_<<AC&3*_E2?;95$DQVT^U;+,1GP"22]F[$TE
MG4><Z$4W.KK%V1<J5.#86FC-;'*2 ]?0(@ R$D KS6,4J!QH3E _DZD>,O]7
M !B:V[<T2#Z:$@"IOWA 79+01"IT)".(!(XK1*3[/ P-/^!@1A7@R76ZD^Q!
M;6HI7@>/.A]T=8,@ SM0P\\?&L)U ?#//6=8R+G/_@<X*$(GJ,/R0<@Y=EO*
M" !8PH[@YZ-YX7JS(,CKL0,D%Q,F+$E/"SH[([9N.',)8$R@4)&%>H^@F$%^
M20H!P%( 7Q^TP[U_DC>"DN;L:L/QSS\E\IP\#G!A/2%-50VR#G9TP_7 JRI1
M">!@C%T$D<3#P?'D)7JWO=B1K;PD)"YWMQ4RIG&2E%@J>@0.3>(M)((.,7P+
M)+S.WVHB1\8#*FZC_QS$3,BN 6.,*L2O-L1.R ;_Z"14SIE"CBQ4HCK(HDQ&
MYCFD)<F,:YA( T=:AB7TH1:>0F98:&N>:D=4  @@+"\4H4<&D%R$ZS8(@JF<
MZNRH  B@QUQL18!\RC1P#F) RCKF0F-4(QY8@ E:<)8$ DSFPF28BFNXJJG$
MI0_\X_GZZ:/R!%L"PU7<@VM<;K)VA,:LCWP.(N7$:6,Z9K?ZAUN@@;ZVHS<P
MY1FTP&#@QK*:(.8V"@ZUK4+.I0FV!IS $%T641%88F/<Y.8$J [I1@N/[,6&
M4%R:X.2$$!$?ILWN(%*(:'?ZXB2<RV,(0C)Z)@5-Q@YK2!,1435&RNAP#BQB
M _4NPA3)(I7"0H'<10!"_\&T>H)GTF8#4>[IZ"8.NX5N)L:\4BX36XHJ7"8:
MBTL1S&5<MJ<R+NLPWFW@[F[C@F4[_.8Y1M"%@O$4Y(9AI$4^! -QQB,-^&*;
M0$G"#D)DGF'I^H=UYDU [J+8,J_=?,N5E.>)/B,PA.H>A\_Z- \8"7$W'B"%
MO.4?LS!$(H9H5BG8K"!A9"*J(L,"6$^8JN)V@.8@C;$]%K(F&M(Y#'%N_"G2
M_NDWA$$8H0=<&*EW!$]^0@L]) .?+DEK0H>A,&DK<-*5@!%B^&!LW&66B/$C
MJ^\AFC(H.(JYWDHQO(UK1N+D/E*=@.N*.B,J1Z?='LZ5'D).Q,0"KJ>C9,+<
M"/]A(=(ORLIR7VC!459$\E1)(3@E7WS 1QR/22 OJ[S20? 2J4(&9-)RRJ*A
M D/A>GH$PQXB'@I-94YO%]&R"AKSF$ZD9ZI (0QD,)F"0_)R4Y J^9;L#XJ
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M3ZVD*^LVQ2KGASSHBGJN)7VF<_HT8&?TW&"J(01.>OA X_XV*]!I4'R'<Q_
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MSN_3(D/-QH$WXGI<?X  HDH10YA6W-&GB,.^=2SN['NX+]B#:/FT&'F(C,J
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M1X15DR>KTJ3KGX-_TGNU<+NI!;S(A]J_CS]_UV J #PXI8\N#H#A'T?"$!@
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MX:F.(MP$#'1J\".,F4S,>C9.E&G!AUPBB5K^Z:2&I/.4W?S*]NZ #RW@+J*
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M!)#Z"''01^5CW83Y%.4MJ>]/DY7R_B:F7=OV;=RY=>_FW=OW;^ E!9)LO0L
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MJ -[I1;L>=!S_SW]??CCE]^E8"F_># 60D%VGV#.3:G9+JG-1*1"SBGJ-YC
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MQ4:6)M @1B:.$P,T0%:RF^5L9U6DC'_&(!.:]6QI6\)8 &#6M*ME;6MKTU@
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MH_FX4:A@S*/3@JRP/+=:47HIR33_BQ_5*DX:4H;PJXVBU! JB+7&64>TV(4
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MQ+:'E@A:56A>YZO8;=%)M!2T.':N(I27G<1,WVIJC-5F7HT=3/_KR7U9!0:
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M&D=VE"2+U+ZU8(A(^T36N7ET9LXC\@^U.9&T.JF(AG/"D'%Y5M>-[? _)_N
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MU=201R*9I))3:;6DD'ZM9X59>>D" 4'S5-'1+CYDI%<%D-2$4S!E79@? F_
ML<Y_@#5'D&A4UA3<$:+YJ-=DZX6UETR:V:2?3'2B=666^VS994)?ANFF2)F=
M1 MZ#[X1QX,K AK3FRPE^$<3?&9X)YUZVE19G4Z26JJI064"0#VGLMJJJ^%Y
M]VIVZP1@A#ZU '8G1G8TE "+ Z 49CZ$+"33L"L%=D=\54ZDQ9H3^8%?/E08
M=J<NZ+4VK+14-!&,K_N(ZJ=>(LY$;H_@LL K+2=5%FS_>EH42^&Z8LFSA:T'
M-201/LZNF$^T$U$K*DO8SL5.NC-E=&->X9*+J:P/0XQDD1%37+'%135YL5?
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MSB 3M=T [@A<RA(HT',>'U!!;!*1&1B\%9^=22W_&O% @!9LMI#$/2 4YZ&
MXZ!!".Q8RD2?%)I!'(">X.@#<V\)11V?E:H&J  !8'  (4,1*4 *DI #0>0^
M^/7(F3V#$)8K3E0@\(P_W$!F>X)E64!I2W!%(Y;5S ?6?H AECC0C^&$GO2
M)$YSZI"'XI1'X)9EIG)IX7  Z\-1["//>5BA#WX[$ZS % ];">9%S=J3/^_
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M(,3O+LADEJHQ7?"D7G(C,-]D,$*R&U-%H\9E,2RO1:[/0-#,-NC2%@D%#BO
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MW0E1J%$K=M1L6#1;$9%SF@+AY3()D)4%Q,*$%^W%4)=Y0(4N1 @+R$<S6GN
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MNY:Y$!+W@"R2P(C2,@X!2"Q1TZ[F@"EHN);)("90()RXJT*+D"G58HL;B<W
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MVI/_8+JE-4K9&G=MW9 T %H\,]H2&=&?14-W*R"94X1W5-8: K=9 ;D'$ :
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8LS9O,S=WLS=_,SB'LSB/,SF7LS@'!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>dcth-20250401_g11.gif
<TEXT>
begin 644 dcth-20250401_g11.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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M[>+9)5HRJ3TJ6CC,%,;<N&";^TGZ<A:"H3*BYXS5R9'EU],UCV5T2R6X6MF
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MJ@$!DM-U('9UD( [6"AG))0T</-R[^6"^G5B&SB&([9P2(@HML1 T<(RL**
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M?#WV#,E,C2)Z3,D<L@I<BA5.D6W:6T"IGV3)VL^:NU:Y/(!ZD??'*6[Q%>2
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MA=QW7NSZ!XW/+C>^^-# _K243Z>LB6-,5K=79WQ4^!9 2]9#0P@ %4R2+5+
M""9/>1QQ .JPP3SP??7ETED6,,][14M,^*<&&?S[IZ0>^XX C)@D2C#6BX8B
MT/,2!5K-.P=H#%N&9#]G\2U[7?G8*<SDJ\C8!B+I4X2/#%(I2L6!*;I08'S
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MM/GD&3HD 4QJK98 VK6<H$^6G\V3?].D8Q.?\N*$:\;-/ VN*K,3<U),^-)
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MK'WB$2 4LDPZ,B%YM    3A*PE& ,P2(1KB-MM0P1PLJ@M)%Q$X4<T"'% G
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M6;Y##B]=E>.BX8*! $,A0"4-4$$"H(&C %0@013X4%HJ%I%X($ + K##'^Q
M"+M$QY/R.$ M[6"R!__\3F4\[!>%0A$/"D4CEDBBI2V%N22)@>V(P,"8T;X4
M#;HL)HU),E0"0(&IM(@) $" !B&0PDO7J,MDQY.8*(\($SLH FSRXA*U2O:H
MYR5$F=N"R0T"1)1\VI-)?ZB#%1!B$@>(,Q0*-=0P![,8INPB0 * @T3(YA8_
M'&!O2H%!0W;&,4S9<B$Y,@)#!N.##\%*3 X@S#H]H052,DY(1_029V#8$&2\
M,AJZ&@T';**=2&0J;U("@Q-Y95%M5L&5%EM+'05@BBH M)P12JH&.XDNIG[(
M M&05<=B5H4P'"H:LP1F.QM*FGU8DX+3/.JH1FJ7EKYT*C\*0'GJ.4PT&166
MJ7'UX5"QTD^2--.L HC$ *!!3X9*)$HN%9YF#A4,!T1)KU<ERSI$B;N\0"PB
M9NILE 1PA$,&PUMU4R4K%V)*5&**FANQ9H2P&0"2;!,WW7QF,%\I356.9:!Z
M+9$Z&;>SKC)V3#G\:4*L.9,X]"9'>NV,*HDB$!RH0$TX0L"2F"LOY0:1GXA5
M+$'=@LY8$6JD5)HC!<U*_R?\J>-,E--%J%I"D'D0P@(FX5 ^" %4+70U'K!A
MAWISXA.'0,)F HO'4N);5LDX!5VP:5*SN&64KC[FO]]!L'MG"\*86:$BO*3.
M?+<R-)2Q8P79XM!K>).O=:S@#L&HP( [L!$*OL8.&DJ *5RB30T?9I[>P:_-
M]MC?Q+PW;6LTRFP/TI@$8P="K;$O;_([&A_G%ZPGTLXIFG(*LWE2($5@$S#^
M)2<BW\D($O8J"_JP1X8$$LE0#@II41:/]CX &HNH"4(W(BLA,XTA BDS?>=!
MG%U$V%/LM<I(M)1AFQF%*$+^X&Q9O.$^(*O-9GY,GHG4YX%H\R#:^405'KNH
M3?^C6![J%7*6UT$2H1QA(HG6L7[Y"QNC1 3.>5:2C4U!B_M&.<=0BN=^%=P'
M0Z\F&L&(,+#[>XH*1^44NH8R4/-[,_6N11%!T<6N]<NM2_=LSEZE"*[%F^IS
M.HPD)YF3:&_XX?TN9&^4D\>.%3(/#C<K5!]6$)^LF)!E*YER>D[RA4E2MR]#
M(,OS+?-1I(VR5)<$G3:AQ;%M.F:\4865I,U6?1^N'*!Z*I'Z'D"NL;T1%P]8
MM/0M*XM#69$RDCC4]<-517+"D*) )%;G>?AXD<$":9IFA#!9+H?S<<.82862
M^4#HEK:,&J7\X'EKI.E/>>*CM!B=#S1/#UDRN _34 7_*<%( #) C9M0CW!9
M.52NT8L$R:3P$&.#N:5=6/B0)J@U[HIH(FRK #J+K(/0-:D"'(J>$;+HHBM7
M'LV"ZALUK5L 86+?.Y&XBRPC;%V76GE+K"#P&FE6VR1-C&AA\M[S-B+I7BF)
M!TD6SJ7LY13%"AF, :0B]RN3OC)(8>$(^54KOX?:Z"BZ24XTWR:;38?QM4$,
M:6T01MH>GNS7)!-"&6>VV@LQ^&@L(^AS=RL$1$/QEK>,$&.F\S8=X>6D+PB2
M-V^$$9K-% J*$+KN-9.+4KN)U(>-\&U=D93L70")?<#\%8I*, \F8( #7N,W
M:NX49.Z"XB[K3(,K3&4 P&XQ_U FZ@+O#H"A+:0.MC)"."@O*'3)5#)/*KQH
M4:!/UM3N\#HC!"'L&6B.[(;H\!XB#CJ.V10!8U@([8 O]A1DCCJ)N^QGCFS"
M3\(.H]KO2-(%&0)D6G8B_A#C(XX@]2QBR[XE1]1$\6)$.(0!M&!DMI;P2SJI
MI*8E9*A(0YQH'4+L#AJ/],!.)M0N5NYE6=H%#2*!NIBB%J(PB1XDL8YD)H3F
M4W+P#YB -"3)DA2O!&^&@YAE" WFKBY'6@0D**)F1O@E+](0^_1A&"0!4T+%
M7M!#((X@'KZN!=H/.0PF 8*!83 NQDJDRCQ%"*G((AXH0N0.[4RC,_!B51JB
M1,8F-O\"C9:ZXD1ZD2,$X!G"3I*&,3T:;Y.2PI"H**B^$(7624M"[/<*+0 :
M0/PV8@T9@@ISL4=,P]BZIC(^93WD(1HM8,L<;R.$81(,Y.,FL40PY_;0$6VZ
MYORT"1W31>6\"Z088O;R#4TB8DO0!1U%#BIZ9!C0@!-/H6*(8AZLA2@PPA-8
MP-B,+1\B#:.H$?O +\^V J%F(F',QAE$3,:X1A<:<9Z&""7'L$X:(M5RKDBB
M9%H&X!CB+Q:GPC0L)"?R81(P(4H6;29S) $J T9.$J0DX2=U9 <]B?3XL*8Z
M P\7;H[2(Y0B!+WD!G_*KY!<$C=VZ<8R[F:^CI%:S2&H:!W_*@ 2G&@?9>.(
M9([>%/ Z-(0B%HZ[8! GON^2C.X20N6"HL,4:$[WAJXB<@8B!J,(U(!/T%(M
MF4P!(:!JJH )G*8CIP*7%$]2IL+NKDY/0FWAY,XLNQ(_T'!R'J 2VU(%TV.!
MS *SWN .,&LN&(GK9N*H#J^&:"HS@V(]EC'OD@3F\LXDPX1-:*$(\"Q2LD<U
MNO'^1"T*G0(ZI(,ROF\SR^;^^$6Y:NMRK*"A?K-,&&DP?8(N0 <ZE"2&:@51
M>"X.'W-4"".4XB0J3&$R9\0NE03T]$[[6O,UU6H]%DB2N,L'Z7*VR#)+F(WN
MV,,W4:;S-A-=NI/_P@2A6-,U5>5F_XI00A.#$&X@\U9 D) EG<XC9^ SAO:R
M+R=37P#3[]*(+5DHQR;'+1M"*<) $7,H^*Q3Y":+M_X #A3A!\8@L>+)ZA:%
MBI8(-4Q"1WD4BS*JNYH-\2XK+5LT]K2"+6.$+?-G'2)F$0)N00C"UTQBIO &
MOQ[R*);HD/#KAQZO(H3L9OSK('JCW@S0(];(R/P@NC!DB3KB+X(!-MQ-!4+(
M2V)L-1IROWJCOFIM&EO"1(CFUFBAA,8T=[;L-9A@- +."Q>M"E122(",%F*L
MOVJL%H*D9SA(Q.H433]1O)Z$!>:);N0D%TM$*.3$5>J$6^[$*=017[HB4251
M65A"*QBM*/^H(#R4Q0)<L0F\5#:F+2E*3$/&207"2%;HP@@LI,^J  CX12FL
MHN$00QWV9LOR-"B)PB#N('C8)?Q0Q&.\E%?3* NKD5UPI0]NT_4V[4Y=\UXT
MM2DBY!SE0UN]$#GD5%A#T%77(L=B]2G7A7)V:M'BE%>9P"I)K]@XZ&!!<8G8
M[Q93DQ""0$.*U2TPM5"%J%Q3Q[5>!5FUY-A0*00+*9>ZHO5."#DXQ$_O9!=Y
M"]'.<4]QA&[D*TX"U6(5[EYH[&9:H""\8X9V]DX5D+<PI4^IHS;QAEASQU[)
MQ0XF\V&<Z&AU55RDHFZ>]BL>XEN/E!AS34DOAQ#DHUR]=3?6U*O_MM;E!."A
MED0U]LIB1L,!J,"I*@8NV/*"UJ8IF2TA3(:48H6ZL"0NFR5 ^/:#B(2Y!D2;
M[F6@^%8?AJJU+NL@,/9 ZC5N0V3^UJXB=C(W-N5:Z$MME$\J'L:>"L1%WFHM
M!)% +PN%?N0!A&4;J0 ZPY-D]K8"L[))"-0TA>/= B!$EFN4+H'%I%2C3O;;
M"!%' *!2X(JL"H9&BB\BLG94HH0"_F[H/&$@?@=9\NBFB"*G]F&GY$57FN4!
M7+#%=/;;&K=T40>TJ 3??!1C X )RC P,>5P39(:B^85$?6(:N4&,N4[!/1F
MD"F\QFE?SK<A'-*JHK<N-H)4$. 23%7Q_W+&0!S7(IYA?N'"!XF$<(O$@A$W
M3"!$\53C3@! >@=I82Q 4NR$@VU-;:5&2B*!Q43X3&)XEU8@(NYVKZIJ,T=W
M@O<.<MM$<J-E=Z=7B]YF;U<$NDIB=C=S4#6D92PE@0=)**8N)N+%99JRB8^W
M4T!'';6P9:S4!5FM.[<,@O/HAJ%72A#E:"@"".L'6\V(VD*(/T QDFHACS:G
M0,)(<EQG<#KVDS)G'7J6/V8/=OJX? 8C^_Q8WY03<;SNC66G0# FD:](@?W8
M'OD#-?^&2O-8/[P72!P9<@0B ?;ICX$$;S'("@50DA4GNQ+@+_1C-.A7=*8G
ME<NG5EKND[*+;_\5YS6A1R"N2Y4E!WM,&9B)N9B-^9B1.9F5>9F9N9F=^9FA
M.9JE>9JIN9JM^9JQ.9O3IX=FL8INJ(8LYV$" 'V92#I%1X(>ADQ7%)SEN'WQ
M0X4"1QX ])/?.>L*!YYAAYT=YX/&,+K<&7&D2'9(1R+P](BZF3]8*!FT!7G[
MXZ#Q(XLH352X$G#T^87J*^MJT'$JNFS.UH*^^9^E1V^&F7 Z*!X @&R$HH1T
M2!%O>8H&*8+L6)DI*3\*22-D6?'NN=IBYX],<_"V B<C9X\ 9Z;/2*=S^J4W
MAQDC1]YLVBR4&G$RB79VPX32DRR(6GK0N<0<@E/I^:K5XOH*0PO>0X8G!.]O
M O)P]FB'1OIPGEJ$G!&1!V8%5L"F5UGM,&/:SO%B\\.K3R>J__G'E\XJM_8*
MGJYN=9,I0""@L.S@1T(+OS(%%)X0K9HE (;*HKBC?R=%1Y:JJ;:WN=1R-@%@
M Z:*NNS NK!+6PB")3D@9XR76P;#E:I*8G+X/RJ*"?Y*0$#GG="7)4E"F(2E
M;F*BMY()OD0:<Y0KI58J07*DLP=$%TS)<5.X?_LIL??EM!)DH>S)L"<'GR1[
MO.I5YX1+2[A;L)'+^1+#NFG+-O[ !J118MQVM&.;L2_*N4\IE7JE7D%+@V1(
M&VM3=@6[;8B*N 0 4:+)(H!ALNR)G+8W-6#5K\(KG4)%LF=O.E1+5"3V>?ML
MO0'  !![&-O*KG1B*J)M40RAH23<L/\B<;IA@KTYP+*RB"I@KUVR,[TAPIL
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MS\8#)&/B+7-B]JB2*OJT,$8T.B80$TDCPQ=C> DS!BV/%KH"-?QR $C2[^*
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MF11&$15$H59J)+&0G6HK^EOLP+ )A@KZ#"DKB ABH^%-7(7S%.J8U^C@YJK
MGE.,1:L8?0 7%F 5*A@>G8VO)'F5"JS6>B=AJT)3AA!@" Y8 MB(KP!5J*)Q
MT3LJ(,EA::&EHM:$"K$!EDJF*A.L%?1+G/P:,($%A/_&\-64Q:%G853[G/W4
M<B] >$O6@O:5L*B4I?C,2M2:1$2D" "25"C+Y]BA5-\">*TTV<JK9'00)CKS
M=+<JHR03TM.,AK.KY;L(,J@+7H0>X8C'[+"'"X>98#0$ 2?1A[$<  8AZ1,
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MC!!#-OMA&E:(D"J0OX+,SWZ/!WT),FZ% W_@AR"Z4#_JIST@#/$LR")V&@<
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M#7;*)+;D0S[<& $X@P0@M;A"$@H(GXI@$R<BPDB+FU8Q%(((G1H9CT%!$@=
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MH0H>!/ @VD2$_P[@%-07"6$"COH4192HLF ^0BDS*F2X;YU"("9W*3Q2,!Z
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MIO\RK+R]]+)OA3;\9;/C=0VGB/AG*F*Z?( &JQP[Y/VA[17I1^=D!#UEA-9
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M!3",H5:HYT7(0Q?,'PN4G3RLP!W0YY6A"1"<!3!PFDHXB@!XU%GHPR+ WE8
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MPO0B4# G1 )P@Q:*-U:90:!!,2/J5)H'('SU[B(9G1&6KK)3DQ%N9D?H"NF
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MKPM+#&=8OQOF\$J?&5ZB@9:\4)KG>6TFTH$$:;5KW92#&/2ZZ-%*5A"I!ZT
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M?5Q7;#1XA2DH$$L(@BJ A$D( "^(@0EP"F17@-MG,_- !2*X#\    * @ON
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MQW,(>  P0(C $  P((]Y2 450 B$:!#]F(8J\()M_RA_<2*!"]B !K "*(B
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MOXJ4/EJRQBH0Q(JR,IN #+N)#KNS[Q:M,-J)'$";0 F5=]"/0;B?3/>6 S*
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M8];I013!17).ONCR ZN2$;"C*H8*4P&Y-J,!"T:Z(E&R J7@'?GI?,"FLNC
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M@1JBUWI?"(B$MZO@ Q74N **@, Q!!!UJOK@VMGFF8S]1NSA!"ZPUT'3/HM
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M\;@3K[@J%A"&M%'9B;JJD-6"#EM;Z(Q-*H#//F!/:.NL[M"0."LE;,,0BF!
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M,>5I6]N_\)(!**72!,9@F&/SJ-FH]H.I+@5V%N,)]<D1&HD/*:U*L?\+2'&
M-&B.CE;- T$#HS;-I9WBH"X$&*XXFXH+#F!/FP43JDX7JI"NMXX'^M1IYOUJ
MP0X SWVHY-H%G^WHE9;J*1F OP!"0M N@!9CSUT>\OV+R8@'.*DGC_;.:"CL
M *EBVA'D:GX&S=Z)@5*<%Q&Y8T[0D, 'E WI >!@Z;7IIM9.TP#0T@N (MB$
MKK" X[3(UMKJL$-%29B$GP:3/:GG;@(ENM-LE]ZKN!;81E&<T>:1YPQI']YK
MD@YFV@U=4Q8X7<"/TT[GI@ "3Y88[:5I5!P&-+AIM)@+G6;?#(7HDS!HF)@N
M&2D"2A"&2NZV;\N5X'9-8$ABU(:_-RYB]<[_'I$.Z(-8;URN8A+YOMAEVOE>
M)P$8<&%8@29P8#V=C-2.M_')!#CHVV[M48NPI$GX!$$>6T'VCQ W70J74/5.
M;)(@9:Q.!BOX!"OH9F&L;+!6[9A&9]KVF'+Y$#T^DGG !%%;Z<2\B!^0\=CU
MXFC6+ OH<#,)QI:&/SN6\!A-+K#><4_=315U[75X7#1? 29 \I"(2<UUF2-/
M%C\0DV[=\A7@;&G!<T^N\I' ZH!S<.$0J4\X33U%O(:(22[G[]H^EY"%V'70
MKCB#AHW \>L"ZW5  #? YD)[;AV%/U'.#Z .$%2V[?&9!#@0*?-FEMAE;[<]
M-!-/YRO/\@"F706?_ZY@$"WQ'O,;IM[HGG!<WG&6!O9;K!@0R^0OGY4YIQX"
M'_&LM77CCO3?,U#DQ3?S\.'0;M@5B % ?O%"HP6HNJHCSJ@2/]%=7YQS]M_H
M?F5T5^:=B#9<O@@P2!;8$_1]AI,73VVACA!94>^]$  PN VP%NIN-7%']O;0
M1N<:[EOL/)<5@($.T(T;" KR;I2!4A^=UG@F_\E ;@R)5CH+&'?>H8J$U^P6
MV[1J]8X:IF=Q*_':Q6<4F8R/WV?ZS&1D6^6;7^P0K27D/7ENEG@OGE* /XO%
MCF5B4@C-)NFA'Q'DC7GY.E(& 69J\=D%G/>'EO2JJ+J=>( J^$ (P-X \?]V
M#&7>4\"R^B2)M:41;<8*C5B;Y7XD.Y=[>+?YD]T51K5VFS=Z+Q3ZZMT7J)J0
MJ2?OX:U=E#9PBW!TP)[Z;FO3 +GW?/?,;N_WFFUH+^1Z;&][SPREUJ4PRGD^
M\.&*HQW9SI$>9A':>"H(%;TL=0P,5><3F<D',% <5=>(H<VLG#-S%*&?\\P8
M3ZB"T*_KO9?I/XV-!.:)/4$*.&,7IJAQ+Q_^GZ <,&8ML+A]U-BGP-F0_=LF
MIW@9>]9^B>I^+QYLB-3+E>,*9'A;<EMDTQ_V=7K^+3=P[:"?1,Y]UD]K93PD
M[0<(*A:BK5M1A)"%??OB!8BC\*$\%G?VK0M@A.+_"B/Z$"J4M^*.1P[[\BF"
M$.WA/ET/HN4CM%+?+@&G@,GTF)"DA6>$ AS11TMFRX3[/#:I>+&@D: =5S1I
M^3+F*90JH_E$<$J?+@&A4.[3IPC 2HH6,1Y)&3;K1&15RG)]"* MW+ARX[Z5
M*Z_*17E47BIZ$'*HEH9**2)@Z?)D6YM=%5GP:2&?'Y/(M-1<P5;7@*AM:=K9
M%TQ%@E.Z0H]$Z--!*)(\45;LN4M%X[Y4:0%(.-4I5:A<UP&0V946:JQ _:P4
MIF5 -)J:(:IX<&H>&).ZK"X.GC6UP)2D\U%9O3O '>&>JHB4%[B)1X=B7<.>
MB[*N^_CRY].OWQ9^7%TF_Q]R[^!9!0 .8$*%2"F-I1!T ("U%5?<"=75+@H^
MP*!>8$$2VFC+*<30#2H$\,-)&2JD3R02;J525/-D)YR&(WX&0 (3O2@@@05-
MI) P5 2HQ8,CT0;6+N!U18@ -YH'0 !%R*8(!]R)].(# W(@3P!G> BB=E3E
MB"00B#WD$VGK9+:0D%@EH*6. 73I9$="SH6???;!V99Q"@IP$80*6G32/%\M
MR-612?8%378+?=155BV.I(A%))JH$#LZ/G!A5($>,1A1#7[54YT"=,:F6.%M
MJ::7'5$A0!]]F@C3F?J,NJ8?%( !5E3Z^%%@1:)JT=NG!"J4ZSZJ_HF27JC"
M])$H5\>RY:J.",!AJK$1]O:L7'/&.9^U_%'AGU<B>652,#K2R(&M!09#FD='
M\,;6B%N"115C0\V*0"1G,G3C: 0=..*/%01YAXB0>5MB &&X^= ZXO((&))*
MKE1LJGY.V):#7Y8X+#*21F*5B*P%T.&'(9*6YX)FGJ170EB-F>R+,?X7X(!&
ML',P.[LZL#!:;UZ[_S///<.5K<_V><6NSQ[=&'0P P6]----.TW7T]5&O732
M4UM]]9 ]8KVUG%PK!+35^M2"IWWYRD4+T5[W/#331C,=3 6E/IV/%8J^IS;>
M\8&M=CS(,3WST3WG\T?@>1M^N-YJ[XWXX(4C_GB#OD+^^.),5^YT/E?8#=<Z
M10XE.5QT;SZY7'W+S3.5CE_;.-;K:'T?Z8=?'O9.332=+M*UG1X[[US/[O/O
M7@<#P'Z]3SZ8\5X'S_/R>>OSXI[)\[Q1 +:W;5GNQ4/>O/1==_\]^.$'S7V<
MY(M_/OJ\FU_?^NF[_[[B\"_=OOCM["[_TOHPZ#[]\O6//P #N+/_N:=]^O][
MW &C-H_[.8\83UO@SA*H/ $.D(+NB0>J4K(RGE6,=)!Y76+6 AFRR8<["CJA
MYRCFA\?<RG+QLZ#/I@(1\L!P<AVKX 0%YX>+8&9TJUMA7$9('X'9I0I-8$<*
MF=9!^NB'@?01TRDP6+A@^&8NW.'A!JU&P/1M,7D1.1%U!,<1#XZQA%1(FWN0
M9T6$J+%G781:#7G61&VA,8YJ2Y0;7S@]*O PC$HL8[):.)\VPB4>+/!AG CI
M'AFV[9#7LE4?$3D^.V(K=*#314(2%#(-1N6#*''5K@" @!MUJC,P 9!S$"4A
M4$ (0 * 0VY<24+>( E@ B 8EE2UR4^^1D*G$%C_N!S@$&9-BR5K40AW7(.L
M$1'"6[(92@M.$:EB;L0"P1QF+U\9#7Q4P0Y^4% FO[)+%1;HDUNZ4U=XI(^%
MZ0,2)FJ),\,2$;N]\6<<!!TP3"*/66VRAR-9(60:H((48@4![AP+=P1:I'TB
M"41>"4LP"N:FC=01*V'I" WK),H[Y ,OR#SF.4D(JGWD<Q_)$">6_/G!@ [T
M:-/AYT42.E [A'0H'O4* L!PT7FB1)==(A& :,52\!S) 6 X4QYSN#/(@#,K
MN#S)L?X$&0KLRE-MF1$[I34A$];FE+YLI5#W\A5MHH2;5D*2]=HBK#U5Y*P3
M>QZ ;M8CALRJ.#I"IRX4_Y2 B.(K,]/9505B5=7.H(2*R-!36BF"(02(LTO\
M^69MG-I0J&IU?\RCI/_@8K(A'0$?5#!)/K2PDH !$G?Y..HVLX.67+7D3!EZ
M'JJ Q5=@ 0LB+.B#@;J4KJ# ZZ(*T05J/M>8G?0D*WVH"!.&HH*>T")N%)')
M=*)"DZ-9E"6GDBX$XL&4?7 S*3M)KG%S!=L[S,.(D"D+24SRT-U5LRT5L9UV
MO?L8T] B-,+I RU6PAW?E-2>2HW39BGJ61VP1+31B&YIAHLJ^STD0B8I2 =:
M(A-W...S!7Z893S+P@+Q%"YS_*@1[H+>HT*#%DKKW"D\DMSN?LEL K9P:$>[
M'?_3$*D/[D#,L0;"CHQL1"OTB"A\,Y*2(N6JMOGTDE="(P_8!(,ZP:C"?%'E
M#@<11 59+)\>([A#DI(*=PB>KH3#HQN$62;', DN3?H 2<]0)T<)82TA$@ -
M(G5&.3U=01SDH96X5',V"VW.+Q$2C1TKLT=+-@DQ5,Q=CTX%=RGA& !ZHI,B
MP:2*OU+RG@LK@ -W6<A?VC(P.NT:ZDP7>)A-'%P(/91#^O.Y $/J2-O20SPR
M4WL=98O .H=;A&6PD%HQ4R=OA6)()3%R30+B2*CP@Y+P:R7!R Q6('!K9 KR
M5YE9,G@V8@3]/$0EA!+*%:FH(6YRE(\461D25<=5/87_9XP^>0 T;B4P1SL)
MBMAN=QWW44_8\4S5\QQSYUY]DM#.5VO 1E0"=**T5@<<*P% +2=)"@&YY/6$
M)TQ;AE <[1(_B)'[\#>K5Q9PLQ&<D'@TD\(-(Y1WLT01#LB.4EI"-(^0$"5!
M::]GJGC#:^V;*^M+9L0%-NU_D@O9J?M2O)+=I&,2'3+^L3F-;2WHCQ^,NU:X
M@R%W[9[4M>:W"3!%TF/==<=T>[0FT>Y$3*92HU<=&,C)^FXPM)UJ)[LL:U\Z
MKNG.\U,7D,^*J !);7-1;L;!SCC_TB0P\94SN7TY:HQ'4$_XF%TAX U;.:TH
M+0^HV^:\DPBI^ D;PI5YH $3_[MJC""]$MAR/OL4GKT4@99L\=K8O J%MP M
MIL0"4Q!B]@,HQ9:S%MK,;Z6\/?&#?T"O)_4T")!$?\BS2T%C"[CM-X^Q?3XQ
MV6%^^VYM?P^\61!#^,8+']E2N>BY3(%L1G8T[8RR'LTI*A=@^+:C%]%'XK^2
M&7Q8QDDM\?URJ![X,1*Y&1X;F=]#')E"I!]'E OTC<F2C8RX;=]0'$I/)=[I
M>5+X_8JE[=U__5 D)=@Z1!XX80KV4%N!. 8[D&!7!=\\2(+IU88::6!Z$,M:
MZ)EET<DD7(*'@(0%CL8SI)Z)$<L*F%+O65QFT%\T9(IVB,:,"85V$<TZ8%H.
MJD,2^O_&#&X9@@7%"LX>"+$/W^E,?@P []G=1957$P0,W>F% Z2!)F3(#1$<
M2@ .7,S#@+A).UQ"=P1.YX3"P3G)SG%%,*S #TS")QS@LA!"!303PM@70@1<
M;6E6,^7>.D! TL3:/SV=5PB%'>XAN0E1((:.\Q'1I0%?DPC$T2W&<'& +G!
M)58-''5?SV!&&<+$&1J1&I++PG#%AP'A+C+27=A.L=S()E(@+VG/77" BK2A
M)K@=53QBD9#B&);A!@8++LZ=+AI<+_Y>"TGC%$;%\.R4903#Q'E,X S/#Z3!
M(4Z>4##2N3@1JLGB/;G&=L1>U8W$+D8BT"T&!]Q+Y)1%1*7_XSK.X!CY(W]4
M =9QGF8I@@"\@1H469F,ABF.2-*UR41@8DKHDYO 83T6"!U"GTRP@T)"GVMU
MI,V=$:MT$H$8I N%82Q2#!4X@".)VZ^ !_DMD6>,3%9$ TU29/WIG<TAX.&M
M&F[Y4S4%G-^!FT#P5K(IR7ZP'$D)@$ZQ!% 6U@%(A$> @=TAU:<I)=$$!1KJ
M@[E]Y%P,Y6*4X[O-6<&)& IZQE6"! N 0<W=S0<F4DS.9!7ERDTNI?-%I6:H
MQ&#T9,/UA2*$446 P1?^5OV=$3",#"TXV<.=!5=:DDR"8UZ"ATKQY>N<'& V
M(+/]QDIX%@[P"%0]IA;4',TAG5(.69=0#)O*2)(8RJ.6703Y59,T,I-05!]H
M#MQ2ZMT(;2(R"<1Z?<D8,2%&'0$.QD4P0@I3.)HS?J8<0L0)FLWY+2&>(0IR
MU&9Q7F<C1@,&Y2"*:6>/K)EXWN8D_[FD?VD6;>0FC&G!Q%5$'.285%#:9RA9
M=@RBNF0;+?B5Y]R%$5#11!!%SCC:4DP$R<G;852:XR7H5Y#+J81'?9T"?'J&
MI\G>TPWH"2*,"E@%=XQ)? 4+8X06I?W$3/1GAB$D$>&&@EI2.4'?:@QB4MQ*
MN7A%<) H10S4+UV7U-2ET*RGJ8"6>XI%?$9(P<D:J13$I0@2RD0#=#P A39%
MH7"'=VC6A]G4?](G:%2*AW!81C!I1?(+[0D7DT9'J.28R1TI4X@EKKQHF2E"
M:-C(KXA2BR39<VB! \B&5P# L14(=^A3EB:5;*[.MFR6)PTH7I B2^[#,;R2
M?&)HDI(+@__J:<Y!* *8@N20Y4@@I"&I3@7F16#<P4=F"$,4FCENB)#UB>!9
MEX[!@-P-G" E:I.EF 62I!.Z:H_T!Z$"$8;.I?>@I\_-!4.0C2YAR;%\R)=B
MA8+X2W_NREC %5B8DK2@$[(B"2Q%50# TB<QBA'<)$<(R\38'+,J2<(1@@_4
M%8-DC"B1C5=,5+12"[B6HRX 'HZDR4"TA%']B;7"TK3QQDIX:_&!3H*E&N7%
M%!LU8&4A$SMA$@/U'%WVS*CR!TI15D,QAED^VKS<7QD)RYJ,44'8#HMPX!3Y
M%O]I1%X%0 5$PJ&L*S&.R@\H2K ^Q+!*K+&RIJSE5+H&;%>@*P+_Y$7*NFDG
M!6E;M%.R,FFXNJG"P>Q7,)8?>6"@7LMG3,J8*$54H9,)I@VZ4L"*M.L"@L7P
M"4JKO,@HF2#SV51/?$6(J4"+O@P"2 G:_99O5 C6&MJLLFRE/&B%/ !4J-1V
M)A84K>LLN5;4.M_30D+@IHS6FIJO_JI=1%/B-J[\,*Q;!(TQ1E H[@PL3HX\
M,&[0'-SF$D)B&0_D?HWC1E MY-OH(D[H)@_8Z *OGJ[K@FZ6/=(NM.ZUD%_0
ML [IL&[35&Z<R,-DJF[LOFX:U8WPDD[JPBY<1"!L%B_S\NC4F$\$YN L_N[.
MZ$( * WD*._N4B^ [03M&F_P-J_X N_I_Q[O^)XO?:2N^:(O^\;FUJQO^\:O
MXHXN_,JO_:JO_>9OWN"O_O;O^[IN_T#0^4B07.B# S4- ?NOZ#JO H\O,< C
MH/XOZ1QP ],O "]-NC7A]PC1(FF/SW!P["0J^/"OV@1C)/)B%F$D?;PF_-S+
M";/&[+V+AV6&=GUN?42;=][C_(0OWE07XO1DMUV9TX@P[P!QLB6F5(S,#I?O
MTAA25-":]#A=?'B<SS@@[Q!H^)!PWF"Q5"RM(M''+BPM^A %%TLGI_*BDHF>
M'&&8Z5X6 ]^1!^>N&#M-&6]P7WI8!R*N!1>-GMA!&#\5R7PKPE0)@*C77^FI
M)J44O2#)?Z*2=?_=:]A"UF-(S/Y,:V8D<JGL8S(1TRMQ53A-UI?D%V+,4Y[^
M26W-&@+L2CEY%3K-C ]("BL!E2^QE*?4U#X( S^U[--H\7S(,JT,VW,]AY_L
M23 :#2@I" )TQFA\@K92I>$NTY#$T\FP "3<$BA/Z\2T%2I9%E)R5CX<++"P
M\)?T4BJME1$,&GB\,$3H,#:S4K[ *2;+$(!VA1^D5<4E@#"LP"L/2[CTQO?N
M:-/&B3;+,"?CR60TE&CHU2EHU"AU!90@9B!+[W2($YXP]$1 $<,8U>]&U0.P
MTD!/"#!K'#B7B3N5S'28 2./R,%ZC%N%R &H,B9O8FE:DWUAU3,/2U'_05Q+
M[G'1<%Y>Z1;V?%FQ1>]IC19/, N!Q1BG\="[Q!]QW=>:O9:;ELHNA"85)+6!
MA7)KRH11*&K_^0%Z"=IPUN2-Y%.)V9=Q.5ITY55/+,,@AT? 09YSI!>;146.
M7$"8T8.B=5?%H,PN\_!< -=69,SUE46T]9E/1*/MD3'V*'5>/1B/F<8NH%D2
M5==^85>H 34/)<!63->2;14@D>(\%>95H(5:*W&HM)9:^AG6?81N DJ&4B1:
M%TGCI8MG :DECFBDK9J&5+5W"I5L9 HWI6UFO?%\$/54OI>AQ&A"Z(5(--HQ
MG=:9$!JRV@:I%5N.#5I&F-9122B'"D2599%@_\-6'WQVH!4VHDR<8$>E#S8!
MF)0VJA"I=C_W=0>.\C8IIW%*>Z[$L-D?BE$WD3Z:=$4C>(^@$+LQ3_=,'P:=
MO#'=;5*)]8R<D^5ED> 1E81UD29;4J#D,P5M$PEFL8G;82?=NP6A?P!S!B-3
M Q)"9YW@%=$AJQP8:N><U@V%&N]<4$AM1:J$6OQS!&.-^0@,<.[C.H.$$;TP
M1]8*$+*1@].=O?6@MMU=1UG/O'G'#:VH]KEX[/W@9&Y$'!<YX*ASG%J<DFGY
MMJ7Q'=ANY]3!'Y2MI/;7B#31:9_"$"**;U62<<L'0T2XI[A;?B6#1TE%'(\&
MV"DEWK5E$BOY[^;+LS01A,XI\= )S,Q<QM<-83)%^JT8#;WQD5$"89.WZ,.Z
M&AZ!.$=Y%(J="S2$'8%@NBL^^O(6_W>"HXY//^$(>B%*&!*%? 3YL1]"BDC;
M5M.:9<V:=6$%J('<*"&OC^UNK7JUB8GZ,;7%5=T$'E+U;6+;-F&K\4?O5=Y6
MU+#;I@@,GEY[_1\2GD*$?,@9([@$V\<+QF!"J$-(NHDP[*"'7 I"UB#^28([
M(8<[?AU"R)[%W2KVX9[NF3MU<"$+6L"UVYET:@2+5[N)>?N0+>CKS#L/$E5S
MQC81%DZU,T:BI >OVP%C1,0ER!F+<X42&J3;21\ ]NJZRWJN>Q/K05?#J(<,
MZ0,,ZM]$6E^M!SPOHI]]Y5]O>+=H7!0PWZ@75E_C4=%Q%0GD);UE=+P%N.,
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MI,5U*B6NN,/QU,:%$JLTT1=,0"DJ'!P.*.4'J49%%B:NM!BRX<.(-;%FS0I
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DG?(IH3(JI7(JJ;(JK?(JL3(KM7(KN;(KO?(KP3(LR2\@   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>dcth-20250401_g2.jpg
<TEXT>
begin 644 dcth-20250401_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  = &$# 2(  A$! Q$!_\0
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MOBC6_!OBVZCGUZS=KBVE\M8S- 6Y&% !"Y0@]U< \JU>KU\\_$K6+/QO9/\
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2*<JDYZR=Q1A&/PH****S+/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>dcth-20250401_g3.jpg
<TEXT>
begin 644 dcth-20250401_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  > %T# 2(  A$! Q$!_\0
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?7FER2@B2SOXO+FA<$AE8=#@@\@D$8()!!K5HH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>dcth-20250401_g4.jpg
<TEXT>
begin 644 dcth-20250401_g4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  D "4# 2(  A$! Q$!_\0
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M_P"14MO]^3_T UUGPVTZU_X0#P]FVA)^PQ<E ?X10!YM_P -A^$/^@-XB_\
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/R;%'0;F)8_B31110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>dcth-20250401_g5.jpg
<TEXT>
begin 644 dcth-20250401_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  G "L# 2(  A$! Q$!_\0
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M,>7+:>7LLK@;<HN=F>GOG\*Q;?XBV'PD_:$#RV5C/X7O EOJ6GV\,D=O+$P
M)*O\V17B,WQ*\4W'VKS=>OG^U%6GW3-^\*C"D^N !63K>O:CXDOFO=4O)KZ[
M88,T[%F/XF@JQ^X?PC_97^"VFWVD>//"?A:QBN'5;NSN(\GRB1P1SUY-?0-?
M(G_!,;Q1>^(/V<;*WO9FG-G.\:,YR=N>!7UW009GB3P[8>+-#O-(U.)I["\C
M,4T:NR%E(P1E2"/PKYL;_@F7^SVS$GPA?9)S_P AV^_^/444"$_X=D_L]?\
M0H7W_@]OO_CU'_#LG]GK_H3[[_P>WW_QZBB@=V>V?"#X(^$/@3X;.@^#-.DT
6W3"YD\J6ZEN#D_[4C,?UKNZ**!'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>dcth-20250401_g6.jpg
<TEXT>
begin 644 dcth-20250401_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ; "(# 2(  A$! Q$!_\0
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ML9[QXD;3[Q S)"C,%WNBYQC+#UJ6X^)VAW5O)"]GXF5)%*$Q^&M41@",<,L
M(/N#D5VE% 'CRKX+5@1_PLC(.>3XF-:/C;QM9>)--T[3]/T[Q#+<R:UI3@2>
>'=0B1534+=W9G> *JJJLQ+$  &O4** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>dcth-20250401_g7.jpg
<TEXT>
begin 644 dcth-20250401_g7.jpg
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MZM_C77447"QR/_"OM=_Z&+]6_P :/^%?:[_T,7ZM_C77447"QR/_  K[7?\
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M1<+'(_\ "OM=_P"AB_5O\:/^%?:[_P!#%^K?XUUU%%PL<C_PK[7?^AB_5O\
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MN_\ 0Q?JW^-==11<+'(_\*^UW_H8OU;_ !H_X5]KO_0Q?JW^-==11<+'(_\
M"OM=_P"AB_5O\:/^%?:[_P!#%^K?XUUU%%PL<C_PK[7?^AB_5O\ &C_A7VN_
M]#%^K?XUUU%%PL<C_P *^UW_ *&+]6_QH_X5]KO_ $,7ZM_C77447"QR/_"O
MM=_Z&+]6_P :/^%?:[_T,7ZM_C77447"QR/_  K[7?\ H8OU;_&C_A7VN_\
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M24GPHTVS\+W3Z1IG@F-ENO$E[9+)'<7=W<H\;VL4D\$J+!%PJY9MWR@^<_\
M! W]O/\ :"^)OQOUO]FOXT_$S5_%>F7/AR;5=%N_$%^]W=6=Q#+$K1K-(2YC
M>.1CM8D*8EV@;FSF\)+V<I75X[HKZPN=*V^Q^L%%?E?_ ,%U_C?^T?\ LF_%
MWP?K'P(_:1\;:'9^,-.O9]0TB#77:VAF@DB :%3GRP1+@J#M&T8 R:ZCX-_
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MN6IAG3A&=[J1O"LIR<;6:/<Z*^>/^"9OP\^-_AK]F'P_X^_:-^+GB?Q3XO\
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M+9_#_B=->NFNKBS,5RUN]U;W$F9?D*EO+9BK*",*2&7]NJ_!3]FG]@_]H_\
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MU\T_\%8?"_Q1\>?LG+\//@SXAO=+\2>(O&NA:7IM]8WLEN\33WT<99I(R&5
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M'_XZ>'6\&^$-0N;[0/#/@SS_ #+R>9Y'VWEW)'$QMTDEDE$*J=[LN]BJ^6?
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M_!S1_P B7\(?^PIK/_HNSKU;_@W=@A'[!E[<"%?,/C_45+[1DCR+3C/I5?\
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M]/0YH0J*NI-=#\Z/^"HG_*7WQ?\ ]C=HG_I'95]<?\',MAK,GPZ^$VJ0*_\
M9T.M:K%=,/NB9X;8Q9]]L<V/H:ROVG?^"*G[<7[27[5&O_M1S_$+X6:/>:SK
M$%];Z6FKZC.EL(4CCB0N;%3(0L29;"Y.3@=*^Y?VI?V2H_VZ?V5+CX)?M V6
MFZ'KMP5N[6]\/7LE_!I6HQ%Q%<0O-% TBE&(=&13MED0-TDJI8BE"5&5[\JL
M_NL*-*<HU%;?8\F_X(,:G97_ /P3=\+VMK(K266N:M#<@'E7-Y)( ??;(A_$
M5^:'AK_E.G)_V<]=?^GZ2OLW]B3]@#_@K5^QD^N_!'X=?%WX:V'@C7]0^TW/
MB"Z2>^FT]RHC:ZL[<I'_ *08U0%)<QDQKSQD\1X&_P""#?[67AG]JVX^/&A?
M'SPSI5KH_C^76O"^HZPUQJNHW"17IFMYKN,1Q1O(ZA&D'F<DMTIPG1IU:DG-
M>]M\Q2C4G""Y7H?K%5'Q-XAT'PCX<U#Q7XIU.&RTS3+*6[U&\N6Q'!!&A>21
MCV554D^PIWA^#7[;0[2W\5:E9WFI);H+^[T^Q>V@FEQ\S1Q/+*T:DY(4R.0.
M-QZUS_QX^$^F_'?X*>+/@MJ^J36-MXK\.WFE37MNN7MQ/"T?F*"0&*[LX/!Q
M@]:\E6YM=CO=[:'YX_LR?M(R?MW?M0>(_@E^P#X!T'X'_#J"!M0\=>.O#7AV
MTMO$.NP"78BQ%8]MLTC.VTD.\8WON#?NS\9_#/PU8^"_^"UEAX/TNZO)[;2O
MVC'L[>?4;V2YN)$CUED5I9I"7E<A06=B68DDDDU]9_L@?\$-?VV/V>OC3/XK
MMOVO],\&Z/+$]I>ZEX%GN)=1U"S+!C%Y<\*11$[5.YC)L89 ; )=XQ_X(0?M
M+>%OVT(/CW^SK\>O#MMHUOXKBU[3M4\6W-U>:I9W"S"9C*C1.MXWF9.YY5,F
M?F*DDU[,:N&ISDHR5FOZNSSW"M**;CJF?1O_  7@_P"4;'B[_L+Z1_Z70UX?
M_P &T/\ R1SXH?\ 8S6/_I.]?2'_  42_9'_ &D_VKOV5[']F'X=>,_#-R]R
M]G)XD\6^+[V6VN+E[9E<%+>TM&CS(ZAB<J% VA3G<.!_X);?L!_M;_\ !//0
MO&WAGQ#J'P[\2V?B1(KO3C9^(+^W>&^AC=423=8L/*?>H9QEDVY"OG Y(3@L
M!*%]6_\ (WE&7UI2MI8_.G]EG_E-;IG_ &6O4O\ TKN*^AO^#F33]:3X@?";
M594?^SI-'U6*W;'RB99;<R#Z[6B_*MOX5_\ !%/]N?X9_M;Z;^UL?B)\*[[4
M;/QD_B"XTK^U=2BBG:29I9(0_P!B8H"'90V#C@X.,5]M?M_?L,^&_P!OW]GE
M/ACXQO8=#\16$J7^@ZQ;9N$T^^"%70DJC2P."4;A20%? *@5T3Q-*.)IS3ND
MK,RA1FZ$HM:MF-_P1[U.RU7_ ()M?"NXL)%9$TBYA?:>CQWUPCCZ[E-?D[_P
M37_Y3#>%?^QYUG_TGO*^W?V)/V%O^"LO[-O@Z_\ V7C\9_ 6@?#R^U"6:;Q)
MI[37VJV$<F!-_9H9$6-Y,9!F4B-B74;LAO/_ -EG_@A?^U_\#_VC=,_:"T[X
MX>"- ET'79;O1HY[:ZU>5X2739<1XMU;=&Y#;90?F.&!Y"IRHTY5;S7O;?.X
M2C4FH>Z]#]6Z\?\ V_/@)J7[3O[''Q!^".AH'U+6=!9])B8X$EY;R)<VZ$GH
M&EAC7/;.:];L$OH[&&/5+F&:Y6%1<36\)CC>3 W,J%F**3DA2S$#C)ZU+7EQ
MDX24ET.YI25F?SU_\$B_BI:_L^_\%&? UYXW+:=;WNHW.@:HMVIC:"2YBDMX
MU?=C9BX,6[/3!SBOZ%*^'/\ @H-_P1(^$O[77BN[^,_PD\4KX%\<7C^;J4@M
M/-T_59?^>LL:D-#*>,RIG/)9&8EJM?!R+_@MU\$?#-M\-_&'A+X3_$N#3HE@
ML_$MYXEN;:[DC7 7SG,:F4A0/F,8<]69CS7?B94\7:I%I/JGH<M&,Z%XM77=
M'VAK.LZ1X<TBZ\0>(-4M[&PL;=[B]O;N98XH(D4L\CLQ 50 22> !7@'_!5*
MXAU'_@G#\5;RQD$D4WA,R1NO1D,L9!_+FL.3]D[]J;]JF_MC^WO\3?#EOX-M
MKA)S\*OAJERECJCJVY/[2O)\37"*0"8$"1L0"<XY]X^-?P=\+_'+X+>)/@;X
MDWV^E>)-!N-+F>U4!K=)(R@>,= R$AE'3*CM7)'DI5(N][/4W?-.+5C\N/\
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MWC2*.Y@D",K I%'N5L$,I8%M^%*5>E'&SDWHUO\ <.=.;PT4EJBW_P '*?\
MR;+\/_\ L>V_](IZ]&_X-_O^4=^G_P#8VZI_Z&E>;_M;?\$JO^"@/[;OPM\.
MZE\=_P!I?PC>>-M,OODT>".>TT/3K0Q,)#'Y4#//=2/Y9>1E555-J<<GW?\
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M1,9+2VM(XK60R[]T:J IW?Q< <]ZMT !0%48 Z 45Y1W'D7[?_\ R8M\9/\
MLE^O?^D$U?CA_P $&?\ E)'X7_[ FK?^D<E?L%^VY\.OVE?C=\%O$_P+^!NE
M^";>V\6>'9M,O=?\4>(+N*2U2=7CF5+:"SD#_NC\KF9<,QRA"_-\-?L3_P#!
M&#]N/]BW]H[0OVA/#_CWX5ZV^D+<17&DW6L:E"MU#-"\3J)%L6,;8?(;:P!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#.\7?\BU>?]<?Z
MBO-*]+\7?\BU>?\ 7'^HKS2KCL3(Z[X??\AW4?Q_]"-==7(_#[_D.ZC^/_H1
MKKJEA'8****104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &=XN_Y%J\_P"N
M/]17FE>E^+O^1:O/^N/]17FE7'8F1UWP^_Y#NH_C_P"A&NNKD?A]_P AW4?Q
M_P#0C775+".P4444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M (*.>()_@]\9?V9_BUX4 M;V/XP6WA680#:)-,U2(Q7$) X*XBC8+T#(I&"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAS;3Z99:;?L\-CJ>CSQ"*2PEDC1WAV%4DBD"/L9""C!SAWPE_9>.G?$[Q_\
M'KXS_P!F:GXG^(EG;Z9>Z;8[Y;'2](@B,:6$3R*KS;RSR2R,B;V8 (H49OV\
M+\_E:WS)]G*W+Y_H>#6VDZ#:_P#! @V92,VY^ +SX[>>UD9<_7SCGZU]%_L0
M:GKFM?L9?";5_$KR/?W/PVT26[DE/SN[6$)+-GN>I]S7E4?[#'Q2'[,[?L'/
MXVTD?#+[<8%\2"ZG.M_V']J^T_V9Y'E>2),?Z/\ :O-/[KGR=U=C\9]4_:*^
M&?QP^%/AWX(ZIX1B\ 7%PFDZYX/N+.0ZE/$,!I[9E!6.&VMU+DDJ 5"G>9$
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MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DN
MK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8_
M_"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2
MZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\
MPDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 )&Q>-79"I*@E3U'M2T44 %
M%%0ZA:RWUA-90W\UJ\L3(MS;[?,B)&-R[U9<CJ,@CU!H FHKY9_X)>W_ (HF
M_P"%]Z)XI\<ZWX@;1?VAM=TVQOM?U)[JX6UA@LTBC+N>BJ  !@#L!7*:W\</
MA/H_[<GQ/^$_[=&HRV$4EA97?PD&KSSIIMSI2V@^T"Q"$ WWVCS-Q4>>YVI&
M2$5:W]B^=Q6MM3/VBY4^Y]HT5\/_ !.^/'[3WP _X)P>"]*\7:OJFF_$?X@^
M-+?PEX=U'5SYNIZ9;7U[.;66Y+9+7<=@@!9OF$NTOE@V>O\ CS?6O[#'QR^"
M.M_#>_U*+PWX[\8)X(\9:9?:K/=+J$UW'_H=^YF=C]ICFC;?-]Z1)&5R<+M/
M8/OWMYV%[5?E^)]8T445@:A7Y*77_!=WQM^R/\2?B%^SYJ?[/5AXIM_#OQ/\
M31Z=JB^(WL9##)J]W*$D3R)0Q4R, P*_*!D9!)_6NO@+PW_P0P_9M^,GB;QC
M\9_VA;KQ?_PD/BGX@^(=1-A9:E':P6]K)JER;;:OE,S;H0DFXMSYG P!77AI
M8>-_;*Z,*RJMKV>YXQ_Q$VZW_P!&9VG_ (7K?_(-'_$3;K?_ $9G:?\ A>M_
M\@U] _\ $/?_ ,$^O^>/C;_PI5_^,T?\0]__  3Z_P">/C;_ ,*5?_C-=/M,
MK_E?X_YF'+C?YE_7R.,_X)\_\%2?&'_!1+]NW3='O_A79>$M*\,?#O69HK2#
M56O9+F>:ZTY2[R&., *J8"A?XF))XQ^BU?''[+O_  2M^%?[#O[8FE?%7X"7
MGB.XT75?!.KZ=KD.M7,=PMK/]HL9("DBQH1O59AM;/\ JP0>M?8]<>)=&4U[
M+:QT4544??W"OF?]OG1?$/PL\<_#?]NSPKH-SJD/PLO[V#QMIMC$7GF\.W\2
MQ7<Z*.9&MF2.<(,?*KDD &OIBL_Q3XE\+>$- NO$?C77]/TO2[6/=>W^J720
M6\2'C+O(0JCG')[UE3DX2N:2CS1L,\&>,_"GQ$\)Z=XZ\#>(+75='U:T2ZTW
M4;*4/%<0N,JZL.H(_P *TZ\2T+]MG_@G=X#TY?#'A3]J/X1:590,QCL=*\6Z
M;% A8[F*K%(%!)))QW)K-^)G_!1S]@O3/!5Z)_VAO!/BH7B"S'AS1-?M;ZXU
M$S,(A"L*.=P;?@Y^4#)) I^RJ-Z1?W"YXI:M'E/_  5,_;E^%NG>#S^PS\-?
MB#IEW\0/BE?P>%;L07:/%X?M+V5;>XFNV!Q&QCD91&2&^?>0%7G[$\'^%M'\
M#>$M+\$^'H#%I^CZ=!8V,1.=D,4:QH/P517EY_X)[_L)$Y/['7PS_P#"*LO_
M (W7J^B:)H_AK1;3PYX>TR"RL-/M8[:QLK6()%!"BA4C11PJJH  '  JIRIN
MFHQ^8HQGS-R+5%%%8F@4444 9WB[_D6KS_KC_45YI7I?B[_D6KS_ *X_U%>:
M5<=B9'7?#[_D.ZC^/_H1KKJY'X??\AW4?Q_]"-==4L([!1112*"BBB@ K\S_
M /@I1_P6#_:&_8H_:=\7_ GX>>%= U6&;3M-N]%O];CD;^S#);#S56.-D\T%
MOG&YOE8G(8' ^_?$7[1_[//@_6[CPUXM^//@S2]1M'V7>GZCXHM()X6P#AT>
M0,IP0<$=Z^</$7P0_P""9OQ'_:RUO]K3XS_&_P"&?B[5+VRL;;1-(U?Q1826
M>FK;Q;&D,33%)Y';!!=2$ &!G+5U8;DA-NI&ZL8UN:4;0=F?F%HGPM_X*F?\
M%;/$T7B/5CXD\2:29R8M7UN7[!H-CS@F%<+#D="(4:3ID&ON_P#8S_X(#>"?
M@5?V_P 0_C#\>O$E]XJBB/V=? NIS:1!8N1@E;A"+B4@X(;,0[,C"OLRU_:I
M_9-LK:.RLOVD/AW##"@2**+QA8*J*!@* )<  <8J"#]L']F_5OB-X8^%'@_X
MO>'_ !%KOBN]N(-/L/#NMVUX\*P6D]U)/,(Y"4B"P%-V#EY$&,$E=JN+Q$X\
ML(\J\C*&'I1=Y.[/GH_MS>'_ -EK]J+PK^ROKW[4^G_%2S\1^)XO#D]I?01_
M\)%X9O93L@-S/;(MO=PF0K$X=(YXRX8F3# ?:%?)^C_\$=/V5=(_;,G_ &TC
M?>(;G6)?$4GB"+P_<7L1T^'5'D,IN !'YAQ*3*J%\!_50%'UA7-6=)VY.VOJ
M;4U45^;Y!1116!J%%%% !1110 4444 %%%% $5I8V5@KI8V<4*R2M+((HPH9
MV.68XZDDDD]2:EHHH **** "HA8V2WK:DMG$+EHA$UP(QO* DA2W7 ))QTR3
MZU+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %?S,^,O\ D;]5_P"PE/\ ^C&K^F:OYF?&7_(W
MZK_V$I__ $8U?IGAS\>)](?^W'R'%>U'_M[]#-HHHK]0/C@HHHH **** /W(
M_P"")W_*.[PC_P!A+5?_ $OFKZPKY/\ ^")W_*.[PC_V$M5_]+YJ^L*_GG/O
M^1WB?\<OS9^I9;_R+J/^%?D%%%%>2=P4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%17ME9ZE9RZ=J-I%/;SQ-'/!-&'21&&&5E/!!!((/!S0!\L_\
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MI.AS^+/L]E-XFU.:![O9:P!GC6*"0E,DKN.,E3C.*X/_ (AS/V[?^AW^&?\
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MX275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\
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MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
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MO'3OB=X_^/7QG_LS4_$_Q$L[?3+W3;'?+8Z7I$$1C2PB>15>;>6>261D3>S
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MH&X1S,7Y"^6!C+#'U?7Q-_P6,_X*9>.OV$/#GAKP3\&M$L)_%GBQ;B==2U2
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M'\R3DDGDDDGDU_/69XF&,Q]6O%6YY.5O5W/U'"4I4,-"DW?E27W(K?8O&_\
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MU%'J-W+*U@D?E"6*1!$NUS(Y4D%HE ^?*[X:4(5DY;:_D95E*5-J.YY!:_\
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M?]<?ZBO-*]+\7?\ (M7G_7'^HKS2KCL3(Z[X??\ (=U'\?\ T(UUU<C\/O\
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M'7XJ?M(?'CXC_##X&^,-.\-Z)\+YK?2[O6KK1Q?/JNN21M+)#M9U$=M  B2
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ML&^<RQ[@15+[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\
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M8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\
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M0?MK_';X-7]GX!\1:)X2^''B(^+O$USXHT2;3Y#J<,86QL88YU5IW65G>25
MT(5 %D8L!5<U/F3OHG*_S_SV)M*WGH?4-%%%<)U!117QG\(OVS/V[?VI_P!H
M?X@>$/V>OA5\/K#X<>"/%EUH?_";>+!?.UW-;ML=8D@E7SGR-^ $54=-S D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M -G-5\+>.-=LO$]GXF@UPZG;:G_:-P\YN?)D"X8MF,X&8M@/S*U?HU7Y_?\
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M(M%\52AC'9>(;^;4M*.>?+B1V,EFI/:,M&O\,0KXN^#O_!*_X4?LU?$68?\
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MYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P#
MMJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@
M#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'
MTC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?
M2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO
M?_ MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBFRRQPQM--(J(BE
MG=C@*!U)/:@#$O/"?AW3[26_O]3N8(((VDFFEOBJQH!DL23@ #DFOBG]I_\
M:";XK>(3X%^'$MZWA^&<1IF1V?4Y<X#;>NS.-BXR>IYP%W_VPOVLIOB9>R_#
M#X;WS#0(9=M[>0GG4I >@Q_RR!Z?WCSTQ7I'[&W[)*^!8+?XJ_$O30=;E0/I
M>G3+_P >"D?ZQP?^6I';^ ?[7W;245=DO4L_LI_L=V7P^TF+QS\187/B*YCW
M06Z28&G1D?=R.LA!^8]L[1W)_!OQ@H7Q;JBCMJ,XY_ZZ-7],]?S,^,O^1OU7
M_L)3_P#HQJ_2?#IMU,3_ -N?^W'R7%>D:/\ V]^AFT445^H'QP4444 %%%%
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M:+^T-KNFV-]K^I/=7"VL,%FD49=ST50  , =@*T_C_\ L"V/Q]'B/XA?$_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF>*;Z34O$?@KPUXNGTJ>"]D.Z6: ++''-&YRVPL'4G:H9<!?T\KXV_X*$?\
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M_:J_95\+?M/>']#DN-:FT+Q3X.UV'6_!'BJU@6672M0B8,K&-B!-"Q51)$2
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MB'PU,G]D67P&D^&=KJF?W#ZQ>JUS(BN.&, =!(!]UI #SP-(J'*D_AY?QO\
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M ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ
M-BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
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M)OHC4_8V_9);QK-;_%CXFZ:?['C<2:3ILZ_\?S \2.#_ ,L@>@_C/^S][[(
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ML6!;S?*]/+\W#^FZOK__ (*J7E[I7CG]F75=!+#5%_:*T2" Q_>,$HD2=/\
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MIM[JOAGXLP7MA:ZQ#));/*NG7H'F+&Z,0,YX8'('-?&/_$2'^W%_T2OX4?\
M@CU/_P"6%>MA5BEAU[&W6YP5W0=5^TN?6/\ P0MA^./P5M_BM^P_\>[&:TU'
MX<:U8WFG6LLXE2."_29F\EQP86,*RKCC-PQP"2*^_P"OP:\/_P#!<W]K+PW\
M>/$?[0VG_#GX<G6O%&A:?I6HVTFD7_V58;-YFB=%%Z'#GSV#%G8$*N ,'/4:
M_P#\'%_[=^LZ7/I]AX.^&NE2RPNB7NGZ!>M+"2,!U$UY(FX=1N4C/4'I2K8'
M$U:KG9:_GU'3Q-&G#EUT/VUTC6-)\0:5;:[H.J6U]8WD"S6=Y9SK+%/$P!5T
M=20RD$$$'!!JQ7DO[!%Q/=_L/?!^ZNIFDEE^&6AO)(YR68V$)))]<UZU7F27
M+)H[8OFBF%%%%2,\V_:G^-'COX(?"V;Q)\+_ (,>(?'7B&YF%OIFCZ!IQN/+
M=NL\WS(!$@YV[E+G" KDNOD/[-_[0OC^/Q'IOPZT;]A_XO:=J/B76A=>+O'G
MC_2[.S@EDV SW<[PSR'=Y<8BAA50BA8HEVHHQ]3T5I&<5&UB'%N5[GA3_&*R
M_:3^(?Q0_8E^(?P2\5^&K-_#=Y:6GB#5;4+:>(-/E1;:XFM6[A3<H!USNYVD
M%1XNGP[_ &@)/^"=+?\ !.T_#K6#X_733X._MHZ5,-$_LKS_ "QJOVXKY/E?
M8OF\D,;CS/W?E]Z^Q-&\":!HWBC4?&R)-<:MJB)%<7UU*7=8$9FC@C'W8XE+
ML0J@9+%FW,2QV:I55'X5V?S0G!RW?_#'RMXO_9@O/V<_VB?@[^T1\,/#VHZO
MH'@OX?GX>^+;+3+-[F]BTA8PUE=QP1@O.(YUQ(D89]L@95;:13O"?[+EY^T/
M^T;\8/VBOB?X=U#2/#_C3X>+\/O"ECJ5JUO>S:2Z%KV[D@D > 23-B-) LFV
M,LRKN KZGHH]M.WGM?YW#V<;^1\1)\._V@)/^"=+?\$[3\.M8/C]=-/@[^VC
MI4PT3^RO/\L:K]N*^3Y7V+YO)#&X\S]WY?>O:-3^,-E^R'XD^$W[*VE?!/Q7
MJGA:[TJRT&#QQ8VH:PTEXQ'9VD-P>SR,$!Y& V1NPVWW6L;6O F@>(_$NF>*
M-=2:ZET9S+I=M)*?(MYRK(9P@P&EV.RAFSM!.W:68D=52^)::OYL%3Y=F?._
MPA\%^(/V+/C_ /&*>Z\ ^(];\(_$GQ OB_PS<^&-#FU!UU2:,K?6,RPJ?(=I
M%CDCEDV0E7(:12AKS0_\$Y/BPG[!;:2MG9_\+;_X6H?BNNF"\4P#6_M'F"Q\
M[[N?LW[C?G9YG.=O-?=E%-8B:=UOI^']:B]E%JS_ *N?+WQ=\$>(/VU_CM\&
MK^S\ ^(M$\)?#CQ$?%WB:Y\4:)-I\AU.&,+8V,,<ZJT[K*SO)*@:$*@"R,6
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MJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\
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M(?A'X2^"_@R#P=X2M<(GSW=W(!YEU+CF1SZGL.@& .E=11*5P2L0_P!G:?\
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MSA\6?#MKK5MXLT*]NI-&OK<O#<6MK+:QRL6_@97N[<J00P/S*05R.RK\U?\
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MW_1I?A/_ ,!Y/_BZ^@:*T56K&*2;2(=.#=VCY^_X=5?\$[O^C2_"?_@/)_\
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M9-T9/ 8T?$7X\_![X2W\.E?$3X@:?I=U/:O=):S2%I5MD(#W+H@)C@4D!IF
MC7/+"GRRO:VH75KG745#IVHZ?J^GP:MI-]#=6MU"LUM<V\H>.:-@&5U9<AE(
M(((X(-35(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_ +_ (*B
M?\G_ /Q1_P"QC_\ :,=?O[7X!?\ !43_ )/_ /BC_P!C'_[1CK[_ ,/?^1I5
M_P '_MT3YCBG_<X?XOT9X)1117ZZ?#!1110 4444 ?J__P &ZO\ R2/XD_\
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MA_[<?(<5[4?^WOT,VBBBOU ^."BBB@ HHHH _<C_ ((G?\H[O"/_ &$M5_\
M2^:OJ;7/^0+>?]>LG_H)KY9_X(G?\H[O"/\ V$M5_P#2^:OJ;7/^0+>?]>LG
M_H)K^=^(?^1QBO\ '/\ -GZKE/\ N5#_  Q_)'X@T445_"Y_?84444 %%%%
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MG]@?_@AEJ_[4GANS^+GQ8_: T"Q\-W!#OIO@O4X-4U!B>3'+,C-!:OSR/WK
M@AD!K]*?V/\ _@FW\!_V'?B+JWBSX$7>I06NN>';>PU+3]4O#<O+-%,[BYWG
M&TL'VE0H7Y01CD'JJPP=&FX)WEW,(2Q%22DU:)]$4445YYUA7"^._@+X0^(_
MQE\(_%KQ=IUCJ'_"'Z1JUMIUA?6"S!+B]>R/VE&8X1DCM9(^A)%P>1CGNJ_/
MO_@OY^US\=_V;OA5X*\"?!7QE)H$?CF;4XM<U.Q!2\$-NMMMCAE!S"&\]MS+
MA_E4!@-P;6A3G5JJ$79LSJRC"#E+H;O_  43_P""KO[+G['$=[\-?ACX,\/^
M-/B+&&C?3(+6,V.D2=,WDJ#EP?\ E@AW\88QY!-'_@A;\9? O[0_[//BU?&-
MMH-UXUC^(.IZKKUD+&%7V7SK<+.D>/EA,CRHH'"F,CCC/Q;_ ,$[/^")OQ?_
M &K)++XM_M!/?^#? 4Y6>%9(]NJ:VAYS"C@^3$PY\Z0'((**X.X:O_!3S_@F
M/\9OV//C4OQL_8N\'^)(/ MY8P+;R^$9[J6[T&=(ECE25HV,PCD*>8)22"TC
M*2"!N]-T<+;V$9>]W\^QQ^TKW]JXZ=C]%_\ @JIXE^#OP;_8*^)&I^(M,T6Q
MN=9\-7.CZ*GV6));B\ND,,:Q#&68;BYQT5&;H":^@/AI:3:?\./#]A<(5D@T
M2TC=3U!$*@C]*_"+]C+]A?\ ;%_;_P#CMH%Q\8K/QG<>#M+OXY?$/B?QE+=-
M&EHCAI+>![DYDE<+L"IG:6#-A17[\  # & .@KCQ5.-"*IJ5WJW^!T4)NJW.
MUD%%%%<9T!1110!G>+O^1:O/^N/]17FE>E^+O^1:O/\ KC_45YI5QV)D==\/
MO^0[J/X_^A&NNKD?A]_R'=1_'_T(UUU2PCL%%%%(H**** "OS?\ ^"C/AO\
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MG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\
M?H4?V=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C
M#_WZ%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\
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MT"J/$7 48 _<QU]_X>_\C2K_ (/_ &Z)\QQ3_N</\7Z,\%HHHK]=/A@HHHH
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M_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\
M\^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG
M_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZK^:KQ@P;Q=JK*<@ZC.
M0?\ MHU?TP_V=I__ #XP_P#?H5_,_P",@!XOU4 ?\Q*?_P!&-7Z9X<_'B?2'
M_MQ\AQ7M1_[>_0S:***_4#XX**** "BBB@#]N_\ @BUXCT/3O^">WA*TOM3B
MBD74=5)1CR,WTU?4.M^,/#)T:[ UJ')M9/XO]DU\S_\ !%*SM)O^">/A&26U
MC9CJ6JY9D!/_ !_S5]2:WI]@-%O"+&'_ (]9/^60_NFOYWXA_P"1QBO\<_S9
M^JY3_N5#_#'\D?B/1117\+G]]A1110 4444 %?JC_P $_/$V@V/['_@NTO-4
MBCD2VNMR,>1_IDYK\KJ_5O\ X)ZV5G+^QSX*DEM(F8VUUEFC!)_TR>OU'PF_
MY*"M_P!>G_Z7 _(_&7_DFZ'_ %^7_I$SUO\ X3'PQ_T&H/\ OJC_ (3'PQ_T
M&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z%?T&?S64_^$Q\,?\ 0:@_[ZH_
MX3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&
MH/\ OJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z% $J.LB"1
M&RK#(([BEH  & , = ** "O$O^"@WPO^)GQ=_9HOO"?PNTY]3NHM:TR^U3P]
M'.L;ZYIUO>1375@K.0H,L2,,,0KXV$X8U[;151DX24ET%)*4;'RY\4?A1H_[
M0W[57P=^/WPB\ >(=!\0>#M6FF\5^)M7\-7>DDZ(UI,C:<XN8XS=2/,\:JJ!
MUC7SF+*&7>[X0^"_$'[%GQ_^,4]UX!\1ZWX1^)/B!?%_AFY\,:'-J#KJDT96
M^L9EA4^0[2+')'+)LA*N0TBE#7U#16GMG;EZ6M^-R/9J]^IX3_P3Q_9P\6?L
MW_ :[L_B1###XM\9^*]1\5^*[6VF$L=K>WL@;R XX<QQ)$A89!96()&#7NU%
M%9SDYR<GU+C%1C9!1114C"BBOQ'_ &^_^"E'[9'[8'[3FL_LZ?LI:QXGLO#F
MG:Q/I>C:'X($RWVLF%V22YFD@_>LC%68)D1K'C<,AF/1A\//$2:3LENS*K5C
M25V?JS\5OV'O@-\3?$LOQ&TC3=2\$^,I!_R.WP_U)])U-C_TU>'Y+H?[,Z2*
M1QBN*_9A^ '[6GPJ_:K\5^)_C[\=I_B-X<N?!EG9>$M>NM*M;&:UVW4KR6LT
M-NJJT@!5C-@^8",XQM'Y0_#S]B[_ (+"^%_B[;^#_ T/C+1/&!\/G7X+5?B)
M;VTSV2SB$NQ-V%'[Q@IC<ACDY7&37Z>_\$S/VL/VE/B,^M_LR_MO?#^\T#XH
M^$+"&^%U=VB0C7=,=S&+I?+_ '3LD@V.\1V,67&"& Z*U&=*F^6:DOQ7H8TZ
MD9SUBT?6M%%%>>=85Y;\;/V2OA?^T%\8O /Q4^*>EVNK6_P^CU*72]#OK,2P
M2WMT;3R[E\G!\I;=\(58%I5;*F,!O4J*<92B[H32DK,****0PHHHH **** "
MBBB@#.\7?\BU>?\ 7'^HKS2O2_%W_(M7G_7'^HKS2KCL3(Z[X??\AW4?Q_\
M0C775R/P^_Y#NH_C_P"A&NNJ6$=@HHHI%!1110 5^87[5G[+G[#P_P""MFJ>
M*_VVO&^CW'A;X@^&H)-.L9O%OV(:9K,,-O"(K[R94FMXI((C)%*S+&S,5SD
M5^GM?EO_ ,%'?^"3/[4O[=/[<'BWXE_"^Y\.:)H=GI6E6D&H>++NZMTOI1;
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MZSK%]%:VEK$TMQ<3N%2-%&2Q)Z "I+N[M;"UDOKZYCAAAC+S32N%5% R6)/
M '.:^(?VM?VI]0^-&LGX>?#Z68>'8+@+F)3OU28'AB.NP'[J=SACS@*XJ[$W
M8I?M/_M*>(/VA?%47@KP1#<C0(;H1Z?91(?-U"8G:LC*.3DG")VSD\GCZ$_9
M*_96L?@MI"^+_%UO'/XHO8<.>&73XR.8D/=C_$P^@XR6SOV/OV38/A98Q?$7
MX@622>)+F+-M;. 1IL;#I_UU(/)_A'RCN3[Y52:V0)=PHHHJ!A1110 4444
M%%%% !1110 4444 %%%% !7\S/C+_D;]5_["4_\ Z,:OZ9J_F9\9?\C?JO\
MV$I__1C5^F>'/QXGTA_[<?(<5[4?^WOT,VBBBOU ^."BBB@ HHHH _<C_@B=
M_P H[O"/_82U7_TOFKZFUS_D"WG_ %ZR?^@FOEG_ ((G?\H[O"/_ &$M5_\
M2^:OJ;7/^0+>?]>LG_H)K^=^(?\ D<8K_'/\V?JN4_[E0_PQ_)'X@T445_"Y
M_?84444 %%%% !7ZP?\ !/'_ ),W\$_]>MW_ .EL]?D_7ZP?\$\?^3-_!/\
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M<D JP^7>F&8-D=,X5(X5/DMIOUMZ=#&,H2KM<WR/JBBBBO/.LYWXL?%;X?\
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M_P"0[J/X_P#H1KKJY'X??\AW4?Q_]"-==4L([!1112*"BBB@ KX3_P""D/\
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MB(ROOS5+_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
MOI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z
M6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'
M_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=
M7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)
M=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0
MO?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"
M]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#
M8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C
M_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL
M?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_
M .A0O?\ OI: -BOP"_X*B?\ )_\ \4?^QC_]HQU^\O\ PDNK_P#0H7O_ 'TM
M?@M_P4WGENOV]?B=<36S0LWB')B?JO[F/@U]_P"'O_(TJ_X/_;HGS'%/^YP_
MQ?HSPBBBBOUT^&"BBB@ HHHH _5__@W5_P"21_$G_L8[+_TG>OT9K\V/^#>O
M5;W3_A/\1DM=%GN@WB*S):$CY?W#\<U^A_\ PDNK_P#0H7O_ 'TM?@W%O_)1
M5_5?^DH_2\D_Y%5+T?YLV*222.*-I97"JH)9F.  .YK'_P"$EU8=?"%Y_P!]
M+7RE^U[^V!<^+X;CX4_#F9K>P#&/6=0CE!-T1P849?\ EG_>(^]T^[G=\ZDV
MSU&[%/\ ;$_:SE^(]W-\+OAM?L-!ADVW][">=1D!^ZN/^60/_?1YZ 9]#_8V
M_9(7P3!;_%;XF::#K,JA]*TV9?\ CQ4CB1P?^6I'0?P#_:^[S7[(/[,5]H-Q
M;?%KXC^"[JXGPLNAZ=(@ B[B>0-_%W53T^]UQCZ<_P"$EU?_ *%"]_[Z6JDT
ME9"2ZFQ16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+4%&Q16/\ \)+J_P#T
M*%[_ -]+1_PDNK_]"A>_]]+0!L45C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_
M 'TM &Q16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+0!L45C_\ "2ZO_P!"
MA>_]]+1_PDNK_P#0H7O_ 'TM &Q16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_
M]]+0!L45C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM &Q16/\ \)+J_P#T
M*%[_ -]+1_PDNK_]"A>_]]+0!L5_,SXR_P"1OU7_ +"4_P#Z,:OZ3O\ A)=7
M_P"A0O?^^EK^;#Q@2WBW5&*XSJ,_![?O&K],\.?CQ/I#_P!N/D.*]J/_ &]^
MAG4445^H'QP4444 %%%% '[D?\$3O^4=WA'_ +"6J_\ I?-7U-KG_(%O/^O6
M3_T$U\C_ /!%_6]0LO\ @GSX3M[?P[<W"C4=4Q+&RX/^G3>M?4&M>)-6.C78
M/A"\'^BR<[E_NFOYWXA_Y'&*_P <_P V?JN4_P"Y4/\ #'\D?BS1117\+G]]
MA1110 4444 %?K!_P3Q_Y,W\$_\ 7K=_^EL]?D_7ZF_L :[J5I^R#X,MX/#5
MU.BVUUB6-EPW^F3^M?J/A-_R4%;_ *]/_P!+@?D?C+_R3=#_ *_+_P!(F>]T
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+7]!G\UFQ16/_PDNK_]"A>_]]+1
M_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM
M&Q121L7C5V0J2H)4]1[4M !117EW[9?[4'AG]CS]G7Q!\>/$E@U\VF0I%I6E
M(^UM0OI6$<$ /) +L"Q )5%9L'&*<8N<E%;L3:BKL]1HKYH_9&\2_"#QWK=K
M_P +9_:)\.^/_C'<6::KJ>E0:ZDUKHQ.&\G2[,.8DA@/R&XC#2N5+22$D 8?
MP'U2V_;E_:%^-^J?$B\U&?PM\/\ Q5_PA7A#1[35)[:*TN+9#]MOAY+KNN7F
M9=DWWHD10A&6+:^RLW?9$>TO;S/K.BOGK_@FK\>?&GQM^!6L:%\3-9?4_$OP
MZ\<ZIX-UK5I0 ^H/92*([AP.-[0R1;C_ !.&/?%?0M9SBX2<65&2E%-!1114
ME!7X]?&[_@H_^TM_P3G^&7C#]@<_!C^RO%$>OZQ-H/Q*>^91=V%]>SW*WT47
MEXEFQ,P63S,(0 R[HRI_86OE;]L#_@I5_P $Y_@MXTE^#7[0^L67B+6=+99+
MO18O#!U06,C $!RR&-)-I!*[MP&,@9&>K"RM.W)S>7H85U[M^;E/S4_X))?L
M#Z;\8_%5Q^V%^U#8-:?"GP7(;QYM5@=H]>OD;Y8PN"9H4?!DP#O;;%AMSA?T
M*_9$^.OAG]K?_@HCXV^-GAKP3KVA:3X8^&=MX:\,3ZWX=N+1M>@DOS<W-V&D
M0!$1T@6.)COVRE]HRRKF6/\ P7Q_X)P:791:=INL>)K>W@C$<$$'A-T2- ,!
M54'  '85+^S/_P %L_V=?VA_VK-1^ T-\NF:'J<%K_P@>OZE;/:M>W90>?9S
MAV(20O\ ZIAM#_<^]MW]-=XFKS2E!K3[E^IC35&G:*DO\S[8HHHKS#M"BBOG
MS_@H+\//V]_B#\.$L?V&_C%H'AF]6*0:G:W]CLO;T'HMO>-O2 XR,&-3DY\U
M:J$5.5KV]12?*KVN>A?'[]JK]G?]ESP__P ))\>OBWH_AR%D+V]O>7&ZYN0.
MODVZ!I9C_N*:_.;]JK_@X]'^D^&/V//A1ZHOBKQDOX;HK.-OQ5I)/]Z/M7Q-
MJ_[$?[8OCC]IF/X2_M$R'PMXMUR9F;Q#\4_$(M[>]8$*6CO)6<7AR0 (3*Q[
M#@U^E'[*O_!O1^S9\,!;>)?VD/%5Y\0M63:YTR#=8Z5&W7!5&\V?![LZJPZQ
M\XKT_88+"I.H^9_U_6YQ>TQ-9V@K(_+/XG_%?]M/]N35-1\=>/M5\:^/UT2W
MDO+\VEA-/9Z1 %+/+Y,">3:QA026"J, DFOZ-_A-_P DK\,_]B_9?^B$IFB_
M"+X9>%OAY-\)_!_@;2]$\.S64MJ=(T:QCM8%BD0HX5(P "0>N,UM:+I%EX?T
M:TT'34*VUE;1V]NK-DA$4*H)/7@#FN;%8F.(248V2-J-!TFVW>Y9HHHKC.@*
M*** ,[Q=_P BU>?]<?ZBO-*]+\7?\BU>?]<?ZBO-*N.Q,CKOA]_R'=1_'_T(
MUUU<C\/O^0[J/X_^A&NNJ6$=@HHHI%!1110 5YS^U#\:?V9?@M\+KK4_VK/%
M/A^Q\,:@IMYK+Q!;K<IJ'&3$EMM=K@XY**C''.*]&K\G_P!L3]B_XU_\%,/^
M"L7CCX/Z_P#$I/"_AGP!X:TR73KF[M6N?+LIX(7/V: .@D:2X>;<Y90-FTDE
M56M\/3A4G[[LEJS*K.4(^ZKMD-]^TU_P;KW?C$W,O[-=YS/N^W0>'+N.SZ]?
M(6X'R_[/E?A7Z&_L=_%O]C_XI?"N,?L8ZSX8?PSI[!7TOPW8K9_8789Q+;;$
M>%FP3ET!;!.3UKXK@_X-I/@6MCY=S^TMXM>YP/WT>E6JQ_\ ?!R?7^*N7^ _
M[ 'Q2_X)=?\ !2GX16?P_P#C&/%7AWXF-JNFW]J+$VEP;:"U\Z59X@[JZ(3%
M*L@(^:/!5>-W956&K0:A-W6NOD<\'6IRO**MY'ZJT5#?ZCI^EP+<ZG?PVT;3
M1PK)/*$4R2.L<: D_>9V55'4LP Y(J:O,.T**** "BBB@ HHHH **** (KU[
MR.SE?3H(I;A8F,$4TIC1WQ\H9@K%03C)"DCK@]*\-_8O_9W^+O[/>O\ Q.NO
MB%=>'+JT^(/Q(U+Q? ^C7]P\EC)=^4OV1ED@02*JQ ^:&4D_P#/'N]%4I-1:
M[DN*;3/"_AYJO[1?B#]J+XC_  F^,6J>$?$7PZN=&$^BVND6<BW&DQRE8ULK
MUF 5Y)HS-(5!8A8PWRK(JUQL?[#'Q2'[,[?L'/XVTD?#+[<8%\2"ZG.M_P!A
M_:OM/]F>1Y7DB3'^C_:O-/[KGR=U?4-I8V5@KI8V<4*R2M+((HPH9V.68XZD
MDDD]2:EJ_:R3T\OO747LTUJ>-?%W]EV34/B7\/?CO\$UTO3?$WPYMI],LM-O
MV>&QU/1YXA%)82R1H[P["J212!'V,A!1@YP[X2_LO'3OB=X_^/7QG_LS4_$_
MQ$L[?3+W3;'?+8Z7I$$1C2PB>15>;>6>261D3>S !%"C/L=%3[2?+;^N_P"8
M^2-[GRS'^PQ\4A^S.W[!S^-M)'PR^W&!?$@NISK?]A_:OM/]F>1Y7DB3'^C_
M &KS3^ZY\G=78_&?5/VBOAG\</A3X=^".J>$8O %Q<)I.N>#[BSD.I3Q# :>
MV905CAMK=2Y)*@%0IWF1 /=:B%C9+>MJ2V<0N6B$37 C&\H"2%+=< DG'3)/
MK5>UDWKKO][ZB]FDM#Q.V_9X^)WP<^-_COXN?LZR>&Y[;XE1VUSKVB^);NXM
MX]/U:"-HA?P&"*3SEDC*^; WEEFC#"5=Q Q&_P""<GP\_P"&*V_9)'BV[^WM
M>G6O^$U^RK]J_P"$@^T?:O[2\O./]=QY>[_5?N]W\5?1E%+VU32S[?AL'LXG
MAUQ^SO\ $SXR_&;P%\6OVCI/#D$/PU6XNM#T3PS=SW,6H:M-&L1OYGGBB,2Q
MH&\J!0Y5I"QE;:!1;?L\?$[X.?&_QW\7/V=9/#<]M\2H[:YU[1?$MW<6\>GZ
MM!&T0OX#!%)YRR1E?-@;RRS1AA*NX@>XT4>UEMT[?C^8<B/.?V5/V<?#O[*_
MP6T_X2Z%J\NJ3QW$]]K>MW,0274]0N)#+<7+*"0NYV.%R=J*JY.W)]&HHJ)2
M<G=E))*R"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_ +_@J)_R
M?_\ %'_L8_\ VC'7[^U^ 7_!43_D_P#^*/\ V,?_ +1CK[_P]_Y&E7_!_P"W
M1/F.*?\ <X?XOT9X)1117ZZ?#!1110 4444 ?J__ ,&ZO_)(_B3_ -C'9?\
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M_D>C_AY)^VG_ -%G_P#+=T[_ .1Z\-HH_P!9>(_^@RK_ .#)_P"8?ZJ\,?\
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M]?K!_P $\?\ DS?P3_UZW?\ Z6SU^H^$W_)05O\ KT__ $N!^1^,O_)-T/\
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M%4+_ ,5>%]+S_:?B2PML=?/O$3'YFL6_^./P7TO(O_BUX;B(ZHVMP;ORWYH
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M4444 %%%% &=XN_Y%J\_ZX_U%>:5Z7XN_P"1:O/^N/\ 45YI5QV)D==\/O\
MD.ZC^/\ Z$:ZZN1^'W_(=U'\?_0C775+".P4444B@HHHH *_(W]M'_@GS\8_
MV]?^"NGCWX<ZK\3+3PW8V?@[3M7T"\U6W>?S--6&" I;0AEW*+II]YW !MQY
M+ 5^N5?C]_P6=_;Y^,-G^VWIGP<_9\THZ-KOPO:*2S\4Z5:&359[FZM$FEA1
M@#_HOERHK0E2KLA+9 4#MP'M/:M0WMOV.;%<GLUS=S<7_@V2UXJ"_P"V5: X
MY \!L0#_ .!M=Y^QO_P1?^(_["W[:GP\^-]O\8=-\7Z+'<ZG9ZFL>EFPGM/-
MTJ[$<@1II!(I<;"%.X;E."NXK\6?\/+_ /@K[_T5OQM_X1]O_P#(M>S?\$T?
MVM_VVOV@/^"C'PN\+_M2?$7Q)J6G6G]M76G6&K:<EI#YPTB\3S0B11AV"NRA
MB"0'(&-QSW5(XU4I<TTU9_EZ'-"6&YURQ=[H_9:BBBO$/2"BBB@ HHHH ***
M* "BBB@ HHHH 1U+(55RI(P&&,CWYKX.^+OP:_::_P""7NA7'[3/P1_:3\5_
M$/X>:7JS7_Q!^'?CV6*YF-K<W)>ZN[.>-$$4HDF>4JJ("69VW\J?N7Q)!KUU
MX=O[7PKJ-O9ZI)92KIMW=VYFB@G*$1N\892ZAL$J&&0",C.:\1TKX/\ [67Q
MH\ 1?"S]L'7/A[_8TDL7_"0_\(/%>/)K\,<BN('%R$6TCD**)0OFET+JICW;
MAO1ER[VMU1G4CS;;]#SGQ%>W6N?\%P/"MKJ,C&PT_P#9WN;W14?(7SY=3>.5
MU!Z,8P >^%%>:?M<>(?%/A;]O[X\3^ 994E;]BW4[R[-N2"MW#/(()>/XU4_
M+WP37UA\=OV==8\8?&+P/^TM\+KS3[?QGX'^UVBVVJR/'::SIETFR>SFDC1W
MB*L%ECD"/L=2"C!SB#X2_LO'3OB=X_\ CU\9_P"S-3\3_$2SM],O=-L=\MCI
M>D01&-+")Y%5YMY9Y)9&1-[, $4*,ZQJPBE+RM;Y_P!,S<)/3SO^!X-;:3H-
MK_P0(-F4C-N?@"\^.WGM9&7/U\XY^M?1?[$&IZYK7[&7PFU?Q*\CW]S\-M$E
MNY)3\[NUA"2S9[GJ?<UY5'^PQ\4A^S.W[!S^-M)'PR^W&!?$@NISK?\ 8?VK
M[3_9GD>5Y(DQ_H_VKS3^ZY\G=78_&?5/VBOAG\</A3X=^".J>$8O %Q<)I.N
M>#[BSD.I3Q# :>V905CAMK=2Y)*@%0IWF1 )FXS3BGNVQQ3BTVNB1YK_ ,$K
MIK[5OB-^T[XAU]V;5)?VA=8M9O,/S+;P!$@7_=5"0OL*^0KC4M;N?@!/X)61
MQX7F_P""AYTXC)\L6!;S?*]/+\W#^FZOT+MOV>/B=\'/C?X[^+G[.LGAN>V^
M)4=M<Z]HOB6[N+>/3]6@C:(7\!@BD\Y9(ROFP-Y99HPPE7<0,1O^"<GP\_X8
MK;]DD>+;O[>UZ=:_X37[*OVK_A(/M'VK^TO+SC_7<>7N_P!5^[W?Q5I&M3C/
MF?6WRLM?N(=.3C;M<X[_ (*J7E[I7CG]F75=!+#5%_:*T2" Q_>,$HD2=/\
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MQS7Z'_\ "2ZO_P!"A>_]]+7Y_?\ !NK_ ,DC^)/_ &,=E_Z3O7Z,U^#<6_\
M)15_5?\ I*/TO)/^152]'^;/QU_:JE>?]I;Q[/+ T3/XMORT;=5/GOP:X&O0
MOVL_^3G_ (@_]CAJ'_I0]>>U_"^:_P#(TK_XY?\ I3/[TR?_ )%&'_Z]P_\
M24%%%%<!Z(4444 %?H+_ ,$D=6OM/^!'B&*UT*XNE/BV0EXB, _9;?CFOSZK
M]%/^"/G_ "0'Q'_V.$G_ *2VU?H'AE_R5</\,_R/S?Q7_P"2.J?XX?F?3G_"
M2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+6Q17]*'\KF/_ ,)+J_\ T*%[_P!]
M+1_PDNK_ /0H7O\ WTM;%% &/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM;%%
M &/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM;%% &/_PDNK_]"A>_]]+1
M_P )+J__ $*%[_WTM;%% &/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM;
M%% &/_PDNK_]"A>_]]+7\V'C EO%NJ,5QG49^#V_>-7],]?S,^,O^1OU7_L)
M3_\ HQJ_3/#GX\3Z0_\ ;CY#BO:C_P!O?H9M%%%?J!\<%%%% !1110!^VW_!
M%_6]0LO^"?/A.WM_#MS<*-1U3$L;+@_Z=-ZU]0:UXDU8Z-=@^$+P?Z+)SN7^
MZ:^<?^")W_*.[PC_ -A+5?\ TOFKZFUS_D"WG_7K)_Z":_G?B'_D<8K_ !S_
M #9^JY3_ +E0_P ,?R1^(-%%%?PN?WV%%%% !1110 5^IO[ &NZE:?L@^#+>
M#PU=3HMM=8EC9<-_ID_K7Y95^L'_  3Q_P"3-_!/_7K=_P#I;/7ZCX3?\E!6
M_P"O3_\ 2X'Y'XR_\DW0_P"OR_\ 2)GJ'_"2ZO\ ]"A>_P#?2T?\)+J__0H7
MO_?2UL45_09_-9C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10 D;%XU=D*DJ"5/4>U+110 444$@
M#)- !17S!\*_VS?'WQ;_ ."B,WP+T33K:#X<'X3W6OZ#?-$&GUJ:/58;/[:K
M=5MR?/6(#B10)@2LB8W= ^.OQ4_:0^/'Q'^&'P-\8:=X;T3X7S6^EW>M76CB
M^?5=<DC:62':SJ([: !$D Q([L=KQA<MJZ,UOVN0JD7L?05%>5?L:_M*Q?M3
M_!*#XAWNB1Z5KFGZG=Z+XKT>*4NECJEI(8IXU8\E"0'7/.R1<\YKU6LY1<9-
M,I-25T%%%%(85^+?Q0_X+=_MJ?LT?'3XD?!7PNOA37-)T/XE>((-+G\3:7<3
MW,$']IW!6'S([B/<B9VJ""54!0<* /VDKY=^--E_P2Y_8ETN\UG]HC1? 5K?
M^(]:U#6II?$'AVWU+5M2GN[J6XE<(D#SR1J\AC4[=J*J*6XS75A9TXR:E#FO
MT,*\9M)J5K'YS?\ $1G^W=_T)'PS_P#!!>__ ";7NO\ P1 ^*7[3/[57[97Q
M6_:[^*UOG2=<\+V^G:E=V=B;>REOXI+=;6*)>C&*WCF!Y9E\P%CEQGT[P;_P
M4;_X(<^)?$$.D1^$_!ND222!8;S5/A4L,.[/&9!;$(/]IMH'<BON+P'>^!=3
M\'Z=J7PRNM*GT"XMEDTJ?0WC:TDA;D-$8OD*GKE>*Z*]6$*;BJ7*WU9E2A*4
MTW.]C6HHHKS3L"OC3_@JU_P4+\>?\$]/&/PP\:>&O"<'B+2M?M]=M-9T"YOC
M;+,R'3WAF614?:Z9D RI&V5QC)!'V77C/[4'[#/P1_;#\<^#M>^/FA#6]&\(
M6>J"WT!YIH4N+J[-ILF:2&1&Q&EO(-G(8R@G&S!UH2IQJIU%=?\  ,ZJFX6A
MN? /_$3;K?\ T9G:?^%ZW_R#1_Q$VZW_ -&9VG_A>M_\@U]BS_\ !(W_ ()A
MVLI@N?V:=!C<=4DUR]!'X&XK#^('_!-7_@D9\+O"ESXV\=? GPW8:;:;!-.^
MMWS$L[!$156X+.S,P 4 DD\"NU5,N;LJ;_KYG/R8M?;7]?(^0?''_!RQ\0->
M\'ZGHG@[]EFPT;5+NQEAL=6E\8/<BSE92%E\H6J;RI(8#<.17ZO_  WU"]U;
MX=Z!JNI7#37%SHMK+/*_5W:%2S'W))->!?\ #G?_ ()K_P#1J^D_^#:__P#D
MBOI#3--L=&TVWT?3+<16UI D-O$"2$15"JO//  %<^(GAI)*E&W]>K-:4:T6
M_:.Y/1117*;A1110!G>+O^1:O/\ KC_45YI7I?B[_D6KS_KC_45YI5QV)D==
M\/O^0[J/X_\ H1KKJY'X??\ (=U'\?\ T(UUU2PCL%%%%(H**** "OS5_:W_
M &V?V<_^"?G_  5;U#XJ3^#=<U/4?$O@ZUTWXBV]MIT&84V1/:WMG*TH+OY<
M4<4L+A 0BL')&*_2JOB[]J#_ ((S_"C]M']IWQ-\>OCG\1/$>GVMY9:?::%8
M>%+RWB<)# %D>=KBWE&2^0JKT R3S@=.&E2C-^TVL8UE-Q7)O<YC_B(R_81_
MZ$GXF?\ @@LO_DVM7X*?\%>/V;/VV?VK_AE\%_A!\*]=:_75=2OY-:\6:=#"
M=/2/2+X'[-Y-RY,K[MC%QL\MG&"Q5DY__B&\_8=_Z*I\5_\ P>:9_P#*^NI_
M9T_X(I_![]C[]ISP1^T+\"?B-XGOAHEQ?Q:]I_BR]MIO,MY].N8%> V]M%AU
MEDBRK9!5F.05 ;>7]GJ+Y+WL[?<9+ZWS+FM8^VJ***\\ZPHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *B%C9+>MJ2V<0N6B$37 C&\H"2%+=< DG'3)/
MK4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !17YB_\%4/^3M+W_L!V7_H!KYQK\ES;Q1_LO,ZV#^J<WLY.-_:6
MO9VO;D=OO9^RY-X1_P!KY30QOUWE]I%2M[.]KJ]K^T5_N1^Y%%?AO17G_P#$
M8/\ J!_\J_\ W,]/_B"7_4?_ .4O_NA^Y%%?AO11_P 1@_Z@?_*O_P!S#_B"
M7_4?_P"4O_NA^Y%%?AO7V1_P1Q_Y*3XS_P"P';_^CC7KY#XE_P!MYO2P/U3D
MYVU?VE[63>W(K[=SQ>(O"K^P,EK9A]<Y_9I/E]G:]VEOSNV_9GZ 4445^IGY
M"%%%% !1110 4444 %%%% !1110 5^ 7_!43_D__ .*/_8Q_^T8Z_?VOP"_X
M*B?\G_\ Q1_[&/\ ]HQU]_X>_P#(TJ_X/_;HGS'%/^YP_P 7Z,\$HHHK]=/A
M@HHHH **** /U?\ ^#=7_DD?Q)_[&.R_])WK]&:_.;_@W5_Y)'\2?^QCLO\
MTG>OT9K\&XM_Y**OZK_TE'Z7DG_(JI>C_-GX\_M9_P#)S_Q!_P"QPU#_ -*'
MKSVO0OVL_P#DY_X@_P#8X:A_Z4/7GM?POFO_ "-*_P#CE_Z4S^],G_Y%&'_Z
M]P_])04445P'HA1110 5^BG_  1\_P"2 ^(_^QPD_P#26VK\ZZ_13_@CY_R0
M'Q'_ -CA)_Z2VU?H'AE_R5</\,_R/S?Q7_Y(ZI_CA^9]:4445_2A_*X4444
M%%%% !1110 4444 %%%% !7\S/C+_D;]5_["4_\ Z,:OZ9J_F9\9?\C?JO\
MV$I__1C5^F>'/QXGTA_[<?(<5[4?^WOT,VBBBOU ^."BBB@ HHHH _<C_@B=
M_P H[O"/_82U7_TOFKZFUS_D"WG_ %ZR?^@FOEG_ ((G?\H[O"/_ &$M5_\
M2^:OJ;7/^0+>?]>LG_H)K^=^(?\ D<8K_'/\V?JN4_[E0_PQ_)'X@T445_"Y
M_?84444 %%%% !7ZP?\ !/'_ ),W\$_]>MW_ .EL]?D_7ZP?\$\?^3-_!/\
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M5C_8O&__ $&[+_P&/^-'V+QO_P!!NR_\!C_C7[X?SF;%%8_V+QO_ -!NR_\
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M#C:A_P!'@0_^$&?_ ).H_P"(<;4/^CP(?_"#/_R=7Z-_KEPW_P __P#R6?\
M\B?*?V!FW_/O\8_YGYDT5^FW_$.-J'_1X$/_ (09_P#DZC_B'&U#_H\"'_P@
MS_\ )U'^N7#?_/\ _P#)9_\ R(?V!FW_ #[_ !C_ )GYDT5^FW_$.-J'_1X$
M/_A!G_Y.H_XAQM0_Z/ A_P#"#/\ \G4?ZY<-_P#/_P#\EG_\B']@9M_S[_&/
M^9U/_!NK_P DC^)/_8QV7_I.]?HS7S%_P3Z_X)]^)?V"_"GB+POIWQDM?$@\
M0:C#=-,_A\VGDF.,IMQY\N[.<YR*^A?L7C?_ *#=E_X#'_&OR3B+%X?'YS6K
MT)7A)JSLUT2V=F?<970JX; 0IU%:2W^]]C\D?VL_^3G_ (@_]CAJ'_I0]>>U
M]^?%+_@D]JOQ.^).O?$6X^/$%H^N:M/?/;#PT7$1ED+[=WV@;L9QG ^E8/\
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MQ16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\
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MQR1L"1WBPRG&0PRK#!!((-=;;S_LY_ML_!R1+G1M-\:^#-5?;Y>JZ1)Y$Y4
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M]&X_^7AK'_R91_Q$')?^?=3[H_\ R8?ZKYA_-'[W_P#(GPU_P;T_\G=>+?\
MLG%Q_P"E]C7[!UX]^SU^P/\ LF?LJ>+KOQW\!/A1_8.JWVFM875U_;M_=;[=
MI$D*;;F>11\\:'( /RXS@G/L-?G?$>:8?.,T>)HIJ+26MKZ>C?YGU64X.K@,
M&J51IN[V_I!1117@GI!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5SWQ$^%W@KXKV6G:3X^T>/4K#3M5CU :;=(KVUS-&KB,31L"LBH["55/2
M2*-NJBNAKS;]J?XT>._@A\+9O$GPO^#'B'QUXAN9A;Z9H^@:<;CRW;K/-\R
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M&_AFMM\,7FJ>X+QNOUC->Z^-/V:/"GB;X@ZA\4O#/C'Q%X1UW6])CTSQ%?\
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M+?+:Q72'='-<32*AD*-AA&J[=RJ2[ ;3XY_Q$J_M&_\ 1O'@G_P*O/\ XY7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P#
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M&NNKD?A]_P AW4?Q_P#0C775+".P4444B@HHHH **** "BBB@ HHHH ****
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **XC7_VD?@1X8^+6C?
M?6?BIH\?C/7Y)$TOPS%<^;>2;(7F9GC3)B7RXW8/)M4XP"3@4?'K]I#X&_LP
M>"Q\0OCW\2=/\-:2TXAAN+TNSSRD$^7%%&K22M@$[44D $]!5<DFTK;BYHVO
M<[>BN&^ 7[2OP*_:C\&MX_\ @%\2M/\ $NE13F"XFL]Z/;RX!V2Q2*LD38((
M#J"001Q6K>_%_P"'&G?$>7X2W_B>*'7[?PVVOW-G)#($@TT3>2;B28KY2#S
MP"LP8A'(!"L0.,D[-:AS)J]SI**\4^$W_!1C]B7XY_%-O@K\*/VA]%UCQ*"X
MAT^&.=%NB@)80321K%<$ %L1.W )Z FO1?BO\9OA1\"_"<OCGXQ?$32/#6DP
MY#7NL7R0JS8SL3<<R.>R*"Q[ TW"<96:=Q*46KIG345G>$/%GA_QYX3TOQSX
M3U 7>E:UIT%_IEV(F3SK>:-9(WVN RY5@<, 1GD URNN?M-_ ;PQ:>--1\2_
M$JQTZT^'EQ#;^,;Z_62&WT^:6".>.+S74)*YCEB.R,NP,BJ0&(6I49-V2'=(
M[NBO*_V<OVV_V5OVM9M0L_V>OC+IWB*YTM0]_91PS6UQ$F=OF>3<1QNT><#>
M%*Y(&>16;\=_^"A7[&/[,_C>#X;_ !N^/FDZ)KLZHW]F>1/<R0*XRIF^SQN(
M 0009-H((/0YJO95.;EY7?M87/#EO?0]FHJKHFMZ/XET:T\1>'=5M[[3[^VC
MN+&]LYEDBN(74,DB.I(964@@@X((-6J@H**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HKB_C=^T3\#OV;O"K>-/CI\4='\,Z?@^5)J=T%DN".JP
MQ#,DS?[,:LWM70^(O&?A/PAX3NO'GBSQ%9Z9HUC9M=WNIZA.(8;> +N,CL^
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M\AW4?Q_]"-==4L([!1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M *(LA9K6]C:186G$A16N4SQD[6P#QGUC_@J%XK_;/USX=:?\'OV1_P!G&_\
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M8;>=HC*BH+W5U#*0R[Y;F"!F4@_Z,0#D CS/_@CQ\,/CU^R#^QYXI^''QK^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!G>+O\ D6KS_KC_
M %%>:5Z7XN_Y%J\_ZX_U%>:5<=B9'7?#[_D.ZC^/_H1KKJY'X??\AW4?Q_\
M0C775+".P4444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBET5BJ<6KM]6%%%%8F@4444 ?AO1117\5G]X!1110 4444 ?<G_!&+_FI/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#.\7?\BU>?]<?ZBO-*]+\7?\ (M7G_7'^HKS2KCL3
M(Z[X??\ (=U'\?\ T(UUU<C\/O\ D.ZC^/\ Z$:ZZI81V"BBBD4%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY4',P_X6A8_] J;_ +[%'_"T+'_H%3?]]BBBCE0<S#_A:%C_ - J;_OL4?\
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M]BBBCE0<S#_A:%C_ - J;_OL4?\ "T+'_H%3?]]BBBCE0<S#_A:%C_T"IO\
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M_H%3?]]BBBCE0<S#_A:%C_T"IO\ OL4?\+0L?^@5-_WV***.5!S,/^%H6/\
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-,7&!7*T44TK W<__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>dcth-20250401_g8.jpg
<TEXT>
begin 644 dcth-20250401_g8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  9 %H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4ZR/%7BK
M3/!>COJFK7'V:S66*#<%+%I)9%CC0 <DL[J />KFKZM::#I5YJ6H3I:V-G"\
M\\\APL<:@LS'V !KYAU;P3XE\3:]X'U/Q;X@V:5J'B7_ (2Q= 6(QM9100&5
M!.Y<^8L7EP+M"J \I)R0I !]4T5B^$?%^E^./"^D>(=(G:;2M6MTNK262-HV
MDC==RG:P!&0<X(HL?&OA_4_$VH>';36["YU_3T62\TN*Y1KFW1@"K/&#N4$,
MN"1W% &M<7$5K!)--(L,,:EWDD8*JJ!DDD] !4>GZA;:K8V][97$5W9W$:RP
MW$#AXY$(R&5AP01SD5P_QWQ-\,[ZP<[8=5NK/2IL'!\JYNHH)!^*2-5SX-I$
MOPVT9K9%CLI1+-:(H 5;=Y7>$ #H!&R8'I0!VE%<O\3O%+>#? NKZG"OF7RP
M^390YP9KJ0B.",>[2,B_C7SQXPC^)VE^'? 7P^\3>(]'T339+F"VU37[.^FE
MOM2L;<*TTC%U7[,9"(HCAI&+S@!AU(!]7US/Q*\63>"?!.I:M:VZ7=_&(X+.
MWD;:DES+(L4*L>RF21 2.Q-<%\:-=GN+'P3X3EU>TTO6-=\06PN!!.5(M;5C
M>7&TGD QV^PD\?O/>G?M6>)(?#7P)U?71-"[:?<V&I6\32!1=/!>0SK$I[E_
M+P,>M '=_#?Q)=^+?!FGZEJ$4,.HDRV]TMMGRO.BE>*0IGG86C)&><$5TU<U
M\-=#'AOP#H&G?:$NWALXS+<QG*S2,-SR#V9F9OQKI: //_B#H.J^.?$6D^'3
M:20^%50ZAJ=\60QW3(V(;/9G<06Q(^1M*QA>=YQY5X/^!/C3XAWEW<_%?Q%K
M7DVME)HL-C:7-M"+V.3!N)C+;1JXBD*Q;4RK 1X?(.*^E:2@#Q2\_9O.GZ=X
M9?0O$MY+KGAZY22PO?$0-Y##$L#P"-+>-HHTVJX8%0"2@W$C-<MX7_9+U_X?
M_$[6O'OA[X@Q3>(M6@:UN;K7-%6Z>2-V61BQCFBW,'4!>BJ@5-ORYKZ5HH \
M ^)_[-&I^,? FKJGCOQ+=^+IT^T"?[?Y%I<S)M>&+[. 8X8PZ+AHP)!DG>3G
M/IGPQ\8:/XAT.#3],T^\T:73(([>;2KRRE@:S*C;Y664*X7:1N0L" ""00:[
M.B@#SV^\.Z[XP^)EM/K%C;VGA#P^WVC3XS,)9=0O2HVSLH&(TA!<*IR2YW<;
M%SF_$GX!V7Q*\>Z)XGO=:O8#I(M?)T]55K<F*\CN68@\DOY2H><8 ."0*]3H
MH \ET3]EOX?Z7/XAGOM*/B*?6[M[JXFU@K,Z;G+^6A"@A<L>N688#$@ #I-'
M^"_@S0KB"6UT4%;=62VM[FYFN+>U5E*D0PR.T<0VDK\BKP2.AQ7;T4 <5\/?
K!^J> 6GT1+U-0\*0KG2Q.3]JLES_ ,>Q.,21J/N,2&  4[L;J[6BB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>dcth-20250401_g9.gif
<TEXT>
begin 644 dcth-20250401_g9.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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M58W0L5D/-*L 0@><)H=(GRUMQTT_;23@E+_W-L>$;ENPMDT.0Z*'Q4B<I:%
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M9E4F4$,WR:FDY6(1 JNO#63#$+T1I55X:WS1J< K$^OEGM7%+PFR5'HZ=1I
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MQ&^< WT9EV"K%9-@)C1=IBI>J0*'26O1E@FJYY/(@7+#&%.Q!HB<N7\QB9)
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M!XI-T6.1ZT,S/'?I3//?^A!#@M8, ?8 P0[ @VC[#!Y$F'"?/D4!C"C41R5
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M0[,E9! H^PR3WU :J<126SPQAQ2$.<I%TT/M<!C17X&Y!]-E"G+WHDX/$>=
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M+W+:<DNO6$.M*T"[,Q5*XZJMNJ$"O@0%(^='?R#T'%OE"09 #N.%Q"^IP#H
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ME"NAI#G58N:$";%Y9A[N:1HWQR<2?>P(>J(Q:D;WP=,#E>MVN&HG<ES2UKT
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MS13Q3QDB#!B]M)05(>$\:GSCUI"X,D2^Z.X^,F$#!]?#! :F@LW48+N@6<F
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M-F(*<74NY5@A$O401UEN_>A.VM:+'41\@1$)!@(:#I )4<5>[P(M+]8Y^P=
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M_Y-!UR$.+:2&+*>T@]AP<QBS%H$59#D@X_*;'.R@)Q%Z[$CKKIH6YRH>!H7
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MA3U7B'U9/BT/,FE*=G$O!*G390ISS) L4M=U5]2FJ!5LK0?0ZG/\*7"7XWW
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M@LLX(2==J*@JCUXFZ(\6P7(7!QKD187JHF.-RR/TV04L-U7 :3>P(R](& "
MD)D*'1EOLLV%+"@3\91]13M)R-@!0 >4T$;)C^/V83PWO/4$ "=E"LH*MK=S
M4_OU%V4W:*[&#@M@-K9QXG+4WO/KZZQ%B.M['UY<II(W/J&I(BQ]"K&#^:$R
MXIV= Q_:MO6CB*O\<N\K@ET_L@U21,>%CC83W-+\QNTAWG8+93"=91)F!7$(
M&CVTT*;EL(U:F]N':_]D J#J$02 ,M%'&-*SD.0I4"CE&YY,?N:]TMG*39KY
MV>G2MSIZJ" .!#26KQ81 #6X23HDW(<RU*>\,N&E5'=YG>"BYSX/4B\_O$#
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M;](CMDKR.221EJ0C)97R=E3 ),NDY[H$D@CS$7\"QBJ&149"("TE$ECP7\
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M# YNB])&^6=,"$H]=H^[.+ ,F5D_AV(PEV^IZ.Z\]VXL *5ZM>51B%,JKPH
M() )%;PIQS: *O855X]KJ8 E&  $D,;LARE2*B9MK6AXXD'1<VRIFC@$;?*1
M_T3_W3Q: (] OD]E;<J2?V7_QB+G<8SO?,) G@#2YQ[5/.]GP"O(6K"GO=F!
MC"M7"=!IOF09\;FG>$^B7?(R0:7"9 X.O?D= &3G&^Y!95S( \ /9I</YN&D
M-)E!W@/:%XIO>1!#0FI18<XWP,*@"4)MH2!)3")"JN4C4W! 4P!W1L.&K$\
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M*L$2L<$Z%J(7<1)E%"(4K --T^(S%2$166$OY(B?@-DX(Q&IEG<CWH,B-YD
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M>A/YZ^V>?M,K:>H9O_%6( D?;R_B)!BRNO13)K9"(6>?*T_8".D!!7XIOU)
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M(0IP0.D >-'5TA:!C['YVHLFGUJOVW!6.?<!CT_RM,@A2 #@B@M9WE9TT4]
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MP5RT(4>9.:4/D0<"PC"V'W#AI;:"J_:,C6@TNVV95 8Z"1^S*FYQ-Q*=),2
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M21D=T\B-T>TDX)4(V6U?IK-?;X7-$VJ)#1$-9 K+T14]\# ]7D4:RS5@&EY
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MQE@IE])NA^:%W!O*(&=;Z\^C_A-L(V6J^4[\+6QWJHNW+T+F./66I9IV$N3
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M8Q7RK!7,KBTB0V4ZS"5*ERVOCQ60JM<9 .A;S6D-Q^)4I"OX9)$> -0&]02
M#:1(,FB9D-YSSHQ=X8W_S3UR:[ODNN+9RYG:)V8-Q$DDN_(%D\Y\XK%C&7U;
MN[&[6<V!,]M1006T);-;!!W1VYRPC[/138$;Q)]F7<7=9ZKPNO_\ND*(G,^
MR$G@"MZJ+JFX*YCC&&,H%R:0KI5GH;:OV][21"[U9T&8\NT.;1D'@)GZQ;PQ
M<D)C75J96"E*XLKH&VZ#^>%V6D0@B#1_'RG9J)-RB"9BSK63W;(O/$CHLHD\
M!V+<-*XGWL,?)%B:M]E1X;37;:CHW;<[1J]G'N-F:>5QY^JTZU:@N[T1-Z1
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M8PP&5GV@F[,(3[A0X+U4&S=<0FFQJF;C22339H1=R[PM>5$32U9OC$JW,-3
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M:TUJPM'.HJ'NZ2P0X"IDT,T8\*-F@@71P@6;L 5G0O_@1C)0R4"*K9*6T.E
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M0+N"9@O@L;TPXIS50]%*=4NOD9*="[O=E0(Q#2,VJ[,^*]+B"F?/MZ8R>WE
M)RZ1M _7RP&K!;;! B%K^4'ZL*A%)Y\:1-%JYZ4>,G'N+W ,ZT&H>FOC64%/
MZRI,-)BYPL"/^;>(LGR2(< HR[JWY&3?B.B>>:A7AL,'-L*;ZSWRVV#Z6Q_
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MLN3)E"M;OHPYL^;-G#M[_@PZM.C1I$N;OMIN12B![<   /  %,5A:?;I6Q1
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M J"P"$70K#9%L2GJ'!FJ'_3*HKZAL<GPKP&@I2\:J0<[E.VJJZ(H)#>)APF
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MX];6N_?T1N(3OQ\>M!IQ=D/_/^=KS#YD%N9-2"B\SD>^Z#>9NX@3U""KJ\Z
MTWT9CS*]G-W^0&3$;*T;+(+2U*(J81U*>\?!6<T_JCUCY9*XOSHE,-[83+-;
M*#0KG-5G(DBS<6^O#+\_B/:6>@(>^Z.89L'[D 9CI/EHD!"F<B!9ZV[_"M\N
M>H+(U;\IF,681M1!53RMHTU9#*@&.6G5FP]"U6=G**R6)'@+?QM#58#0@0Q
M@#C[#NI;!("@P8,.#[93L7#BQ",'V0%X$&V?/()P]LVC @#"P7Q4!(0Z& R
M@V7[V*E ^3+FQGV[,B+T$^"C/D4!@.S3=U/C/D4 @!X<NC&DS(=) 2 XI8^7
MQZ!4_P*D#*IE9U"%1(5)).I4Z4.,,C$FJ#D/@ "7)K$BW/K1)MM3,T=RK#I/
M(H2--_LZS2O [L6J(%4$N*,5@,6B!#7MH^?U8"V6+N=M 6"A,."2)[..A2J5
M*E=])UT>W"N IQ;&@4WC[,D6M;Y("YO2'3RUJCY"7/>M[-N1Z]Z1T?318LM3
MX6;!?BW/Q.WPIF[2<S&*#:Q]._?NWK^##R]^//GRYL^C3Z]^/?OO"3/63$U3
M?M.;%--J)WO0J.:X% '@9]5MT:AFESZ5420 *$_=%Y]#LDUT U0;"0.@6G5U
M]1];H#U("  -O:80B)&!\5^ U-E5&6X5LN5@:!KF4%-'"Z<!T1M%$B*P$6PM
MZI,914BM59]Q07G84$04P75@?T^1)&"+3A6W4 !A]!=2 )L@5*1G&C;Y$&Q&
M.*6/'P!4L$^% 188V558$OE;E 1)J)&-$4Y(UP/:J89:4"IF9=]$^"GY7U/Z
ME-C@017>^:!(3S[TYI15GD08@W^Z>"A%#2 &6CL+9><HE9O9V-!01-Y8IT*"
M9J5:2CW^AQ24$DE98G,S+MF>K;?BFO^KKKORVJNOY!F5J$,=!=B1 /$-(U(
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MBL'&AOCUS(JN.[#;]->T:GV)FU20 &A8MD)&V$NB9KJ0M+P'1&&KE&R,0$@
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)9$JJY#X$!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Delcath Systems, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000872912<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pay Versus Performance</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for PEO </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually Paid</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">to PEO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2) (5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for Non-PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NEOs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) (2)(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually Paid to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-PEO NEOs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) (2) (6)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of Initial Fixed</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$100</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Investment Based On</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shareholder Return </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Income (Loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(8)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(h)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,876,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,386,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,520,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,678,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,099)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,508,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text">For each of the three years presented in the above table, Gerard Michel was our Principal Executive Officer (&#8220;PEO&#8221;). Our Non-PEO Named Executive Officers (&#8220;Non-PEO NEOs&#8221;) were (i) Vojislav Vukovic and Martha Rook in 2024, (ii) John Purpura, M.S. and Kevin Muir in 2023, and (iii) John Purpura, M.S. and Johnny John in 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 2,157,414<span></span>
</td>
<td class="nump">$ 2,520,314<span></span>
</td>
<td class="nump">$ 1,472,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 4,876,184<span></span>
</td>
<td class="nump">2,154,023<span></span>
</td>
<td class="num">(188,099)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;) to our PEO has been computed in accordance with Item 402(v) of Regulation S-K under the Exchange Act and does not reflect the actual amount of compensation earned by or paid to our PEO during 2024. The dollar amounts reported in column (c) for 2024 represent total compensation as reflected in the above Summary Compensation Table for 2024, adjusted as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.696%"><tr><td style="width:1.0%"></td><td style="width:79.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.637%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PEO</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary Compensation Table Totals for PEO</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,157,414</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Additions (Subtractions) for Equity Awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock and Option Award Values Reported in the Summary Compensation Table for the Covered Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,230,036)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fair Value at Year-End of Outstanding and Unvested Equity Awards Granted in the Covered Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,155,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">886,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Covered Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">570,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Covered Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">336,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid to PEO</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,876,184</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 1,009,355<span></span>
</td>
<td class="nump">1,109,506<span></span>
</td>
<td class="nump">770,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 2,000,353<span></span>
</td>
<td class="nump">952,501<span></span>
</td>
<td class="nump">266,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The following adjustments were made to average total compensation for the Non-PEO NEOs as a group for 2024 to determine the Compensation Actually Paid, using the same methodology described above in Note 5: </span><div style="margin-top:6pt;padding-right:-4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.696%"><tr><td style="width:1.0%"></td><td style="width:79.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.637%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-PEO NEOs<br/>(Average)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary Compensation Table Totals for Non-PEO NEOs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,009,355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Additions (Subtractions) for Equity Awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock and Option Award Values Reported in the Summary Compensation Table for the Covered Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(427,819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Fair Value at Year-End of Outstanding and Unvested Equity Awards Granted in the Covered Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">829,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Covered Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Covered Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid to Non-PEO NEOs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,000,353</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company&#8217;s cumulative TSR over the three most recently completed fiscal years. </span></div><div style="margin-top:12pt;text-align:center"><img alt="3050" src="dcth-20250401_g7.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">l</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Actually Paid and Net Income (Loss) </span></div>We commercially launched the HEPZATO KIT in January 2024 and prior to that we incurred expenses related to completing the FOCUS clinical trial and preparing for commercialization of the HEPZATO KIT. We have incurred net losses during the periods presented. Consequently, we have not looked to our net loss as a performance measure for our executive compensation program. Moreover, we do not believe there is any meaningful relationship between our net loss and Compensation Actually Paid to our named executive officers during the periods presented.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 152.79<span></span>
</td>
<td class="nump">52.79<span></span>
</td>
<td class="nump">45.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (26,386,000)<span></span>
</td>
<td class="num">$ (47,678,000)<span></span>
</td>
<td class="num">$ (36,508,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Gerard Michel<span></span>
</td>
<td class="text">Gerard Michel<span></span>
</td>
<td class="text">Gerard Michel<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Additional402vDisclosureTextBlock', window );">Additional 402(v) Disclosure</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">We are a smaller reporting company pursuant to Rule 405 of the Securities Act and as such, we are only required to include information for the past three fiscal years in the table. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The dollar amounts reported in column (b) are the amounts of total compensation reported for our PEO for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table above and in the Summary Compensation Table as disclosed in the proxy statements for the applicable years.</span><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The dollar amounts reported in column (d) represent the average of the amounts reported for the Non-PEO NEOs as a group for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table above and in the Summary Compensation Table as disclosed in the proxy statements for the applicable years.</span></div>Cumulative Total Shareholder Return (&#8220;TSR&#8221;) represents the return on a fixed investment of $100 in our Common Stock for the period beginning on the last trading day of 2021 through the last trading day of the applicable fiscal year.The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the year ended December&#160;31, 2024.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (1,230,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">2,155,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">886,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">570,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">336,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(427,819)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">829,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">243,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">216,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">128,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Additional402vDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Additional402vDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text">From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has granted new-hire option awards on or soon after certain new hire&#8217;s employment start date and annual employee option grants in the first quarter of each fiscal year. Annual grants are typically approved at the regularly scheduled meeting of the Compensation Committee occurring in such quarter. The Company&#8217;s typical practice is to grant annual employee stock options shortly after the date in which the options are approved. Also, non-employee directors receive grants of annual stock option awards at the time of each annual meeting of the Company&#8217;s stockholders pursuant to our non-employee director compensation program, as further described under the heading, &#8220;Non-Employee Director Compensation&#8221; above. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The Board and the Compensation Committee generally do not take material nonpublic information (&#8220;MNPI&#8221;) into account when determining the timing of awards and do not seek to time the award of stock options in relation to the Company&#8217;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text">From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has granted new-hire option awards on or soon after certain new hire&#8217;s employment start date and annual employee option grants in the first quarter of each fiscal year. Annual grants are typically approved at the regularly scheduled meeting of the Compensation Committee occurring in such quarter. The Company&#8217;s typical practice is to grant annual employee stock options shortly after the date in which the options are approved. Also, non-employee directors receive grants of annual stock option awards at the time of each annual meeting of the Company&#8217;s stockholders pursuant to our non-employee director compensation program, as further described under the heading, &#8220;Non-Employee Director Compensation&#8221; above. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The Board and the Compensation Committee generally do not take material nonpublic information (&#8220;MNPI&#8221;) into account when determining the timing of awards and do not seek to time the award of stock options in relation to the Company&#8217;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text">From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has granted new-hire option awards on or soon after certain new hire&#8217;s employment start date and annual employee option grants in the first quarter of each fiscal year. Annual grants are typically approved at the regularly scheduled meeting of the Compensation Committee occurring in such quarter. The Company&#8217;s typical practice is to grant annual employee stock options shortly after the date in which the options are approved. Also, non-employee directors receive grants of annual stock option awards at the time of each annual meeting of the Company&#8217;s stockholders pursuant to our non-employee director compensation program, as further described under the heading, &#8220;Non-Employee Director Compensation&#8221; above. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The Board and the Compensation Committee generally do not take material nonpublic information (&#8220;MNPI&#8221;) into account when determining the timing of awards and do not seek to time the award of stock options in relation to the Company&#8217;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>17</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="dcth-20250401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dcth-20250401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dcth-20250401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dcth-20250401.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="dcth-20250401.htm">dcth-20250401.htm</File>
    <File>dcth-20250401.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dcth-20250401_g1.jpg</File>
    <File>dcth-20250401_g10.gif</File>
    <File>dcth-20250401_g11.gif</File>
    <File>dcth-20250401_g2.jpg</File>
    <File>dcth-20250401_g3.jpg</File>
    <File>dcth-20250401_g4.jpg</File>
    <File>dcth-20250401_g5.jpg</File>
    <File>dcth-20250401_g6.jpg</File>
    <File>dcth-20250401_g7.jpg</File>
    <File>dcth-20250401_g8.jpg</File>
    <File>dcth-20250401_g9.gif</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="50">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>24
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dcth-20250401.htm": {
   "nsprefix": "dcth",
   "nsuri": "http://www.delcath.com/20250401",
   "dts": {
    "inline": {
     "local": [
      "dcth-20250401.htm"
     ]
    },
    "schema": {
     "local": [
      "dcth-20250401.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 9,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 17,
   "entityCount": 1,
   "segmentCount": 9,
   "elementCount": 266,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 50,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dcth-20250401.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dcth-20250401.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dcth-20250401.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dcth-20250401.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:AwardTmgMethodTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dcth-20250401.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:AwardTmgMethodTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dcth-20250401.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dcth-20250401.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dcth-20250401.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>25
<FILENAME>0001628280-25-015761-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-015761-xbrl.zip
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M_>#X '$A 8Q+7#VQ0I,ZH,G;Z>?'1_7C1OE/C7J3GK^E\2+]HX+X[CAY0]_
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MCLK7_-'SI2MZ$T*,&WGGQ1@0GQ@0S[FFWX'CH; 4_[G5/*X+M!QQ#7K91(0
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M36@['F6KL1!Q7_URG!OBOD3:8-'VO1-Q Z+>Q_/3MC%E 3WO:MM637SXR@E
M7\[.;[E)ZNUMAQQ:5U]NQ(>K]LT9_F&,7C7R=9GL_.LZZ++M+HUQ?GG6 6'S
M#!G'3>?7<TP%ZIP!7?KP^?Q4M$]/K[Y<DJG]X_G-A5X*"JCMRZ\F$^GC>?<4
M%OZUT[X1,!:^?M8Y[5Q\Z-R(71/XL:%MZT';@+15G=9&;MV0MD5)VY%%VM97
M>(-=[*_UZC.%H8;YH&UQ>76Y\^&<J'5-M,]^.^]>W7P5']K=<^872-@O0:O
M?MR=TR]DXKSZ"%P)B'K.0@&<Y P8P.>K+C<%OOUTWBUV!MY0_S6A_H IK8,-
M]=]0_Y>A/+N@*'6!>MQ0+OOOEYV;[J?S:Q)'.S>W;: 6'SJ7'2 JYVC(H-\I
MJ..B?=G^=4,YUHARX$FW#C>48T,Y7HAR'+YY?WIU<WT%NG!'_'KU6^?FLGUY
MVB'R<-/Y#$^13(#BNPGJ6!L: 6?:VOA$-C3BA6C$'N8#W+1!$2'#6%?\?G[[
MR1"':Z ,\'!#'-:#..!A[NYNB,.&.+P0<=C%EAZ7.\;CILWA.>O%ACJL"76
MT]S=F*4WU.&EJ,-!69X)NL^FK)T;"6)=: 2<Z>[&!+&A$2]%(X[?O,^HP49J
M6$.* ">X>[2A"!N*\#(48;_UYGWWR\5%^Z80I4T9Y1NJL!Y4 4]Q0Q4V5.'%
MJ,+^F_>@/71OVQS[IM(XVK^W;\ZZHGUKQ\?M="[/!/4/:+;>82GE#=%8$Z(!
MA[RW,4!LB,9+$0V,BVM_%;]U;KI?NNBL(&/$Y>E&C%@7B@ GN+>)E=I0A!>B
M" =[;]X70_IO.M@J9$,1UH,BX GN;>(;-A3AI2C"X9OW5D\?H>/HLQY H$$<
M%(IB;8C%FA +.-S]Q7((-\1B0RPJ\>FP\>;]IZLOW0X2"]40K-@Z;$,;UH,V
MX%EN:,.&-KP8;=A]\_X*Y(6;3<3TFA&"W0TAV!""%R0$!V_>_PYTH".^7GT1
MI^U+\?$<TZVN;CJ;(E-K2![@./<WY70WY.&ER,/QF_?M:ZP'<OZ_HGWR[#*8
M-4P*IXI4G;.?5NEH[ZP=.3G>%.?>4).7*SMQT%#D9'TK9^ 6SM9[^4#*/\P@
MY4U=DVZ]=[GFRR^K!_BS,LX/:\<XZ0@WG'/#.5^()!RU=)>MT_;-V<]*!]:-
M"N"IS20"KZA3XNX;_=&F4^)/UBFQJK%STVKL#)#XQYGT^TXR+.WCO/>\/L[-
M@SV[D?,:M'C</S@068MFT;Z702IK*]_B,==5^JMHMHX:>]]CT2_02?$?9?^9
MI[OBP0JAR52YQ-<%:AQ_29!]3C/!N9IS'A2DW];A#]AC^;G<#J600=\/8^F*
M<10^3H07"Q %O+Z7P*/>)&M1C0SAS(MD/PFC6&SA<\Q&:37>T<_T[^:[;7J-
M";CH3N)$CN*:. _Z=;&E7E>_UM07>I0'67P2IE'Q41KK!V&DG^%*3L,1@&]B
M%I&$HB?%?8B;<!(!(ZF3"X+4\<6%E G(NKC6;A+VOPU#'UAE?E?Y5PLC#Z5/
M S<;)XV&<.JCNN@XV&0^$'A (@P6[ S[HJ@K?LSDY3AUX< Q- \:[YK[7,!;
M>(%PQ+T7)0C/D0+]((Q&>#*!/T$TB^2=A_##G^#Q,$G&\<G;MP^R5[_WY /A
M9KT?CMZ>G=Y^>HO#UL4-?</"CABE<8(G P@J0?8EW&TV3_:/Q=@^G81/1V2K
M;/$JZ^+68/JW('R($3F"4, B$T0-.'>87L(4L'))UZ*(3/ L@A\ Y,D0;I1P
M9=R/O!ZLQ<-'<+.NZ8IU$P>N!5S]NC@?"$!;]:F>"C8[!L%M\M2$6W '\&O'
M_2<@>( CXFN1# ?;-?H AHG#(!:!,]*KD.J>]W&C#DWVZ,'I/WB^3Q<&H1.G
M_:%9#G_F1<+U8#^2H(U'V@=!TW6"OH1OX;+S.ST)Q_#/U+WC#2Y XW]P:^*C
M^N[N[J*MB9O']=WCW1=I3=QLU7<;^R\RU,%^O=%H_< VQW!J2V+*%]EMA+O^
M&]%W0$<G*;D?&?(5C1X'?V[CLW3-[TI:VV7;Y)L>VVP,*)?%%/EJ [B<^!N
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MIDY-%NN6 [W=SYS*.FB*AS >I'02KNQ[<4DF8=]>#$RCJP2Z !?93Q%AX?'
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MS[AW 12NG_I.9$A$!5FX#6&X)+2(K=X!XFG)LJQ%/(31-[6K 'VY."1LR9\
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MLW6XS"*6:*)SXF^Z4(RM&)">P?$^R$6H^R17M VKFGS!F8\"#[0JT6$-^CQ
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M'W'&.V=RJ;J*^4],2&W%EP7@:+!SXZTDO),$6K8&$3["K@>H)YKF/$;STZY
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M@9K.,55W\:'BH8H),?0S="M1;K67WO+X%"R]H8E=K>/&XB+3Q"A!VZ=$X5,
M\Q'S32UXT3#P(EE=,6.#7J$!Z32R[!:R0H-TA DE"1>QB$'"1?9=ZAA3KAX]
MD16ZRL;E+#:<(:NWKS$KLO%LC*(4(2;C#7'A^1$+88-7&9/Y35(6ZG4:@8E7
M%^]"6=AOL21,'D=(KJ2DZ@<JX/R1G'%8@H@M)ZK+)@(]I-A$TT1VUC3PO>_9
M>*[JT/"O7&*\-G,+T\8/BGHHEKY9?,-%1S[(CT.OAX(0EA;U^KJHMLV<&+>
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MR10;;0+UNU-EIF!/$?<+U3;=?/*$6O<[&$,-8M&K"F!Q0^\>);"Y^9A(8NZ
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M 1Y#1W[[U^?I<EAK$93>N0HNG$8U,DFR($>6_(B 01*KTFHT.\@2\YIH<20
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M$-VMR^RHBTDH9-G+'\G<$<+I"&.AVGDJ* Z\UC(L#OE.1 T)9B$YX,>@PU&
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M681U4!K#"Z2B8BY$W1LZ)7#/VW\R+7"&3<)\K#;+LM+'#<3%GO>,H0O4Q^'
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MI5-5O+WW@I4K>4BOT@2T/:Y_KNI6JKJ55Z=LMVXW?K0_?)417V7$;QOK;FE
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M@11=^S6XYSW<9 1U@/V3LM1D!^8$^ YDCQ-]QA2)\\"M$>OU(N<>BYU3D!Y
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M-,Q<0H?,8E*I9K:*4;]2Q;O*($"/^$C=^K.ZM7VXRCB0P4KK% W\9J3K?F;
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MN:=]<Y6F\^3#^_=HYTQ8^K3&T>P]S]J-XN0]6#\[7(R?O'^^=WCW">U4'J.
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MH,V#$)^O=87V\1?@Q7CB?/7'5R)X_G8:6M/AE2^FSI&>=G#"8W@*03E$**B
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MCP^>=)^LVJ[:D_=)^&)(K.CJU*H$\=TG0^5F3'[(;& 7\+,2EQ/_L7E 3EP
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M<)$D>\OI #LPR;!)2(0>ALQ=%4)SJ6@T"RX]^L-'Q-49-V[;? &R*N7J7#8
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MC I9LW0H0#37,VO(VO!,/M";(!22JA14XQU5Y3WETVB;R-E/!"S42F7Y(9A
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M)SAX3%</JXEFJI\:Z3J-/; +?6J1-I_S=<D\P.[F&(O&$F%_2&WX*<]C2\R
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MC^KQ&/'KW!_RGW*TTYX.EYM =TJ<D,,SH@V[,^G_FV-]'1L(WC7_!3!ABZ1
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M"Z#J3,6F;TW+]#<(8@S-"J)TTWI=Y=A  #L45 4:^TNX%;F\JC-OZR+$CAD
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M;9P_]UODDUD(7919W@6&7B9^:SNN+9BXGKB;^LL2GWU;A=I.610DJG;@]O(
M?-1LJ3XU<& ,F,N?U>G,HQ'.")Y]&&DDW3@ZO&7X*)FE#?=JQ/K:R:; T"@
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M!XF_C1PK1#)OK\UL[M_/.).A..:F#F=JKZL_8%811=OFM%6<NJ[32\<-Y7*
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MK1DIA9F%@6_P_(BHLKFEO$'86.+:4Z.SNG4B005ZCDPECMZP]A>3&0KU+=W
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M9]9UX2Y#])PZYW4&,]A$ED[B^@F%]\J.@YZ,\[KM@SF^-T^ S=O8[*NO9JS
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MMVFC,R"\^],-+$)HXZ[J9321M05CLX,V-.P("7SF?G/W.!TS\1@.6E8=Y]2
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MP]]R$$KB.2LH.MTFWAI,W!4@H9+5+50%S*&0KG$__(?1^-1WTIB#K(4_F\#
M\HO87U;U35K:;]QE]0WDNB$0J0I>U@E]^DFWAG^915.M5@F?)E:94^(&')L
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M.WPZOE"S A/D.+,6]HJSZI@?!EX$O$GT:\WK*$ 9@\[6"-/[MJL(O7=3\>O
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MIBB<F2Y)WLJ_VS2[N+E(0E!<L)5\Y#T _)!CWY%2VBH==5Q31 S.2O8./M%
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M4ZUMA2S4D?'>07/AZ+Y;_0%02P,$%     @ +T>!6DQ^K)O_3   (%(  !0
M  !D8W1H+3(P,C4P-# Q7V<Q+FIP9[2[=5Q;S;8P'%R*ET"+4S1HBQ:G4"P4
MAP370G&7XE:@A>+6XA2"!P^N+>[N4KRXNWVTSSGWR'ON^][[QS>_V<G*[,FL
MV;-FZ:Q]/W7_$T  EI:3!B ]%#8D-@#@?A>)6=G<SMG.R=S.GH:;XSG@I82<
M BHJX*$@X5 @:0-0R!ED*)#? X"O3:U-C)S-:=3<G9Q-;9S8:.1L33@HD+4!
MF(I24!HM)55Y"F1G !*  MGTSZ<R %/6R/8MNYV+,P6R 0!948L"^>F?.Q:
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M;P-0/BP0,C(*TC\M,28&%AHZ$@HJ\L-M30( TL/4'V:.382!AHGR0&9D%%0
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MHPO-3B2VI'K??Y/F,UQ,)H!2\FPI3&*?D,)4$^<)'KL0%LDD1>B6"$VFY%D
MZ\Q#-RJ?X29!<=BAP8_&0=FX^:MA@>T.5M!!5]213('- /-5FT@/0%MC*A%
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MMJ AD3CXYQ5;I(7,V]GK8=:_6:N>\3F3K/=K[I-5O0=P51\D2[FX/)&?US9
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M]N-H1M69%'NQC+LG?OY7J'KLW(J?S8.Q64;BB1?)S*NZK70+33[2IU$_5TU
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MM=OTBMYK*M%Q?9I7KS!'<WATUTB/%I>G-P<(.W,Q+C.)^4.5OK%K!K[U>#]
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M *IU_>.[N)5LLL]2[$#?*U@% % ?_]E02P,$%     @ +T>!6E! 8?FAYP
MQN<  !4   !D8W1H+3(P,C4P-# Q7V<Q,"YG:69$=F58U-T7[8\AAFX0E&X8
M0&! *9%N)(<2<*BAE2Y!!QA@Z(ZAI&,(:25$.@<$9"@!*2E!*15!W[G^[_UP
M][?][&>?O?9:ZSSGZ.AIRRLX%A%K@7X!_R^@ (    P X "  $    (%( @
M@@$@. !" &   (,", 0 PP P'  C $@ 0$(!) ) 8@ D#D 2 "P 8*$ %@%@
M,0 6!V ) !X \%  CP#P& "/ _"$?V<#!"A 0  $#$#  81_R;_94"B @ (8
M*(#[5X-" "@$"H4@H! ,%(*#0@A0& "%0:$P!!2&@<)P4!@!B@2@2"@4B8 B
M,5 D#HHD0+$ % N%8A%0+ :*Q4&Q!"@>@.*A4#P"BL= \3@HG@ E % "%$I
M0 D8* $')?S#\6]M* ) (  , L#]@X6   @(% %!(" 8! 2'@! 0,  !@R)@
M" 0,@X#A$# " @D@D% $$H% 8A!(' ))0& !!!:*P"(06 P"BT-@"0@\@,!#
M$7@$ H]!X'$(/ %! ! $*(* 0! P" (.0?A'P3_&H1@ @0$P& #WCQ$,!,!
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M0 @$&$" 00DP! &&(<!P!!B!@ 0(2"@!B2 @,00DCH D$+   0LE8!$$+(:
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ML*?3OC)1$XF_1-]_R _2WAH+KC!9FYC:UJFXH&1*PI7^^E2+&)><!](-0</
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M37(WEJML+:_+XBUW6SES]GZ1/H_;M5I_+EZ\6/*DGT@DFI4ZFPE NP[(A&4
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M5*\2]K;OFDF**R"W8)R\6&I25.+XP6TFD3NK;G<YQ8G9*&P%5'=4K@??/C#
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M>B!?Q^FDHE'3EW7WV7^] 4;#Y8>"(M3]QV$PI(O= N>OY_(G/X-3.\D'M#J
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M0F98:&N>:D=4  @@+"\4H4<&D%R$ZS8(@JF<ZNRH  B@QUQL18!\RC1P#F)
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M(;_T9T;XY2/&_)V'D2BP%J&I5T)W.:C5ZB1CP_TAL>FL"X<74J,P&#>%9@+
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M%DGW\SOA&:I0XK:D_X6_I\O#X39D",!\[K<B_)4F^55[#_E\T?>6T<)K6)8
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M.A#2ILHT13[SN!-?9W) <IT"YU:J"D*"'BNBWP$?5#CZ0"9"D'A>)A1<>HM
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MR$ EG5^OJH"UD!-J(R?6S2LRBX<6,""OPHQ]&%?D6 JH>H ]S$YOK98U !I
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MQ(G3=8!Q#S*HJ%J>J/G$0?7'< 4OB_G;(%-_AWJ9[_CDBF65P/J@T'J#0!]
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M%>G?/D!;R:*BW8K_F7,,RV4]1HG:JJ]F!^*Y76$")>#A1)Y%QW>I[%&@9D^
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MTJ<^SY+[8"$@#CT0;5O8Z+ 2ABT] -\PK2D)G[)V<BJS*XJ<K#VYX83^ !@
MQ(-H^^AI 0#@P;)]^:K V?<0XKY@ P8^U*>((L%%!W_P"@!''Y4X#]EEU$?(
MPL."!Q\HBPAQ98 TT=CA4&A14<J7BB#LTQ<)0  T*QSNFV<0020!H1@6?2A,
M1= T"G\>_/CPZ$$$H5[NVW40;(Z*1JD$?;-(P,"O#_9!!> @$Y4*6%=P[7H7
M;UZ] ";I]?LW[\4$T?!%#7!GW6&?/&D>OB@0<&3)?_/]:6+QCY&'ZP:<NBM/
M@.>'_Z ]ZZ/%8:+G> -*97ZH*R6PE!<MY//# >)%S7?G52E"B>&=8*'WK?:\
MS@(DG5TK']F<5I%FTOODL?[C/"+LO.R(][XS?1UQG[LZPY97Y8[//W&F=YV7
M$^+[Y1%-6QBX3J!VAKLY)ZOBW#0.M(L(M(&FHZ4(]/!JSJ?3*K.#.N+J,VZ?
M=1(X!;;[.I/M-0MTPTN?*D8*L+V'&&)/0EIJ4U >%D33"[]HIJNN->PFNQ''
M''7<<;), +B)Q\G8@2S((HT\$LDDE5SR2&%T8-(O -" 4J^3(-,%  'NR >E
M:-99(;W$1M)%@#[DH0(W8+2D,K+@+-+E@5..PNVN?*@ @KTV+H&()A@6[+#0
M0(K@E%$%W':)\TS<!AWN%%HZP"N>I2X*H E ]RG),R[7Q O.4^31@H.+G.-,
M-4'CK&\?7>C\; 4C3!.HQ2T520 9%N[0)YC\..CMLN#TC,;.)L@1*!]%4"/6
MV+LNTC(?4%/5J=,Y\:%"H#Z_\U.B%DXAE;K.J%.!2.8(J=96-W^U5AXPBZ4H
MUF('&Q VTQZM<UP^RR5DSZ..P*>*)GY=AP5_+5OH3F"IL/&E7&7,:+5H.D7_
ME<V()<Y1&0!<FMBB0D;"F.../?YXXA A])BOCP4;R,XUW\LRO<4 "'47%0+8
MTRO%0,YMO=P4">J'L;HZ$R&N/LU2,T8C/$4?2-X"(Z65'X!O90$<6@> ^7+[
M*H B".& V_8&#4SIF>^KNCK/2-/G*X0\&_ S 3RAMC0L!3BCLW6B0@#"72S@
M=Z3*+ELY ".BT6<C " 8?&?#?=;9@;)HYK!!GJ/IS0:6?1*F++R[-9LXVZR.
MJ"E%UM3G.JP,$D SM+.D&VF[ V =WI2H_GRAS!1!8&/ !>]MI*P0T*RRC8L-
M2O %J4! &.+.3KL"NVY^GDUB+/9X'AD6AQ[[[+7__W@7($"6<OOPQ1??3H3'
M!_FB5?\ZK^4;PWN138C/GY_^B*6_N/[\]=^??R5+[A^  8P,U<(E0"C)CS+]
MPI$N G>])"&C+ &(DP$I6,%]? ( ];#@!CG8P9N!SX,A%.$(25A"$^[O?B=4
MX0I9^#\6OA"&,93A#$M8,?S1$(<Y'!\(==A#'_X0B$$L4@J%6$0C)LF%1\18
M/@"QI8$%L#D,PAX3^Q"1(0&K=$FRVZ:4V$4/^H@>7A3C&*,T)3*RJ47P@Z*"
MMB</*[1/(L1ZXI%H<T8["M"&=]2C&).XQ^>  0 ( ,7.(!.UW0#N"%S*$BC0
M<QX?4$%L$I$9&+P5GYU)+?\:\4" %FRVD,0](!3GH8#CH$$([%C*1)\4FD$<
M@)[@Z -S;PE%'9^5J@:H  %@<  A0Q$I0 J2D -!Y#[X]<B9/8,0EBM.5"#P
MC#_<0&9[@F590&E+<$4CEM7,!]9^@"&6.-"/X82>]( D3G/JD(?BE$?@EF6F
M<FGA< #KPU'L(\]Y6*$/?CL3K, 4#UL)YD7-VI,_[\".3B[F<,W:&[5D!*9U
MS"5IJS)-0K50&RTX)QB'\1O ;J6+!)A"13[1CD<15R8N<8 =*SA".].U)7AF
MD@6AF,<U6YH/*\!/85SBYW=6T 1]#(JD%>KI3_,#2H&F[YQ)Q5X>E=K4&/;1
MC_[=7%M*@I?&!AFA15PQS;[>&#R&."<XNNA)<2IY*0GEI$0OJ<]7:Y?(FS(1
MCKE1T72B^(<[9&@A5; #?&J9H8EV:#K:(=T1K"HO?H&UD6^,R#H26KK@*6PA
M-\4K9&UJARRN P&-HIU3.0LE']VPLZ$583K#B:E:!B<>40&+!>2AVH.P]JWH
MX5>O_L"$TY D+1"QD&A@TS"U2@(3!F&M E]9BR/$B#[ %:YO?:57OC)DK]!2
MU&R2]5/6AL:ZM;M#:L%2-7ZE1Y_XC$A.!P9=+(&%4O#J;@#>H,!+#< 4?!7_
M[7R5Q%3ZWM>"4-UC8&=SG;2FU::WLHQW\GK7PY'U19$JS5S+NI@?C $:.3F1
M>B[S4.70AQ8/F 1(K\N5$Y'NKCKQCF#A0V*=Z,VW>FMK6GN#V#C8U'D5$DB(
MTD.Z)K"M0SF&2&7XD]F0XA?(/))>&(-<Y/Z1UH^<&9RJM/NK\OU*7VYT(D_!
M:YEVS2J@^+(78AK,(+OMC;AV70@AN)C74:F@-ENKV9;0DU*?>O04P;A0HE*%
M&U19MVP_M;,KM1PL]M6N"5(>KQRK7%!L]0E#.FD1A(*AK6A5%*E&EG1D[#MI
M2XM/OWJDD(K]9I2=-=#3Q$-< )9P';:2+@[Z<%T8TAKL.^F(1[=1J8 B'N"?
M*F,GPXNS&P JL B!S".9K118A:.B34*6F+K0NNY4 1WJ!C+D,B">U&5&HP7K
M@-4RTPQD>@:D;<V9YB#2#*F==G-I<^_#1^4\][J_9T9V2R:[4-I/CMST;GO/
MD(CWUG?$,KWO?4 P*,V#$@'!J9?6%M#?"1=AI17>\" AV>$1EWB0\SUQBT>F
MWQ?7^,;]B$$-<ASD78%XR$E><B-6W.0;SWC*6=YR&*+<Y1(?><QI7O.%3\_F
M,N]+SGG>\PV"T><-GWG0B?]>].TQW.CL7GG2F=YTB9'3Z>\>>M2I7G4C(=WJ
M15YZUKG>=;]\UNN2GGK8R5YVK)<]M%M'^]HGHXQ,$./M<8<[,4 [\2&S_;YC
MQ_O>JP3([JYW9!J'.=^5JO:R9S2N/T-SCN8QAH+KA1V[B7R.3@)KHSC^)!?B
MV#P:<0HN:;Y(K?T<Y]68E\\[[*!W480#E$'WUBM#&<D@"L<QJ&["%][=M[?(
M+E*O>/,!YE6/-QYN[*0^R10+UL$O%L*I]!CATY'6S\=)M<I\%S"PA3DK"/S%
M!Z][<1J>[&IJGVD"T .9.4?TX_FFG9*R[?$>!+M8RX$: 2X .YR$)<DTW+^I
MB33_6@3 F(K':<  UH+A( 9@D!!@9S2G+:C)>4QC;E1  -Z ET1*U"PP<"0"
M_DRA7OXO (5I9QQ "Y;"(FA!\ZB&L K%3D0P 2X!_J B)0YNR5@":0AA,(#A
M,!(#O!@*(FBM3F9OX\[.^_Q([]".]\8/$C)0%S(K730C1D2/_>Y@6N8C^%(E
ML^8!#&AF-&[J9,B-8*2C"EQ%19*&G40':6@M%*:EK()O6?R%"F+P8&C))Y)P
M2ZB@3%JK:$+C/#!*#_^##6<%&I+05<P0H#ZE +7$-.9,!8Y@'HYGP6!E$;]%
M=@ZGM? D^G:!6="D0B@E-Z[O!YU"XP @$X:PJ< O[-2A_<QH84W2A;4*!2N"
MJVKLA%BH /1>8S"*[R&,)C<DX9(\3Q-Q$?$D(C14D=LRL2>6!7X&Y61.9CC"
M1#S0!KNB[SP\9%80YP&6D1#F0AGKA4R*L0[M QEWC J, !?/Q*(&XS4@$3=:
MZ\#F 1:I<3 0[Z?BT?)6[P>W[^( @!A($??X,56XZ*>\I;4(JU4DXB-@4!8-
M)ER<;R!?@XO.I (&*30:$7C&$=S POZZ\:>T)/T2\46<STH&9UR@@1:Z:U,
M2J<(A0/LI+L>X!G* BP$(OI.1A$<@Q@[T@0_,L.:D3I:Q4YT@B$+,OTR"@X0
MDAO7)#SL@!#*;3&P[R7R 0C_56X4_=&<3-'K@A$B&"@]]M <3V:?FN46>3 K
MPU(GW@<BFO$B.N,G"28E>#(K%>/_ML0/*J"D8HRDL%$@Q.\NR&26JC%=\*1>
M<B,PWV0P0K(;4T6CQF4Q+*]%KL] T,PVZ-(6"04.*\ K50 "F%$Q;,,';&4G
MG)(^HE+CQ"#WJ%*/*F8?21$:QZ\F-8-,S*157F5;8I&A$C(W=,%;X.Q3YD,'
MS^0*WY L8C VHT]T;@42$!$-?5,G+R0EW:6A!I%( K(&(?%1U,1,--$ZZ2PG
M=2K"$/$X;R7#/,4.X0?_YJ4)UU*DU)(*#L< ,S,\9R<E#U,?:@$A%L<3LP\?
M+4X,_P# -,,)[/A1!Z^F_"1P*UWQ* +@!\   NSD%K4 '2%B6AP#2R))KMY"
M*8ZC/@D.:$#IIQ1#*SV)UP@0?J;%_NK%2LS& ;,#N^H%#\<CF@8";5Z4F.Q0
M*?,#+C>S)BM 1%]"+ZGC#9OEP&8T!R4P$M ,6 SB!R"M&MTRM3YG]91!$Y)!
M$X8!%(@!&43SXM" /_MSC\3@!KA4KJK/TC*O!C<+8]RR$_\.\$).%,'TC@!
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M'N6G-9HJK]@L!V0U:J1#&,2-JDA4TD7@J*,*2OLE+OLAZ%C'3.0_#JO .'L
M2HD_8&4P5+N68INJ2L<X]*-T2(..4<8*^.#'0BI&B/+QNLT/R/$_GO*M[$H7
MYB*OHJNU<Y$X.ONR+H06B@8RJ)H/L@B1=2NS^"I>:D$S;@O#<&.S=0*[L6.D
M9H.;*P0"TN4'[.(\4'NQF(^U<]NU]Z6YPXJ]9\ [OO$CPAP #I(8L_&.):UB
MI0:$.TQA8'[J MQ$'O[.0]BADR'$H<DW81I,I)3-*-"@2 _CNVJ'"?CJP?7O
M("Y$.U)#K9X+/7S[,@I$QLG*80 //O0LC@8G9M1&69[K8/XX-XPK1F"<NN--
MMS2/.YZ!C58CPISCO*P"#A0$R2UB&'@1 !(@PF9#Q9 CP)X2)H.BP77BP2/\
MO<>LNRY$&)+)_EJ9P_U7C>)-.^9!Q&5&"A6D,DZ<S 6  ]-\<CYM>A/_'$"7
M Z@\VD):8S=@H].LJBND<_<:K,1'PU9BAR%^ ]I:3+OP*E),P0\0YB00JWU:
M"J]X1;#$S#@X3<S*!L=H23M^6CXX!2B7FZU2>]:F2YAB/-E>0AV\I;/#\#E.
M(81QC,>JNT(0X VX3+-RS*8NX:XW@]#SP] 3 -%SK-0'V-'' ]*U.E8HW3>
MHU\PO3)";" VO=/Q0AA\7=#Y\=-W>89!FL75$<0(!H6I(-#^*5=JY58T^"66
M<)48F4[,0U)J\COPW*?='4-.145LJC1VP0&V,HY;*OCT0T%*PA28C,8JA%T.
MK04X+,<4YE" I:6[&#+\6*MWC,RVTD]D\U#$_]/X])VC'XV*'X6@),)%!@6"
MU">+C_2C6KJ1&<CXUEW2KT56WETEY9BH_(^U[/T!\!U7FMT*^UV.GP4T^O(P
M_BPX.,I=#A[I3P(,$R_="8^C!3-45HTBDF9I:B.+A@?4=NV.V=[K01G48N>G
M@D)K5B3:!H;LD:;'XP25QA?4)&F53XNW\[JMCL;;;H6\J8H*9EN@*;$*C$_A
M?4+6W6O?(4.,C0TAY.O7#;\D 8!FOJP!W<_LF=EJ8A@!+L%/PKHLP>0E\"$C
M+&)K5$UF+'EPE(;T<WM\)PB4V_YNWMXPBD?N)[3NH8W"*F3V.V-\!2XK]O3K
M,;?*0PAMC&]!T)V"DCBFC%7H^9O?<P%.@DK/@YC(^Q>K/BN(_4CYA+A_@K1?
M_=>?_=O?_=\?_N-?_N>?_NO?_N\?__-?___W?WRF R#T$3*RKZ#!@PCG10(
M  $<A! C2IP84=\N#A0CQAMP*J/'C_OD">@(LJ3)@_H4/8@&,=^?(R</KK/
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MR"()B@!!W@X_LGY$I&@AH!CT;M!CPA$)<&(DJ&X&@5\'/Z[F^%*PL8K3T?T
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M:,P##)URUPK^F !D:,%3[%!!'$WB1T!6I $>:PX=L[8/86#-,96,EARK8(,
M]""1-L1+&#)IM41F#20V$( =%I8ZJE7$ 7LTPND*"*D'R.J5?+0C ("5P(K
M  !&P&363/:&@TWIE0X PRUCF;IV^4R,N\SC(]O5RW9A$E78$:,%.I:=8!Q
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M0;8$([_[3:Q-1,<1#L ,A"81!D3:12J0[%<D+P8;%VD2M;$8%[9@J[&I9A*
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MX;D@H^@U7U/#2_\<Q>.!/_-914UTQ8:8M%<L'%)Q"!D:'7; *. 9D:3@P9'
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MNE8M54I=+93K@"**A@,]K(0\3T85V4ASU)0X*C"0$@=8%O;[V)P\TD7*!$5
M $P8M0=@-F>+.$__?<&/:Q*2^#8+I;J#J+EZK%DNB550,#=;Q J,70PUL]F9
M!-@AX9(2<8-@.8ES'8F?#9%U;"Z)ZS7NI%3%F!(U8S-5<YV:9 YI"[^.^[$!
M"1%Y*#D;JC0#@XP64XQ)!5L,*@3@/(@_L $#?;=XZQ(6@T&5_#B)&1!X18_E
MTBG#2M,1@;>7*UQQA;Y-""Y+ZXN[^35*4!$WF]Q*H;<\RL^:,SHD,;U"#4_9
M&EL3#=F1==V.*EF#%!W \[>9E _R<]:>P;N#J(+H:Q!DZ#M%2  5:= 8J8/
MTS=9JKRO<%8;&5IX2RMT400]A!@6$(UBV3R\[(@6I3ZJT]&^'+Z9/!**_\R(
MSB"0LR :#@",#AG>3PU(+EL\J>N VPVKSLBZPRL_!P,\P6M"G@E4J5M0Y-B,
MR+@1[ANH]("0%MLR[9A?X.LRGP4 "F/.V$,]YX4]G\&72D'>UW 80VD"O\.7
M*2%."BZJL\A>!"TX[T LV7B[K;NNV,O@3S&0O,BT!P".NPB)Q3NZ,HS2@LLJ
MQ@,7GIS$UR7B%(K=GL0,]/"?)YF(&621/E-#G=G'&DK!%40S\6 EOQC$%YP9
MSP@92)0E5EL<2%R5(2S"SOM,MM IQ6L+70@ (F":L(J9%[3!+E93M?3*-LRS
MKD!-D]E+&=RC&T! ;PF%ES0)%^1.%.F48GD:KO^A5+#XPT"$JEP!F(Y(S6])
M+R<,!HV[(3SB#Q:>6MPDE=H35X,*-U(REYRJV80!Y?"0.@"@PCQ:0@I)I -&
MF$ZAP'RS-X>@SI;A&4ATKU$Y%8?IC)+IE#^VEE/4G"-6Q2)^Q5ATYA=ZX*%H
M425>!)5T/ZF;YK[1AUJ01)=8!ZNEGG78YN"AQG-&YW16YW5FYW9VYW>&YWB^
MB6@FBM"!29< ,4HI'=8%+R\*P\;AE/U[B7])5.:IA7NFYX16Z(5FZ(9VZ(>&
MZ(B6Z(FFZ(JV:+\YR-T$I:'UF0FRH%UPH*- !OYA!_[!$VV9'9>8!R[@9[@!
MB38M9YAXL:D08F]#RXW_\UR',!V W04EXF@]6<"30"!?,0P),KB6/HF:?LV4
MA@FEONBGANK^,<JDX-B42"*EX,]O=@JQ".F54!+(V>6D".LL"K[B"H^#%*FP
M^+*9]),L30EJ@R_N..H^X>JHMNN[;@KES*1+#F)O2HQM,KBYL*=5T4QP$B=+
M:,MD^*-V$3,LG*B( X-$A4XEC!1ZH2A%\"4'<*=1*BAOF2Z&,BV2,)FKXB2^
M9;A/>H9P2@#QC*=_LF6?841%R)WEN&0P8,TCU0<Q\R<X<\AD$".5A>E\R+#=
MALQ0K*AVH4L;-+JUY$WTP*2#LABU5*<M,XM+L8"+&@F3R3>0R(0[G1?5KI;&
M0GZ#T\#N<5GLNVO TVGN\ NH)+W*Y]2K<!( \3A$<;J$XE[NFUYO@V@CX,0'
MX=3KQC"9.^ALFC$4.JJ8PI0/"5UDI/_&ZP=7Z+D@BU/3#N,PI;Y@L80QJ7PA
MC['[4>4J.*"+JJ,"A;$@J[M8@;K#J!'?#: J$,/9E\B3BRAY+1W5+#O-2+&@
M#CGFSB(8J] *\61V5C4\\>IRG8+0CBV+K?E%-<-9T :-K,AX*B>7TL-)R[PZ
M.VU-4,/Q<0.5E+0*1B1/CMO.TJ"<4'G+2U*!-T)35M&RX1#UW"@R*A; A";-
M"[7^T4SF&=P2 /\,JE"DMDZDLOQ<T2&G$3'=&!SM#=MZ+:$!4<YB <PZ.KT#
M&WTA*/*P<X2&\$U/Z'F0A*V)!+_@F3%V%(!3Y?C@%6CY 6Q%RC7REP(3%3[X
M \X2EXJH57C_?+ (DSY)Y0 -2K*883XU2R0SN]4[L/222 L-ZM^8N]9L'8!T
MH0F-&3-9>I)?C[6&@(0CZ-_(J#098U7>O;%9HP6_0-9O'T6PX8A:U=)I+W>5
M ;9L;;!B6PY=F%^#>-L!>(:+_13WN!:00+,)&Y>6X=6Q  E0T'<:<=@S4]@W
M^*'86?5L!3[CX&2CY4%:,63N ,W'*-;6Q@HYR];B2[51'0]0[3!""1E_E]5A
M;0AU>+:%QV9.A_EH/JJ!*(A:F'?6W)>#J>')TW!Q>0@M@  J^XU:"S8/+]-B
MJP"EI9'-!0\>D53Z++1\8V+8(@E:\,X'K@HBD;B\_7F;]>&1P]J3_V"ZI35*
MV1IW;=V0- !:/#/:$AG1GT5#=RL@F5.$=U36&@*W60&Y!Q &@#3[BV@+^?"S
M]D(G0Z2,D' X-]>'P8I<PK<8IE^12KNTO.GZTT4XC6#()BP)X2B2D: R;K%Y
M>D>)P_6-OF>(>. 5QZ4[9YL.?H4WFJ5O*ZA:+&.K8;B$%5#FF-=]UUV'@NL-
M8<@.DQIC!H$R-1:7#3$8]A(\83"B5B6[%;"#^"SR%/?'1O'-5!HZ;5&I\XL\
MCP S\-V[NQ"5C(22)B"Q)JU T:LAYJ>@[*@/XXMB[H^KB%R+C$B.^45_(QBZ
M$ZSWV (("]!V"3BER(@N"]'D4>FP[D$T??^T.NRK6%&?(HCR6+RQ<FI=@E/Y
M%'%(N(]AA2I&]CU,5N6(OF )HE4$>4J>BB/!(.:C(N".1(7RK-RY.%&?+@@#
M!7RR8DK1$8OK!GR$\.Q/DZ%]: FM4G1?OC]1@ZTX4Q CAXH]5SX,5E">2GDK
M[LCM6%0=1(L5A]XD:I%=P8<1H:Y#< JM6BIL$P2#@,\K1@@;^[!\@.QLQJM,
MY,+4]>"9%<I( 5C0N]-M*(EI];)N[?HU[-BR9].N;?LV[MRZ=_/N[?LW\.#"
MAQ,O;KPU1@ "(@DPM0L  BT.-8;>E["Q,X_[&N,CRA#ZG9$"+N5=!R" CY>Z
M AP9>3Y.]Z)#OV[_5X&>RA&<%G!"<"\@#D8K=1?*=A A0P5X^V!4FFIZK5>$
M%00F]P 81AP(72CB.0<  !#I\UR'"_FEEB+*P;'/07J-YH 61DQ(TG</*%+!
M3C3-4R(.+-@Q48PSUHA1?B-*Y(!]\!'U(8<0+(2@C!5<B(!\"$)IT8I:<" 8
M4GFY%\!*%T%U$A7H6>$)"Z&D2.)X$*U'!%$W*F<$314%<UYZ1H"HI$7?0?DB
M1>O8!T1WE*T#P8(6Y4/4H92A2=Y@+H*8UUY2GE(C._;9 $%V!.Z4W'(%K9<?
MDZ',M]=+>@TZT'D/+',<JZVZ^BJLL<HZ*ZVUVGHKKKOI4PM]K<KUU3I1_[WZ
MBJ*WS:.%L*WN^A60KAZ;;*[1OAI4<,#,)"VVV6J[+;?=>OLMN+GFTT6<K9I7
M6D7$OCINN;-=&  0[1['KI==%O=NO.'J.YM['1+HFT0"-+$OP04;?##""2N\
M,,,-._PPQ!%+/#'%%5M\,<89:[PQQQU[_#'((8L\,LDEFWPRRBFKO+*TP@ Z
M8F^"&2=S;7-"NE>$9\:*#!"R!G@;S5+=C%L^AAAD;VSQU?;S:Q@%4$2)(08W
MJJE#R\;03WIU9X?.'QXQ(,],LSPVV66;G2M2Z )7H[020:L6"T^]K:Q)L39K
M&]NF66T;.P.8,E%Q=[NFU3S5=9NW187+;>@?S (F)/_XV9%+/CG'^@B#8-9Y
M:@& DOZYJ @,'$87(I(!_/"1 U0DD$R) >RG @ .A%;ZZ86!(35KZ[ 8HF!/
M G6Y<D#1<EYIOIL*.T0U^AE & \X4T48P5ND"X=&I-@=)D3I?-+F2KHIP.<V
M<+A[7A<Z$(KN5#S .O$XD;:EO1A1$":<;KH^I'T(<1X-_%328CV7-G**D[!@
M@#6Q#Q@>\"-:7 D"P(! 11X8)R2%:($;((1RP#"_ *3E>RZB10QB9P4[8)!#
M?GM41(87G?C=Z1DEY-!R--*]:-@O?*1IS?*:!QI/:&<CY'D&]*27C\W)[BON
M4XZ@'H"/,NF,>D^S B9@9X'_%!GO(L#[B43.DR_*<;&+7LQ6/KRR#V! :D%A
M+ (AA#(76BAI'0+H0SX(P8%=G"^.5WICV@AXBH3$1QTAL:,;X4@(BK &&#^Q
M(W?\\A @%H6,E[G)"NQ2F3B%$29R7&05FA 9N' @2Q.$2K,*Q\/%742.8;2>
MDG[%QFBX,3QRY,R''G )/')%CX]31!# (D8%T4(C+  %)$JSD:<D[Y!5X%HN
ME:8@181D(W981%0>:)$E D41$/@183[C$7T0(EDVX:81!C68(\3#;[U<B(ZL
MN9"Y9 0LA@M+$[!$$IO A9!C_*,<"]<'K0S*C"I)T3R\8LW!L2 \UMS('6@Q
ME@;"_\5%GH%&+=UBP (=JBB-0885^ "XBV!%*X_CD2(A%<9&6N8M<_DB2E.J
MTE?- Q,EPI,NOZ(TB5B/+0JI#$EJHL"\Z&,2EU#!3Q)R*#.MIBT>VEY-;FK4
M.7$H>//(1(D><"P!O&$3\6BJ]'@)@!]H@I77O-8B(\02F +I9TLDDYGL%<8X
M5.0Q1:%IBM:AU)W2I#N1X*E/@7H'H2*HJ824"$7BHX]>_%0 :9VD/O[PAKZ>
M9S4_"]!#N.E-L"I020&JT?\$J!=A8&)S.CFJ$>1!E2\-Y1-BA&M4AD*@?$!S
M-$V545J81JVQ9FJH.V%D8IK*I?^Y)AZ43=1#H-&X065'4/_]$6,^ $&?06%T
M@ \9JL["$H>AWI*<6,W</EH:U9Y0]5\K_2YXPYN;C11A$WD;:44"^M:#?$F:
MVW& (@C9F!\1X@>4:&Y"AJ)1=,W70PIMS4[D=$W+7&LO'(%#8R(BC$BL  9[
MJT@R.KO38Y3',2R@3-Y4 ]CL0C&C&XUI>OT2H/;R5X'7"N@9/%3?^WI$J#"C
M$FDS6E\UZ!=P-0J+$?Y0+/]%1;)A=$,!A4:3T_CW"()Y2"34-L8'3 (4V4RA
M0P8 C2]A3\3L74FB]%&(E6QX>A1!BK"8MA-]\O,!Z 6QE^8V2=IZ)(PICL:8
MRU0@T!0E418A8SX*6B",:C19(YW_S$>-O#?RFM>R"UX!TL2KZ$4O6AX%&4D9
MTQC'#:C3F7$]I!R#@8 ,7;)S?V!+ .[PP#SO\0&<;N!@5F,J3%_)S"K93@(>
MB1$%8I$6#GBU3"CY:J,&%"892898:=:L<[JE*8<MI04F38@*K/,.EW9E!^2R
M$L\D&,<L"?5'N\*L%!T*%&*)R4_BZJ$_<"V5NW1::"^,)"6?,C+'>*.TL<DE
M!PF%"G?<9UP* M",S@B=7$LM47A;DTVCI3"B0K1%9,)I"\0G/L&5M!RY(J(=
MJ5HO =7D0?VRGM(\)%"5"<J' N#=17X:TA7]<%B^UF(+H.64L(Z3HT62$;<(
M3\F,OCG._U'Z/;-,5!Z;@\CWX-"L8#1 "_"*R'..SK8Y!8 "+\') <I4NG@M
M4-#E @:+CBZ8[]2Q1)TZ!8CJ#9V)[J-2X!'G\L#@F.J(TR@488B8R$3*O?R<
M?UX7^I>(;O1\Q2@42S^/T_.C @O8+UG-\JA]ZO3?&WME2X9G;^8XPQIA&%WM
M[I&1D?&D"ZKHI4<LCRH8VD.( , @*O$)>K.Z\].FAN1.2(\=LJCDQ'CI4Y];
MKWL-#__B8%C*S$%NY78@@%&+=HZ(A@L^JI8C? ]#:ST_\(X**O E=FS.,(;R
M.L_#+J^<<[_[W&^[J^BET^U/*R'D9Q7X$X:7\\L&,1Y35VOJEL";=<C9^_:_
M/_YI)<%7!<LT,(55OYB:_OV?P6#$?^@&/J@.^U6,^(%%U B@;5 0=N4?!5:@
M!5X@!F:@!FX@!W:@!WX@"(:@"':?V+A&6=E,G+C,FMV&^QG+(9!=;7@<JZB@
MKNB,,MW&#0Y'";8?4DT>$.S@;] @ AX?U< *$.;&AV3%BS4- ]E&#HX@%$8A
MMT .<AR$V\A>:2".JY03#&)+'M6@FN&&/A$,4G32EPA'&?)&X?0*K5"A;H0%
M71R?<(S_H136H1T:1Q;!R\\03O= U 95'(S92?7LA13ISNWP1.L@31[^("BI
M$!A<"0(<XF$\B@L!P F=1^VDSOZ,$4S-AY_@3GJUCI(]AOCLR17=04#=#H=(
M7^JX3G8E(D;<@ I0P.;4VA_66 /DCVN$42G>P8#4$ VU3B<-#P<I" KY3V,U
M2-I]1A7<#G:IANV HOM4 "UL4/%(2:_P(GA0$$2D3U-)GS4ZX'D801B!00"\
M02WZ8C,&3W=H5"[.FZ$$$18!3Z@5QN98 .\1W#$:!0"EVP!I5BB.HUE9P>T\
MC3S:P3Z83RC,PPJH8FAA%>$E(EAL3@/4WQU>)$;R1LQ96E0<_PH)<4 8P4%&
MH)-W^4\'0(Y)T)P=*4+/G-E)O$4Z&<%.W(1*!%(<A5-(2%;?G((?B<0EO5%W
M'$8W&4I&?9L<P9@P!5EZO9IGX!89/4]4Z,(P^A(??(EZC:1)D-&4^5)3[$@J
MG11K-)1UK Z_K81Z->%&8 ),WH$\V=-&CA!4= ?&2485G*1G?)).O)$=T=NL
MH1,/%470B"6UY20AR.0;60?+G9.EM605O,$*1&5I6(M+3)M4,9$OT4=#(<5Q
M690"08FT%=Q1J1I&-%,Z11,$>4E2[@A%%(X=-(Y@2L9CQA(RO(3@B-;B!!37
M9.&%921O]F8,^D01I$:,F19;+9/IR?]AO90@,'"<?Q4!8Q5C6P%G:OR/28 9
M-D4%9QF=$933WQ057>V*/^:)%3C95E%"NPQ68=%'4+H3*D)5AXQA=>U#=WP"
M8P& $?R7>3"9<!YG]AA$C_7@H0S0H? 0*#RGBTQ") !59U&5)K@6AT!* E)5
M-1D96&&*=H ?9!U5\WW><4;"==%'@+I3'[!#9P& U8U18@:6%93"<_H VW7(
M)(2"QPU*._Z7V,PHT+E4A]2(TB0$];S6)W&90D764%()80&5?\IG4;8'V]&5
MDO)0'S"- /6$;E6 <IW$$OJFEFZI@@P#@]64.]4!5K@=EK(A+_F:X:6D92G"
M\YGI17@IHAW_1"VL!@.)4X"049-!1<S54O"Q#9*Q6Y"UE!9$V@_0V/'-0Y -
M!28<&'8<R2YP*):V)GW<33Y, B3H&\"1B9/]Y]QHUE"025-,ZHIA5)3"J?78
M$VOH@ZD>A,P\EYYE&%0LD#U]R#"^G15<0H&%9:(2Y .D 2@H%-O$YU#8P96V
ME5B!A20PQU_.V7A"DW$FCE]<% N4UVFD4G7X*" :18^9DA4 V43%4:$.*V\5
MCICZ8K0ZJ2@=">#P!9J!6(AR*;SZ9BNIQET2A),EFQQQFW:D*BAMC_G)TWUJ
MFU08UHA=23/A!Y8HE/DQ! ?$G&><6MO%$3SBC&FE!<U86S"$VC15_T'/>$;,
MS5IS(6:#',I3:!L#201$; VWL4!3;,5EMD88L=PNK(^'=84=^ %,N 5S" \D
M"J>JS2M[M4<F14;("ANKKBG2),7/Y)EIK42NQ6/'/D P@4FKT81)Z&O)+D1C
MSLXJ=4='.)=DQ,U(_LHT-2DR%!"DW9A874<"^"R,!5"040^[?1O-W:5;\(%8
ML.N@2)MUT.QA'$1%&87))H^>Q:OA8B0%I5*8N&@?'$N'0)2MLF5!P!B:=M[@
MR:KCJ<B=0%1GQ X,R*2&]DA_$,(E*AVD2)1>) H[((@#] K3I4>R!)3XF)I_
M,$<RR!E.2%]JE8GC-8OGZ%[V5&4N"@!"!MAF$)E:?/3NZZJ$]B5NN5"0#DR9
MTR*0F2D264U$PD)+[L;8B%8?V<'%[-X$DR@"/N+)]@*<09V'RM59(BK-3IS<
M\/;*&GX<]J6)B$3IX[A>("H"\>[%8[+&\H;6XD;(@_@%&2V)OPB6PD)DYKJ'
M RCEX4:P!&?+/!0IP!PE<*RGK5RAH9 +4>Z8SYB?K)#:K;BAK 3-!*>P"H\,
MOBS@;SZ8;B"JFQKA&=:$]F9IJ[B)O\Q*$;9A#])P !3G"@\Q$1>Q$1\Q$B>Q
M$B\Q$S>Q$S\Q%$>Q%$\Q%5>]L15?,0>"[S8^"NI0 7PUEC%BXD=$(BABL1F?
M,1J'C,M1FW_=&V#<1$%9BT_>6QRA:AK?,1[G,<1H5AB%SFOQJ!90%2C,EE$U
MBAX?,B(G,L$4SC]6 0Q47-NA9YRNQGQ9UG\I,B9GLB;?RF/(;&?ZK/+4&@?X
M$<2&YB:?,BJG,G&D8H=,8I*PDH>XWM3!69'!Q<"H,B[GLB[#A@SNLB__,C #
MQ_P&,S$7LS$?,S(GLS(O,S,WLS,_,S1'LS1/'S,U5[,U7S,V9[,V;S,W=[,W
M?S,XA[,XCS,YE[,X!P0 .U!+ P04    "  O1X%:N"T2\'OW  "D]P  %0
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M\4@4'HG!(W%X)!Z/!O!H.!Z-PJ,Q>#0.C\;CL0 >"\=C47@L!H_%X;%X_"J
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ME_[+RZD*9GO(\[Z5B,,P\$&SA&R_@XEFPM\U,AZF1)V?2S*M0@MMX^BV%Q>
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M:81Q*S:<>^_)J AW9O+4K2G&68;K0ZQZGYCQ2=\KPWI2WQ=*]O,_3HT)NY]
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M\6,8 >$%[MP(NR.E\U]C&1.A%84%4\\+F;9739^/3'C!B'#]=2V 6 9;&54
MO=/<>T)L6S"Q]LV3A?H8:(N3:8:],VVDM\9L:%+XUKG!BG>%3N92S#+G#DJH
M%WL51\';R:AVIRY$*$38LK[!R^A$T7#@Z/Q>7.3 #?I>A%@YQYK5"+ ]CVOM
M]-V]<&N\1$:4NNXMBL$?'ND,4^97*B$('R.?E>3(730(P\HQ8*D%3,$HX.']
MF]S12)\,5.IE_QB6-%BXY$4MM)'C_8_*R0K.3/!$);GK[@;F?8])W'W.]1[J
MOQO=\)!WN)S#S5B\L5TSQ9Z42EU@6!['I10U3^FMH.==J%]0K\L0JO+Y3!!
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M#R<JD-)G%P$T8H<* 'Q [,&2=!D+)MXLZ^XO?3P$P &$'D2O)0LV \*M70
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M# =$2:]7)<LZ1(F[O$ L(F;J;)0$<(1#!L-;=5,E*Q=B2E1BBIH;L6:$L!D
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M\9:WC!!CIO,V'>'EI"\(DC=OA!&:S10*BA"Z[C63BU*[B=2'C?!M79&4[%T
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M*QL.G+PP4+M3A,>CCB08&B T>ERXI]L%FP#-P7RPT?>XM\JIW*+ Z7NU2->
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MD?5%2^(H5J0B'KB%$N<]?,62'WVVH78ATYQD_\*OQG;!*8"AV^#T)XCCS.[
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MA0H!\('('.D4+O<ORS Y=)BQ5B8^.:0"-Y''AR!2DCFKS-&( =*F&UV2&2=
MS-D$D6=_W6*4J)!"I2J"%I)&")(0KU1&2%9CI+WFFS!; &?HE6.1 DA#Y1(I
M6EC1+D!TAMC.V &1@#4*;3WK#F8;B;.S]0 4Z*T/"4"L-2H=O/AD6%*;>J2,
M05)B4*>(OVIZQ%F$[*?M.*]%"RZ1#K_*6:P$Y_!EJ7C>"I8#,B1K;BL%+%]1
MRB)9\N4S:Q G 6""9.XR;8B4\R<**6JK-+3)T:S(SZYA!Y8JL(@'/..".SKE
M'_VS<& GO=,NOG=B0D<CNYPXQ?^6F@^6X9DH./O0S&B.>;4Y_.&PBSUQV?3T
MV,^.]K2K?>UL;SLQ-1I2M\M][L1T2?KHCO>\Z[V&#M][4BGI]\ O:+""+WS@
M94UM:QM^\8QOO../^1P$3/KQE._P1Z5=^<QKGD(R]_N/SVQVS<L=\0$PB.A/
MC_K4JW[UK&^]ZU\/^]C+?O:TK[WM;X_[W.M^][SOO>]_#_S@"W_XQ"^^\8^/
M_.0K'W$^X77BFA^AH#Y+O0MJCA&!6S@!+HA/=X>0]8?)]JH:\[:'X[[1,)_]
M;Q<.[! R?X3$KSCL/^A5M8P00S;[81I6B) JD+^"S,]^CP=]"3)NA0-_X(<@
MNE _ZJ<]( SQ+,@B=AH' +1&5-U7@6CG?LKF(-8726K'@4173'Q2*&NR"R/(
M@"*E$.Q@!,% 'TD7 !#X=K5P&&"B>/_+ES_+<DQC13(/@BD1LA7LT'=CYR2'
MHU-X!W^),X2&XR1%&'W:9SA "'@-DH3SEU]BEP\TT3P1L@L&,"]B9R264B'2
M)EQAPH.[DWK#L8,==H1E&!5..'@X^!R$!7E5X%G091=FF"!3&'9Z""$&)AEJ
MIPYQ=TQ)>"ENR#V.IH"O4&*TX !9PW&'XQDVZ"#  B)WH''[1F=.M ]21"R'
MMF]/48F7" ?;MTACP4E+T0!2LRDL,&,!$&2_QF:-D8I=6!]O00$-D6B']H)=
M16VZD(I=URV7> ?Q@"408$_G%@"Z98NDEHN75E:>:!!=82R8R#TW@"40>(FK
MU$"5AEPHX1#_$2%B9S9Y)7%HM%(A <  ?M*)(((_T@@BHQA4P)@_'P( R.*.
MU'@E =!MI3$OGH%XI^$L@@*+XVAK ?!Q[W&*\1!# A )'D$0AQ:+\/9QZG45
ME1@,#O AL9B->?@'=4!6]SA1!#%CB94?N01O]>A0P+4+VE-BA  #*Y)TL2AK
MN^@L&P8J(BEIY*9RU(=Q[RB+*I  T'!N*,DLNEABR*B,5> #S/@,?E")\+:+
M4,-MQD94SBB153"*$$87#.F3W@@1%YF1-[&1"H$/+-!!KO,8-@  '""*J'&'
M16 G$D*+,T$R)A&0G\=F 1F3;8:1@G-AKB@1 [D7*&:.WYA"RTB4_SM2C$-G
MC2BYEP@";_C(:=HVE$ @#WGF(B(QF8,YDC<Q;]X( $:0$C6)),@(@05YD I1
M&:ZQ&+%269LH%,@5DU^A;W#P9  $CG!&%L9"$I\)?&GA-(1P&CWE:'7Q%+>D
M!<@2#W2E$=;%%4:7AWJ3$/+2->DT+Y7369NX/M]$(:F!?ALR#U2P/ABU%=SD
M)!.&)O<$"=YY3NOC%?XDG.&YG7? B7YS)\G)%5@3#*%Y;4WQ'.-9&/@982>E
M"*XX@,F!%](T6I9""^WQ;$X"-\_VG*C$GP/54"NU67$H(=_T4?4C4]+$6/YY
M(U+4G>LDG$ZRG."$>?F@2B)A*M1I-&$A#_]\I4C%)5O  HZ@MA,:02$V"D4L
M.IQGE3\KTAL'L9\>&@T)=UXK]%Y-H*'K@#444S</  DSQ (%5!/<V5"ZL#FJ
MY"1'HZ0W2@BB$@PZ>C9Z-5KH.5KL1&>*P)[P:0'ST%P.I5W-F4]06AR@ Q%\
MDAI=NDI:D!65EH*44Z&85X@^R@% :D1"ZBTXJ#^WY <JP:+*:6.[,R)<D315
MVA):\ !IL!:7TJ $]:!FF*+=V54R.J<PI3\J"@VTX*.Z0UC@*9X.I4R4YAS1
M1JO9I:) 92=UT5/@1"(A4EG&F1@ )EH) "DA(EO^.#X'8T<M]:R-X:<L&A6"
M^G^*("J'Z"12F5'_)X4=,-4WQ-$5BP4YR@H56-:#OU>6IP"%@S1 UE,3C!$D
M&1$*BI4<%BAD5E,B,W4:(N&>7:,4YI$1?: :-7<H)2D=ZB  IG>O]6$7BU05
MI4-8ESH7\I$Z/3(=TK$.I:=X[1HD^UHSQJ%#\LH7([(9./6I :1;M!%ZDT$_
M_4*KVI83"W,4\4%T;A@CC#$Z95(=>X0SYTIT9)&DX&@9.#@[_@&R\2H7-]FO
MO6$Y5W>#;:9"R-&-;)%<C%$=US&U/@(9:$5P6R)%"&8:,"6P5L '<6D1!<)O
MIW!RP50P&%11=Z@3EWHG%N,F%XNP,F$%DX=E4KFTIH"V$%!((/@IYS0;_U+Z
MLE[5%V:Y1F39$ _Q11?DL:X!.$;'$P?J%,(0+)CXL@SZ242+$6KA&!<$,&5[
M"O"C$LV:$+#Q%AE+?9>:2]PQ4.>Q@X.9E?[J%L0QNUKQ,$"QLCLSM2OP ^/8
ML&L20$T2N(WD?'>+5K=T(S,!N/!RJ1M;;1)A)] K5_]SNF"#/H!2$,0W5A0D
M%HR#7+Y$,='4!SY'*M^6KB(A-+/#LT)Q1#-%*FV#0CW#2Y)D8G[R,8$",GJ3
M$HABJZ#%*!HT%U.BO^%"*QQ!AKX2#&5A-"&K)Z 3,;Z2$2SC,N&&H)ABGTXQ
M-ID6*+C[9.I"%CHW)D2%0M\2+K4%L/5RM)K"*?^UXBB@$L)L,SQ?"#7OZT9?
M"*9)XRO507_"L3V*.\)3TQ*/6RJ!.DY,6S<7X%Z9HL+B<@?DQ!::405V !4T
MR#9P$"P6@JPAG!NNH32$$\0)(2W>5C'"LA;YZQT&+"5<.U++$L54]2;C) "E
MT,4.D0 +,Q2.1AHEW&,,*BI$'#C: 9S,4B0-G#0&10OM4H,2P5:X$L))LB1K
M>9[UVP06E$6@PC9,$"EK$L)@N$)ZXFA^&$% 4;^>IG$T6;]MHBD$=<6[$1-B
MW"'Z5BF"7!]288*4Z,5\C'4*4L9&0Q/M.B(71BHD42S*>B,CPDU:(70TU\Q<
MXJ:/K'L\(1KNFB@8>;7_>M$;](J ;8I"AQ06/E0YMI%.**1]K&LKZO5 +UL5
MAC)(I9,^ONIT[@,\ZXPC''?-'VO.G]JUKZ)%O0%'<D1'L7J\;:Q>@!)*N?.R
ME>-P):(\S,,X.5($E! \<< U^D5A0^-P^A,&!D1+[[. "])(<2#.-='/;=M(
MA$48SS,@08@JL=%0$(TVRW9!6/86+70<#M=0C$@3<4&^=IL0XS,ZBP0;*YTH
M$U3"D5. S((^56?/P4-/,$$<.?(&+@1R.2<FA*N\"I$727LP(UT?W\Q!"")9
M@8PF\?  <<D.<X)"\A(2!P2J"RW0!YU"O48OY+L;L-&YRO86K$-+J/)*ZVR(
M_Y1V0@A25$U!K(($/9ZL0I*3,I<2L>/S,DU=TML'14@Q [HQ13XD/4;;+1L2
MB>B+$X*[/?%A,5 +?(IU%?98J_GC5UFC6I$<OAFFH7FHB?DC1MM%8<Z\* ?A
M,77E6^0GROG;+,Z!K2A5)O/54M0D7^O3248E0Z]YW 0EG8#EVEMC6GJ4*3&1
M89$\*E9!",65B:)R6+6@)7>2'U&#,R$,-WZ +.F%8 RU8 JQ&'I%"^-26DM;
M$[L=HFT* *+"I^M44TXDW$(*7ON 796U7:<POS2,5\ 2!'QBIN9)?A8,WP1%
M!0D=EYRE.60V$$_ULSB#74"(W^/RA4[1%O$ :2H58/_,]"=UG15 &.+B)IR-
MH:,'E4T5M1(QKAT:Y=Q+(=V=P;5Z.XPALE=Y6EIDUE4^;ET*/EZ_HU!+#%3^
M6X(HG&&$AR.,^F 9M@Z[G1CB<13$Q6OAV:]LU0?(E4OWM1?F_>+U0G] 2*MK
MU0*Y4S?MG:W*9MQ5Z(?O-<5O_D1B11S$N53C*A@&UC$LP 2V@S0WI5C35.4F
MB%0L\57=?./8Q2#Z8P2RY@#]JQ)E>DN!M0_DH3"(:A3 XJ15  164EQUL8FZ
M,Y_"MU=-D'((P+ 'TX7%A@">5:"TKHO5VU 'XU@5(G(NS!!2(DMAD70MELX'
M&QQW868!H&>"TV>'Y@!B[(G_P<$0,*;LNGAE)3D?)N80$+ ,9?4ANWXV.N=C
M+W=!Q4:-RYD5=EA#+>XGH%!#/Q=E"B4XQ]X3O\X5R?XQ4_?CR.AL$T,XAR0N
M88!]UBI]$+AGRU[FZP9RYR9R#B5+*X*ZWB+Q/%F@=^!+:.3O0\JK*]C/&;]2
MI484S!8 <-D![(?H$4%"$$]4_/MH%C Z&9]R$ZD0M2YFL3:4%*@0] "-H69E
ML/SL>U*@<$#PSP8U_<PG/R>6$D]8)(=.\;4E>U8FD;/*U2L<9,4]].'NF_[Q
MP "!\OZ,#L%T-3\K0'<1;(YL)V%!H5%F;X\IY@MI3J'.)?:'"T$%]=QK,K_S
MMZ83D6]?E5%9;J9 $2O&9HJF$HR6;&-![8T?^3,_@6+Y(11 APVRRC#0'SZG
MC]NCZT=9*LZ4 ,_@1_*P;DCF1-VX]9+H^J\/^\04#RT0A:\?B;$_=[>-^[XG
M%=2W^[\/_,&O=A+XO;C_>6DO_&EW>=2<_,WO_,\/_=$O_=-/_=5O_=>/_=FO
M_=O/_=WO_=\/_N$O_N/_3_Y^QX2<)8=Y]ZCY ]-2& G#4\1Y-G2^;TP."+EA
M!SCSD]_+:V(M"Q#[!.[+5^7.0(3K$D1#V-#A0X3R6!P4N.X!PXH)3CG4%RF.
M/EH<((XDF<_*1H' (& D25(?(2,M=5EPN>A@," M'[Z,*5"?L)SY_AS1B5"?
MHI5%E0HL2'&?/!4#4.K3%<"I2Z#[%+)L&4P%@ ?*J/BH0G1IPYD#\UUQI@,C
M,D4 P(8ZZU!>EU,@1=;E:Q2FW15F^PYV"$P RGUIZ\H[A!B87,@ CL232KCA
MT<A)+4=4<=@G+:L/<>K<^E#Q9M2I5;ND1=.H+@![5]>E&GM@, A\)2(>N$[S
M_^[5I;563KT.  *4\E9H? A\L"[9J-<-8$D993XM/1LZGRT<I.#!!9NX) 3>
M+HM3^<KS%3_P)5'N18U?G+V/'7&MQU&R6\Y[Y/NZUCD,) N",:*6/@:CRK6G
M+%AGKW58,"(:?79YP+^S<*MOJ?9>LVU##JD0@**CS"M*P\MH$>PTU$RB")^R
M@@. N:?Z<T@]$SDT"$0>-\PGK@ NHNJ!N%R31PL '*A".X'D20#%(14)@";,
M @ B&HNBR8<*D;82A@JP&%(.# 'LB N *[=[,K=]J'* B@!Z.A(  6("L"!,
MOL)/(.@&8@>!2,+<9YZX$*#(J[D&+?2J?8*Q ".)0/]1Y$T.YJRSQH-T>=*S
MI@8"YH")VE3$AQRT!+*":*"B\Y0O!04& 3#6).A4"A4YHLHT![(TIH*($/$@
MS!P @SZ!YME1JX4:_>J!4%1-()F3U@%44,P>"(;8EH!YU*<_QILS@"/PL>(.
MJA;J]#85 B S%,S0Y.K<)I&L4]4 8  @@"8JO'?"* /8RZL PA" +E'O;2*>
M:>DC]#A&"?KCC9/:U(7(*26FF,KUFOKQ7E2UPO;34(\BE<)=]F5H84.K-/.(
M7N$\M#.($_1)D0H,^:0+EO1!-("/)HV+V8*%93 >%LR0JB#M7J().(5.0?GE
MN1X#P *3\CKSRGZIO)JK72W_EO+?= 4F6%=9":K"UQ&?0I)G<<G55$N#](V3
MH5=C149>)OGD@):>"@(C2;K:39/I!R"1BT&?CDV,8I%^ I,^7"EL%=NGT/.)
M$":4"\,J1($&QEQ"+)B8(>'V 1G844O=.( <H &2W)+C%)526]6F,R9YK.BC
MZQY[[^NHE6"\E9 +=Y-GR:/P-<K6+-LD_I3=IH-^2>F-LX J#M:QZJ@NP1TN
MO267/Z+YERX*YK#C13H?>MV_9_%RP8 !][WC'PW&W+*.LD"Y*^_/69&^*8)J
M5+B(L6*R/@(1[0Y-J1"#CO*#'2DD$AS0WU/REQ8!V8%[^Z"% /J /?W!C64&
M$=#T_P1S/**4D'_14,E1S*>"Z!2$*)TZWP(%F!B:7"L:Y]-@>8[2OZD5Y3NZ
M0L_Q#BB 3QAD2QIIGD#4,:(EFH(6%U$.>*2GJQB5,"WR&) BBC>N\D$//37$
M!Q5H]+W$U(E^5+!?LA#BJ$Z%<3=R+&+[[B/%1Z$0>^Y1! 0/(D$*>I%]=ZC?
M#A<BO::LT%&F2T HRNA&D%SH(0)BURZ0T\$^J(>"NEB)/+@$D=(EIDOT@4XA
M_2=#_0DEA0EP'17S][SH2<6 6$SA@&")'@'=X9&\*5'S5J@M?4 BATA4HAE/
M89%6#A(D*4O+^B)R$EITH$DK,(+^7)BJP'B,(3/1QU#.<_\=16AD-S7<H JI
M-Z(-]@9RNSB,]F*2RQ_1I"FCTR&\'AC!!$RP@L*3G@L'N:6+-$5X6FGG15K3
M*,_X3J%\8<>2.L7%4.B0H+QAQT* \]")E+$"!)/' *!1B#!8 !]7, 4A(+02
MB981: VI:*HLUZFVI;0L\4B6HWARHV,=Q4XP 09]V@82!\ A)3YM'U/\ !DK
MN?0@/67(0U< @QD:)'=C*X@=_, R+11A/0-!QBNK:=**/&"# /(3%8ZPFRUM
M%"(5&ECS>BJ1@VP)/#K5F9#^0M"2QD0=$(!&2 CB!R-<U)LZ>4EDPB13._S!
M#KN@P$EJ=[G&>5$B"2)00BCG$W;_YG4?>TW5CG2*43NX(K+8RI).G6>$E!:5
M*7\@5\9V!%>,]J$TVHJ(6<EJMCH,!3M:/:MG <C4?8CK%#J,'BD?\(R[ZJ)C
M%;JL:%B)E&U>[P\]>=] 9I*SM/CU/182$QAI$=0F64Y;N:.L &%T$+AJ=&R7
M86<H0 O6:R*DI81C"'>UER:AW&$7/F!!-&RE'-1]%4))9:_Z*I 1TB4 &>TC
MD%Z<=]85R,RR&#$6>ED "K!J,ZV!R[!O6 (;R !-AS>=:&) A5ZI--%L5L4J
M;Q'252-D"<"B"FRHN,/6X:[DOEQ9:(]'LC '1&)$S5.(ZURCXOP29%S:1!9#
M=%8%D<BC_P7(L%:!]@>F$$?#KSX)!I01DF07V8<^$C'%8^<QKK3H!5ZZHLYJ
MQR,N,T7&,_H8AA==)^>QQ4>;)6K2DM63%)[L G%D+L_GGG$2E$4B )DT2!DS
M\XP=50W(0KX#^;H<'62 J0)>]&]DCR#1,S-J)C!=<J..&[=%&"',H59)4P$A
M,T\:EEC< 28 BV4%JS(!$)ZX C):@)C< 4L7'2"?(F033/ ( TF;/C6Y;F@<
MI,:8/@IQQI*I(LV9B40H;\;UF>0RL#=2J4]$/N2T%Y+FD"3:@[D#=@OR>K]#
M#S<R<?(VG>S@5P]K][^62PRVV<$""3]$&),PW "DV+A1=XM/B/]S#XO4TP%5
MKI@6<MX(G3G=3Q5)5*?L,+>3+XT090. V5@R=[6%C6UNQ16,QJ9QL2BM#S_H
MFM>^/N:\65;J05$Z(K]NLBA3 @&-&[N;495MF]$RM,I8)!E8E@N@+QWK+,,O
M15$NM43EX;W*@4)QE7MW N*M;CM@<-[2)MU*V/$59KO.+//0N8_=_A#N3K35
M"QIB8C2SCWB,W70K61 7-X+(*H1A?!5@K4D"#O,X/,4S5Q1(WJ.ME6T5^:X"
M*ND,QZ7G?>RB8Y7;"#L.HZ(O7W7%CW6(BE."L7]Y)ACZD9@#5-MDFK%V*W&G
MY&[.'' IDTXJM#_,3/Q>8N?MI35WFB[_D1/:FP1 @DV3;1,M((!6U@(G'H>)
M.^8?0E.,?(>LZQN5#DPRP2];@2Y(B_M +Y>T#'-RCK63Z&WXWIJV.0S]\+&<
MYT\!^H=L*3-[IU!:YL[-C!D7WH,>_$"FV*NT<LL9_),Z (RJ.("KT_HYD@@&
M!'B#2D..&\H\JO&F!8&($?N#.%@?PE&[T(NJ)J"M@@A!GRJ+_]N?Q2..E]@+
M3MJA]Z,:\9,_A' \R!B>&>H63I*8ZU&$'H" [^N2NWN*B/G!#K0NBN,S I&I
ML[*<K= 6'KLM0>,3"!"NB'C!0PLXM=BZ-O&#Q&,^D,@-S'"-@K !RMF* YR]
M:1. RF.RVW -_VZR-;OKIK 3-X9[.[?3&7'2@HNHG?<(IA=".7@9-B<L#^6(
MB=')!S] #JB0)\#:!V%HM/99Q,7!B&VSK@Z()*?1@EN9HE2!(8U1A';:$XF1
M#0_;.VC@+D*A($+HI(D8G5=$B/=QPM'QI"YA 3O8JM6+CCW2A098"=KZ'.@!
M QT[&D+(B:ZJ-/JPJ?N!'D"$!D6D)KO3Q!ORBDJ)&"D[)B@"1!Z#"@]B"BK(
MB?,I.C$:+OI0"8*Z T)I+KAC$!>)I%3YI*I@&4(X/H+@$I 8D>EK+6P)-K50
M!'-4 6([FM>:".9RG9UJ @/J1Z?HE%54"6B@19;SB=-P$A(<1$$LC_]2/ QC
ME(=8B08620MA),8\4DCNLD@.8"!": (M1"OD8:>&V8D9/)+G$C>1R$48@@CU
MN(A,\YZF.1*:8,GRP:8[.*CH02?BV<AJ9$1BB2=EH2"^<1Z'I()J6H2T<3/K
M:DEN'",/TJ3$ !?U\ P%8BX:I)NPS# T(@A 6*!R;!1<@J)PPI(_O)Z#:HAS
MV2,<P8XK.1Y"LL:)>89)K$2GN \>$Y<$*0AS7+0A$8:7RL>K",8&N(AB_$,(
M@#0+@YT'($'U: +UR"$8V@UVRB2VY$,^W!@!.(,$(+6X0A(*")^*8!,G(L)(
MBYM6,12"")T:&8]!01('0+&*RTVG0!&!"(;_"NBF,TB7GNB(>U$#"IFXY.LD
M%: <Q+,NU] NPR&PU;$3()D0/C*/)&N31;B7OPP?X^.E0C@B=K$UU1Q)J"@@
M)-%-=!.)A5E-K\--,-%-70$3!R"$"Z"IOQ,2V("5(]Q'Q)F'OP&O^-0A[=*N
MU1, ,-C#G=@RSFN3[4P373B,T'2(LQ, @?D[M%NOCN*-3$L2DX(*KR.$T%B'
M97&O)8L_%PV8XU,/JU ,[2K/N=&5*P V%BB%VUR@(*V-Z305.@F#BS@- $&@
MJM2*%VV30$FJLJP#$F*.TO"D +"!-ELSAU#0&;F$%4A*.J02PQ&:D<B'D@&
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MT?$ B=WV219]=.7Q7KQ^#!'7\\93@2>QC9<0@#P)[,[ ]*]I;2>G<SX" !)
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M;V0"%70"#_6*UWK,V$K5S%;9EC.*>(SLCW&P  6!N!MV/V_P0MTE;RJ \!/
MR+Y]\E0  !#@3L&"^*@,;%APG0H!H0H>!/ @VD2$_P[@%-07"6$"COH4192H
MLF ^0BDS*F2X;YU"("9W*3Q2,!Z DC W\BRY+UY%F06#J5BX+Y] @BL+Z@(
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MZRB!+4:&,7>.I?.*'0F #Y18 >"#)U9_B0Z-B0Z.0_>.PR@Y87AC;I@X(>F
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M"\:P$T,-OJ=0A Y25="!:ADX%(8F/88&1>-1-5PF#[9T S'0Q,0?6<Q=%!P
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M1%&82:]1MF<=]2T C"96D@;WCM)5CVP!ZUSB@L8 M?063C]K1'8V%VN_BBH
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MXQ_^P-.?Y<R_/[V'K?^CY[__2$5^ &@DPR=\6),/5!  =[ /N@  #Q -!H&
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M3Z@0"_F7)!@,*C"9B.F*HWB-#-F-#V )A<F-ESD02AF YT<X^?".EZ "1X"
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MM6UOT%/8.^*4US_O8W!)(W.9SD24-ATL70B!&J+7>E\(B(2WJ^ #%=2X HJ
MP#$$$'6J^N#:V>:9C/U&[.$$+K#70=,^BT"(V]#:Z0*;T,O7!*&4OVK_Y=L<
M0)0X ED41?H_$GJU@<AND=U=J=*-V5A\='U!DI>=:RK21-TO<DM*G<O2?))J
MFIT\9=;BY@B3JLE+_^/VZ'CI-VP7W81,2='Z,@D4J-^'8I 9%\[4R.G0XOD
M&PYTWOL<CC $SR:3<P2IW&:%A"Z^K58X7X4H=2[1Y("GJO0AF'M4ON!]]2\A
ME2NCS) JMSI<;=KN%'_E2("&9\R%+JZT"O4]&K0@CX=L_]/)A2>%,1DF8D"L
MZ#::D/[;EPH<V8Q3D*Z*D"Z,4S'-4!RK^!^^^)"VRS(7<S]XZXB 6A(.V(C^
MD)H5B+&ZX(WR )6MT;_8RXVKF N>D*\)VKW>_V-!CO$U!#(G@N*,HUJ75[F5
M;G&5,<&.&4*3DI*3TFH6SB@I@(N5[)$GKS(T&0NSV*,AI5LXTW@41*I!7/HX
MCKBUSMJ-[:JQ!W@&<2L]B_F^S(F4U BTPWNUH& XWV,\,725CZ,2':,4R0H)
M1;DT6[% J:F5^\(4/'$TA2&VC_.)F%@67O$6F$HDFC+$IFJN'UNT%G3$%Q(Z
M^1@&,7R X"$FW?D@Q'"*VA&BIR&.87HXRF(Y:=*9N@O%CZ D3$0XQ\B:K\J:
M4BJFW<&;K]F;%O.)5!2^G6@>I0$5JT@ >6"! +DU2QR(8%)% DNXO# +XC@P
MQ6O$#4K%4>L-J+"#@N+H _,[B_#;&2-,-F7YI8&8B-^X"Y511:N(,<JP*63H
MH47QDNDIF6\<'-H8JM)AGKO*M6=\Q'R,H$C4QWX$&34,)RR[I]#8I]WR1X9:
MO(-42,/BQX5TR)-8P9SZD!3TC'4X.'V,R(?4R(]XP9[;*=,#R9 4R9$DR9(T
MR9-$R914R94DR31,2''"-@43$"V@2'_,R(W$R8[4/9SD27!RP9X$RIL$RH74
MR5X;2IX4RJ.T28!4RJ7<HZ)L2BU*RJA\Q*FDRA:$2OO)RJN<(JOD2M[SRJ_\
MN:T,.K'LQ[ T2R%#R[3\_RVRC!^W9,MQ8LJXY+6UI$MQ@LNYO,L@L\N]!*2^
M],NG;,C W#7 /*!Y:*=1F0>97 E]( ;&/"#'A$R4D$PBPL>'K$R-S,N7C)"V
MB8F:S,</R;W&5(1'\0,!VJ=#0Q(D\XQ]<C4@2<J)] B!Y)]X&"GX$$V2D ?Q
MZI'>.,>"2,R<.4USB4DA*4Y8ZC]3$;6VXD$%$ZG@++32M)^+>$VH*:SCY+7<
M9$C!' F"6"E0JL[0[(Y2L0H!N@@>(8@^7(GSW"+.A!I6PS7[80<6*!0C&\^1
M6 ?Z'!5=6*D1V07UE(W1# W?G$R2(%#+3,[!D(G]DY-S% _6=*%]&D@9J\D#
M_?^Y\GP?[AP)[/S,I'J72Z*%*B$(SD K.:,%G@'&4,B'EBH=Z=H5X-0%!,B=
MY=FG'F"F1I'1J5"6TK'(N:"R;L(33UHFD_%03-PGLM@*G@@ "I@QCS@D)7&
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M!D40%'VHA2;1C>9+@"Z<#&!T+C@YVH48N<SZQ&A0!NIL%F1*S0/1@KR*'M3
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MM8FTT?^E^[VNH&7@>6 [:(@S\8G<IL5"A?A> $,OQ2$&J_4-T+1>#14)@@*
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M?B0[EWMXM_F3W15&M7:;-WHO%/KJW1>HFI"I)^_AK5V4-G"+<'3 GOIN:],
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MTK7)1&!B2NB3F\!A/18('4*?3+"#0D*?:W6DS9T1JW02@1BD"X5A+%(,%3B
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MO!5&%$9CE]'BOG44XPFHJ)&6!6 0(A8,1K*DQ74J):ZXP_'4QH42JS31%TQ
M*2H<' XHY0>I1D46)JZT&++APX@UL6;-"D!K5Z]?P885"Y;KV*[R6/39!VS
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MY"9TSEG.<N;C#_M3YSO1E4[FR#,GNBP:-"WCSN0L")YCN<]8#MG/XC_14Z"
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M<BNYLBN]\BO!,BS)+R   #M02P,$%     @ +T>!6@&=TKB;!P  * @  !0
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M)E&P':EN*G7A%S05_;\#4$L#!!0    ( "]'@5JB'=Z]^P,  *$$   4
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M\1,G3UVZ?.7JM>LW;MYZ^.CQDZ?/GK]X^>KCI\]?OG[[_N/G+Y"_&!F8&6$
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M_VBV!QA'6P(=9//;:DR7_;!VW'BQI+LX<]E--\4F8>63&]T==W8F_YCL*A+
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M9Q>9.PO:C>>&\GT8F/IW4$L#!!0    ( "]'@5H$+.CR4 ,  /P#   4
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M\1,G3UVZ?.7JM>LW;MYZ^.CQDZ?/GK]X^>KCI\]?OG[[_N/G+Y"_&!F8&6$
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M1_@.,7LA4'"-K/^UO$.0_Z,=.GR$A?4H&[@,+G! XW%P^4>.@(MF!5<,7HT
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M?@FZWL\3%P=/93T]EE)U1*G\6-4AEN/<R)CJ;26%EW:E1)\/!2 _Z&HK$-/
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MJQM5C0])"#3=Q.[F516S*I*R?&Y633[6!(F4,P?V1K#/N^SR;9"_=G6+\!F
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M^MN\Q*GMW!'=YBRM%Z5U5;6<^V,,GIN3P3]QOJF'-O>XY"A.3 AO[P4/^F2
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M2T7./X:GX'CU+@$&-C&S?><0=EHNYZ95"VYVY%ZZY7YZ/&4Z)VRP:K0A32O
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M*14K<*K?W($6'J38MJ&K<;'>AOQV9S[\+R#_3RBL[/?AH4O)#Z<''!2ZT/S
MBD<%LU"4<7P]+^Y0\53V/@?'Q6?7[KG;G0L_\9!7CZIW.9IL00D&0HDUT"3,
M3K*Z1;+R*^S,?$2U.5G@-Q6_4-9X4NX]0E,[]Y)LN/>1@- $J0<BA0NO:JW7
M')1- ]LGB$@.V%31]&.89@1Y*7%G"[\BKD/N=KB-24Z&0N]E:NO9<>H*&GAL
MV\"GS'C/>&#"5_//?M:&/RX]/\U@R3NS.Y8 A^36"D,JL:#39%*_]+Z/V.NA
M@^ZE&3;SR0R?56LYO/WHUH'TR8^MU]8U.(V_%6D]4N<2ZQ/-RLB1_S#9=-WD
MC>J;*I6?1]34'QCI;P6>"3M]F[/@W-S3 ET-)T):AVT;1X'YG?<;DEG@XQT&
M2^ YW>4-?/42E@NRV190O%P\P@+@>DP:HXL_A<S:C_B&\O/$R_X4[[_^^%'E
MG)2[+<97K!O^;FT#STTVHMRCEJ,4@/!;8WK@%8OD- *YNT GO]9Q<;BR3;"S
M/9<-%,&<IREC>F2P^>)0[0?VP])4 6^Y#=\89&"T=@N X%'H06..6#"H-[Q+
MUZ*G_AY #1E?VL%75/VE;K&%!'\11<ZE'NC;S:"@LA<^[('#U_:17A.T\[.P
M3S!9P)RLY UAIMC51#CLW'CW[1ZQ+^.5+Y?<"L\LQN!!M%[Z20FCHVX!/?[[
M#OU3'6PO(K)ZVSQ3-2:*-IU%AMJ<&W,1THM!=4D/XIFJ9K;*BG6OZH85N#C6
M5!&5->":[ B5H0/L,G<<Y2I9, 8.]%V>?AAC7 \8XRP>"_711%H)_<F:+W[6
MF(LX_A0I$- W:$P[E?-%_M.-5B[I)QKKR32V0>)]\+WF,=NO(S1!+$79@.@<
MTA7QDJF>6C$DJ!^^,#*+#D3KZGT-;BDBOTOUY5'?;ADGT)J$WJ79PB='"E$J
M@$RO9#-Z !IO1X(Q$053EE63):3U58@:(ZGJIHT')ZHY[_OYW<\,M2V9L@W/
MO<W%>IO)S>6C)2&Y"R9%3=,'4UQ*?W[4EYFBR! 5>CEP=!#G/.!J4'PK=%(^
MO?YW^A=VQ&F,8:;)6IZ;G%-2S@W1PZ34N[.[N[_HH/A LD;T;ST%&ML*63OB
M/0D*<(5[$J6%[Q.AZ12[5PP0#VL>9W-MZNS,ULH^]6!=.U?VW$4.I9,F7<BP
M\M2O0<%Y>9M.+A5B4N6I9XW^4;7V_Y6;P#JV"=R?)4XY"3AJI>@+482)W)D=
M!L'G6\;58X_>U))P;+FS?I#-FAW<$E2H?<5.;GK,JUHPK]V.S[R>N^#/YDJ,
MT  1R#('0BM@C.@5:L0;][9]:R.&9^G!JV9GN\X5,Y5NAR=%GMA1N<!_OB;A
M5L/U=DLC><!@"7T2UH>0I%VP"%V2Y/D)XP'R<,>(\*2 F MEPZ]T-O.,; _[
MW1,MLO'2 [)!@^]XWQB85''%&ACZ;-:'C&:7-;=+LB$ !86^!&K<G*FC+AAP
MA!.:N/M"QX_AGAYO(66=MS_ AH,]J/V4K;U+7Q=]QVC_+YW-;D+=.B*E)1R%
M?MSYQ!8Q]<B0W_9XV7\8' K$"J&]+![!02$??B,R$$)ZEY>]Y%FV-APGRUN\
MB1-&Z5V5^I_9W@A]!!,L=V8L<&'-I6($*-YZZ<=.59Z;X+1##:9Q9-9Z9+:C
MM"NXJ.EFA9WI3*%BM<>(;_E# ]#G(.YKBJ\4_[\;[[.;_!VK>F4LH D?0%,R
M4U(*_]#1]G_L1PEWB6#GY[6XI]1%8Z7-ERH#<T15"X)ARY8-T;<'<[-<+E=2
M.*+8('7ZIKV@9HZ<QT4AB7OL F';7](?#0H(WS!M^E8H6_+LUS'^],^ISC.@
MXZ8*#Y6Z6/#[2^$$-4IDUL>V,L!2HI5:@#U)&^=^ A^#?88FHG;.SZ3006&>
MY'FAW2%X1_GY)\UBN9D;*,N[<&(A*9&PT>WOVTT[_FYT.W1'(&*1Y AE!\(M
M"M2CRSCO^NUSRV0W./9)B*Q>D@E*M/.P42($DQY]TS_[DZ8 P%]]'_^NKTRP
MF3\?@>B9?E^9$?#><'UNWEA:_+WCYV=GI+H^OWM7<>96D%G!\A#2%5W>P0G#
MPEC@1\$#3RD<-9*)/#\1L_Y$;OSY V.JPM9+P'%[C^LQ8M\#WMD%/S= _KS?
M&)+/G//!_7Z^^R7FJ%'%&[IQN07=HW=M<'!,.)C_-S8>SHH2\Y%0G]:3>SF'
MC6C650*4R\<3-D>.O<KU.&+VVE)D2H5?A6-08FTHGC0 L#% [B/<=XKHB(P7
MNJEEH>NHA1&\JI#KSPF.QDO M_7>H#R_[%C,CIAK">E%EU881MHETD'>8S#Y
M"/BR5M](4E167!-<^,>T4"E/UBU4W+(J)=&N=!(C*"WV8>4!7FBHRH _AW2>
MA='?WO,4ZVD8%T4:\'\5,>Y$*"B&QN)FMI!+S6DW^6KU!,M-G[*I5%WWM/]P
MZX.J;'2APON2K5/$R[:I:RAVBAM!",]$Z#$!V@DCMWT[Q>ZT7'1L;!!>2YE,
M->5\%6DJDW-'W,+(2NGU:^]J#_5Q.X9/6@G_)U3J_T=-NDU[/IUU4(3EP]*W
M(Z-_?C)Q/LI\3NNDB<CJV#<FB,Z?I5O@  [XC!G)O0/(J'3L"L65N*QZPWC>
M?1 Q"-L<\LR)>HHS])0!BEUXM59C!2#<M$7T,3TPV9IA>H,.\MR)D^2MZ]M(
M^%7"XD@4K'II2GOSN^)\8LJ D17QFK#$*R>X@']RNIQ-\%837$;GS0V)[8TU
MBR0ZR!T-*(;CR3A'9'H1M'M$&%C<L7O:@5*<#.1JZAI9R,2M523[_&+-:#H.
M MVSLWO#N!T_?.FEON3XS=>,K#GXX'%Q969/[Z'3+K*YM_7<P.Q5Y'?1SY]'
MS-\GWQROEVYI:4EQC6.58<TI3S];D_GGR, E)JMIW^&SU=M]LL'G^'5:@HEI
M-#:&TCK&37T!=T%G%GEN!9/O8WRG]/DFMLL;&AN)SHUO%R)\(L7\+BH\/\IA
MY*=TYH!?\@(K4SSMZ_1G.HA@MS.K]A'<6+WEC</R;AZJ<^ @1[[;1>TD:^0(
M\W7[5ZB9']]^><G5R"IA):Q_\^%T$^SS7=4IF!3M"YJK(QIWR?DW5_!''?TR
MV*[DLY=%GT5.(6*'?!%\VK:IM0*>[^D@-9\+^9I+"],&J/)4I>SY_S+0_2MS
M'>/M%B>6$)[X,%^@2]&$^8CN@ZL;#=737^XJ40O!?M%8#!TT &_D[K+ 6,UU
MZ=B6>5<YW@%\[0F8S398&\'AX>Y0><0BEC/F+1&?C=?+!XDEN"HMS#S3;+;3
MKRI'A4V#_<#IX/>EA2JOR5ZTD3SO-H&GDKY "F$;WY0AK3%R<<3O<V%SZD4U
M\NLG\)CI.LHIZ@M]-MBW4G$))4".:&% O/SXZ'"AR02O[</2M+-'4?(,C^E&
M^,C=#+3[,<^/6V@K2>2WO'7KWZN</MHWQ@=51V+4EOK1!#-G8E)KF7U$YLA6
M"R8K644Z%7__7-6H@_WJK3<O*F(JGX2!XH+T P&M<+(-K0_;!$U@*+!TL,AO
MR53$"92< 9P[0<\2QSI 0J6]PCA>_N+H])E-BV>0'YKL8GJ__V.=V/>1K"G)
M1CDZZ.$$; @E16A&X+Q"A1G_I_9_C:P+\'^D[\=Y3]KD"^?]"<WS1I?F+^B)
M$XIQD+28V+*8N]1R53V]4"CGG)-"<@B8(Z7T:S\.=X%_WUQOV:W46O![ME^&
MJZD<\Z4'7QKEOAPOJ7]3$N I%^D<H$N:G0Q=X"!I @WU$1ZF?+<: 6C]%T_9
M.XNYR@E]=P+G>7*VE3:4_!6N-C&D);/8Q9SB8,*QC0'HY;KTUL.# ; #*2NY
M"(D7PG%CTG#@;FBZ0W5"C"%A<\.([WMSF^'SM,#*@3/V4Y]_/ST6*9\^?/J6
M?6*ZUN=W9Z?%)+<N$$U@0W@R"SBC,8?P!=]_C"C5]OPG? ;N0[8@>>:L14K_
M!:^@U@Z#VS8&%QRN]K,9HEY3'N>OSIE5&*?2!G5&4CL<R3&TD3%@V[L$#W<5
MUZ2-C"BHAJM_SC,;(;YC:D<?J:2^T3/ (3A@6*R$ H'S764]67 SO-!C/MMV
M6V3UI-D L091B&)#OJ:IT+Z\\Y'DI4E0P@'YMKO%.&BRYOB/ @=_LIZF3FF6
MWK4SY^1RU<.3[]_./7-$O_\:^_G@Y!@Y:F%F"5%W@ Z20*G101X^, 4@Q1/Z
M\NZ/9MVUAK%?CZ4O5"582-<.=[P?/)>>TOD4E,KO0>U0'5GSC1DD!;6H(KY'
M:#3GO6!$2-<1KF<FPZW D;V5EM(I(R=JS JB/E:(?-(G:KV)+!(C/TFYL7N9
M.M+CS^O8*@?6;;>_9J8975H]/YUO3.:,L9)\KPOK&EGQEXVY2 Y\%&.B4JV#
M)4EB4./49ZN1=TWR)+_303Y[%MNMN^%VKD3$;88$%*$\ *R7L7$ZU0DNA&-]
MW=XZ&_';YU9UGA YCY?./A'(%/,-53$]RW2K.C('E/)A6+NZW>]5M6"Q,Z_>
M-(W-68-43Q0CE1!/H+8PE>A&E09?K:<P]Y:'TE?0VS6\0C-VG^Q$"UJ""4?@
MS'69>JI:%'Z]'[UN!RX?6XK7HB)A 9+CH;#$.=B()!_J1 R4B.T;F9VRX!KQ
M)Y[5]2V)-B0J+_1U1,'JF?U/HA]V\9<&#8I -(_O?E&_GU#[X=%C+.&F13*"
MT.=/ELT27*!V(F\R/)0-.6N'AQ"R8ROP$,S=NX&T]BS5\$/DPC;M[)C&Z_Z8
MD7J4K0.U5R<HL,7W>3A%P&IW_P9Q9.M+S7>YI%?H1ML4YN/@CGM/3/*JR74?
MN+:\T80;/Y!-T,?8QIW'H?L>DW+4LM"T.QT]>\H=3+S'Z*#06]FH[DZ=%5(X
M\(Q8N*+U$*4,&QV+"&*%B=;W32671WAL1S]MXG+PFI*!JXWP&\EE'(V\I1A4
M?]I5R?](&G1V!1?>-9)!TP5:R3J#RZUXE)RQ?S#2"R77_J$ERV+R14:Y$$%8
M.N_K'1FE]8^+=SS2S^>'GY0IU1^8_=WR,^C '7^)#JK/8GA>G/[=NX-+T(PB
M*T&=NPBR8401%S^<_6IQ^ QB:]L#;*OQ&Q\YLO6:K V$D^P Y6J*W+>FR%#3
ME0^E9,>I;1<VE>I73B;N'UK=F1/GMQZTZEK:!(6M'FJX.MP(=704M4Y+Y[W/
M4 F&^1K.UWY:9$A,WRCX_OY>W77WV(,:R-^'%AWY;QW_OQM:;&HP!/VC8<E_
MVO[3]I^V_[3]W\3VB%'?BIW;V1MQMW]+3#3^*=5W6R>QKF6*[XX!7*/V"Y_T
M_!Q^3UK6-6C'UBFS0BKKEM<1'Z4U!""'9U!"!H5-W"^/J![0P3X6,Z26-2UH
M]I,A$Z6;R_[WXX:ET]M+4U^ CH.VC@4580>X$P[!^$$B>!F,'WWUY3Y_@: =
MG.TX4N_'R_D?9E[ZW\Y=.\FUC]$;[C,NW? Q,C%TP,Z@P@7JF]1(:?GZ&QAU
MNQXZB ^E!QO'@L!+SR4XQCJ<:S>+H+WPQ_KJ+83"Y%!QIX.VTF?^L=&7F@I6
MF\V<!^X]%(0^-6M$V6M&T4%96E/HMP,#JG$ZV)YHZ@U5+F"GGVTI2\2[$%.W
M;_;*/%SR4)S\K"0+XUJDB=5:S)%U#WK0;G&/O-]2DHBW6P,0]J.& H]>V:U6
M35.$PONQ[\"]B,>0]^O5Y,OV$2^Q/6@^BKE$28WJX\5^ \ZBSODR60OI6WU_
MI1\]@E84$6%&3+4!'#UP@@'W;,N*0DH'@_R0$MN(<(JL_AD@'B=^?>:.CR6F
M"^HK_SK(OQGY9&BNC$T>-W_PG)/).<+[_@K<[TVZTMEZI&?KBB21+Z"%#C+R
M]&9T_T_X+M=_^"'V*!UT<I_!YO31&UD9:$(5A*9F3#' TD',AW10J;XFPR?R
MX<!P"/DOY %DA>9QZ@-V'3+]:06\A  3;B.$X5W7T0$+6L9HP,Y]65FI1_+$
M[V?EC?$VOK,JGD4_;UKMG,X\?Z3FGB($YV*Z(ED^21S8:F=<O!ZP(Y^@S139
M]4$>%I;*?!@-A3!O'H:UGF@*%N_&C)#21*3.2/<G0&V>^OO10;7,$DVDRX$X
M9Q'S:.6Z$$L;_EAJ-\J3B@J!G*2<(X[TP.?>=[=Q?7W-W?V%/*/G_W*F]VYD
MARZ<MR]<1W'=J-DM\T&\Y-E669#OC]01HD5*C/(RUY&?O3"-Z5]45;.FK% \
M[75(MF-O<GK[IVNO-DZ5_LZ_I'UC/3=+W4^MJU2-4-UKP?9C48>@]5@YU%G2
MMM&L7LORW1,]NY,?/K>]W62E@]C'D;S?T/X(0"'\X:\UPD BV ><X&#SA+-?
M5URIK\WOUFG7UM0ZJV/,N:8#0;Y:.$\*?S")8UQ/($J!6M;!ARN+B!N*"+X^
MC8>^T>!38TU08K\T+P8[ ;MUT?0(XMVKQ1SX@U9<0;V$-4/@_45MA0G^6.0&
MOQWI@3S6<<?V<J?:$2)LMZZ&90DEXU7=':-3WLR<,NJ_)'+=+>E@/UL@DLS7
M11,<I7 M*ZMVZ4L\[*O^?A@BJ'F!KR2[3[0_GF CL+9!8]LAL_'ED<5C&.RL
M^^P7.BACNO9[D7S6<KW@>$^IQ+C4N[?C>-?FAG=-CV5O74L5D#$\=;;F(>@4
MZ&SUV8"B=)A+NN?0?-IM2T,7KS\#VYX1?UN9%P7Y^ZH]FP$7MU#LW^1YJV0R
M=E=\ BY)99UVMNK6/<9O:?*B/%41A!RB@X SQA1!;E(2-17LC16BL &1R\Y'
M;9+\=<W;1Z&_/ZQ"MWKDWN[9N&;D#1]#!;:B;!5./_I(WN^%-,*W]I:H 2L]
M=Y6!O:5A5<O&V,(H6 4NS40A\>T)<8DKGQ]<[1+_N<'-$W.204@]*,;4NB8T
M9GP%W$\')<%4)E7]ZOP;S67LB(8)!5$^<WT-E1?4^Q1RYIB%K$XR/7K>%'J_
M];3FIM%FOT9KE=C56<13!X5N+'#6DR+POG<T(LM67Y8HG^LIKPQQ+-P2Y<K2
MEA?H[LGY]MBR\D>V[S8=-#-"8^5:0CRR(S%"D':>$D64VT\M?TPMB>%X/5QY
MU67U7OZ':RIR4DM)0P;O9=C)%Z=)KZEY?O45[]Y1*_7%>S@5>17+B8EQ-8K"
M[*!"$%/_65:PG^0LVA;(6,Y*E. &.I?I(!Y?E%+GAWB+MX3M%O\(0IU@WH*I
M7O<E-I.XC]9A)^Y>%^Z2"ZM-Z[VI]S;K[.[%)(DGSJO;(Z59^.'E/Z?ED,H)
MR"TD$C9Q".\S _, I:HG++QCF>&$G @/DO6[H\&7WREWSLM?:] .R8SXDB3_
MUWE)+[O!0S"%9YQD,P;V&Z2#_&5B<6(E+A >4QQK!S@PFF=\>5+"X,P'D/'Z
MJ1M_U202)">O6/Y.#+8-*6G5]=WT-[]MMW[ < ![T7]?)I;'P7[67JDJX_FM
MNMS&=ZP5["(S:T]77LOF6ECY./R?$['E@IIF49C<V5X5A]-\3JS]NP]S^5N<
MCI@._)7WTVKT'U:=_9_6X&KZ%^F@'+0-'?3V"1UT>*'VT .Y[MD/V=7:1)-X
M$0RXUH ]6QX92/F53)N/21; &],6J9P8Q7+T+7WM?YF0H'YB^+ "_+-NAPP=
M=%_9C@XR6T?6*:TR D@ZG%+1W@TF\4["?Z%\#KO1I<$[!^(X^(#J,.*U.WI7
MI8(F\*?+[YK._^/I*LN[LW<V;8-^8#(JK>=&^(SU^(S$98V$W=WU3EZ5BN\:
M!L6\9T [JKVI=9H.\I9K:<WX1'W986)BS (:\&&B3&1]G!)*0;$"8C3V8\2>
M%4@W-R97[*D[P7PM(ZMG3BRZXEA_BJMR77"&QTRFQ)T-3LZ$BXG-/ ^TD@XK
MNN%L-,$(=IJS]4<TEQZX?,%<)-.W1,$H#F/*)X7WR&"2D3HEL62YHIJ 9J=)
M+W3!B2S+B.3?LWA7+_S+J1 OE5)^UP*;BS("S+^/UH=$0Q<O*8/-TSL1'_+
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MH;=P9:!Q;EHQ[,((83*T!-?QV:J@5.1.H%Y9*6?A059IC;V+3'7>VN"F/<H
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MX/U:??04Z)IC[/7TVQQOOBYX-DZ_8V\::]"O)W:M<1#ZQ(GK$9 [L*C@L0=
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MB?XM;9'^;:V4(;HG[7Z#WW:5]G);\L68G5K!7^9>C4C7L-6&*G0G+LG@!#!
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M_Y0RT7VW<">QQH=ZCAUHG%NG\F'PIJNC9*$_3B\65>2,E-==065%/K,BU6K
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M]V#*[D.=KQ?V4/?7)+NIXN2G462_MP5U!5I+] 8-Y)5M:B_00S>AV=/;KC-
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M\OKAT%NRN?]@5Y_4*?#I3IPFITRDE2EW3Q&0)6[Q.!(1C!C&?.P?)//K$M>
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M[L:\I)F$%=3A]_\[?;ZI@J._H+^+!NRJR#;8>AO?.&KL]^5LZ\M'_+_L_C1
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M*YAP",=]@FP'7242)PB3,3[W!0[O)^=Z]*ST!6WI+:HQ\' %[5BOL[*O-AZ
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MLAM)AA1YV/GR[MBF+LR<?1GQ+.4/O>6F.+FR6?]@5YG4WR6\H_BLU17D@^^
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MC-.K%NBIYV$'WN,4]QA\[KDB.$"I?.97%^W^Z%' MXXV#.DJ')"!MHY[$6Y
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MTF,9(KY)S0TGR,A$.^1M4MO[ :?>8F5G)D3?%E=Y67;MZ'6! XNE^?I\$$G
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M<"R5>[WG76UMQ8>*Q)V=V3.W0T^O&RN&W+AVVBJI$>*5"H11*NAYFSPQ8IV
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M;K]0NG=8(N1KHN,Q(\%UQSL=#\]Y-??@\DR/%Z T%M;/3MGK+M]9606@%3=
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MZ\#H'.U73]C2$)R^;_@S."<]NN>UCR"610(F$[B6*DT.=<GK?.U=P8P,S:+
M"T6^219:ZC]T#]5!YS]Z5:-K_D 8>^*?$L8N>BZS%"]:8#[R!"M-D@8'YBN'
MK9(U;FKN.#(J=N*>X=:N63 A)7"0D?^Z#8W&KAE_!W\%N;+!J]7'%K"_6JWW
MM]:NV%7/I@G\P[^7LY3J.?SM=H+^]FF<%Q<PN](V9>FH<#7HQJ;40#D(*/U\
MB"G4:[[.%!UZ!O(">:HUF0LYZB@O]");FNAQ<<>"MPFB$\_YX<1Y65/K#P\C
M'T:E/[=8-GY?4#;@4I(*<_3DHQTF3U2!8(33F1)!6HUCG/IIG5.0MW#-/4^]
M.-I$O+-ON>5EH@C/Y_O27(HOE&2>Q>^'-@::C5%FZ&]0FHL8/A5U49K2KFH6
M00KQO:1?/BA7&=E'&.$9\PQ+7*J9F74:T9R(X+W(FZQ4\K',9X27J.*INJ2E
M.%<"'"OIP(@A/0#!0A<$OWK* ,V(M-2AE1OL761S;>\BC]/1\!4);LWRTWH@
M[^$//4=&7!SRBGJ6;FV:^/SZ[GOOYX+ )KF6P0&C&J&;SC)$?5LH;+#]L(]U
MIE+80N/7M*L!LZ8^MP,#SGW!Z0FG1-QM_2H$5SUP_F!ME@+ZMON,Y]C>/S=5
MF .4I@Q17*CO.VTIX1492LE&]4(J!R6O67UN/"3Q4:3/^!U?;15+]*\)F84G
MBK0?>?GYBUC:$[>KX=UP0"9EF2>'YD V[R"&4*_]4,]MQK!^]I3RL&!SV5R:
M]DP^^>F8BRG)L5%[[)Z5QS?A#47*96 )CQG%,3BDISQC,L5()O5O7'5% &</
M?,E!>!'PA-!;,2^#U=34O/WN/"]O'VOL,6W*%X1+E\+L;CD()'HR7<SNN<V3
MM$+?U(F) ZT/+K ]&^=3V\MB?J$1\D109;D')+IE] RT"WJTS!3@XEI;2)7*
M92VA'?9G9-^C% 4\N>9'\0J[PW>1"5E\Z<&SI4L9IZM/'"M1R]Y?3DU9=# V
MS77)4UG7_?$V4O&K]L5(Q;D>X+A*2\\8CL#3\JR4'LHXY2(E6F_U3BRCB![;
M-?;=7ZE^RM. ^_1)A^M)&'6W-X)G;2B; AB%^F)_X8[5T0**#SU%!P:N<[F.
MDBA_6-@11Q5/3[^'-;/3W W&-?N3'1B$5-HL/1\[.=7+2,+'_5C'Z^>K1-8Y
M8D/G"Z<\VVP,81-Q%4CC D8KNE(E%N;ZDL''Z#T-Y?2MNOGJ5=TE,KSUZ,3$
MYJ\<-MJ=UFWX3LB!7PH#N+E0ST&>3_+47QXA-=KZIE#BR>9SK4K6&M7]A\<=
MLJ^,/S 7[\:PU6H5<)>N1V[00SDYDMYO8S;I]Q\&_&+L[*(HO=9#0+>AQ^"4
MZ4%UJ*0OU9Q<$C=\N2IQC39J97PN,P%BUJ.2M,=/HS1D7S)'%B31?4=S]^69
M3$D+C*(R@IY_EN."/= @ZFN+G\:QTZ"3'BJ72<M#9J,9TE=*8X=8(R\?QYN=
MA,A(?>KV<*G12PG;<#=F,[Y8.631.S96H&%P^5H^^SG?O:FS;7<<P@VO:!B,
MQK 95HZO6(//)7K^7]=V-YTQ !-#WT4$X3B+*V"C96VZT%)2^^N<"7>50[9%
M7]PD'%N3Q^R*N<\>?]\A0:@7P\KMAM\?V"D$3:"%P=$V%1>\ S+Z=R1L*)(%
M7W3:3FMV9; 862L_&=(S\IH[Z$HB?O;GS'.N-$-9<W?DN3,W, W+R85?"F<.
M4/.)\3A4/X)TOQX7;?P56V8WI[I"?2PE41O;4X(X<I^MB]'S K"<]USV(7M2
M8$ VJ?@4561)5P1]<&%9< /+]:,(\\,N]*%29:NO]0<3.Y9[_$E##8K!#*YW
M@%"EKET/48DP7-U(W_ WSP<!!U("@R 4(R9ARRQD(P:[-[A/Y $]9]!U38F0
M+<-0QS0*<G"C4?RN#SQ>5ZQG6Q.X%^>?M2E\/K"=U60^Y>-D'EJT_XVF=W&#
MOHZDVZ.ZMT73J/S>:[A%+53*GI^+/J2Q*_WZ')TZ;P0ZI0L?OI:ASSXQ-QTH
M@YP]FE-RDOCWK_2/U@=\7IX)U#J0_<GJ99- W\M>'/3X78ZV"V<Z.0R6@OOJ
M-"DJ] R&,J/''S3N4DFXI;U$33D03)8V(R-YLA _=9)/VVT;4:Y8'[YP-+^5
M)U74$-:HVE';>^/=@,V*4:2':C-CMPTK(ASFIA(.;KZ&4VZ9O&3AEH(,$?C;
MT06A1TKM21+9#K:*0[<$IU-5U4(NW!$ZB5/X7'#S'OI#1]L1JFK5L@1#HT^_
M1:5*1+@U:-&KB FY32\@PD8R]5],1YQBQ%%*U!A+&#GOP$NN#DZWBI,U'E[\
M>+7O\]'HX\X.R0ZQ[Q(-SQGFN=$+D_J[5NWTEOMM,M7)/A2[I&M "FEK"MND
MWK>!XT>>K<3\\K'?<P1?.K#A1^ UO'TB(:M.F^-=@@$OY?0AT^!T;;S*<MWC
MU8@)&.CN,535ZV18JY%VX.DMXU*<4FS*NPN\,2>.^@G:>\QD&CHZ&B\W[KN6
MI=NA!R_'*&&+F9"7V](!&)"$'T2:0<NT44T]4QXRR-/4A[\B#91SM7 4Z&A#
M/_W5M)^]01)TG@EQ6X>O5*_Y6#J0,3?H;QM$:0^ ZWA<D%;NLSLDUK9F5ZVY
MX)43TUK/R0?W9XX\%XP5=_=6-E1@N9;KEP#9L@FW&E%:<C-R/E3M\LSX@;3X
MEST&9N,/V.4D3\.++"N2_)>P$SM1(^_*=4S&*+Y !LEK"AW+4$9]^^A[/\ S
MPG3LYM*H2L3]%:6I_DT7:9<0VOX#[]:3#;YL?]!,MLXZ*&O7>O#*?[HPG67O
M<S/*H%H9$;@G]4TN[";J&QA.=4_3[I*$VTI&M>#<%WA:S#_5?-^ 'QSO\1)Z
M4V LUNHYZT<(;RU][:G RFW^[H23QVM3#ZH.T@0X2\9VH(5ASM8ZFN>J6M\3
MB[V)PJU5/D+DA9URWO*+C+W[S/RZ9)R0/\2[3O2&\A43V#[UZE<DCVNC8"\?
M27]#.\%'.EJP'[%-'C"\<DA!5SY<LG5K=*+*ZY"A][F+A$M*;5W'993G'$(Z
M1R,+DJKD>M^_?6OVIV.4'_^E;52P$.SD>\P:F@D10"^#F&OTU/ J$<6";C*%
M33,AC.-,R _0990[E&!)6XPK+]!-3$C5Y>U8>2;$*PS 7O&5!3%L,>;@OV-8
M$,(UU6#7#!@RNW>"+./=*B)+?;N-"=F_,FYK@SP,)"F-MSY4H<D\0:C%"J [
M:G>&OV,J8<0 X;"B7,"<E&MI.7#,N*:RQ/V87C[O5],/(.UYYGU[2W_O+!4;
M3+[C&;[T;U*KV!%S%?WMLC:&*JH?G&+&<&N/A.^Q*4)Z%/[%L,J]QW3=87C%
M)8KYJP3]] 3VA^4.VFM7'IGXD:"'D#<':.+%8]V3M2^%&.W>*415FS:M*XN/
M]G>:)\3ZK^SC*3% '?5=*/^P(Y4D3S7BP7V!S<2?"Z/J#U<-YV;R&7:JTV;:
MD4[TA*O65RQMS#)PY>^GQXQK/[7AKE3V&Q0)555M>.Y]H/7-K>-L]_MVM>7Z
M#%F!MWT6UQ,K\U:+?F:6&"%^8O'3F$H,70A-JWJ\RM#/8D@94EV9D%YG)J3+
M!R03T_ZD4<6UU<T4T&?-GRYA',1L8XK0^76GF)#S:FC2#=@V_S\U!O@ K7WC
M&,$*3,AD)^@$_GB(DC+P8VE8"88\#0E<*O+-(O1$HBM*B#H&E,IU>N@!C8M*
M^ >UMR]?7]>62,CT'Y[91$6BFZ"PZ:= '*.#';:1/-HPU_)UZ4P[^83\G5/J
M<E+6KO)?C.YWER/9(EX)&3[%&PZUW';MQZBI1TL+%ZPD.@\]-]5#G\=T__I[
M_6$07WNBL=.>@^CE_R\5,Q[!_OCLX SF[QO=I-UD0N*5YNC^H,5>IS)\"-!M
MB3O8#E@W)G\&MG(#U@+MA(:K@1/GQ.!N__MD_V,2,6GS]_*-?TR;B. VVE44
MW?X;0X"/L>F.#FL!4$*Y_1WI[/ZV.\\5M0=X\1; M D=NNCD6E[@DZ!LTLCN
M?2/MZ^W@D)B(2;&=FH1>V4L2X:)6MU^$7I!Z\7AN>3;[QZN.3"6H+&I\@J]?
M5Y'F1G^I8TNZLS:TVB:$$_#P5E2Z9)1@A>%4JC7.,ZK7&ONH5..L;?4M_^P#
M#D:SOQYV>8I,I20"1N0]%"Y5(NS073(CS2?P>*1VC+1I=&F&Z(>##SHYVZ0?
M7Q$Y\[FG;X(3N$ZJQ==5\2.U 8_7+BH^3 @4_G:>9/.J6FG]Y0N?1X9SU;KE
MJ_]<,ZG,D4>/'C,AP8_.I<W.+C$AD.UA!KLL::M52@K@)."B[(_V.Y?#!'6/
MN]N?ZO=8N2-_](>=0<3]K[D)]4?7]?._Y-8'PL^SG#<7V?M:P,+[V*)QYZ8R
M[W3D+H,2$-S6Q". H[EA6!>5T8(I5@SQ"#FX56P_5B5ZU1O-/>I*.950Z+*E
MZE?P7J8OZ"-^EM<@XJORZ[/;?5AKQ;6E-ASI05P$BH5F3NYI0H1CRCZ0S7M"
M: %%"Y7^Q-R(OM9N5Z$LK?,Q!\H?B)T)TO^D@;A+.&UX[B6\,&"B [U4W8/X
ML4#D#F,<R:>G8^?Q- \FY&DEFG:_S@'?0^,5GNR(1GO@PC$?B</MG@)-.8!B
MBXU)KE->&VO5J%PBT=#IP747SMB3JDMV<[3+8V_0O:E_.7EDOPZNOZ^[8ED
MQ*C2Y)9V"T_2B@H[X-."$BT/,)9P,PJ0&3:[:2#U)*TS/"Y>(;RQL>FL#+EO
MYF7?L^QS13,_VT[(3#]'7U^ CB1-HG<KT?:$G4*>(<,ZT+R^.^(:YOWJ4 $]
M]MK*9\?W\)]P$[NE%1I?QOVJ$>*O)&"9(G]6NZQ"YD4\2,_EB('4^RB0E($.
M/>A>G0<9UVJIL91OI]Z0D+-0&1I0.W=-E%;^6?S&(>N7^3%?5).OW720_])K
M>6LTLO8<)QB#N)$L9,OF+2EV(&VR2+%5[-R/MF^O"JWTO?9E/GOW-#JVXSW1
MGH\)*?5IPSSMH!I11.FO572TG7A_8KAHOG>'=+2F&'[-7W'N_0.)\!5')\FL
MXCF*";T"YHP9LVQ*T54#.*=@547/"H2*<NS/WZK[\&3?^^1CT_LA1.\3,15/
M[Y@_;0(D0:@LMUN.UZ4GR@>WE\%'<RT?T#%TELGC2J],.I_"L$"VN,N$\TTJ
MB]">)>9;[<GR=A6T%[;POU^T'3]^UAH7&"=)S\%.YJ%YL4[P9S6#&*(\]9@O
MMKE!*<4X$]?B/QPV&WR#M+FY=*59V);X^3L-\!)(B-@3W,*+L*>=&?#TC@NK
MX2[*NRE:?+_<W;I8]GXQD:/L5$>>S" Z"LJ)%"17X8NK2"D$C3A)1@2!2\M6
MZ<K( )_IL/CS^"<UZ:<K3Q?FM\0KVK;L*.6&;HA#N7_HQ+"&I%M\+W\G=#Q<
M@.\\))TE4][DQ@RKT]TS[6XVM6_'!4RMA?YU1P+;<<")."*&>H7& JZ"A&S0
MJS$A4L4A/O@X+NN.[(F1A2<37A<>BG4IE:_T)GFQ),WQ&M<+-CAQ^)6,**S!
M(V$"6$?8B&*;?VZ;9S2,EW86;^S<+J4_>K\B8-JV8* J_'*4 /)S[^M%@4.B
MG3H5C_%N"N;*4]TY[>JOYSCM.PA;-)@F@P.,D7J4_MT&5(I,2$)!$@)0V"(.
MH4YK=HR51)^\";QW84)&GM3$X$*796T5+S9E:ONF[I40_[%G.5*4M)</(D@]
MRX3P>(+?X"&Z=]@W@$&S0Y/S2R=A@#QN.80<-V7YC+$/R05D>!#&/5NW+-V/
M+GPW2?AAV^1TKNN759D+MDH<[8<D<77CO28!R4?T-)>5Z/X2#9W8[0!ZX-R,
M<R,&4,@E#E*-4'T8#EUN&@+HJV)(#NJ>\+VUJ!58%;;L@?HN/5CDJ.<<*ACX
M9M"6Y:GL%2]$S68PF0V/"6HXOC DYAQ3;E BW;?9Q86 WQ4)".C2?E]\*T$\
M/T'&*#UPYF=NZ-&J@C!>FPSW1QW)'>8*CW)1KC>/OXV<U?B/JJN23%UY!DZL
M*DA7S@W!C9)D=. $48>;LNV*,G#AM"-OVY33E2EYB2QJB>^51&\5^RON-WN4
MDW_R^7C"Z<38N>\;EABD _V-FLJSU(Z0N@.IK$-E!"9$W-[( X\Y:&4LUOG@
M=E3WIU1#B9#( ]=G$R\EGGYC/O+"J.&_D.OD-GST$_F%HKVCV-A!W)KT(:G2
M_.(::]X IE+5]&3<(48_SW-T'^J+9TC#ZLD?$4S($V?J3^&UK^BZD@!]PVN&
MXJ$6HA;7X_6+^)YE?9*7OZ<D.&,O1\_U(L/M $U2%+[RS92Q5[.-1_U6E,-'
M;-"HTAF30I)-Q+%;,C4O>#/NX"].UB6LW/P,NX=^BB%]9:/4>PK6 *<>3SU>
MKR@+?./(YW?L>\M60^\<8^K+TBRR88.>OM'_T*NC>E'-\H4O@I(A1W .8_ C
M;P+.[P%%2W)LQD,_O,@FY[PRZ-4^F_L1[=[<.5(;J\G=B_QRXY0AU 'BBZ%D
M]+2=\YG$-:N$CH;%J/>PNU9N32C%?F%PNI3CM<J:W&1>/4U<O''%.RJ$,VA-
MO_I1P-F)IA[^09=BV\F2=C@+ZCOTH%I<%/;@YI7:WHHT+]E:(]Y8JPRK=_%?
MPIXGGA5,&-AP.EJ3FISZQ,%8_3'H!X[\APH0OW<)7F1"VNR%^];IN00CSGO>
MZZN\I[93V[# % EA]!D+5. _A2_&%#75KN%2(8LN)3I8>B',V4X3Y@*4YFC
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M,B&N-#AILT$K8O,]_W;]'1P#]'AE*QF8<N3-7EOH>O.R$0AN[S;8[,9C'UI
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M&EQ,><7%K;?X6+0OR$GW/LJ&^@UBT3#I&(4X/3B#A<KBY"VYF6[Y(8C/Y<7
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MDP(YI/E6KO8WLMYK[UU"_&:<02Q>.0;Q@K[G5U/^\H+F_T8ML$(@_\G@'=!
MX (FG7!!L)=<"^)*>1?"S2G?[/PW'ZH/E,0-S1 "Y9.$U1J\6\XOB3><R%B2
M5]>K[M;+LFBK?!TW6>B-];IWV:>MR,5I#Y%".. \<J!B/*X )"7!C9DD?0PB
MQB8!T34]5!?K?@>!<:'B0O,M1&FKP3%($[+[&+&KAR2C7AV#1D:ZH#]#2TRA
MKR%X5I<8*LZ8HF+_+BH!:WQ_#(J.4Z>"-MTZ.@H7@MRK]SN[![E'I1]B452/
M#9X[,B&12*(4O77??Z#W>W_9N=9?]\U!1?6:B,4/ C+D5DV9=33](F#@@?$N
M IX9W4-K-A'02AX]+$?!FB-<\BLN?B;S?2J??Q,W[96.06_G,RBGP/@J=O[G
MO<N-4=KL E8R'CZ'^QX"B7SLVMR&LW?]H8I'R&P4SISY2,T033PQ@U@]W>Y5
M-7H,FH51S79EZ!B4XQ> #,%GH0U3;20\AO-73S^@>1"_O3=>&?2HE4BY,/0>
M,=JC3?7K5$_X,XOB@14XC<WQ"X[IN=.]P)Z3!<=9&JT5I"("R9!N34%<)+0;
ML+TFS#ZD?$/2,+6@QM#<]S1R ,DR"H4ANC-]F7\K1R-PKR&D-#V22@85?A9$
M4P?S+'7X!A27$#UJ2^#?5%(YL'8,VG5IHHZI4AAD5>X8=(D*>G\R1S^N:D!A
MOC1'D2_<A "&8(I!P=\^'@3+CT\BGZ3^24571Y>I4YC="=ZG^N]7Z]1;TO4H
M$O1(K/V46R;QQZ!-.ABU_P3WOWXN^R:B2&A7Z$7RJU:=,B#<&*CV*+]6X<3?
MHOO[8O@0/;$&J;*WWU%5@)&EQSZIB?X(E!LQ67MY[F0Q+6S87%)JV82C>+U6
MZ)U_7(GI>GCEPJ18>H:H3K"!QH^[,[XNHQ,6D.^MU&ZU6N1(IR%+>G_Y ]H.
M_NK<RYE$D..C<EI/*BP\D02,_M6O?_E2_O]N_=_[&FD!6AV IH3[00$&1%\[
M,[D8LAAIC=H"XY=ZT!=D46YG%$K5#=Z'E.XOXUQSKOM);J$)M?.'WKD%%2&(
MT[_>7"@#WRV6A%=[?1IM\T3>'#D'Z<1Z-3[NBO<<;U_S"=D,U1N%%J/Q3-?>
M'8/T7C!36*@*E?9'/;WJF'^KGT'@PB&D7&@!HM*6JA(0ZCQ30?VN^"#B@3-Z
M;P>?=(3,5+!<:R!I)U!%9?&/J/!0Y6,=@KW@H4U).@DF"5+57=R4TO0433H&
M4:6/>OO/4833'E1U/091N5GF49I.:#:B1WDVBBQ  P&TD!3C LK%O@G(*HY*
M#KH8J-WY@C<R&*DZ3;7#KQ&DZ'_K.]?D[T1)7:%Z6-0B,E24'$:ZA)4[MX;F
MD8'KJVN][_89AT0-EZ0ZQ!?_"-S=_NJ=$_N;^Z\T?4 YCCNJ?T6Q[%LZ1JQ\
M<_IFO9_+#R<?2<Q'EA)3:T-$&P$B@OAW"_6'*[UR@ BA#*^&-6[#<RTM]7 E
M5;J-HS4^XD:]6%_?(/J'O/7L\\IA+J+RZ+]2!^B@2A3(RQ<>8IW<;7_U5=;A
MVN:<^Q9RZ@@63>*)&GH_5AI;6W"FN$G2,]5D$_R/J/G ,8AE)QZQ2E5*\1+J
MA5P4GCU F!)&'<1<*.4Z$!E+#/YW:OTW6G\139V6;W(4$ZIY3F,&8EJI1%,+
M<61,Y?>"<&UH/A*G-W(DJ$GE=-5=)F31^DKQO[WCX3%H1HE@CH=L5BW::7?R
M^O>XV]G)'3BWNT>-W>8[&ZM,6/I"Y;5E7[W112%1)W%1K(X_M"X87XV2YG"L
M&J8KLWY<B%Z$FT2K>W3SK#".G OK\9YX%M<@,A6S49Z?@0VV^P_U:'IK95'L
M_[HJ_Z_J_][!&D3N!*J35'(Z!CWO)[GO^5,9<[BO+[^-1?.D#:$E@G&X>]",
MPG+#;_N1%[+!>ZI]):PFON52NG\<4DY)IM:3\*M]X%#3._KR^=9G)9O"P?:_
MB]I::D,?_",*'OC7&HI4)+_(1HR@^B"_0AW_@?9ZOY>[$7M_FHLBCT%"X.\\
M#20BR8'B\LN(\S=5UUF6W,#[ 2S'(,QIQ)%J$A#%]T=N.ZAR>T:>VN7$7YN7
MB__6>8@H%9(:4SV,?X >I<NZBI(Q##5S1^[2MAZ#JJP@^^SV&D0>RB!%FIP,
M<2&++VHD]60;/=.0Q:Z;EEY+]HC/\]F154==O>T0JHG_*M]_:W]C7KQO^O6S
MF5R_X9O55SV)EY0_]P5-+ZD,N]UO'6RS-L:_*AS?SO;[03XE5Z)ZWOI.5DVL
M 2FI]Y;4U@[@+?MG"%B9*6Q4RYSZ^!@4=74=O._UYZVD$4=BJ%>(OW*0\K_W
M*$(P&L0W*,6,:J4^_R,*K/#7;OKA_PDO_?<64_9V_ITI.>#N@(11Z28G+DD7
M,'59,C2ZH2&D8@KC,[["H_1EESR_%0_K-QMK/^S^RCGR21I;!/<5T&_VO+2G
MM3',#?,SVLP\FH[)@7:W:J7>[5X^.%KAC35Z]E7UV8#];JQ-W:\@G?]8B3?U
ML/_[2L:1$L7Z/OV%1X'7J3#7Q_^.)%1UP^(A.$O47#;! R#CY1>GNV'1!/!W
M52J\9RW./%WRSN;' (S/+4/6@4UU6Y(G&Y3V_.EET*E#,92Z#QB02B*Q-RPR
MQ[9ZX++[T:?K9-CM1RG" 9'\#VO1S#K!G%1UFLT0K22MI 4K9/XP?_[=0.>(
MT[WF].;RMG?@A>\1#6V#<*J-9=ZA O;$8]#H#=PAA>TUBF04@J#.T&UR'>0Q
M;,Z$\!*(P**2*%>3[F8;X"(BZK-AK@Z<M5RKGD7.%X5!7(\"'5*?GGX*XO=&
M=/H<@Q;?,!39=&D*"L:SP-GI($=L33N B,E6.(Z(/09M%>&C,":;Y,7@7&Y,
M B4O3Q17GQGL>L&DZ&L5C'96J.^^#L?>[7'IB['%X[6ROSBG+<;>R?W8/2*1
M&1X6W:?LKJQ.<IC::RUPKB!XVT_^^<2-75T[GV0!'&(2N,T;<!:Y[T-BU(UH
MV-8(<<\\9FTRN7PE^;EF;C0)2K;F?A8>E=KCIC!=!-+P_G;M@!51A"1ON/8
M7_1SFMO:*>9B7? [A<NS-CD.3YF%KXUW.L?GW>%%,QN;NTN4P.15Q^\4SUEJ
M./2B&BQ)+#6=S4L PA06Z6]V<]DIPP"PG_XHI_PYZYQX0G^S/$*2@)@AH"EG
MZX@&:T;8G9FE3@@]_,;KN\*W9Z$1FZF_AFM>7;WYK?QC3GS88%,_O]2>"5:)
MQ&+9@SR!<C3A"/V&YM54OJ&N_795YCWSN57KQZEG?GB0Y^;5PE9R^*N?G\&\
M\;;O7$(#HG31D,4W7,]"YR$UW%N*(0H+)Z*A[NT">/["I\75)9'06NO T<MF
MO^0&JS_Q?[%TEZ)5G%&][UQ!G[AC(I4SFNNX(R$%?K]O)N,IW%*?N"V]^?KR
M1N.#Q?CXQ(G?>TS?_G6=5>TO3OF0&B/]Y0D@E6KLPI5_O5GSF?17(9>O6;]+
MY,?J_%G2$.#'@RGTAD06TD5\$16*H&+0M:>SWVT$.6XQ$K+??Y_O%WEREA_;
M?:E/FZ&,@45?<-H&!ME<(3XA74B1]?%0ZFMGF(3",CZLL06RIX-BA*U&3?A>
M6+&_(U:D0-5(<F0DA3=T!H&[4Q4#K8/UFC!:N0>Y= T;HSORSHS#WEI=M)G3
MCQA>GGBO*^*3M_5:_:><3,)@4>@7T(GGE^FT;";NK<V]/OSVE<FLC:"I_B?O
M @>B4S&Q?I9($IP4;K"XJIF5)]U.U%1-H31\Z1\E3G\#US!3K96S"0-)LF$,
MX5B&H"]Y^;8I56*N2UY'IL7VXIS8D; X_.WS\TUR'0-5VE7I))VB6<H $F=J
M0K^>1W]RI M92^-/L)<873KR6,1SYH ?AYOJK'ZRO2D2:?06YF3Y)._Q2JF5
M\J#1G/DNM_2EEL)_.7^W8^)?@\[_OQ0I? V%B6K?TZ9'(9LY]ZG6U^,@=& Z
M(?0;!&>"GN$F%.-KP:RA:B01ROR41^W$Q\@]8A!EVJ-9/;'TTT+ -TR1=ZK\
MGF_'^4/ 7;'[YTQ6CX51W["K^\;Z]*_ S'KZ2@C=9FEM[O@TA0<YXL1)K#L&
M,;E1!Y/JA$<;CT'+F'+$KA,8]ZL*$$.3^9(H]KQ49R9FN8K LSR#'AV:;2=1
M?\(;?E>]02B$'OZ! B]K+;>G22IEE+,-5+Y.I>@9D51',_ *T9V%6LQ&['M"
MC@+<P:1,/=+-"QF4D EB ;4VZK_R!HR(SC;(KK^]S#'HDY?7,:B(H$BDHWI^
MC= .ZA67S5+L!HJ?1 .8DL,_H%TK'OKZDEL0ONWSA0;T'DUY.F#UQ\] $%GY
M,.]-Q2,TZZ\W\"6%@*Q+[VM?U[?G)5!<)IV451L9>(M,B[<)E&13'<[%?PMP
M_F]67("JWCQNG'CD#MQA"<9Z?XW7.-=S?)TWK\@GN=/C_/KV]HWW H6CC;P<
MEGDD9G(YQ!D]:VRS 7L!X?5A9A\I?CY-:+;#N;Z]^Y2_0/GI2QR8SV!)L13/
MO332N?.R ;<&9=44=/UM-T&H\GE=HV]M7G_CU(]F03%ECF1>YY.*(]*236)%
M[FZRCV</5=<E^=5,QP]"-!EM#-HCUZ?6.;-F?RW<P0_S@0;7AY('M6A8.T\7
MEY[_ESVZ%1>JH40C(L \FH(!*.QAGUQ\N]BG*;C9DH>+!9$YBO)%9FMK6V[E
M->V7:GGY(R,>S^?R+'0\D'Q?H(Y(E=Y.%XCGL#OA%1X1!G&N8C?$(!D"H+9-
M8ULR/F@F&WL3[Y^W\'PQ/_-XK*QF>,(J)\T%67JX--XH8\7%2M7\5?!,K^YZ
M6VHF1E$8J\FON*Z[ "MXQC3(U<)Z>A.L1R)$\G<4090<#G$&?W<WF%*7QPDL
M8'?,6U-%\4PUY6ZL/];90"WYL3=BX]@P<33WKOL[KH1#DZ X @R0\B=S[?P!
M@*Q4MK7+#ZYQ(7'R$28 #:+E0N@W396T>_CTJ1IW=]>E$*8018_( A>VK9>;
M8:+WBQ*\EP=J6DXU6;W8+(WHFPB_FQ4*'5/!0!EYQ,]_)Q/S6U<(C\BE[6RA
M4V@F82 %EVW:>KE,.B@R^X.51MTOY)4[M\UTN\-7!ZWXZ-PO5^E6"9EZ^;D$
MN=U:E>I">"3-G$3,:D)IX'=Q7"4.):3K !2K7S="9[?^N&]L.7TI\$FEW\DA
MAO:[)]?/7;QS73U\>\+LY?)9;\%7]](S,<AZ[G"*3.@WY$?+!!(KYA@4:7E-
M\PJ>.T*LO@'7,YM;TVS'=6J(O3S/[-)<D^VG97UIEF6]'N0G%(E-C; %]"]M
M@7M1N+LFB<WDPY?[-JM5)F&^B LCY2/OA_@\]0LUGR3KL IZ2F[^=+INNP,N
MG;"8P"M>TNJ[-KUSQ/,UWD7D.U4%O[K]ZP[=?\7GV*<6$=_]"3DXY.8A,8@4
M1(YNEW=G66U8$ -*0[ CI^W6V<XLM7E<%RF>4+M =^4\[Q62X^>"7QT0N&4G
M"F>% $0K&X@/5PE(@?935EUH%I]SX!J[-9A0G^*<J&@ZYQQ]39]5/9?@U>J[
MNA-50Q[B!#35X,:$?IG>@U^&@$,O!CQ;,D (V9VR:\W,^OSB4#W[[<*=_@>@
M'?N<IZ-].L8YY;^+O9I'F(X<:U='5K?;SY +CT&NT%.4,3#.'/P<60/I; M"
M6VN>G*[C]^Z=341*O#[G.C8\.'<4U^ES_X?FV1/%-[\N#D(D27;$)Z$+T-J0
M'@3S 7J6KG]!V,/"1 C"O#;[B@BS0BTC9RIPHN+$%I,QE!D5*L:"<;=AG*$#
MJESOB%JDP+'7X_T"(A^YLOQB?\JOS@8Z^;&Q=N19W),N4.,\F?;:E^9C=6?G
MUV<M-09!JZ)V6)$"SA*SG4&)_-;NVG_OZ5J[%^GZ[+0)"8V3FA* ,?DB3J:X
MS+\HP",_QNI@JB']76.[B^!6^(B!<(P9[4LC8?FSG*SOZ[/97=4$D#KP9*0
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MXL'14^38/JZ;2MQTD&:]E"F%SZ)S@@Q2G.L;W9"'(]_[F&>TNU1?5R_!^!>
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M,FI7^_T:.Z [837G5O8K7^,EH?J1BH73H^>TM&\B5"PD_4B6)6[6$!+74*>
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M]\MC);+N7\[(.08EI'8+XJJIMN,YF'5 %N)+SECAT_;*RU8GL*X4ZX0$4QV
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MBW)<NA7D; PJ(91OHFX%["M#\ZG+,#@P30=(@=I95(CJ*$ZBNOI<&TPK^X?
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MI?)P:<P,SLXT"OW=D4$7Z59:1?U ^$U&&:%:55%>%82S9,^1SI5$8Q5ZW4@
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M" Z X $$ ""@  ()(-   @<@\  * %!0 (4$4&@ A0-0>  # !@H@$$"&#2
MP0$8/+ $ $M08 D)+*&!)1RPA/_O;  /!?!( (\&\#@ _Y_S'S84"B"A !H*
MX/Z+02$ % *%0I!0"!H*P4$A>"@"@"*@4 02BD!#$3@H @]% 5 4%(I"0E%H
M* H'1>&A& "*@4(Q2"@&#<7@H!@\= F +D&A2TCH$AJZA(,NX:%X (J'0O%(
M*!X-Q>.@^/_R^*]L*!) (@$T$L#]EQ82 B A4"0$B82@D1 <$H)'(@ D HI$
M()$(-!*!0R+P2!2 1$&1*"02A4:B<$@4'HD!D!@H$H-$8M!(# Z)P2.7 .02
M%+F$1"ZAD4LXY!(>B0>0>"@2CT3BT4@\#HG_CX+_&(>B 20:0*,!W'^,H"$
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M"9NI]-MZ_O=$';T$GD?T=2O_O;#-\$%3UHAJD4^ISM0D]BG)=MF&/^R652D
M/W'\"M,<82/[2JXD(E=KZ7LGXK6GX,!KP A!;,S1ZL-H,N;XT9#9\ W'1]O,
M!?<O[8@N">Z?RG0J#UT(642O".S;!HLX\NR^WD&5SR^]I@]KZR=O5;NPSOE*
MC^-'=+C+QM#DZ\9+%C0<,MO"4*< 96-=XG1Q6!4(BO>['^8]*7C#M'LM18:E
ML=6,M;G*>H=E%UCJD?,3NH<A9"<D4M.C&*8@"8QIZB^WBG=95HNA#/!^6.=
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M P1&.IW?RJ4;;#"SWMAW,.12_$:>9,8V_' @M"*FTC2Y_/)@LY1ZIWCQ)_J
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M-[G#]<&%,I^<Y2UW^<MA'G.99S#E*W<X=&>><P!'PN(Q#^1R=1YTH0^=Y>R
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M3 N2*\E*).[M8L-4'^0OY&/E=C<LG%GP[$RZZ<_0OL*FN#6R4<Q-OAA/S<8
M)^;I(?+U\V,H4CE))LG.!' XAT]L_@'L,N8=K4TS7D8HBWV)(_<V[,_R\<T7
M[,=RRO-I6LL  @  !*#V&3R(,*'"A0P;.GP(,:+$B10K6KPXD9V 4!@['M2W
MB*-'A^P>C#Q)45\MDR<UBEPXCT4TE#1KVE0X;\6=FSQ[^OP)-*A0FCEW.PX]
MBC2ITJ5,>>HC!*3I/GU69OK45RB.U(H@'UCMB/6'PUU1MYJ5R"Z 5GV[$GP]
M"S>NW+DVTZYM^Y:N_]Z]?/OV% ; J]1Y:H+.PY&WKR(((P$+9BAO1F*_4H6I
M$*AC,N7-G#L#M2P0B&;/I$N;/HTZM>K5K%N[?@T[MNS9M&O;OHT[M^[=O'O[
M_@T\N/#AQ(L;1\H+5#LXQYL[?PX]NO3I<_6%V305>]?1#O-9.15)J\&G 9@/
M=:E0GQ\ 1A!B!6"^HK)E^^95B2\Q'Q4XB[Q&'CT?1>A=),Q&:!GH7G_<):2/
M)@_ELX51]2TBT ,%X41A8!?JPXM  N!WE'H"C0@ @A/I0\R"%R5#7S[WR34/
M  &\5)\*)HZD3X0?K3>B!1#-DZ$#]!DT#!4RIF$5D ()>= N) Z@(D4N@O^X
ME3XJQ+$=9RA&B10]%Y(6X&UL,:9>>UUA- \9^C#R54XWE"54@8GIHT5@;:J@
MED7RK$"C1<+$,4\.!I'%$#M\4E3@*1AII&A$<C+8WXE^M-<0/8O,.)XB@NTB
M0%[Z:#H3IS,%8^">XB%%)YP=X7533GW&)0^>E!H43(E</D2/(I@:E(].)U(A
MVCZ<*CJ/"LS122:PT7 H@*(@^>A33E0.]B)IK,:E'@>E[?FJ;%1Q]!2T*]WJ
MWGX*&B1, J1VR]. [A$2 PLOL=. L185Y5$M< 135DS=XIN1 $/Z*?"!KXXK
M4;@,Z9,,"Y@<6A_$.9UJ4$[81<R<(M#NHT@%2BG_/!*IY$8T\5YNNC7>(C'<
MB)$P+&2RPL41L[L0H^--NH\P4!K$J,U3 3L5SE=10;%9^A!=6C [8PM5:3G9
M@=LN7HD(0 +0:)IA#E8-DS671QM1[*S"!(#)90AP9-\/=9:';K-M*\JU0&SG
M[#:#?FQ0"Z58O5&%>,ED^,.0^A0I(W/MC A$KQD_$$EH5N4J(QI5@*TU(R)]
M.NM!,8:V#SV-:\C0V&@(I/5XA,^M4%IHF'WYZ>8E.E6' /@ !F/I$3Y0*%0O
MG9 MH;AHE$96/=7>/%3XZ+,^?QAQ]*G7'A1WX0H56'9@RB@B_4-E,O2WW.;I
M(XF'#CHI(T?1EV[?#3*"_[*( Y__D)@\B"O.,>-')F/DV0;1$W[N#<VS-B35
MIPII6-NT]I&63'RG8@[K5.<^!P"MZ0=.[OH(F^PC(5XX\")'.P);'B,/EAV-
M.:Z""/]&%#BZ54]_]0E#Y%8PK<$9R7\@<0#@HI&6RR&,0;ACX3Q<&  TP)!C
MMO-<A0IRIJE$:FPN?$ R"&C ME7O =?+G@RS1SW6"4MNW4I& .F3OO(Q2%/8
M0YT7CY0D%P9F&4<3R ">404TY.\E9PR  &N8H<P8I'L 2&%."E@B4,@N6)WK
MG_YJ^#G1'$X@&YO-I\JB,)6PS47%&R)(4 810W&D%IAD!P R\Q2OZ(=)G.+(
M@/\TL@QI&807;$-E>@AA 7F@+";*H$(EC[4(E*VK/D";!Z;H031)DE %4?G4
MU"A4M"9A$B&^!!<AIL9*F2'$DUJ[9*@,9#Q5'00PU<SE-=&F+%?N0G\=>@Q"
M=@F23F4+5U40R8#4HTU73@4J4U+F6U2Y#U86C9K1T$^>2JD]6,)DB/ED6RT0
M,).Q<41I,U&E-?7C%F7L@Q8?BI@V*_;+8-:";8!!:"B7I2ET!>!+"-E3,;TY
M2HX %"<K  6A$&@!EWP*?5I@S+ ,LL.%Z*.=33H #+*7D15@*5(5@]A!3%4?
M ,1 ("E,CR+0=SP$1G!9SUS6(KH)@&3N YV+<"!%2;C_ N91P79?6PA7U7E5
MJV95)5.K:D%UA[#M>#(JQ#B: U1J('[Z4RL W64VI5I-MS)TH(5Y*!7<0H_$
M;!0.T?CKG@KKS:,5$U0*TX\ =I+#B$$695^MT2V5Z):4@@0 42G69$NG4$EJ
M)6PSNXU]Q/.4LH#*((MA:Y((^A"IS22$(H$=W5(YN:(RYU%T:Y3FKE3<]$SJ
M6\*R@(NPM$-IE;5MC?45)>LW'D(P9D#X3-T&2WJH EUN$1Z;WJY<-=WD)B2S
M"&Q6>N64J.L&S78.(=4I8ON@*AC%MZE*"']M"4SG+1,G]D*(>.=INV9JCT<D
MNFBQAFK.0;G%MD4%5'!IRY*G_]"7F8>Z;D@C)AZ\O+,0C3S(2C0G5/M0JKO,
MG%%)EE4(./CL(]JM+G;TDSF67LZM(+EH0^CD(PK79U?9M=TN<S9@G8;4MP5:
MQBE1UQ#[9DG#6T5H>VEVD'4].6/;1="G&+.8@]"",;[5SQ&$FUPJ#UEWMMQF
MIYCLP.=])+I"E:]3'R.G<V',1=K$+S#U5ELZ+RY3$,@2B.5KWZ"UYYT"G2V5
MY4%DV@ ON] *\U3&A3T2914B\MW>E7GF7J3MHYZG+-@^AI$)R[229?/TT2Z8
MU\X ?TK3636>IC>B8%G7 @)6&==@?Z;5^K :7\^3,\^6-J5BW7I@!_%9DVU-
MHF:YI/^$&)X,BC+1N(V ['\\;:_@!#I-+\.2?K3Z+O12?9E]UJT6VHJ8-'5*
MB'8O!-6J9HY^(I@)JPPVTR2"0_-2QFN<1KBH.]%UP%TD$H8"1M,#WW:9_CWJ
M:B6DF=]BAUN:;!!EH+J)4P%5!=/3[>G537MII2U]%9RR@5=,X@G1>":V  !>
ME_H4UX)X>HB![1+ICJC[.'%.HJ+;A:$ZVS3'9/.V$PPK#^H!4U;0@.A1+5(C
MB-U%W82RHWV*4B_4W./1 IS*9)\#[H/G&C%%TVZVZ",YJ-41C\]*H %N14\T
MX#TW";]'!(< 'WLF"ELXB9C.\W'Y\MVR@?KE_* M(=?6T@+_HK4#B2M>%:^\
M/9!O%@ ?D E-/'&X7/_9HA\@# E.#B0;KK!"N-5V["K1)#47]>GEI9!V8*KF
M>C8P)L-.;8=@O+VG*-EZ.\5>E90>72KXP3 V(;)U.D0?$JN;>L[,S T^7SW.
MBW ^M(!YS5_8S?1YI$$@C>6@^?CZV=_\N:GPSPG'77,2IT6&&3]-3-7SPU W
M"E[6T7D&M;EB5Y+\ +6*7J_V:KPG3,-P/0$G>Z$0=-PF(;^G(H8F+" $>ZNG
M&?7$((ME@$NV08DR3DFR?096?,<G,G/'=XL1*@\ #?LW/2OP \2@"7)R+9(W
M9L*R--;$>&%&7&:V<EKQ*-ZW#^!G-S$B9Q6/8FQ!(V]F]EP+LT,% @IQAT^#
M$SX>A7@80VCXQ2LPE$1=L6T'88'IPG<X(RH*86EGDGO_M&$EW],T63@N84@1
M;O5]>:)U$/=O \(IRT!<:;%HK!9)?Q #Q?,B;+@C);9F5&B"%)B :%8SPW8H
MFD1H-7->?'(TP^==C2)3?B"(XJ4\@*9RC%=*5LAM%Q-VX\%R_\<K?0,2Y35W
M_K5!AZ-NC5(+T (P/[9^;F85G@1]"!%2(PB(XX%<%&@0M:<YF*)*A8APY89#
M>9);MU=GHI9>'(99,1!> N-[1Y-A?N  *L@0+G(QZ14,2:80N?( S':'#D0/
M6I #S!:#$\AAL$4%7E%J.(0@#[80G*AM/$=4:1$&ZN@>])AUYW4EVX%R'&,!
M%/91W%4M934@KXA1;":(6D>#_Y,1@T)%#P66'GKV8G16-,7B04W3:8O0'AA)
M1'RG(+O8.;TH/&SG2T5#D H2BV9X=L]B<@<19J8U**PV<3%3+E%1>8U5+:&8
M%LR!#%0@;7GR0YM&7.XA- "5A#0I+ 82#'D"D'V3>HPW@\:D1)NV$ NXCE,!
M!J7#2MT"&*)A*8+QE&L!C&W36^JT"P&P$\8$C_?5B1TR?!1F&>ZU")*($)/6
M<61R4)X24OI@"PZT2\+@*^%&0F  970#+HJP8I&F4UZ7B"04!FPS6\9S9H_"
ME%\9BC$Y%3.($U)93YZ)01(&4K.$C4>U FI@55ZQF:_EB.#2CJ!V7U2@FJ-%
M7[5BD_\(00]&Q2KTL 7!=EQ)IDKT  8^8CP#AWH?I%- HP^-0V9U@XG/U#F7
M0B5T:2,S,89CQG>$8"<,T8$Y8R-L))T@09ED4E4<,GMGPR&!H5Y)2(JP@SE%
MI3MKV99.!YUNPPY*-W$J4!ACV4]2R1"ZPAQ%HA6/18'VH9HY(R\P:3P&HD$S
MD0S\.9T.L"PG9A SF)DSTH4HLTY/0:$UXD$\-X.]0GBR(0R/P0XV8@IQ=2[E
M6"$2]1!'66[]Z$[:UHL=1'R!$0D& AH.D E1Q5[O BTOUCG[!T ONDV784=#
MXB14I%&"T70O%$.%D&--PIZC!0!,DHC] S])>B3,UFP;-"#_H!$ :D ?\@0:
M/P &*H>E/R )0O6#-D(SAG<0+NH_HQ95G5,G6?HEGY.8.8H F5!3>(H\&Z20
M[H9 R,@@W*EIF (:@1I5S>D]XX&8[6&G3"*'.W26@V(]P70N.W4Q@V5$)2)V
M\P &7SH5O6B!$[<K _AIMA8 ;["CC5(L*I<0Q>BE G A^B&(6\1P/',9?40?
MY/-W,^&B9:H9MB8 ;]!566=J)RFI > &O0@I3*5/0A8)+)$S 5"E'P$X^C05
MC1-$_QA7GZ.E1F1']CDD$_D]^^%M. 6+A4FF:4 ?NY<6W:<%?]HYI[JD17I
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M7W*D_7HT/AQ#LE-1]6,5E4DA.CQV[H/%)PP 4'+$1F($!_9IZYFE:\=#,^0
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M % <L%QO@<AZ*G2YTFFN3FOS$L=\^$,@(D-SIO!?[K"G!0 X[2T<6I8* !"
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MLX K=J"LSJ"YTB@SC7B?^*,%&]H$^H,,-Y0,=PR+BF@1L5"(QJ&8_ "QV<C
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MV#T4AFX)AASP'U>>K2V39<=)(@M 36=FYG@&@'D.%CW5/6A&HS0H)&);I-A
MEE2VCTP>0*N0FU=C&8 ^1:?;M97>L[4Y [F1D7=[@)]:98FK5"^C47VC)W\V
MCZ5.+.,J#,!9Y;5)!JSR",1[@#K:I)U.(@>PSD7*%@Q6$EI@&YQ;"$BVG6>.
MN#>XG5>>9$5""T#!G7B6--?#7NH8G+G)!"1ZU<)P- 1YMTQ;/931 H?_6.L9
M\5+KDME%0)G*&;W[Y9SP23R<>%(J^#LY74YQ<3]?(C!U5#NIPQ"" P.^LQ[6
MV[H;49R[7FS5(02:^>S%X)Q'H1NLN(O-HF(JD"F\CKUL$BK0GC+GYI^MI(Y?
M/ E/DM+IC#C)8T@3P3U%R+0I @[:B(@7^4Q-E4F30#P=2(JQF;T8@AN.HP*%
MH >(#NZJ@=<#4I?Z3IMYTN_3S@J<$.^DNHX-_@Z\EJ#4QIH*^1MIPYT9$9#Y
M%9;1T]"GI$?2<YSV]CV*^" 5<(JMVM8G))F,2+&K@ 8KX(U"L . LVW+PXW<
MGCK_(\Z(6VR"LT?,R%Z. $^)^,\ ZM8?7A#9_RZ,J?MP!KZ+Q,Q=Q/#2EJAO
M:%#=@;&-*8L;^)D,F"0]MHAQQTF)GQ(1S4!>47V6 +CG)%*(B<(EM :E.*#E
M/"SR-:RH<_4:_'D,@,%!?,XZKUA#TSO$H$(6G7"]5LH[;DXB@FN412JT--&2
M/)P<LV[M8F0F;KIL;U+D)%:N_$5B*.R1)F9.!/UFE3% HZOC.@8*4FM%A4V1
M>@ .0/&_C<E54>&8#EX_9)WC2"$9B3]@Y@B;&7,#T@63F% @ 5@SFY'Q.U%3
MT8Y,[\T<!0[-*Z;*<! ZT>;QT,RD&?7** 2)*)2<@&B1T;Q2K1SN]*]_:I?L
M7M&8T[]2#%Z.F):Z_$!BV6U"_RCT\KM$(=V_O&$*/V 8Q)+=,M1%35?,?4B5
MA4 _D#81]%"_?-=BHT#413*Y>;F/79BR@N",52^$5G]WE:D0F2[X.J[U4ET4
M==EN38<##=1 P\.45/>#=-Y2'^3L**ZOM03V$AO XP"Y-;Z/9A7!MH2,$,E)
M1B&*BQN?1%850!2[XV;JR+HZX8%3BG@B(U 7FU&!PUBWND#3; ^U>N3/L]L]
MK:$0 ^5/11AZK9$Y=;EL&%F])=T,14)3G1 [9.Z6CJ@+G]^NHLQ'A,D34UK#
MH+K&[^!#U@Z%*B&.$ \ $QF&3*BC&&EC 6.'>8J,,U_#!TA$N:B0*RDBSB"2
M#5,>JO\0AA_8A>-+%.0F-@(BJL@TW6X>;LE?O[J_PL+WSA2#P!*4$_VU8_ !
M?&B\)&+(A$PB;[:9=8DK3=)<[Q5](&;<C2HADMD4_2ODP-S*P71,V9U0!L&/
MQ:W$C<@PQ4]\""W$"$TD()*0\"**"#T:_0\>(VB9001IQ8H(<701_,QIT%;K
M"M T"*>8]=-] +C)PPP,&+,HD\G/EI+]0(!X$(T=BU#Z" '9IU"?'R/ZJ,19
M"%&APGQ5X"AD-R#:OH,<]K$3<"JC (.+  C(%$KAO!41*5K$N$\8@)HV'QRT
M0+$=BU/Z%CT "2! &DT4@PF(-D^%S9HB0XZD2%'9L$Q;  C_E.=2JCXM 5;^
M_"K4"$L5"3@NU=E144E]BFHBR+1,*L5Y!?>U7+F/+30M#JA88!> ++NF-2WH
MVQ7@Y=*S=(4M3JNP'8 $;@TOGAG SBX!801 HR*P:]*, ,@JEDDZ:F..,U%&
MQ0LXK%ZZMF_CSJU[-^_>MV-2="NP(U!HBG3HGD<%\YV9 N8Z/S6O"N,J9(4]
M5XA]63XM#S)I2G9Q+P2ITV4*<\R0+%+7=5?4IJ@5;*T'T.IS_"EPE^-]P(-?
MM$@<\@P V4C;612'6^4%!Q]%M$!@''*Y*0)!?L4=9YL^]4%#R$?:E1:<(D:$
MA)9U^] RW#[\<;2=0D@MDY@ ;Q"C_TR% R6UH'_6E9B;<@EAYQIVL;4C%DFA
M3'>$0BPJ1 ]$^A2BEGGCT<7B>N_)U%$M < QC(WER2,60Q^UU!Q=Y[%4Q1%A
MUE8A5WZH!6%^%4JH&TV&E18DB ;=N%9YV.F%H'?@B7>=2,%9604H5?CD9C ;
MG;F"F5+-Y]\*&,E)W'[]/?32;2&!LLMH6B14T:5.,G;IE&3-I!Z<S@4:(CV9
MG)00F^:INL^C[BV$$$7(9)>I/L-( H #<['8TB:VA01=<%MV^25>1K)$14D=
M$7)M,%R6-5QAI=*F$#&9@#%4?"_F&2)2D@00J@#LKA2,80 DM,AFW6I(Q0^0
M+;N//%A%0_\(9G;@I<(/@(6)!A5D/:3N8/ML:>9#D!8<%'%#9>F6 ,FH8+%O
M'X,<LLBYH2I5+0R2M^*AN"%5VT%!0452C"JH-E',*H>BYSZ4*8A?<%0H"1*D
M.>V\%5=4H/R>F4#MP[1"3,]CY%*>KG4#?/K\<8.W;5&!D<]-+KR0%JB%J&%]
M%+G9&:]/!\6DKM=*E5XD.7 $G)LO0GIS9](9_5!0@$(\G&)A]/<;8"#!+9C+
M8:,;S4,R*<[2"F2OK8\*5#>^8G\M><JY1 )%O>Q!"1V4]$*75W31E6NIB"WI
M3C?==METO>Q>U!B%I!=4^E$$U$ !N-99SB$6%E&S4K6W8@QT!Q[_#<^T^V$Z
M7I+N@RKOFDZK5TM9:NC'7ZQ^S;E%K$Y]]$L]CHYX\' ?55+4\74Z&>IT?;T[
M[))CM.M#4E(T9*0O^4TI#@H.(<1DKY5 AGQ4<,R_Q+*4V;W&8Q3Q6?B8\I2:
M#*<='>-58@# O%T 0 =K6U$ ;+ R=I@E&JDQVU 4Y >4@,4/#X,2MU:X)'K=
M$ @<*8P85+ RS<0 AR,;(A&+B)M\Y(IU^<'/4DHE/ +R#V((B(:+HC.=ZN".
M6\BP%HXP,@\P<.MN:4+/%#OBAX_H PQE5 Y[,J,?I5#'3SKJ"(2P%92P<"^"
MCGO+2X8T';(H@G_YH ("#,(+!,REB1QY_R+:+*0ET*F@5+SXRH9 IZIV6"LV
M9<D,7L8CQAX)!B/)R*237@> /^7H;DLYC6Z<]!'_.8=73QQ&V*ZX$*;10Q'<
M:N*2W$<EJ?0H&2M0@Z;<\Q#21>*4.VK.3]2BF.;0PW=HJMY$A*</7B@S.(M0
MR]TJJ91(]K(VRCH:D%:V'6_2L3RAW,<HDR*8B,PC#-R"Y9(<LT[>N<4Q;-25
M&Z491[NAK(ZU^PD ,$<7><&M)<2,ID"<1+=H%G1*Z%%/V-:YQ:1@!Q3%M&5=
MJ)1&?:J +-LK6'8JA$3TB*5'VXK(&W-'.RJHP7$G*<](?W8MC:VD,"AQW'(6
MH].F).2G-7'@!O_'UQ'&K04K!0- T AJ$[& L"F'&J21"O,PA2!#J<II2G\0
MVBB '=4P@@O I%9I$WV*9B >K M3*%:8PADQKG)MY41NB3*GT4,+&%3&E#"W
MO9OE[C\GU0Y3'A"):PF#*0[(Q&Q\!Y-<:20_OJI>,E&2I<0.)0W0 >%^@N+8
MV%T()6B87T=9!1G=!2!&3_I:)]^P' ?4)J][Y8K3KB=;8\WE>O/0JP,.ZZR%
ML,4UENN9BM(XS\+ZUC\]?<-A3Y$[=.*T?YRL"!6"FAW$G0NS"#"*I;)$CV0&
MX WSV^ULXT<7>H#1B^4BRF]E,Y0W+*(TG!V(#Q'(%/8>]26#G0E3?J#0B-:!
MQ(>F\)EM]8H5OO8/@D,2#'1B!CO'8M:PB%4L8W7BTJ,,K0KT&8X^*BN R]Y7
MLS=\@).. %W'$C0 :%#5(*-8,=NM5\1X*9< ,#&YHP4MLMA22X0/:]^:_&"S
M8#UJT"CK%.ZR<SD(:*XWR0N 0BXDO?S-[%QZ=*;E'G:10WZ(F IAP,KLT%S_
M D)BN369<CU9>RFT)4<S<E6VN(P73($R">%K+.XVK$WLTZ!Z3N)!VZ50,^#2
MPL;" ( @=\2&3:HL\\*UH:MN" !2*@R Y_]JZ4MC.M.:WK1MRL3I3X-:KJP-
M-:E+;>I3HUIDGIM)J<R7ZE#K[-5&_):L:VV;0<+UTHHQJ*U[[>M?C^R=B<XU
ML(L]Q%4;.]G*7O:FA9T8#O,BCRH;(;-WLXLUAJ'5MIX7M[OM[6^#.]SB'C>Y
MRVWN<WN[VNI>]Z<Q2R]JLUO=!)5VO.MM;W6[6X0+:02OE,.^>]_FNT.E]ZO1
M;?"#(SSA"E\XN 'N\(=#/.(2GSC%*V[QBV,\XQK?.,<[[O&/@SSD(A\YR4MN
M\I.C/.4J7SG+6^[R>V_/K'!!<I.*A;'\+&=>#LE6;0K#JK<YSN8/<); S:P0
M6J)$HZ:Q"02C4\3_>6SA7(EQ\0UM,C3MGHO4434,KW<SC_;*-1ES =RO&QB?
M!VJRB,)H@7N03A1X2P6]&(3.-8_LFGC.UHQ-H;J&;([?D"EC+O\Q(CTO35 (
MZH,8,I7@R!X(]TM/\TVL)*#1019X[,WU>C29[J8'G_&;O;R(!)$.4YIB]*TV
MA6X/X;:)#RB?%;0:/[60ZDB<BC&%_.NIK-HZ;)AUW9&%95(*P::VI4(+%S-)
M'U%'M=N(&#7AR_5]RE[*5;4#P^@OT#5AP@A#'W_,12)6+%K!"-9^ /Z56 3Z
M7J]"&O+#+O7KIE(EENN%,7W:V^RJ>6H_0 RZCNF'%!D!@1E;5=_'5,JG_PW2
MSWU:R6Q<%84>$44")*G(,!#:G)B9<DR76V0@SU&$8+ * #H>08F4"M#-4HQ&
M 1D/P!S$O]E&X8&,,%B!C8E3&*0!&!2?V"C@4?W<+O =IS7?L0V0I;%#$!8;
M9=P IQ#"#31=R.B#)/16GZ%,_7U*B"2@6X#+(I23<-42M?!&5^3@#^Y&D:#?
M+ZG=$L85Z$F%E8@1\!&"$2@"\X!:Y/W,#=R%=L1 $GV,]"U@'(7:?FD<&HZ<
M/FB7TAG9H4&'O%0 -@7 )G28L>B%CBA'X4 &/&U0_[R!,=G+I(2+_)!/%=P!
M"JF%8 #)#,57C%2@;)Q%5P2 H<$A70B&GP79,?]U(!<N!",81!7TRTS P89(
M28MU$N:8E_I(!1(IS),18H)A0F$IPTE4'LLLX;#D' (HG=NUWSS8A$[4G3$J
MA"+\Q6G\EY^U8EU<X^ZD2&6IP2BEV4+8G#3BAL!AA=)]8TV$XWMD@H:Q1 Q>
M"SW8W)]%SK"-T#R,P4!0#%T<8&]@C4/PH>94SA\8RN.Y8AW"Q'B$1#)JXYF4
MG@4XR0_HE9E!X\WA!CHNV;4D@Y]QB0IQ2G4%7&4]@$9M711%U6;4@@.<@3RZ
MAC["Q3$^)"B0'8H8%DTB#D5"V1L54T?>67YI""%40"U\X"*X%@"MH])U9$F:
M%6(PS7\QFG Q(QJ0H8;_ (4U.H4LG:1I69 F[- )_1!%9.1&J@8V^>37B"$[
M@2.UA83-(9I%B(&YN"-LD83-P6%4PL$.K2)68(<RH*2;95W&\9[XE9Y3C 1;
MVL0!&!H&H86#F" PX1!-^!^V+&)P% +K98XVB04MN%&VI!UF+M5-C!!-W-$B
M)  TJ,V25!JN9-V(?$H W "0"=Z)]%*_60L"L>"W* 45U! +V@88@DCMQ=?O
M-,<^Y45'>,>>/)I!* .T%$P.2HYOQHB]8 1-3-% $8+%["0!"4Y;4.=26&?V
M[()I!48J,8]R(,;AZ*!NL .Q-8T9UB:2U)5"NB(EU<(!P,#M65NN'<1UO%OM
M_]C&K0S2H0#.WLC&#?J+JCA>34V2)@@;XJ2=<W[0M5A9E3B&+GG1B;R,=M B
M141@<"[E+H74:XB0@=;1-J(2<B9%3;T)!["#Q=@%8;+4=XKH2C#HCV2/0D!(
M6,#3C0V4=NY&'7F>FYU/=CS1/E61 \)$)L&*@;JGO]R4J @0^;%F:JJ@-*45
M/73(</""@ZCFXBT2E#GI8.C#,F#'@)71BL0FQC7,2%":"@4 ,:V(4A5&=\X4
M27'$6[:&? ! !;S&>8)FQKR%SBD$:]6=$Y$5<7 A"H$4Z>B205U87GB.+.:&
M/M@C5]0"U=T?2#A&,"!2DIWE0WP@4NXG6*C2B%;)O/\,9(*=0JC614K5X8((
M9:X6 N-)3G/$C,^4CZYLQ(4)A^\]8H4(Y3X0@O1,SQW,PPS(%!R$YS;^36E(
M80N^*:48C4'ZCE%])G -AR+TF8,B#[$M@H7TX[1.STHX":LXR2XB5:Q-D(HP
M$I;L!:'JIRNRCZJJJ[ Z3BWTF4#4WQH&1T/ YA*IB)ND:XZ@V-D\!M<8U.CH
M@Q7$"P08U<!" *HFF "!17$0V']A5UEDYALQ(%<H KYBJ<:""(Y$!2!V$JLD
MZ5Z,AL%JK-OD VG-HO:XA*82Q",6 J'VXWEPZL\%23]"1:869L?1VM&$B E&
M@[Q@8P$Q$R%Q1##8:"6:1D+_*(:A]LJC+D0A[%E$_80"<M9"K-!/L$]BT1E=
MG(2T"<.;)HAPL&QR>*)M* *YXDJ_L.6^P%6;G<S#NL;=7F> PMNL#,-),"Q*
MJ$1&.(B\B%7* "G*],FJO@V?, BGZ@6+W$E32$_SB<I]6,SUK&H^4.Q\SBU>
M:$(FZ!5-I:BH[(:.#>-6ZH9MY6?SB>Y!V6>^BD@6DL0(O66"I$X<R!QCT@ZI
M=&!I#$LF4&1$M$P"WH;;/-OI<BA'B%$=.6Y3\&K(:F\W^8Z5/9?#DD=^9,+A
MPL8?Y0MJ& $]:!AP;.Y-W"R>.)>1N(D8G6N^<BK!-5)WW0:@.&]S'@G9J>M_
M<-0\(J3NZG9$)"0 =AT$9KCMRIP'\.HNEL)2@@PO;-S,.?T7CCC_),451A2M
M1K6<16$PB(<ZYP#$B"IEGW3!DV@ 4TQ)1:6^,+68Y_1XRGP=Q9LU;7W=\$ML
M+;-0#)J "G_L!N;2SJ=V8=<4)URIK,SRBDOQ(O[L1OXQB\%H@B:0G3[0RKMY
MFKP^TH5P&/C*IC ":]T"W88ZHWO0PEDT;&R.4WJFIP+;0GAY209K3FC@K7;T
M[1;HD&]T6*EVQ!9D23!PBB3XL;'*)RUZSH6IJZ>]ZQBU&6X0S9[00QALER:,
MU'KT+/Z5S98>CVVTQXE5JT/:WC46TR/!RLJ&+_:@4 Y4\3GE)Q2!Q ,(0PF.
M!Q<_,DN("8=\38H\;8ATQ<CB1\F^"8G<_X6G&:;W-AT#GM0UR;&-#$=>N.Y>
M].#QTAU$-++NBBN.0$?,)62"-=BAB*%Q9ER>O1AU[D,RH08.'<1F#E)W4DEE
M5@ORVHL+(]W/K;/+D&8',A5(I-:(N6((^4LERH,/:1(VE2 8$*>!].I1X8 *
M!.!M3(?ZT:9MA$]!S-& GHENCNW#1L5$ZR$D&V<SF2T$M<=;5N@+2VY*_Z-8
M ,I%=RJ+G#1N$&L@55+^=EI*'<!=!(DQ^XV;?<:%NF*V"@,>>MT6M&(D_T2I
M[-91QVN<<N87IHMKN"R"&LTR)VUN?$U[) \_RT1GA$&<SG0Y 363B)'">JV/
MT$P:ED:+IHS.?/]OZ'XG-&#A2$N'[%X)I]X PP -/P,C?(8Q[W OS"044=MM
M><1L+WTUSOW<K@".C&2=MZ+*JCW$Y2["#U!)+60K;H2J782"1>08W+B%A4F-
M15\U242%BSP$#HQ-R%UOTIUF323 V$D:I$ZM.TG-8@Y5Y^2<31RUD=Z2#(,3
MEK[V86SC4[U$HC+='@%5;>9 =GJ,O+AJ[.;B0AAQIZU OT1SR^S#,'#!N22H
M04 IXN16=7_T&3]O&25620B&Z&PI</S$&BU,KA+8_40D[AS*&+^$_B@"?%NG
MW.[#)*U$GR2K>8B)'VR-05 !<C2B(Q$4?<:-6PE1;^#:VKC4$&+$A$__[Q_C
M;Y0V=T< ^)& "-C=+S7)1,ELBY82VTCY6RBTPU;@'6,PA:'*[351S[7VKGR/
MQB*4ZCX]1JR^4ZYV;^(<RK6M!#:U#7K7UW =I3-="YJX!7_S$XK#T7%G[&?=
MB%NHWDF,+);.'T3'>/L8Q2@1!@"(DI2>5UW%!$/H4 >I"$WDL(+S G'6Z4\\
M%!(K$3,C4)=:S(D31P@+>50@U&$VH&(AF3N:WXO,]CJS5/;IS/ ^ ((%QSJ2
M)5=(+0&E;4%%<FL3MY%=(&[OE)%]F&8C@,WM,;[L!CT0X3;^7)7.6&:YQYUT
M^)G[P'(,'77I!"P)[H,BD*OR'BE#U*%-DH(,_T/IE?KLE8=3"0!W!?:#.!)%
M"^9SS)%%9*YCV"1*3+IMN&.MBRY;:RM81 +DE 9Y<8F.NX:\9&9&4-2\*(@B
MQ.K3S,MH5):9^1GV$I:U U>[1_I0R9C362@+66Q54PEFO1UND%=(^L2=Q 5\
M1E<[JF2L4)LJPD$@V;0[)GOE$(('W^VVOVB(7PP O($6''MD_L"$QJS*UJA$
M ! C'%G_A%CP*!6RUI;#3O)0K-B%^S5*[PC!+7R]5WR]2]@("?")H..XORDO
M440RH-FC[Z^*J<# 0W AQKI@C-; U_O ZTP5.>T#:KU!,F2Q!>/6 YR-#U$^
M=,$&@SU%._79RQH$"__#'?.&.%>;R_8&%P.?'[B]VH?>:P*;C.(]NT4R_4US
MW^/*N0L^ISG;9^T"X>>&5L ?OOT>R(A]R,!]QC%<Y5O^Y7.;A/>FL7U]X2];
MG5H:+PBZYU_,AI,^IPD\HG4$OPV1+N'IO<D];\2^;R0H3G8<YN-^[BO<Z?-^
M[_O^[P-_\ O_\!-_\1O_\2-_\BO_\C-_\SO_\T-_]$O_]%-_]3?_82_$=,?5
M[8H</=C^QPP#6NSU$"EZJ;F@#1_%D(&,]Y<R^=,W$?'O^'?:*Y_RJ[$_]_N&
M<AR!<O@?_P/$/H$#"18T>!#AP'E4CA34M^A!0H<0HTFT.#'B18O*EFG<IT^/
MT8.*'@_J(Q;M84:2*UFVU#BO"AR7,VD2A&F$9LJ7#&OV]/D3*$%]A( $%4@+
MPDBC2Y?J\V-AYKP F_;EBTESWHH8%9@B9"<@5,%=  *$%?@0@$J2^K04_9E2
M:<VO9A/JJX*SJ\NA;FN);&E5ID6K>/-JU-<W;EV(0>'6E%>V\,%@ U BCGQ9
M\(K F#D;MMS_&73HG%0(OUTL&K5#0E!=REL1EAZ5.#2%/0@FX!1G80(2[SH0
M@W!6&!!:.N40%"G0W8D-+IR=NB3ICXJ(MXS=T"+,S=#W42>)E#G-Y#7;O0Z]
M*T%%[]POPWS.7O1Z^/,EP@Q#-I0^7@  (*";C H !) $K'PTVX>>1?A[8)FA
M^*-,GV$"# ".BM@)X+[TDE$0@!Q&TH\L'\+PZZ +Z4*O(F%4$% 3"W$3Z*O<
M"/H*DQ4?4$9!"L^2A+\.H[F0*H%0+(@>'OO31*#=:NPO/T(>1$E"LBK<1Q@,
M 4A/H1XMR(>*'[20\JPH*0Q/'RJ B,VMAQS@T,-]8$KC2QV[(S$D_X$VY&_,
M?>82*P%,9AA)F!\H^LA(!Y"TD\,?&G02@ &@H8C&%?T[:S\ '!@Q+C7O&_/"
M.\X:4JA*'0@K1NT^BE( F0#[2 N1YN(23C#MG)! NA2*,XV.K(I5SH$<;#2:
M11R(A+\V">4/ 5 ,*C..5964-*Q5V6*P(%HNE3)%*]-#*RUE33S+3&DK%=$O
M?8Q,EM)BP5 KW6([6HC7P$ $X(=UF;N37EVKB-=-+??!5]&JJM@4%$@%6'+2
MCT0==*"QR"H8 6)]%*A(9)4MR"H? D3W6/X"WD?,-"J:5P D;QM9NGU.IG+%
M %JD4MMHYLDQ#16V*],M/2&;)\Z ;Q(HJ__M!%+$@0"-B'#"*=VD>60QIV3V
MVX^D,]?B=NLE$4;(I 9"6B,[[(B^PO)1021ZH"'$KRK#FL?F?ZG@S3TNBX++
M."$G7:BH*H]>)NB/%L%R%P<:Y$6%ZJ)CC<LC]-D%+#=5P&DWL",O2!@ @)"9
M"AT9;[+-A2PH$_&4?44[2<C8 4 'E-!&R8_C]F$\-[SU!  G90K*"K:W<U/[
M]1=E-VBNQ@X+8#:V<>)RU-[SZ^NL18CK>Q]>7*:2-SZAJ2(L?0JQ@_FA,N*=
MG0,?VK;UHXBK_'+O*X)=/[(-4D3'A8XV$]S2_,;M(=YV"V4PG6429@5Q"!H]
MM-"FY;"-6IO;AVO_9 *@ZA$$@#+11QC2LY#D*5 HY1N>3'[FO=+9RDV:^=GI
MTK<Z>J@@#@0TEJ\6$0 UN$DZ)-R',M2GO#+AI51W>9W@HN<^#U(O/[Q P.X
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M2C^TAFVV3VIDXA3W(R(J,AAC2ALSQ0\8*1?+AAEAZ']02267,)1(L2P($D&
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MP>,1[<\P1T@<4X']((?X6;;WQF4IC?_X +%/X*XBBHSLTR=,!8  ::+MVP6
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M[_K) )L$L@- &B)4?1%1ZZ-"U"AS=J2U:SU)Y8A;D8Y5&*E5]22+3%7BE$<
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M)(8=!PD@ISVA+%:_3=O@>D.7ZJVT?UN$4I$AGF0'%7B1$)$P)K8/AM@^B
MF5*$)S4LC"T$P[E'E_6<?RM:MV4*2S2,/<806QF=>6#9W?]E%CC^X! *G@U<
M2*=AXC%FC1-AI8E,%/-@#,G)!RUH"X0)8?D2W4UZ+5MQCSU^R4<&7V$U57@B
M.TDB! V:%XKP,*K!83KKE[JXNRYI8^;(Y3Z./RX6PP3)XIAPXEI=VS*N-Z5=
MXX&]Y?@[$>:8BP.3X@3VP!=\6M_E'W2Y.\T1&A60'>:UHX,0G8-8AV7VG*C5
M8$)NBQ !9S-^VE7>8\DP8/15Y)C890[)X%IDM]80@*/+2WZAC?P[)'K>BG%F
M#>4@ST)@K5Z>G^J\YLJ]E!/9D'_FBD)6B34&3,146:H;1'IP7#IS9^7MEXHB
M-@"@(3:+B3W,'-B(B$4&7ZT-RSS_"5?#J.D&+1$1P=WH 6IZ#HM'YFB@0(;P
M&%J4KF$5.  8T(')8 L">UBJKN;L..H*#NKU4>/H"!$L%9\]IFJ)YN4\=HOL
M:5N>-NO@&5R<]NDDX<>D/<)C6F94S0%R>A?$  ^":PC')8[_(6MX#92KIA,
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MB)0&>V$#U[A(M]%+ER<1G9#2HA,$9,YN#O%:0P[U@&0FQ0_AZ>7J $DBR1P
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M#>-04X%6\P8ERET0<N 2*CK?#\G8PPC7@<[^#2O\ ",JR:6VYY>F*,I\L8V
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M0^"[>S.$GKR[]HNT!7+'B-TW=>L:ES<O"/V!](*[WI^^OUA?)/G[A*EX_5H
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MI1##S_6+3_D1L?H/PD-\U^(9 @!;;Q(_(_X.L3]@?VLP)+37P4OE+Q)]\K^
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MHR# "Y&%<J.U"(MDDS9+FHP7N1T@4JO[4SX/.<#1ZKXJL@L'R#Z)"[Q]T,
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MZ),5>:P@>A0%:T53FIC H')5"L&!1-J9T;\"5I,S6B0 GEG#+,%10"T!B4C
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M2))D29KD2:)D2JKD/@0$ #M02P$"% ,4    "  O1X%:>UM:YY"\ 0 ?E0X
M$0              @ $     9&-T:"TR,#(U,#0P,2YH=&U02P$"% ,4
M"  O1X%:>*V$#9\!  ": P  $0              @ &_O $ 9&-T:"TR,#(U
M,#0P,2YX<V102P$"% ,4    "  O1X%:3'ZLF_],   @4@  %
M    @ &-O@$ 9&-T:"TR,#(U,#0P,5]G,2YJ<&=02P$"% ,4    "  O1X%:
M4$!A^:'G  #&YP  %0              @ &^"P( 9&-T:"TR,#(U,#0P,5]G
M,3 N9VEF4$L! A0#%     @ +T>!6K@M$O![]P  I/<  !4
M ( !DO," &1C=&@M,C R-3 T,#%?9S$Q+F=I9E!+ 0(4 Q0    ( "]'@5H!
MG=*XFP<  "@(   4              "  4#K P!D8W1H+3(P,C4P-# Q7V<R
M+FIP9U!+ 0(4 Q0    ( "]'@5J\+Z>]#P8  * &   4              "
M 0WS P!D8W1H+3(P,C4P-# Q7V<S+FIP9U!+ 0(4 Q0    ( "]'@5JB'=Z]
M^P,  *$$   4              "  4[Y P!D8W1H+3(P,C4P-# Q7V<T+FIP
M9U!+ 0(4 Q0    ( "]'@5J)OOJ\Q00  %P%   4              "  7O]
M P!D8W1H+3(P,C4P-# Q7V<U+FIP9U!+ 0(4 Q0    ( "]'@5H$+.CR4 ,
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F+3(P,C4P-# Q7V<Y+F=I9E!+!08     #0 - %8#   *\08    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>dcth-20250401_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dcth-20250401.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872912</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType contextRef="c-1" id="f-2">DEF 14A</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-3">0000872912</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-4">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">Delcath Systems, Inc.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-5">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-6">&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.023%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pay Versus Performance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Table&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total for PEO &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;to PEO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2) (5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Table&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total for Non-PEO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;NEOs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1) (2)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Actually Paid to&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Non-PEO NEOs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1) (2) (6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value of Initial Fixed&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;$100&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Investment Based On&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shareholder Return &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net Income (Loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(h)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,876,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,386,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,520,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,154,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,109,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,678,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,508,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-7" unitRef="usd">2157414</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-8" unitRef="usd">4876184</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-9" unitRef="usd">1009355</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-10" unitRef="usd">2000353</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-11" unitRef="usd">152.79</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="0" id="f-12" unitRef="usd">-26386000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-13" unitRef="usd">2520314</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-14" unitRef="usd">2154023</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-15" unitRef="usd">1109506</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-16" unitRef="usd">952501</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-17" unitRef="usd">52.79</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-2" decimals="0" id="f-18" unitRef="usd">-47678000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-19" unitRef="usd">1472198</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-20" unitRef="usd">-188099</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-21" unitRef="usd">770916</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-22" unitRef="usd">266160</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-23" unitRef="usd">45.69</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="0" id="f-24" unitRef="usd">-36508000</us-gaap:NetIncomeLoss>
    <ecd:Additional402vDisclosureTextBlock contextRef="c-1" id="f-25">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;We are a smaller reporting company pursuant to Rule 405 of the Securities Act and as such, we are only required to include information for the past three fiscal years in the table. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;The dollar amounts reported in column (b) are the amounts of total compensation reported for our PEO for each corresponding year in the &#x201c;Total&#x201d; column of the Summary Compensation Table above and in the Summary Compensation Table as disclosed in the proxy statements for the applicable years.&lt;/span&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;The dollar amounts reported in column (d) represent the average of the amounts reported for the Non-PEO NEOs as a group for each corresponding year in the &#x201c;Total&#x201d; column of the Summary Compensation Table above and in the Summary Compensation Table as disclosed in the proxy statements for the applicable years.&lt;/span&gt;&lt;/div&gt;Cumulative Total Shareholder Return (&#x201c;TSR&#x201d;) represents the return on a fixed investment of $100 in our Common Stock for the period beginning on the last trading day of 2021 through the last trading day of the applicable fiscal year.The dollar amounts reported represent the amount of net loss reflected in the Company&#x2019;s audited financial statements for the year ended December&#160;31, 2024.</ecd:Additional402vDisclosureTextBlock>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-26">For each of the three years presented in the above table, Gerard Michel was our Principal Executive Officer (&#x201c;PEO&#x201d;). Our Non-PEO Named Executive Officers (&#x201c;Non-PEO NEOs&#x201d;) were (i) Vojislav Vukovic and Martha Rook in 2024, (ii) John Purpura, M.S. and Kevin Muir in 2023, and (iii) John Purpura, M.S. and Johnny John in 2022.</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-1" id="f-27">Gerard Michel</ecd:PeoName>
    <ecd:PeoName contextRef="c-3" id="f-28">Gerard Michel</ecd:PeoName>
    <ecd:PeoName contextRef="c-2" id="f-29">Gerard Michel</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-30">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;) to our PEO has been computed in accordance with Item 402(v) of Regulation S-K under the Exchange Act and does not reflect the actual amount of compensation earned by or paid to our PEO during 2024. The dollar amounts reported in column (c) for 2024 represent total compensation as reflected in the above Summary Compensation Table for 2024, adjusted as follows: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;PEO&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Summary Compensation Table Totals for PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,157,414&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Additions (Subtractions) for Equity Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Stock and Option Award Values Reported in the Summary Compensation Table for the Covered Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,230,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Fair Value at Year-End of Outstanding and Unvested Equity Awards Granted in the Covered Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,155,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;886,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Covered Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;570,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Covered Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;336,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid to PEO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;4,876,184&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-31" unitRef="usd">2157414</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-4" decimals="0" id="f-32" unitRef="usd">-1230036</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-5" decimals="0" id="f-33" unitRef="usd">2155053</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-6" decimals="0" id="f-34" unitRef="usd">886243</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-7" decimals="0" id="f-35" unitRef="usd">570777</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-8" decimals="0" id="f-36" unitRef="usd">336733</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-9" decimals="0" id="f-37" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-10" decimals="0" id="f-38" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-39" unitRef="usd">4876184</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-40">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;The following adjustments were made to average total compensation for the Non-PEO NEOs as a group for 2024 to determine the Compensation Actually Paid, using the same methodology described above in Note 5: &lt;/span&gt;&lt;div style="margin-top:6pt;padding-right:-4.5pt;text-align:center;text-indent:-9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-PEO NEOs&lt;br/&gt;(Average)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Summary Compensation Table Totals for Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1,009,355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Additions (Subtractions) for Equity Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Stock and Option Award Values Reported in the Summary Compensation Table for the Covered Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(427,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Average Fair Value at Year-End of Outstanding and Unvested Equity Awards Granted in the Covered Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;829,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Average Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;243,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Covered Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;216,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Average Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Covered Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;128,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid to Non-PEO NEOs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,000,353&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-41" unitRef="usd">1009355</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-11" decimals="0" id="f-42" unitRef="usd">-427819</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-12" decimals="0" id="f-43" unitRef="usd">829850</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-13" decimals="0" id="f-44" unitRef="usd">243666</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-14" decimals="0" id="f-45" unitRef="usd">216393</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-15" decimals="0" id="f-46" unitRef="usd">128908</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-16" decimals="0" id="f-47" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-17" decimals="0" id="f-48" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-49" unitRef="usd">2000353</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-50">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following graph sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company&#x2019;s cumulative TSR over the three most recently completed fiscal years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;img alt="3050" src="dcth-20250401_g7.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;l&lt;/span&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-51">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Compensation Actually Paid and Net Income (Loss) &lt;/span&gt;&lt;/div&gt;We commercially launched the HEPZATO KIT in January 2024 and prior to that we incurred expenses related to completing the FOCUS clinical trial and preparing for commercialization of the HEPZATO KIT. We have incurred net losses during the periods presented. Consequently, we have not looked to our net loss as a performance measure for our executive compensation program. Moreover, we do not believe there is any meaningful relationship between our net loss and Compensation Actually Paid to our named executive officers during the periods presented.</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="c-1" id="f-54">From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has granted new-hire option awards on or soon after certain new hire&#x2019;s employment start date and annual employee option grants in the first quarter of each fiscal year. Annual grants are typically approved at the regularly scheduled meeting of the Compensation Committee occurring in such quarter. The Company&#x2019;s typical practice is to grant annual employee stock options shortly after the date in which the options are approved. Also, non-employee directors receive grants of annual stock option awards at the time of each annual meeting of the Company&#x2019;s stockholders pursuant to our non-employee director compensation program, as further described under the heading, &#x201c;Non-Employee Director Compensation&#x201d; above. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The Board and the Compensation Committee generally do not take material nonpublic information (&#x201c;MNPI&#x201d;) into account when determining the timing of awards and do not seek to time the award of stock options in relation to the Company&#x2019;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="c-1" id="f-53">From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has granted new-hire option awards on or soon after certain new hire&#x2019;s employment start date and annual employee option grants in the first quarter of each fiscal year. Annual grants are typically approved at the regularly scheduled meeting of the Compensation Committee occurring in such quarter. The Company&#x2019;s typical practice is to grant annual employee stock options shortly after the date in which the options are approved. Also, non-employee directors receive grants of annual stock option awards at the time of each annual meeting of the Company&#x2019;s stockholders pursuant to our non-employee director compensation program, as further described under the heading, &#x201c;Non-Employee Director Compensation&#x201d; above. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The Board and the Compensation Committee generally do not take material nonpublic information (&#x201c;MNPI&#x201d;) into account when determining the timing of awards and do not seek to time the award of stock options in relation to the Company&#x2019;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="c-1" id="f-52">From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has granted new-hire option awards on or soon after certain new hire&#x2019;s employment start date and annual employee option grants in the first quarter of each fiscal year. Annual grants are typically approved at the regularly scheduled meeting of the Compensation Committee occurring in such quarter. The Company&#x2019;s typical practice is to grant annual employee stock options shortly after the date in which the options are approved. Also, non-employee directors receive grants of annual stock option awards at the time of each annual meeting of the Company&#x2019;s stockholders pursuant to our non-employee director compensation program, as further described under the heading, &#x201c;Non-Employee Director Compensation&#x201d; above. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The Board and the Compensation Committee generally do not take material nonpublic information (&#x201c;MNPI&#x201d;) into account when determining the timing of awards and do not seek to time the award of stock options in relation to the Company&#x2019;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="c-1" id="f-55">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="c-1" id="f-56">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="c-1" id="f-57">false</ecd:MnpiDiscTimedForCompValFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
